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vi SUMMARY 
This  study  addressed  the  immimo-epidemiology  of  Schistosoma  haematobium  in  people 
living  in  communities  in  Zimbabwe  with  distinct  patterns  of  prevalence  and  intensity  of 
infection.  The  studies  were  located  at  three  different  areas  within  known  endemic  regions 
of  the  country.  The  two  areas  located  in  The  Burma  Valley  were  within  10  krn  of  one 
another.  One  was  designated  a  Low  Transmission  (LT)  area  and  the  other  a  fligh 
Transmission  (HT)  area.  In  these  two  localities,  the  immunological  stýdies  were'centred 
on  the  cellular  immune  responses.  Levels  of  cellular  proliferation  of  peripheral  blood 
mononuclear  cells  (PBMC)  in  response  to  specific  (schistosome)  antigen  stimulation 
were  measured  from  both  school  children  and  adults  (age  range  5-  64)  in  each  area 
(Chapter  2),  while  cytokine  production  by  PBMC  was  investigated  on  a  smaller  cohort 
of  school  children  aged  7-16  years  from  each  area  (Chapter  2).  T  cell  clones  were 
derived  from  PBMC  collected  from  two  infected  and  two  uninfected  children  from  the 
High  Transmission  area  (Chapter  3).  This  aspect  of  the  study  attempted  to  establish  if 
any  T  helper  cell  dichotomy  existed  during  human  S.  haematobium  infection  by  defining 
the  cytokine  phenotypes  of  the  clones  derived  from  the  PBMC.  The  longer  term  aim  was 
to  assess  the  potential  predictive  value  of  T  cell  clones  in  determining  resistance  or 
susceptibility  to  infection,  and  thus  contribute  towards  a  rationale  strategy  for  vaccine 
development.  'Me  third  area  of  the  study  was  in  an  endemic  region  with  very  high 
S.  haematobium  and  low  S.  mansoni  infection.  This  study  focused  on  pre-school  children 
two  to  six  years  old  (Chapter  4)  and  examined  the  impact  of  repeated  chemotherapy  with 
praziquantel.  'Me  children  were  followed  up  for  14  months,  with  praziquantel  treatment 
at  each  examination  point,  every  eight  weeks.  The  main  aim  was  to  prevent  the 
development  of  any  schistosome  egg  laying  stages,  thereby  providing  the  opportunity  for 
the  protective  immunity  to  develop  in  the  absence  of  any  pathological  consequences 
arising  from  the  eggs.  Ile  study  reports  on  the  antibody  isotype  profiles  in  sera  collected 
at  each  follow-up  point  during  the  14  months  of  the  study. 
The  cellular  immune  responses  of  the  PBMC  collected  ftom.  residents  in  the  two  areas  of 
Low  and  High  Transmission  in  the  Burma  VaHey  showed  contrasting  features  before 
treatment.  After  stimulation  with  S.  haeniatobium  worm  and  egg  antigens,  the  PBMC 
from  infected  individuals  from  the  Low  Transmission  area  gave  high  levels  of 
vii proliferation  indicating  possible  experience  of  the  parasite  while  the  uninfected 
individuals  gave  very  low  levels  of  responses  indicating  lack  of  exposure,  a  consequence 
of  the  low  transmission  in  this  area.  Similar  patterns  were  observed  from  the  PBMC 
collected  from  the  same  individuals  after  treatment,  with  those  who  were  reinfected 
giving  high  levels  of  Proliferation  to  specific  antigen  stimulation.  The  levels  of 
proliferation  correlated  positively  with  infection  for  the  individuals  living  in  the  Low 
Transmission  area,  suggesting  the  possible  existence  of  an  acute  phase  of  S  haematobium 
infection  in  people  in  this  area  as  uninfected  children  begin  to  have  their  first  exposures 
to  infection. 
The  PBMC  from  individuals  living  in  the  High  Transmission  area  showed  different 
patterns  of  responses  from  the  individuals  in  the  Low  Transmission  area.  Before 
treatment,  the  PBMC  from  uninfected  individuals  gave  high  levels  of  response  to  specific 
S-haematobium  worm  and  egg  antigen  stimulation,  and  in  the  infected  individuals,  who 
had  very  high  infection  intensities,  the  cellular  responses  showed  unresponsiveness  to 
antigenic  stimulation.  However,  after  treatment,  the  responses  were  reversed  with  the 
PBMC  from  infected  individuals  giving  higher  levels  of  proliferation  than  the  PBMC 
from  uninfected  individuals.  There  was  an  overall  increase  in  response  levels  of  the 
PBMC  collected  after  treatment  when  compared  to  PBMC  collected  before  treatment. 
The  high  levels  of  response  of  the  PBMC  collected  from  uninfected  individuals  indicated 
the  role  played  by  experience  of  infection. 
T'he  study  on  cytokine  profiles  produced  by  the  PBMC  after  five  days  of  incubation  with 
S.  haematobium  antigens  showed  that  the  production  of  cytokines  is  in  some  way  a 
fimction  of  transmission,  and  could  be  related  to  experience  of  infection,  exposure  over  a 
long  duration  and  the  development  of  full  immune  responses.  Individuals  from  the  High 
Transmission  area  produced  high  levels  of  all  the  cytokines  measured:  IL-4,  IL-5 
, 
IL,  10 
and  IFN-y.  Before  treatment,  the  PBMC  from  infected  individuals  from  the  High 
Transmission  area  gave  low  levels  of  proliferation  but  high  levels  of  cytokine  production. 
After  treatment,  the  PBMC  from  infected  individuals  gave  high  levels  of  proliferation  and 
low  levels  of  ILA  IL,  5  and  IL-10  cytokine  production.  The  uninfected  individuals 
produced  high  levels  of  IL-4,  IL-5  and  IL-10  when  compared  with  the  infected 
counterparts  in  that  area,  after  treatment.  The  cytokine  profiles  showed  that  IFN-y  is 
associated  with  infection,  and  its  levels  were  high  in  infected  individuals  regardless  of 
viii area.  However  IFN-y  levels  could  not  be  related  to  susceptibility  and  it  was  concluded 
that  IFN-y'may  be  produced  rapidly  and  abundantly  during  the  early  stages  of  infection. 
The  other  cytokines  (IL-4,  IL-5  and  IL-10)  had  different  patterns  when  compared  to 
IFN-y.  High  production  of  IL-4,  IL,  5  and  IL-  10  by  PBMC  from  infected  individuals  was 
observed  at  the  start  of  the  study,  i.  e.  before  treatment  but  the  levels  were  later  observed 
to  be  high  in  the  individuals  who*  were  uninfected  after  treatment.  Before  treatment,  the 
infected  individuals  had  high  levels  of  infection  and  cytokine  production  (IFN-y,  IL-4, 
IL,  5  and  IL-10).  When  considering  the  ratios  of  the  cytokines  in  relation  to  their 
purported  Thl  and  Th2  classification;  before  treatment  the  ratios  of  the  cytokines  IL- 
4:  IFN-y  and  IL-5:  IFN-y  were  similar  in  the  infected  and  uninfected  individuals  from  the 
High  Transmission  area.  The  IL-10:  IFN-y  ratio  indicated  a  high  production  of  IL-10  by 
the  PBMC  from  uninfected  individuals  from  the  High  Transmission  area.  After  treatment 
the  ratios  indicated  that  there  was  high  production  of  IL-4,  IIL,  5  and  IL-10  relative  to 
EFN-y  by  the  PBMC  from  the  uninfected  individuals. 
The  'signature'  cytokines  for  Thl/Th2  subsets  were  not  as  polarized  as  the  classification 
of  cytokine  profiles  reported  in  murine  models.  The  clones  derived  from  both  infected 
and  uninfected  children  from  the  High  Transmission  area  produced  a  mixture  of  the 
'signature'  cytokines  believed  to  mark  distinct  murine  T  cell  subsets.  As  a  consequence, 
an  alternative  classification  different  to  that  reported  for  murine  models  of 
schistosomiaisis  was  constructed.  Most  of  the  clones  could  be  classified  as  either  ThO/I 
and  ThO/2  depending  on  the  ratios  of  the  'signature'  cytokines,  IL,  -4:  IFN-y  and  H-,  - 
5:  IFN-y.  The  results  from  this  aspect  of  the  study  support  the  inference  that  none  of  the 
cytokines  could  be  related  to  susceptibility  to  infection  but  that  they  play  different  roles 
during  infection  and  may  possibly  be  produced  at  different  stages  of  infection  with  some 
even  persisting  after  elimination  of  infection.  However,  the  study  also  showed  that  a 
cytokine  environment  that  is  dominated  by  IL-4  and  IL,  5  has  the  ability  to  protect  the 
individuals  from  infection  possibly  due  to  involvement  of  these  cytokines  in  driving  the 
ADCC  and  the  Immoral  arm  of  the  immune  response  which  may  serve  a  key  role  in 
eliminating  invading  infection.  The  raised  IFN-,  y  levels  could  be  inferred  to  be  useful 
possibly  in  driving  the  cellular  mobilisation  of  the  responses  during  early  infection  with 
the  failure  to  develop  a  110/2  cytokine  response  exposing  the  individuals  to  continued 
infection. 
ix Young  children  below  six.  years  old  have  been  found  to  be  at  high  risk  of  becoming 
infected  with  S.  haematobium  in  the  Madziwa  area  of  Zimbabwe.  Provision  of  treatment 
every  eight  weeks  played  an  essential  role  in  preventing  any  further  infection  that  could 
have  contributed  to  the  development  of  pathology.  But  frequent  treatment  could  also 
influence  the  development  of  protective  immune  responses  to  infection.  The  antibody 
isotypes  measured  (IgA,  IgE,  IgGl,  IgG2,  IgG3,  IgG4  and  IgM)  showed  little  change 
within  the  14  months  follow-up  period.  This  could  be  due  to  lack  of  maturation  in  the 
immune  responses  in  these  children.  However,  frequent  treatment  could  be  extremely 
helpful  in  areas  of  high  transmission  where  children  could  be  infected  even  at  a  very 
young  age.  Since  vaccines  for  schistosomiasis  are  not  yet  available  chemotherapy 
remains  the  key  method  of  controlling  the  damaging  effects  of  the  infection  in  children 
whose  specific  immune  defence  has  yet  to  develop  and  mature. 
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xxii CHAPTER  1 
LITERATURE  REVIEW 1.1  GENERAL  INTRODUCTION 
Schistosomiasis  or  bilharzia  is  an  important  parasitic  disease  and  a  major  health  problem 
for  many  tropical  and  sub-tropical  countries  where  hyperendemic  areas  are  frequently 
documented  (larotski  and  Davis,  1981;  Doumenge  et  aL,  1987).  The  Egyptians  were 
aware  of  the  disease  in  ancient  times  as  evidenced  from  hieroglyphic  depiction,  but  it  was 
not  until  1851  that  Tbeodor  Bilharz,  documented  the  disease  in  Egypt  in  the  residents 
along  the  Nile  river.  The  first  schistosome,  to  be  described  was  Schistosoma 
haematobjum,  discovered  in  the  veins  of  a  man  at  autopsy  in  Cairo  by  the  German 
surgeon  Theodor  Bilharz  in  1851  and  described  in  1852  (Rollinson  and  Southgate, 
1987).  Elucidation  of  the  schistosome  life  cycle  was  not  made  until  1913  when  Mayairi 
and  Suzuki  showed  that  Schistosoma  japonicum  developed  in  the  hydrobid  snail 
Oncomelonia  hupensis  nosophora  (Roffinson  and  Southgate,  1987). 
Over  300  million  people  are  infected  with  schistosomiasis  world-VAde  and  an  estimated 
500,000  deaths  per  year  are  reported  (Rollinson  and  Simpson,  1987;  Bergquist,  1995). 
Currently  it  is  thought  that  about  600  million  people  are  at  risk  of  contracting  the 
infection  (Doumenge  et  aL,  1987).  The  disease  ranks  fifth  on  the  list  of  the  most 
important  diseases  in  developing  countries  in  terms  of  morbidity  and  mortality 
(Stephenson,  1987).  Signs  and  symptoms  include  anaemia,  diaffhoea,  abdominal  pain 
and  haernaturia.  In  Zimbabwe  schistosomiasis  is  predominant  in  the  agricultural  and  rural 
areas  with  about  3  miUion  infected  and  another  3  million  suspected  of  harbouring  or 
being  exposed  to  the  disease.  In  most  agricultural  and  rural  areas  of  Zimbabwe, 
schistosomiasis  ranks,  after  malaria,  the  second  most  important  cause  of  hospital 
attendance  (Ndhlovu,  1994),  which  is  an  indication  of  its  public  health  importance. 
I Transmission  of  schistosomiasis  has  always  been  associated  with  poor  socio-economic 
conditions.  Co-ordinated  integrated  control  strategies  often  make  little  impact  due  to 
causes  such  as  escalating  social  unrest  caused  by  war,  droughts,  floods  and  the  effects  of 
man-made  water  resources  development  projects  (Hunter  et  al.,  1982).  Increasing 
population  density  has  led  to  wide-spread  development  of  large-  and  small-scale 
irrigation  schemes  that  increase  the  potential  for  transmission.  In  most  cases  these 
irrigation  schemes  are  not  designed  to  combat  the  proliferation  of  the  snail  intermediate 
hosts. 
Five  schistosome  species  commonly  infect  humans,  Schistosoma  haematobium, 
S.  mansoni,  S.  japonicum,  S.  intercalatum  and  S.  mekongi,  while  S.  mattheei  is  known  to 
occasionally  infect  man.  In  Affica,  S.  haematobium  and  S.  mansoni  are  widely  distributed, 
while  S.  intercalatum  is  confined  to  North  East  Zaire,  Gabon,  Cameroon  and  Congo, 
with  some  isolated  reports  indicating  the  possible  e)dstence  of  endemic  foci  in  Central 
Africa  Republic,  Chad,  Nigeria,  Upper  Volta  and  other  parts  of  Central  and  West  Affica 
(Iarotski  and  Davis,  1981;  Doumenge  et  aL,  1987).  In  Zimbabwe  S.  haematobium  and 
S-mansoni  are  both  present,  the  former  being  widely  distributed  (Taylor  and  Makura, 
1985;  Ndhlovu  et  aL,  1996).  Snail  vectors  of  S.  haematobium  and  S.  mansoni  in 
Zimbabwe  are  Bulinus  globosus  and  Biomphalaria  pfeifferi  respectively.  B.  globosus  is 
known  to  have  high  rates  of  natural  increase,  survival  and  reproduction  in  both  stable 
and  unstable  water  bodies.  B.  pfeifferi  on  the  other  hand  has  a  slower  rate  of  natural 
increase  and  is  only  found  in  stable  water  bodies.  S.  haenzatobium  and  S.  mansoni  are 
most  prevalent  in  the  north  of  Zimbabwe  which  has  the  highest  rainfall,  and  where  most 
streams  and  rivers  are  perennial. 
2 1.2  TAXONONIY  AND  LIFE  CYCLE 
The  life  cycle  of  Schistosoma  is  illustrated  in  Figure  1.1.  Human  schistosomes  are 
digenetic  trematodes  (commonly  called  flukes),  are  parasites  which  live  within  the  blood 
vessels  of  humans  and  belong  to  the  family  Schistosomatoidea.  Female  and  male 
schistosome  worms  live  in  permanent  copula  in  the  mesenteric  veins  around  the  intestine 
for  S.  mansoni  and  S.  intercalatum,  and  the  bladder  for  S.  haematobium.  Ile  female 
worms  produce  about  300  -  3000  eggs  each  day.  Some  of  the  eggs  become  lodged  in 
different  tissues  of  the  host  and  induce  cellular  granulomatous  reactions,  but  the  majority 
of  the  eggs  pass  into  the  lumen  of  the  intestines  or  bladder  and  may  leave  the  hurnan  host 
either  in  urine  for  S.  haematobium  or  in  faeces  for  S.  mansoni  and  S.  intercalatuni.  When 
deposited  in  fresh  water,  the  eggs  hatch  releasing  free-swimming  larval  stages,  miracidia, 
which  May  infect  an  appropriate  snail  intermediate  host,  in  the  case  of  S.  mansoni  snails 
belonging  to  genus  Bioniphalaria  and  in  the  case  of  S.  haematobium  snails  belonging  to 
genus  Bulinus.  Asexual  multiplication  takes  place  in  the  snail  intermediate  host,  resulting 
in  the  production  and  release  of  a  large  number  of  cercariae,  which  infect  the  human  host 
by  direct  penetration  of  the  skin.  Cercariae  transform  into  schistosomula  as  they 
penetrate  the  skin.  The  schistosomula  then  migrate  to  the  peripheral  lymphatic  or 
circulatory  system  from  where  they  are  carried  passively  to  the  lungs.  After  spending 
some  time  in  the  lungs,  the  schistosomula  migrate  to  the  liver  where  growth  and  further 
development  takes  place.  After  pairing,  each  worm  pair  actively  migrates  towards  either 
the  mesenteric  veins  draining  the  intestine  (S.  mansoni,  S.  intercalatum  and  S.  japonicum) 
or  the  bladder  and  ureters  (S.  haematobium).  The  whole  life  cycle  takes  6-  12  weeks.  In 
their  definitive  sites,  adult  worms  generally  live  for  3-8  years  but  have  been  reported  to 
survive  up  to  30  years  (Vermund,  Bradley  and  Ruiz-Tiben,  1983;  Harris,  Russel  and 
Charters,  1984;  Wilkins  et  al.,  1984b). 
3 1.3  PATHOLOGY 
1.3.1  IWASION 
Schistosomiasis  begins  with  penetration  of  the  skin  by  cercariae.  Awareness  of  the  event 
is  usually  minimal  on  initial  exposure.  Pruritis  and  local  erythema  may  occur  within  15 
minutes  to  2-3  hours  of  penetration  in  the  case  of  multiple  exposure.  Sometimes  in 
sensitised  individuals  within  5-  15  hours  post-entry  a  local  dermatitis  occurs.  A  wide 
variety  of  clinical  manifestations,  even  exfoliation  may  also  occur.  Tissue  oederna  with 
mononuclear  celIs  are  observable  on  histological  examination  (Feldmeier  et  aL,  1985a, 
1986).  People  with  experimental  acute  dermatological  reactions  have  been  described  as 
having  high  titres  of  IgE  and  IgG  antibodies  (Capron  et  aL,  1977;  'Joseph  et  aL,  1978; 
Anwar  et  al.,  1979  and  Santoro  et  aL,  1979). 
1.3.2  MIGRATION 
When  the  parasites  are  migrating  through  the  body,  fever  and  mild  wheezing  are 
sometimes  observed.  These  events  usually  follow  extremely  heavy  re-exposures  to 
schistosomes.  Chest  X-rays  at  this  time  have  shown  pulmonary  infiltrates  with 
eosinophilia  (PEI)  syndrome,  7-  10  days  after  initial  exposure.  Patients  with  PEI  usually 
manifest  a  peripheral  blood  eosinophilia.  Studies  in  primates  and  mice  have  indicated  that 
schistosomes  migrating  through  the  lung  are  associated  with  accumulations  of  significant 
numbers  of  mononuclear  cells.  These  cells  include  macrophages  that  are  involved  in 
production  of  high  levels  of  IFN-y  associated  with  early  infections  during  the  lung  stage 
of  migration.  A  number  of  parasites  are  trapped  in  the  lungs  where  they  are  destroyed. 
Some  evidence  suggests  that  much  of  this  destructive  process  is  mediated  through 
antibody-dependent  cell-mediated  cytotoxicity-(ADCC)  mechanisms  involving  a  variety 
of  immunoglobulin  isotypes  and  effector  cell  subpopulations  of  macrophages  and 
4 cosinophils  (Butterworth  et  al.,  1974;  Dean,  1977;  Ellner  and  Mahmoud,  1979).  The 
cells  involved  are  eosinophils,  mononuclear  macrophages  and  platelets,  and  can  cause 
damage  to  the  migrating  schistosomula  (Capron  et  aL,  1977;  Joseph  et  aL,  1978,1983; 
Sturrock  et  aL,  1981).  During  the  same  migratory  period,  it  has  been  reported  that  there 
is  an  elevated  amount  of  IFN-y  cytokines  production  in  the  lungs  (Wilson  et  aL,  1996). 
1.3.3  ESTABLISHED  INFECTIONS 
As  far  as  is known  live  adult  worms  have  little  or no  pathogenic  effect  on  the  definitive 
host  (Butterworth  et  aL,  1990)  and  chronic  disease  is  largely  attributed  to  the  deposition 
of  eggs  in  the  tissues,  with  granuloma  formation  and  subsequent  fibrosis.  The  adult 
worms  do  not  replicate  within  the  marnmalian  host  and  the  extent  of  the  disease  depends 
in  part  on  the  number  of  eggs  that  are  deposited  in  the  tissues,  which  in  turn  depends  on 
the  number  of  adult  worms  that  are  present,  their  egg-laying  capacity  and  their  longevity 
within  the  host  (Hagan,  1987).  Host  genetic  and  immimological  factors  also  play  a  role  in 
determining  the  level  of  pathology  ensuing  from  infection. 
Several  hundred  to  several  thousand  ova  are  produced  daily.  Of  these  approximately  half 
migrate  through  either  the  intestine  or  the  bladder  viscera  depending  upon  species.  Tle 
rest  settle  in  the  liver  and  other  organs,  where  they  induce  inflamm  tion  and  organ 
damage  (Weinstock,  1992).  When  the  eggs  are  deposited  in  organs  or  tissue,  the  host 
mounts  a  characteristic  focal  inflammatory  reaction  that  surrounds  the  eggs;  the 
granuloma.  ne  granuloma  eliminates  toxic  and  antigenic  materials  released  from  the 
eggs  and  may  kill  the  eggs  and  eliminate  the  egg  debris  (Feldmeier  et  al.,  1985a,  1986; 
Wyler,  1992;  Weinstock,  1992).  Since  the  worms  continuously  produce  more  eggs,  the 
5 recurrent  cycle  of  organ  injury  and  repair  leads  to  organ  damage  (Weinstock,  1992; 
Wyler,  1992). 
Tle  major  disease  manifestations  of  schistosomiasis  are  similar  for  S.  mansoni  and 
S.  japonicum  with  regard  to  liver  damage.  Ova  deposited  in  the  portal  areas  result  in 
portal  fibrosis,  phlebitis  and  periphlebitis  (De  Cock,  1987).  Sometimes  the  deposited 
eggs  can  lead  to  portal  hypertension,  which  causes  splenomegaly,  ascites  and 
oesophageal  and  gastric  varices.  T'he  liver  then  becomes  hard  and  nodular  on  palpation 
(Feldmeier  et  aL,  1985a,  1986).  Weinstock  (1992)  also  reported  that  bleeding 
oesophageal  varices  are  the  major  cause  of  death.  Other  symptoms  common  to  intestinal 
schistosomiasis  include  intermittent  diarrhoea,  which  can  contain  mucous  and  blood. 
This  results  from  egg-induced  inflammation  of  the  intestine.  Sometimes  when  the  disease 
is  in  an  advanced  state,  there  is  portal  systemic  shunting  which  allows  eggs  to  embolize 
to  the  lungs  and  other  organs. 
In  contrast  to  intestinal  schistosomiasis,  the  symptomatic  stage  of  chronic 
S.  haematobium  manifests  as  haematuria,  frequent  micturation  and  dysuria.  These 
symptoms  are  indicative  of  egg  deposition  which  results  in  inflammation  and  ulceration  in 
the  bladder  mucosa.  An  injured  bladder  usually  has  permanent  fibrosis,  pseudopolyps  and 
sometimes  neurogenic  dysfimction.  The  ureters  are  often  involved,  leading  to  ureteral 
obstruction,  hydronephrosis  and  renal  failure  (Al-Shukri  and  Olwan,  1983).  Sometimes 
the  brain,  lungs  and  spinal  cord  are  involved  which  in  these  severe  cases  leads  to 
considerable  morbidity.  When  eggs  are  deposited  in  the  skin,  symptoms  of  perineal 
itching  and  lesions  occur  (Feldmeier  et  al.,  1985a,  b,  1986). 
6 1.4  CURRENT  CONTROL  MEASURES 
Schistosomiasis  is  one  of  the  most  widespread  parasitic  diseases  of  man  and  is  currently 
endemic  in  75  countries  of  the  world  (WHO  report,  1985).  Over  the  past  few  years  the 
disease  has  invaded  some  new  areas  such  as  Richard  Toll  in  Senegal  as  a  result  of 
economic  developments;  in  this  case  the  building  of  the  Manantali  Dam  on  the  Senegal 
river.  With  the  development  of  man  made  water  projects  the  disease  may  increase  in 
other  areas.  Theoretically;  control  seems  possible  but  in  practical  terms  it  is  impossible 
without  the  participation  of  the  people  in  the  affected  areas  and  their  governments.  In 
most  developing  countries  where  this  disease  is  a  problem  the  continued  existence  of  the 
diseases  has  been  attributed  to  the  availability  and  permanence  of  surface  fresh  water  and 
warm  climate.  Both  are  crucial  to  the  development  of  large  intermediate  host  snail 
populations.  Also  important  is  human  water  contact  behaviour.  Ile  best  control 
strategies  have  been  documented  as  those  which  involve  a  co-ordinated  approach  that 
includes  control  of  the  intermediate  snail  host  by  environmental  methods  and 
molluscicides,  chemotherapy,  improved  sanitation  and  ultimately  health  education.  But  in 
my  view  the  lack  of  a  vaccine  is  a  major  drawback  to  any  plausible  control  strategy. 
Since  with  the  availability  of  vaccines,  control  can  easily  be  instituted  by  a  single  or  a  few 
doses,  eliminating  the  problems  faced  with  other  methods  of  schistosomiasis  control. 
1.4.1  DRUGS 
Safe  and  effective  drugs  for  treatment  -  oxamniquine,  metrifonate  and  praziquantel  - 
have  been  available  for  more  than  two  decades.  Ile  mainstay  of  control,  at  present,  is 
repeated  mass  or  targeted  chemotherapy.  This  is  effective,  but  is  expensive  in  both  drug 
costs  and  the  need  for  skilled  manpower  in  the  diagnosis  and  delivery  of  treatment.  This 
has  been  attempted  in  Kenya  by  Butterworth  et  aL,  (1984,1985);  The  Gambia  by 
7 Wilkins  et  aL,  (1987b)  and  in  Bra2il  by  Machado  (1982).  Repeated  mass  treatment  is 
extremely  expensive  where  high  rates  of  reinfection  of  young  children  occur  after 
chemotherapeutic  cure.  Such  reinfection  requires  treatment  at  frequent  intervals  and  long 
term  fimding  is  therefore  needed  but  is  usually  unavailable.  Alternative  approaches  are 
desirable  in  the  long  term,  among  which,  the  development  of  a  vaccine  must  be 
considered  as  an  essential  goal. 
1.4.2  INTERMEDIATE  HOST  CONTROL 
Intermediate  host  control  by  mollusciciding  has  on  many  occasions  had  limited  effects 
and  has  been  found  to  be  extremely  expensive  where  large  water  bodies  are  concerned 
and  unorganised  water  contact  points  are  involved  (Liese,  1986;  Fenwick,  1987;  Klumpp 
and  Chu,  1987).  In  Zimbabwe,  a  number  of  control  programmes  have  been  in  operation 
for  about  10  years.  The  strategy  which  has  been  adopted  is  a  community  based  approach 
integrated  in  the  primary  health  care  system  (Taylor,  1986),  where  treatment  is  free  to  all 
those  who  are  infected  and  present  themselves  at  clinics  i.  e.  passive  case  detection.  Also, 
some  biological  control  has  been  implemented  with  extracts  from  plant  berries  from 
Phytolacca  dodencandra  (Ndamba  et  aL,  1994).  Although  communities  are  involved  in 
growing  the  plants  and  application  of  the  berries  at  the  water  contact  points  offers  a 
potential  cost  reduction  on  other  approaches,  some  financial  inputs  are  essential  for  such 
programmes  to  successfidly  take  ofý  and  trained  personnel  are  required  for  initial 
training  of  the  community,  as  over-application  of  the  plant  molluscicide  into  water  bodies 
can  result  in  killing  all  water  fauna.  Ile  use  of  other  chemicals  like  Bayliscide  and  copper 
sulphate  are  deterrently  expensive  for  the  developing  countries.  In  most  epidemiological 
settings  control  of  the  intermediate  host  alone  cannot  be  successful  in  regulating  infection 
S and  disease  without  involving  other  aspects  of  parasite  transmission  stages,  including  the 
deposition  of  eggs  into  water  bodies  (Evans,  1983). 
1.4.3  HEALTH  EDUCATION  AND  SANITATION 
Health  education  has  been  considered  to  be  an  essential  component  in  controlling 
diseases  of  public  health  importance  including  schistosomiasis  (Teesdale,  1986).  Since 
the  life-cycle  of  the  schistosome  involves  an  intermediate  host  which  survives  in  fresh 
water,  and  the  introduction  of  eggs  into  the  water  involves  inadequate  control  of  sewage 
pollution  or  insanitary  habits,  interventions  can  be  designed  to  tackle  these  aspects  of  the 
life-cycle.  In  some  areas  where  schistosomiasis  is  still  endemic,  little  or  nothing  has  been 
done  in  domestic  water  and  sanitation  improvement  which  is  considered  as  the  main 
source  of  maintaining  the  continuation  of  the  cycle.  Water  for  domestic  use  has  not  been 
decontaminated,  and  water  pipe  systems  have  not  been  introduced,  although  in  some 
rural  areas  safe  drinking  water  has  been  provided  by  construction  of  deep  protected  wells 
and  boreholes.  Such  control  systems  are  possibly  the  most  effective  measures,  but 
implementation  of  such  expensive  programs  suffers  from  a  lack  of  adequate  resources 
and  not  infrequently  from  insufficient  long  term  government  commitment  (Liese,  1986; 
FenwiCk,  1987;  Klumpp  and  Chu,  1987). 
Ile  availability  of  surface  water  with  temperatures  favourable  to  intermediate  snail 
survival  is  compounded  by  the  behaviour  of  young  children  with  heavy  infections.  They 
contribute  most  to  contamination  of  the  environment  by  indiscriminate  defaecation  and 
micturation  in  and  around  the  water  bodies.  Even  after  education  on  the  benefits  of 
sanitary  facilities  and  the  provision  of  some  clean  water  supplies,  communities  show 
some  reluctance  to  stop  the  tradition  of  using  natural  water  bodies.  While  children,  and 
9 some  adults,  continue  contaminating  these  water  bodies  by  indiscriminate  excretion,  such 
activities  make  it  virtually  impossible  to  combat  schistosomiasis  through  sanitation, 
public  health  awareness  and  education.  Efforts  are  thus  being  made  to  develop  control 
methods  that  can  combat  the  diseases  even  though  continued  contact  with  water  occurs. 
Perhaps  the  most  significant  would  be  a  vaccine. 
1.5  SCIIISTOSOMIASIS  EPIDEMIOLOGY 
1.5.1  AGE-PREVALENCE/INTENSITY  CURVE 
Age-specific  intensity  curves  for  communities  in  schistosomiasis  endemic  areas  show  a 
sharp  rise  in  mean  intensity  of  infection,  from  the  time  of  first  exposure  during  early 
childhood,  until  early  in  the  second  decade  of  life  (Butterworth  et  aL,  1984,1985). 
Intensity  of  infection  nonnally  then  declines  progressively  with  age  (Hagan,  1987;  Hagan 
et  aL,  1987),  although  there  is  some  evidence  for  a  rapid  worm  elimination  in  people  in 
some  foci.  Wilkins  and  Scott,  (1978)  showed  from  studies  in  The  Gambia  apparent  rapid 
declines  in  infection.  There  is  no  firm  evidence  of  rapid  worm  elimination  being 
accompanied  by  a  solid  resistance  to  reinfection,  as  seen  in  many  other  infectious 
diseases.  Ile  slow  decline  in  intensity  of  infection  during  adult  life  rt-ýight  be  attributed  to 
a  slow  spontaneous  death  of  adult  worms,  together  with  a  slowly  acquired  immunity  to 
super-infection.  However,  the  decline  might  also  be  attributed  to  the  slow  death  of  adult 
worms,  a  reduced  exposure  to  contaminated  water  in  the  older  age  groups,  alterations  in 
the  fecundity  of  adult  worms  and  to  the  capacity  of  eggs  to  escape  into  the  faeces  and 
urine  (Butterworth  et  aL,  1984,1985;  Hagan,  1987;  Hagan  et  aL,  1987). 
10 There  is  evidence  that  some  patients  resist  reinfection  after  treatment  in  spite  of  high 
levels  of  observed  contact  with  water  known  to  contain  infected  snails  (Wilkins  et  aL, 
1984a,  b,  1987;  Hagan  et  al.,  1987;  Butterworth  et  al.,  1987,1992;  Dessein  et  aL,  1992). 
In  such  patients  the  resistance  to  reinfection  is  attributed  to  immunological  factors  of  the 
host  (Hagan  et  aL,  1991;  Butterworth  et  al.,  1992;  Roberts  et  aL,  1993).  Such  resistance 
appears  to  be  an  acquired,  age-dependent  event,  which  appears  to  be  greater  in  children 
over  10  years  old  and  increases  thereafter  (Hagan  et  al.,  1991,1994). 
The  convex  age-prevalence  curve  of  schistosomiasis  in  human  populations  may  in  part  be 
the  result  of  exposure  patterns,  but  age-dependent  acquired  resistance  to  infection  is  now 
considered  an  important  factor.  Correlation  studies  have  indicated  a  role  for  IgG4,  IgM 
and  IgG2  blocking  antibodies  in  maintaining  the  continued  susceptibility  of  young 
children  and  of  IgE,  IgGI  and  IgA  antibodies  in  mediating  protection  in  older 
individuals.  These  studies  were  undertaken  by  Hagan  and  colleagues  (1987)  on 
S.  haematobium  in  The  Gambia  and  by  Dessein  et  al.,  (1992)  on  S.  mansoni  in  Brazil  with 
similar  conclusions.  Following  treatment,  the  extent  to  which  reinfection  subsequently 
occurs  is  strongly  dependent  upon  age.  In  conditions  of  continued  transmission,  young 
children  become  reinfected  rapidly.  In  some  cases  intensities  of  infection  as  reflected  by 
egg  excretion  in  urine  or  faeces,  may  reach  50  %  of  pre-treatment  levels  within  one  year. 
In  contrast,  older  children  and  adults  become  reinfected  only  at  very  low  intensities. 
Interestingly,  although  reinfection  intensities  were  reported  to  reach  a  peak  in  children 
aged  8-  12  years,  peak  water  contact  is  at  16  to  24  years.  Butterworth  et  aL,  (1985, 
1987)  attributed  the  lack  of  reinfection  in  adults  to  previous  experience  of  infections 
which  resulted  in  an  acquired  immunity.  Some  workers  do  not  exclude  age-dependent 
physiological  changes  but,  generally,  the  development  of  resistance  appears  to  be  age- 
11 dependent  in  that  a  long  period  of  exposure  to  repeated  challenges  seem  to  be  necessary 
for  the  full  development  of  resistance.  Two  main  factors  that  influenced  infection 
intensities  in  reinfection  studies  have  been  reported  as  water  contact  levels  and  the  age  of 
the  exposed  individuals  (Wiffdns  et  aL,  1984a,  b;  Hagan,  1987;  Chandiwana,  Woolhouse 
and  Bradley,  199  1). 
1.5.2  REINFECTION  AND  MODELLING  STUDIES 
Butterworth  et  aL,  (1984)  were  the  first  to  use  a  reinfection  study  design  where 
chemotherapy  was  used  to  remove  pre-existing  infections.  With  this  design  it  is  possible 
to  examine  levels  of  newly  acquired  infection  and  to  relate  this  to  levels  of  observed 
exposure.  If  levels  of  reinfection  cannot  be  related  to  exposure,  then  some  other  factors, 
such  as  immunological  resistance  may  be  fimctioning.  A  reinfection  study  design, 
involving  all  age  groups,  was  carried  out  in  The  Gambia  where  the  relationship  between 
infection  intensities  and  exposure  was  studied.  An  index  of  exposure  was  determined 
which  made  assumptions  about  the  effects  of  different  types  of  contact  on  likelihood  of 
acquiring  infection.  The  principle  assumption  was  that  the  number  of  cercariae  which 
penetrate  during  water  contact  is  proportional  to  the  product  of  exposure  time,  cercarial 
density  and  cumulative  exposure  of  infection  of  each  individual  and  is  proportional  to  the 
sum  of  these  products  (Wflkins  et  aL,  1984a,  b;  Hagan,  1987;  Butterworth  et  al.,  1987; 
Chandiwana,  1987b).  Ile  study  design  used  in  The  Gambia  added  to  an  understanding 
of  the  re-infection  intensity  patterns  at  the  population  level  and  established  a  potential 
role  for  protective  immunity,  leading  to  the  hypothesis  that  protective  immunity 
gradually  develops  in  most  endemic  communities  (Willdns  et  aL,  1987;  Hagan  et  aL, 
1987  and  Butterworth  et  al.,  1987).  Confirmation  of  the  validity  of  this  approach  came 
from  a  study  of  school  children  in  Kenya,  where  some  children  with  low  exposure  and 
12 high  levels  of  reinfection  were  identified  as  susceptibles  and  those  with  high  exposure  but 
low  levels  of  reinfection  were  classified  as  resistant  (Sturrock  et  aL,  1983;  Butterworth 
etaL,  1984,1985,1992). 
Given  that  protective  immunity  appears  to  develop  slowly  with  time  in  communities  in 
endemic  areas,  it  has  been  hypothesised  that  the  development  of  immunity  is  in  part 
dependent  on  repeated  exposure  to  infection  and  therefore  that  in  areas  of  intense 
transmission  immunity  may  develop  more  quickly  than  in  areas  of  lower  levels  of 
transmission  (Hagan  et  aL,  1994).  Woolhouse  et  aL,  (1991)  in  a  Zimbabwean  study  of 
school  children  analysed  17  data  sets  for  S.  haematobium  infection.  A  significant  negative 
correlation  between  the  peak  prevalence  of  infection  and  the  age  of  peak  prevalence  was 
shown.  The  results  were  interpreted  in  the  light  of  The  Gambian,  Kenyan,  and  Brazilian 
fbidings  on  the  epidemiological  effects  of  acquired  immunity.  It  is  now  considered  that  in 
areas  of  intense  transmission  the  peak  intensity  of  infection  is  reached  earlier  and 
consequently  the  decline  in  infection  resulting  from  the  development  of  acquired 
immunity  begins  earlier,  this  has  been  refeffed  to  as  'peak  shift'  by  Woolhouse  and 
colleagues  (1991)  in  Zimbabwean  pupils  living  in  an  endemic  areas  of  S.  haematohium. 
The  peak  shift  has  been  interpreted  as  giving  indirect  evidence  for  development  of  an 
acquired  immunity  in  different  areas  with  different  levels  of  S.  haematobiunz  infection. 
Mathematical  modelling  of  the  epidemiology  and  control  of  infection,  transmission  and 
morbidity  could  play  an  important  role  in  evaluation  of  the  immunological,  genetic,  water 
exposure  and  other  factors  which  may  deterrnine  resistance  and  susceptibility  to  infection 
and  also  in  allowing  those  responsible  for  schistosomiasis  control  programmes  to 
investigate  the  likely  outcome  of  alternative  intervention  strategies  (Woolhouse,  1991, 
13 1992).  One  variable  that  has  been  little  explored  in  modelling  studies,  to  date,  is  the 
possible  importance  of  variability  amongst  human  in  their  genetic  predisposition  to 
infection  (Dessein  et  aL,  1992).  The  importance  of  this  possibility  has  been  highlighted 
by  a  recent  family  study  of  schistosomiasis  in  Brazilians  by  Marquet  et  aL,  (1996).  'Me 
group  identified  the  host  genetic  region  (5q31-q33)  that  may  determine  an  individual's 
resistance  or  susceptibility  to  infection.  This  genetic  region  contains  loci  that  encode  the 
cytokines  IL-3,  IL-4,  IL-5,  GM-CSF  and  IL-13  (Boulay  and  PauL  1992a,  b,  1993; 
Marquet  et  aL,  1996). 
1.6  SCHISTOSOMIASIS  DISTRIBUTION  IN  ZIMBABWE 
Studies  carried  out  by  Taylor  and  Makura  (1985)  as  part  of  a  national  schistosomiasis 
survey  categorised  the  country  into  regions  of  different  prevalence  and  intensities.  Ile 
data  were  collected  from  14,619  school  children  in  157  schools  throughout  the  country 
for  S.  haematobium  and  S.  mansoni. 
Ile  major  factors  affecting  the  distribution  and  prevalence  of  schistosomiasis  in 
Zimbabwe  were  the  availability  and  permanence  of  surface  fresh  water  which  is  essential 
for  the  development  of  high  snail  population  densities  (Clarke  and  SW  1968;  Shiff, 
1975,1979;  Hustings,  1983).  Also  important  was  the  poorly  developed  safe  water 
supplies  for  domestic  use  in  some  areas  which  results  in  an  increase  in  human  water 
contact  which  in  turn  influences  the  amount  of  contamination  and  incidence  of  infection. 
Schistosomiasis  distribution  was  also  partly  determined  by  environmental  factors; 
temperature  and  rainfall,  which  vary  according  to  local  geographical  area  and  in  turn. 
affect  the  snail  population  and  amount  of  human  water  contact  (Chandiwana  and 
Christensen,  1988).  From  the  studies  cited  above  and  that  of  Chandiwana  (1987a,  b), 
14 endemicity  of  schistosomiasis,  was  found  to  be  closely  related  to  availability  of  surface 
water.  In  the  nortb-east  of  Zimbabwe  the  Mgb  rainfall  and  soil  type  result  in  most  streams 
and  rivers,  being  perennial  even  in  drought  years,  hence  highest  prevalences  of 
S.  haenzatobiunz  and  S.  mansoni  were  found  there.  In  the  south-east,  rainfafl  is  generaUy 
lower  and  only  the  major  rivers  are  permanent  and  perennial.  In  the  west  and  south  a 
combination  of  low  rahifall  and  sandy  soil  leads  to  even  the  major  rivers  drying  up,  with 
water  remaining  only  in  some  reservoirs.  Since  schistosomiasis  is  a  disease  which  has  a 
very  focal  transmission,  Aithin  any  endemic  zone  some  specific  areas  may  have  a  higher 
or  lower  prevalence  than  might  be  expected  due  to  some  local  factors.  Transmission  is 
highly  seasonal  over  most  of  Zimbabwe,  with  two  peak  transmission  seasons  March  to 
May  and  September  to  November,  with  the  exceptions  of  the  Zambezi  vaHey  in  the  north 
and  the  south-east  where,  due  to  warmer  conditions  and  perennial  water,  seasonality  may 
be  less  marked  (Shiff  et  aL,  1975,  Chandiwana,  Christensen  and  Frandsen,  1987). 
Zimbabwe  has  an  active  schistosomiasis  control  programme  in  the  irrigation  schemes  and 
in  some  recreational  areas  and  over  the  past  few  years  it  has  adopted  a  national 
schistosomiasis  control  strategy  based  on  cbemotherapy  and  community-based  action 
programmes  on  sanitation,  water  supplies,  snail  control  and  health  education. 
1.7  THE  NEED  FORVACCINES  AND  POSSIBLE  VACCINE  CANDIDATES 
Reports  on  the  development  of  partial  immunity  make  it  logical  to  attempt  vaccination 
but,  apart  from  experimental  vaccines  for  animal  use,  vaccine  development  has  yet  to  be 
successful  (Capron  ef  al.,  1987;  Butterworth  el  al.,  1992;  Dessein  el  al.,  1992;  Ha-gan, 
1992;  Wilson  199.  )).  There  is  now  a  range  of  prornising  vaccine  candidates  which  are  on 
trial  awaiting  confirmation  of  their  efficacy  in  liuman  subjects  (Table  1.1).  Most  of  the 
vaccine  trials  in  animal  models  have  reported  significant  degrees  of  protection  expressed 
15 as  the  reduction  of  the  number  of  adult  worms  in  comparison  to  non-vaccinated  controls 
after  a  standard  cercarial  challenge.  In  some  studies,  injection  into  experimental  animals 
of  live  schistosomula  attenuated  by  sub-lethal  doses  of  radiation  resulted  in  high  levels  of 
resistance  to  a  subsequent  challenge.  This  might  depend  on  the  exposure  of  particular 
epitopes,  or  might  reflect  an  improved  antigen  presentation  due  to  slow  passage  of  the 
irradiated  parasites  through  the  lymph  node  and  lungs.  While  the  potential  for 
undesirable  pathological  effects  makes  an  attenuated  vaccine  unlikely,  it  provides  a  useful 
model  system  for  examining  mechanisms  of  resistance.  Nevertheless  most  current  interest 
lies  in  the  development  of  recombinant  "peptide"  vaccines  and  DNA  vaccines 
(Butterworth,  1990;  Capron,  1994;  Bergquist,  1995;  Dunne,  Abath  and  Hagan,  1995). 
In  developing  schistosome  vaccines,  S.  mansoni  has  been  the  easiest  species  to  be 
maintained  in  the  laboratory  away  from  endemic  areas  and  thus  most  progress  has  been 
made  with  this  parasite.  Several  antigens  identified  in  S.  mansoni  have  been  found  to  have 
homologues  in  other  schistosome  species,  for  example  glutathione  S-transferase  (GST) 
(Capron  et  al.,  1987,1994).  Two  larval  surface  molecules  are  glyceraldehyde  phosphate 
dehydrogenase  (GAPDH),  and  a  22kDa  antigen  recognised  by  IgE  antibodies  in  adult 
worm  preparations  (Goudot-Crozel  et  aL,  1989  and  Dunne  et  aL,  1992).  Immunological 
findings  by  Dunne  et  aL,  (1992)  on  Kenyan  patients  attributed  the  lack  of  subsequent 
reinfection  to  the  22  kDa  molecule. 
Several  biologically  active  molecules  including  the  GST  isoenzymes  (Capron  et  aL, 
1992;  Bushara  et  aL,  1994),  GAPDH  (Goudot-Crozel  et  aL,  1989)  and  the  glycolytic 
enzyme,  triose  phosphate  isomerase  (TPI)  (Reynolds,  Shoemaker  and  Ham,  1992; 
Reynolds  et  aL,  1994)  have  been  shown  to  induce  partial  protection  in  several 
16 experimental  animals.  S.  mansoni  28kDa  GST  confers  partial  protection  in  several  animal 
species  including  patas,  monkeys  (Boulager  et  aL,  (1995),  while  the  26  kDa  isoenzyme 
has  been  used  in  studies  on  S.  japonicum  (Henkle  et  aL,  1990;  Bashir  et  al.,  1994).  Much 
effort  has  been  applied  to  circumvent  the  problem  of  undesirable  side  effects  by  use  of 
synthetic  peptides  with  isolated  epitopes  (Reynolds,  Shoemaker  and  Ham,  1992; 
Reynolds  et  aL,  1994;  Ham  et  aL,  1995).  Some  myofibrilIar  proteins,  such  as  paramyosin 
are  also  being  investigated  as  potential  vaccine  candidates  (Bergquist,  1995). 
As  the  adult  worms  evade  immune  attack,  studies  have  focused  on  the  apparently  more 
vulnerable  larval  stage.  Schistosomula  membrane  epitopes  are  also  expressed  on  the 
adult  worm  tegument  in  which  an  array  of  antigens  ranging  from  8  kDa  to  more  than  200 
kDa  have  been  identified  (Grzych  et  aL,  1984;  Soisson  et  aL,  1992).  Important 
schistosomula.  antigens  include  Sm23  (Reynolds,  Shoemaker  and  Ham,  1992)  and  Sm38 
(Grzych  et  aL,  1984,1985),  but  the  simultaneous  elicitation  of  blocking  antibodies  has 
ruled  out-the  use  of  Sm38.  SmIO  has  been  reported  to  be  of  great  interest  due  to 
production  of  strong  T  cell  responses  in  subjects  already  sensitised  by  natural  infection 
(Couissinier-Paris  and  Dessein,  1995). 
17 Table  1.1:  Summary  of  Schistosome  vaccine  candidates: 
Size  Claimed  protection  (%) 
Identity  of  antigen  Da  Stage  Function  Mouse  Rat  Other 
Glutathione-S-  28  Schistosomula  Enzyme  30-60  40-60  40 
transferase  Adult  worms  (Baboon) 
(Sm28GST) 
Paramyosin  (Sm97)  97  Schistosomula.  Muscle  30 
Adult  worms  protein 
Irradiation-associated  62  All  stages  Muscle  50-70  95  25 
vaccine  antigen(IrV-5)  protein  (Baboon) 
Triose-phosphate  28  All  stages  Enzyme  30-60 
isomerase  (TPI) 
Sm23  23  All  stages  Membrane  40-50 
antigen 
Fatty  acid  binding  14  Schistosomula.  Membrane  65  90-100 
protein  (FABP)-14  antigen  (outbred)  Rabbit) 
(Sml4) 
Adapted  from:  Bergquist,  N.  R.  (1995).  Controlling  Schistosomiasis  by  Vaccination:  A 
Realistic  Option?  Parasitology  Today,  11  (5),  191-194. 
1.7.1  SCHISTOSOME  ANTIGENS  AND  L%IMUNO-DIAGNOSIS 
'The  search  for  possible  vaccine  candidates  and  an  easier  methodology  for 
odiagnosis  has  aided  in  the  identification  of  antigens  which  preferentially  stimulate 
particular  arms  of  the  immune  response.  Tle  egg  antigens  are  known  to  play  a  major  role 
in  pathogenesis  of  schistosomiasis  (Dunne  et  aL,  1987,1988;  Dunne  and  Doenhoff, 
1983;  Doenhoff  et  al.,  1993).  Several  groups  have  prepared  and  characterised  S.  mansoni 
antigens  which  have  allowed  the  differentiation  between  acute  and  chronic  infections 
(McLaren  et  al.,  1978,1981,  Hillyer  and  Pacheco,  1979).  HiRyer  and  Pacheco  (1986) 
managed  to  isolate  and  characterise  specific  S.  haematobium  egg  antigens  which  share 
epitopes  with  an  adult  worm  antigen.  Some  workers,  Simpson  et  aL,  (1985)  and  Kelly, 
(1987),  were  able  to  characterise  S.  haematobium  scbistosomula  antigens.  Haytmga  et 
aL,  (1986)  and  Trottein  et  al.,  (1992)  also  studied  adult  S.  haematobium  antigens  and 
managed  to  clone  glutathione  S-transferase  which  has  been  suggested  as  a  potential 
vaccine  candidate.  Most  of  the  antigens  so  far  identified  are  known  to  cross-react  with 
schistosomula  antigens  of  other  Schistosoma  species.  Some  major  circulating 
18 glycoprotein  antigens  associated  with  the  schistosome  gut  have  been  identified  as 
circulating  cathodic  antigen  (CCA)  and  circulating  anodic  antigen  (CAA).  They  are  now 
used  in  sero-  epidemiological  diagnosis  (Deelder  et  aL,  1989;  De  Jonge  et  al.,  1989a,  b, 
1990;  Gryseels  et  al.,  1994;  NdhIovu  et  aL,  1995).  Ile  CCA  and  CAA  antigens  are 
genus-specific  and  are  extremely  useful  in  distinguishing  present  and  past  infections  and 
in  estimating  worm  burdens  (Gryseels  et  aL;  1995),  although  the  method  cannot 
substitute  for  conventional  egg  counts  which  has  always  been  used  to  estimate  the  worm 
burdens. 
1.8  EVASION  OF  THE  IMMUNE  RESPONSE  BY  ADULT  WORMS 
The  adult  worms  of  a  primary  infection  are  capable  of  surviving  for  long  periods,  some 
are  believed  to  survive  for  up  to  30  years  or  more,  yet  the  host  develops  immunity  to 
super-infection,  thereby  allowing  the  opportunity  for  prolonged  transmission  of  the 
parasite  (Butterworth  and  Hagan,  1987).  Ilere  are  many  mechanisms  whereby  the  adult 
worm  and  the  schistosomulum  evade  the  immune  response  in  immune  competent 
individuals.  Uptake  by  the  developing  schistosomulum  of  a  range  of  host  molecules 
parallels  the  loss  of  susceptibility  of  the  worm  to  a  variety  of  immune  effector 
mechanisms  (McLaren,  Clegg  and  Smithers,  1975;  McLaren  and  Terry,  1982;  Smithers, 
McLaren  and  Clegg,  1985).  Host  molecules  that  may  be  on  the  worms'  surface  include 
blood  group  substances,  such  as  glycolipids,  that  are  expressed  on  the  red  blood  cell 
surface  (Butterworth,  1990).  Studies  by  Butterworth  et  aL,  (1982),  McLaren  and  Incani 
(1982),  McLaren  and  Terry  (1982)  and  Smithers,  McLaren  and  Clegg  (1985)  indicated 
that  absorbed  host  molecules  can  effectively  mask  at  least  some  parasite  determinants.  It 
was  demonstrated  that  schistosomula  recovered  from  the  lungs  of  mice  failed  to  bind, 
after  3  hours  exposure,  most  monoclonal  antibodies  raised  against  skin-phase 
19 schistosomulum  surface  antigens  as  these  had  been  masked.  However,  if  such 
schistosomula  are  subsequently  cultured  in  vitro,  binding  of  at  least  one  monoclonal 
antibody  can  be  demonstrated,  and  this  is  associated  with  a  loss  of  host-derived 
molecules  (McLaren  and  Terry,  1982;  McLaren  and  lncaný  1982). 
Some  experiments  suggested  that  there  is  an  actual  loss  of  expression  of  parasite 
antigens  from  the  outer  of  the  two  bilayers,  so  that  the  membrane  becomes 
ologically  inert  (Mazza  et  aL,  1990).  Experiments  with  monoclonal  antibodies 
further  suggest  that  different  antigens  are  lost  from  the  outer  membrane  at  different  rates. 
For  some  major  antigens,  a  rapid  loss  of  expression  occurs  within  24  to  48  hours  after 
transformation  of  the  cercaria  into  the  schistosomulum.  Other  antigens  show  a  more 
prolonged  expression,  being  detectable  on  the  surface,  with  the  appropriate  monoclonal 
antibody,  as  late  as  five  days  after  skin  penetration  (Simpson  et  al.,  1986).  New  antigens 
not  detected  on  the  skin-derived  schistosomula  may  also  be  expressed  at  this  late  stage 
(Clegg,  Smithers  and  Teny,  1971;  McLaren,  Rarnalho-Pinto  and  Smithers,  1978; 
McLaren  and  James,  1985;  Butterworth  el  aL,  1979a,  b,  c;  Butterworth,  1990,  Agnew  et 
aL,  1992).  In  addition  to  showing  a  reduced  expression  of  some  surface  antigens,  the 
tegument  of  the  developing  schistosomalum  may  become  progressively  refractory  to 
immune  attack  (Kusel  et  aL,  1975,  Payares  et  al.,  1985  and  Butterworth  1990).  This 
phase  of  reduced  intrinsic  susceptibility  to  attack  appears  to  be  limited  to  the  lung-stage 
migration. 
Another  mechanism  of  evasion  includes  the  production  by  the  parasite  of  substances  that 
actively  inhibit  host  effector  mechanisms.  Capron  et  aL,  (1982),  Capron  and  Capron 
(1986)  and  Butterworth  (1990),  have  shown  that  the  developing  schistosumula  produce 
20 and  release  at  least  two  proteases,  one  with  trypsin-like  activity.  This  protease 
production  results  in  the  cleavage  of  surface  bound  immunologlobulins,  with  a 
consequent  failure  of  ADCC  effector  mechanisms  that  depend  on  an  intact  Fc  region. 
The  action  of  the  protease  also  results  in  the  release  of  small  peptides,  such  as  the 
tripeptide  threonine-lysine-proline,  that  actively  inhibits  macrophage  cell  fimction.  Adult 
worms  can  be  demonstrated  to  release  soluble  factors  such  as  schistosome-derived 
inhibitory  factor  (SDEF),  that  inhibit  lymphocyte  fimction  and  mast  cell  degranulation 
(PhiMps  et  al.,  1978,1992;  Dessein  et  al.,  1981;  Auxiault  et  al.,  1981;  Philfips  and 
Lammic,  1986). 
1.9  IMMUNE,  MECHANISM  IN  ANIMAL  MODELS 
Much  of  the  present  knowledge  about  the  nature  and  mechanisms  of  acquired  immunity 
to  schistosomiasis  has  come  from  studies  in  a  range  of  experimental  animal  models 
(Smithers  and  Terry,  1967a,  b;  CoHey  et  aL,  1977a,  b;  Capron  et  aL,  1977,1982; 
McLaren  et  aL,  1978,1982;  Smithers  and  Gammage,  1980;  Smithers  et  aL,  1985;  Mazza 
et  al.,  1990).  It  was  observed  that  following  low  level  primary  infection  of  mice,  rats  or 
rhesus  monkeys,  adult  worms  of  the  first  infection  continued  to  survive,  while  the  host 
was  capable  of  resisting  challenge  schistosomula  of  a  secondary  infection.  This 
phenomenon  of  acquired  resistance  to  superbifection  in  the  presence  of  continued 
primary  infection  was  termed  concomitant  immunity  by  Smithers  and  Terry  (1967a,  b). 
Antibody-  and  cell-mediated  immunity  both  play  a  critical  role  in  the  protection  of 
animals  against  schistosome  infection  (Capron  et  aL,  1975,1977,1982;  Capron  and 
Capron  1986).  Eosinophils  and  monocytes  are  cytotoxic  for  opsonised  larvae,  and  this  is 
enhanced  by  cytokines  released  by  a  variety  of  cells  including  monocytes  and  T 
21 lymphocytes.  Most  studies  have  identified  the  1-4  day  larvae  as  one  of  the  major  targets 
for  protective  imnume  mechanisms.  One  day  old  larvae  exhibit  high  antigenicity  and 
vulnerability  to  immune  attack  (Clegg  and  Smithers,  197  1;  Smithers  and  Gammage  1980; 
Dessein  et  aL,  198  1). 
1.9.1  HUMORAL  RESPONSES  IN  SCHISTOSOME  IMMUNM 
Capron  and  colleagues  have  provided  useful  information  on  humoral.  responses  in 
resistance  and  susceptibility  to  S.  mansoni  infection,  particularly  in  rats,  in  which 
antibody-dependent-IgE  killing  of  the  larval  schistosomes  by  platelets,  eosinophils  and 
macrophages  seem  to  play  an  important  role  (Capron  et  aL,  1975,1977,1982,1989; 
Capron  and  Capron  1986;  Capron  et  aL,  1977,1978).  Direct  in  vivo  evidence  for  a 
major  role  for  IgE  in  protection  has  been  provided  by  passive  transfer  of  IgE  from 
immune  to  naive  animals,  (Ogilvie  et  al.,  1966;  Capron  et  aL,  1984)  and  the 
demonstration  that  IgE-suppressed  rats  have  an  enhanced  susceptibility  to  S.  mansoni 
compared  with  normal  rats  (Capron  and  Capron  1986).  The  experiments  with  IgE 
suppressed  rats  confirmed  that  IgE,  in  addition  to  its  role  in  ADCC  was  also  critical  for 
the  rapid  recruitment  of  effector  cells  and  molecules  to  the  site  of  penetration  of  the 
parasite  before  the  invading  schistosomula  becomes  refractory  to  attack  by  effector 
mechanisms.  This  function  depends  on  the  specific  stimulation  by  parasite  antigen  of 
IgE-sensitised  mast  cells,  basophils  and  monocytes  to  release  mediators  that  amplify  and 
prolong  the  immediate  reactions  into  a  later  phase.  Capron  and  Dessaint  (1992),  Capron 
et  aL,  (1987)  suggested  that  immediate  hypersensitivity  reactions  may  have  evolved  as  a 
specific  immune  defence  against  hehninth  infections. 
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L 1.9.2  CELLULAR  AND  EFFECTOR  RESPONSES 
In  vitro  studies  have  suggested  a  number  of  potential  effector  killing  mechanisms 
involving  both  cells  and  antibodies  directed  against  the  schistosomulum  stage  parasite 
(Boursum  et  al.,  1982;  James  and  Sher,  1990).  Experimental  models  of  infection  and 
vaccination  have  underlined  the  importance  of  CD4+  T  cells  in  the  induction  of  host 
responses  to  S.  mansoni  infection  Capron  and  Capron,  1986;  Sher  and  Coffinan,  1992; 
Cheever  et  aL,  1992).  Both  T  helper  I(Thl)-  and  Th2-like  cytokine  responses  have  been 
identified  in  murine  models  of  S.  mansoni  infection  (Mosmann  et  aL,  1986;  Pemberton  et 
aL,  1993,1994,1995;  RomagnanL  1992;  Wynn,  et  aL,  1994,1995,1996).  In  these 
models  Thl  mediators  have  been  linked  to  protective  responses  in  vaccination  studies, 
whereas  Th2  responses  induced  following  infection  and  the  onset  of  the  egg  laying,  are 
thought  to  contribute  to  the  development  of  pathology.  lie  importance  of  these 
fimctionally  distinct  T  cell  subsets  and  their  contribution  to  protective  immunity  have  yet 
to  be  established  in  humans.  It  is  currently  argued  that  in  mice  III  related  events  are 
associated  with  immunity  (James  and  Sher,  1990).  Some  argue  that  Th.  2-dependent 
events  which  include  eosinophil  and  IgE  production  may  also  be  important,  but  it  is  not 
clear  whether  or  not  immunity  in  humans  is  dependent  on  similar  responses  as  reported 
for  the  murine  models. 
At  the  site  of  parasite  penetration,  there  is  passive  sensitisation  similar  to  immediate 
hypersensitivity  reaction  combined  with  IgE-mediated  effector  responses  involving 
eosinophils,  macrophages  and  platelets.  Schistosome  cercariae  have  a  protease  enzyme 
which  they  secrete  aiding  their  penetration  of  the  host  skin  and  this  protease  induces  a 
dominant  Thl  type  response  in  murine  hosts.  At  the  onset  of  egg  deposition  after  worm 
maturation,  there  is  a  shift  to  a  Th2  profile.  The  switching  was  reported  to  be  triggered 
23 by  injection  of  schistosome  eggs  alone  (Sher,  1992;  Sher  and  Coffinan,  1992).  After  egg 
deposition  responses  are  pre-dominantly  of  a  T12-type  and  are  associated  with 
eosinophilia  and  IgE  production.  Much  focus  has  been  concentrated  on  the 
immunoregulatory  mechanisms  involved  in  the  events  which  the  schistosome  egg  elicits 
and  which  result  in  formation  of  the  hepatic  granulomatous  response  which  is  the  major 
cause  of  morbidity  of  schistosorniasis.  Most  reports  have  shown  that  the  primary  immune 
response  to  schistosome  eggs  is  fFN-y  production  by  cells  from  draining  lymph  nodes 
followed  by  a  Tho  (mixed)  profile  of  cytokines  (Vella  and  Pearce,  1992).  It  was  reported 
that  by  day  7-10,  IFN-y  production  is  severely  depressed,  while  IL-2  and  most  of  the 
Th2  cytokines  continued  to  be  produced.  Several  groups  have  reported  that  the 
downregulation  of  Tlil  cell  responses  is  effected  by  IL-10  released  from  the  M  cells 
(Sher  et  aL,  199  1;  VeRa  and  Pearce,  1992). 
Granuloma  formation  may  not  be  totally  dominated  by  Tb2  cytokines  and  the  immune 
modulation  that  occurs  in  chronically-infected  mice  has  been  attributed  to  continued 
IFN-y  production.  Granuloma  modulation  is  the  result  of  a  generalised  suppression  of 
cytokine  synthesis.  Thl  cell  clones  reactive  with  egg  antigens  are  capable  of  stimulating 
granuloma  formation  in  vivo  (Chikunguwo  et  aL,  1991).  TNF-cc  appears  to  act  as  a 
reproductive  or  developmental  stimulus  for  the  adult  female  worms  (Amiri  et  aL,  1992). 
1.9.3  T  HELPER  CELL  SUBSETS: 
T  helper  cefls  regulate  most  aspects  of  the  antigen-dependent  response  of  B  ceUs.  T 
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helper  cells  are  required  for  activation,  clonal  expansion,  differentiation  and  isotype 
regulation  of  B  cell  responses  to  most  antigens.  The  subsets  were  first  reported  by 
Mosmann  et  aL,  (1986).  The  lymphokine  secretion  phenotype  of  Thl.  and  Th2  clones  is 
24 stable  in  murine  models,  suggesting  that  individually  stimulated  n  cells  may  express 
only  one  phenotype.  The  Th2  supernatants  enhanced  IgE,  IgGI  and  IgA,  while  Thl 
supernatants  inhibited  IL-4  mediated  effects.  IFN-y  at  relatively  low  concentration 
completely  inhibited  IL-4-enhanced  IgE  production  and  reduced  IgGI  production.  IgE 
was  regulated  by  opposing  effects  of  two  lymphokines:  IL-4  and  IFN-y  made  by  two 
different  subsets  of  Th  cells.  These  studies  proposed  that  the  level  of  IgE  production 
during  an  immune  response  reflects  the  relative  levels  of  IL-4  and  IFN-y  to  which  the 
activated  B  cells  are  exposed  (Coffinan  et  aL,  1988;  Mosmann.  and  Coffinan,  1989), 
which  in  turn  depends  on  the  relative  numbers  or  states  of  activation  of  T111  and  Th2 
cells  of  the  appropriate  specificity.  Their  model  predicts  that  Th2  cells  will  be  helpers  for 
an  IgE  response  and  that  TIA  cells  will  act  as  isotype-specific  suppresser  cells  for  IgE 
and  at  the  same  time  may  be  acting  as  helper  cells  for  responses  of  other  isotypes. 
The  best  evidence  for  existence  of  the  subsets  comes  from  the  rat,  in  which  expression  of 
the  OX-22  marker  splits  Th  cells  into  a  fraction  containing  cells  that  produce  IL-2  (OX- 
22+)  and  another  fraction  that  produces  little  IL-2  but  transfers  most  of  the  T  helper  cell 
activity  for  B  cells  (Arthur  and  Mason  1986).  'Me  lymphokines  which  appear  to  have 
greatest  influence  on  B  cells  i.  e.  IL-2,11-4,  IL-5,  IL,  6  and  IFN-y  are  each  expressed  by 
only  one  of  the  Th  subsets;  this  implies  that  there  are  at  least  two  distinct  pathways  of  B 
cell  activation.  It  is  important  to  note  that  Coffinan  et  aL,  (1988)  found  no  cell  surface 
antigen  differences  between  the  two  groups.  Given  appropriate  conditions,  the  majority 
of  both  Thl  and  Th2  clones  can  provide  help  to  B  cells  but  the  resultant  immunoglobulin 
isotypes  produced  by  these  B  ceRs  varies  in  accordance  with  the  different  subsets. 
Evidence  supporting  the  requirement  for  Th2  was  obtained  in  animal  models  in  which 
IgE,  eosinophils  and  mast  ceRs  during  hehninth  parasite  infection  of  mice  and  rats 
25 resulted  from  elevated  levels  of  M  cytokines,  yet  non  of  these  response  occurred  in 
nude  or  thymectomised  animals. 
1.10  IMMUNITY  IN  lHJMANS 
1.10.1  HUMORALIMMUNHY 
It  is  now  known  that  all  stages  of  the  schistosome  found  in  the  definitive  host  are 
recognised  by  antibodies  (Butterworth  et  aL,  1985,1987,1992;  Hagan  et  aL,  1987, 
1991).  These  studies  have  shown  a  reciprocal  relationship  between  IgE  and  IgG4  levels 
for  S.  haematobium  and  S.  mansoni  infection.  Specific  IgE  antibodies  have  been 
suggested  as  mediators  of  protective  immunity  in  man.  Hagan  et  aL,  (1991)  working  on 
S.  haematobiuni  in  The  Gambia,  provided  the  first  convincing  evidence  that  human 
resistance  to  reinfection  is  associated  with  high  levels  of  parasite-  specific  IgE.  Some  age- 
related  trends  in  specific  IgE  levels  have  also  been  reported  from  other  studies:  Rihet  et 
al.,  (1991,1992),  Dessein  et  al.,  (1992),  Demuere  et  al.,  (1993)  for  S.  mansoni  infected 
Brazilians;  Hagi  et  aL,  (1990)  on  S.  haematobium  infected  Somalis;  Butterworth  et  al., 
(1982,1987,1988,1992)  on  S.  mansoni  infected  Kenyans  and  Ndhlovu  et  aL,  (1996)  on 
S.  haeniatobjunz  infected  Zimbabweans.  T'he  general  consensus  from  these  reports  is  that 
although  total  IgE  levels  were  high  in  all  age  groups,  anti-schisto  some  IgE  levels  were 
low  in  those  under  10  years  old  and  higher  in  10  -  19  years  old  and  above,  which  gives  a 
pattern  consistent  with  the  acquisition  of  resistance  to  infections.  Dunne  et  al.,  (1992) 
demonstrated  that  IgE  antibodies  against  a  S.  mansoni  adult  worm  preparation  correlated 
positively  with  age  and  negatively  with  reinfection,  whereas  IgE  antibodies  against  other 
life  cycle  stages  showed  either  no  relationship  or  the  reverse  correlation.  IgE  does  not 
work  in  isolation  and  hence  there  is  evidence  from  diverse  studies  highlighting  the  roles 
of  other  antibodies  which  may  be  involved  in  the  immune  defence  against  helminth 
26 infection  (Capron  and  Capron,  1986).  Some  non-specific  IgE  and  parasite-specific  IgG4 
are  also  found  in  the  infected  individuals.  The  non-specific  IgE  possibly  competes  with 
specific  IgE  to  reduce  the  risk  of  anaphylaxis  and  protect  the  host  from  the  potentially 
lethal  consequences  of  hyper-reactivity  to  parasite  antigens.  IgG4  also  plays  a  similar  role 
(Hagan  et  aL,  1991).  With  developments  of  vaccines,  it  is  anticipated  that  the  protective 
antigens  may  stimulate  protective  IgE  responses,  although  there  is  a  risk  of  inducing 
harmfid  anaphylactic  reactions  in  the  process. 
Some  antibodies  of  IgM  and  IgG  subclasses  were  reported  as  not  having  any  protective 
role  in  schistosomiasis  infections  (Ehalife  et  aL,  1986;  Butterworth  et  aL,  1987;  Dunne 
et  al.,  1987;  Hagan,  1987;  Demuere  et  aL,  1993),  but  in  another  study  IgM  has  been 
associated  with  protection  against  a  68kDa  antigen  (King  et  aL,  1988).  'Mese  antibodies 
have  been  shown  to  compete  with  IgE  and  IgA  for  attachment  to  the  schistosomuluin. 
These  antibodies  have  been  collectively  termed  blocking  antibodies.  The  blocking 
antibodies  appear  to  be  triggered  by  polysaccharide  antigens  released  from  the  eggs  (as 
reviewed  by  Hagan,  1987).  During  early  infection  blocking  antibodies  of  IgM  or 
ineffective  IgG  isotypes  predominate.  These  bind  to  carbohydrate  epitopes  on 
schistosomulum  surface  glycoproteins  (Dunne  et  al.,  1987,1992;  Dunne  1990; 
Butterworth  et  al.,  1988,1992)  thereby  blocking  the  binding  of  effective  IgGI  and  IgE 
antibodies  elicited  in  response  to  those  glycoproteins  and  thus  preventing  effective 
. 
Epidemiological  evidence  from  studies  by  Hagan  et  aL,  (199  1),  Rihet  et  aL,  (199  1)  and 
Dernuere  et  al.,  (1993)  also  suggest  that  high  levels  of  IgG4  are  associated  with  high 
levels  of  infection  and  reinfection.  In  a  study  on  S.  haematobium  in  Zimbabwe,  Ndhlovu 
27 et  al.,  (1996)  found  a  positive  coffelation  of  intensity  of  infection  with  IgG  and  IgM 
responses  to  soluble  egg  antigen  (SEA)  and  with  IgG4  to  soluble  worm  antigen  (SWA). 
Tlis  study  indicated  that  IgG4  and  IgM  may  be  associated  with  infection.  This  was  also 
reported  in  filarial  infections  where  competing  antibody  of  the  IgG4  subclass  was  also 
produced,  with  levels  particularly  high  in  the  least  resistant  individuals  (Maizels  et  aL, 
1993).  'Mus,  IgG4  is  suggested  to  block  immune  effector  mechanisms  especially  in 
children  living  in  endemic  areas  (Auriault  et  aL,  1990).  As  the  children  get  older, 
evidence  from  epidemiological  studies  cited  above  suggests  that  there  is  switching  of  the 
response  from  susceptibility  to  protective  response  in  which  there  is  a  marked  increase  in 
the  ratio  of  protective  IgE  to  blocking  IgG4  levels  and  the  children  become  immune  to 
infection. 
1.10.2  CELL  MEDIATED  IMMUNITY  AND  EFFECTOR  CELLS 
Some  myeloid  ceRs  can  interact  with  immunoglobulin-coated  foreign  ceUs  to  produce 
contact  lysis  rather  than  phagocytosis.  This  process  is  termed  antibody-dependent  cefl- 
mediated  cytotoxicity  (ADCC),  and  the  effector  cells  are  termed  killer  cells.  Antibodies 
lethal  to  schistosomula  of  S.  mansoni  have  been  described  by  several  workers  including 
those  stated  in  the  above  sections  on  murine  models.  In  vitro  experiments  have  shown 
that  ADCC  might  be  a  primary  mechanism  of  defence  against  schistosome  infection. 
Several  ADCC  killing  systems  in  vitro,  involving  basophils,  cosinophils,  neutrophils, 
macrophages  and  mast  ceUs  have  been  described  by  different  workers  (Butterworth  et 
aL,  1975,1979a,  b,  c,  Butterworth,  1984;  Butterworth  and  Richardson,  1985;  CoHey  et 
al.,  1977a,  b;  Capron  et  al.,  1975,1982,1989;  Capron  et  al.,  1984;  Anwar,  Smithers  and 
Kay,  1979;  Eflner  et  aL,  1982;  Stuffock  et  aL,  1983;  Jaffet  and  Haig,  1984;  Hagan  et  aL, 
1985a,  b;  McLaren  and  James,  1985;  Pearce  and  James,  1986  and  James  and  Sher,  1990). 
28 Furthermore,  human  epidemiological  studies  have  postulated  that  ADCC  is  involved  in 
conferring  protection  (Hagan  et  aL,  1987). 
1.10.3  T  HELPER  CELL  SUBSETS  AND  CYTOKINES 
T  lymphocytes  are  important  immunoregulatory  cells,  being  involved  in  the  activation  of 
B  ceffs  and  macrophages,  in  immune  inhibition  and  in  cytotoxicity  against  certain  targets. 
T  lymphocytes  play  an  indirect  role  in  protective  immunity  by  recruitment  of  effector 
cefls  such  as  eosinophils,  basophils,  mast  ceUs,  neutrophils  or  macrophages,  an  activity 
which  is  mediated  through  lymphokines  or  cytokines.  T  lymphocytes  have  not  been 
shown  to  directly  damage  schistosomula  in  culture  (Butterworth  et  aL,  1974),  although 
the  lymphocytes  are  stimulated  to  proliferate  and  produce  lymphokines.  Depending  on 
the  cytokine  producing  T  ceUs  and  the  type  of  cytokines,  the  immune  response  can  be 
activated  to  combat  both  microbes  and  multiceflular  pathogens. 
The  diversity  of  CD4+  T  cell  dependent  immune  responses  can  now  be  explained  after 
the  development  of  immunotechniques  in  analysing  T  lymphocytes  by  the  methods  of 
propagating  clones  from  T  cell  lines  and  assays  of  cytokines.  Activated  Thl  clones 
appear  to  induce  a  complex  set  of  responses  different  from  T12  clones  (reviewed  by 
Abbas,  Murphy  and  Sher,  1996;  Romagnaný  199  1;  Coffinan  et  al.,  199  1).  A  major  focus 
of  Thl  responses  seem  to  be  cytotoxicity,  both  cell-mediated  and  complement-mediated. 
Thl  mediate  DTH  responses  (Cher  and  Mosmann,  1987)  and  the  combination  of 
lymphotoxin  and  IFN-y  secreted  by  these  clones  is  cytotoxic  to  certain  types  of  cells  and 
can  stimulate  optimum  production  of  major  opsonising  and  complement-fixing  isotypes. 
IFN-y  activation  of  macrophages  stimulates  the  ability  of  macrophages  to  mediate  ADCC 
both  by  enhancing  the  expression  of  IgG-Fc  receptors  and  by  enhancing  the  production 
29 of  IgGI  and  IgG3,  the  ligand  for  macrophage  receptors,  leading  to  phagocytosis, 
tumouricidal  activity  and  IdIfing  of  intraceRular  parasites  (Warren  and  VogeL  1985). 
It  has  been  reported  that  each  T  ceH  subset  produces  cytokines  that  serve  as  its  own 
autocrine  growth  factor  by  promoting  the  development  of  naive  cells  into  that  subset. 
Subsets  also  produce  cytokines  that  are  cross  inhibitory  to  the  development  of  other 
subsets.  IFN-y  produced  by  III  cells,  for  example,  amplifies  Thl  development  and 
inhibits  proliferation  of  M.  As  a  result,  once  the  T  cell  response  begins  to  develop 
along  one  pathway  it  tends  to  be  polarised  in  that  direction  (Pearce  et  al.,  1991; 
Pemberton  et  al.,  1993;  Scott,  1993).  Ile  degree  of  polarisation.  of  the  T  ceRs  may 
reflect  the  state  of  antigen  stimulation  and  the  environmental  stimulation  involved  in  the 
cell  responding.  Ile  degree  of  '1111/'M2  polarisation  may  also  reflect  the  chronicity  of  the 
disease  stimulating  that  response,  especially  in  conditions  where  the  antigen  persists  and 
cannot  be  eliminated  easily,  as  reported  by  Murphy  et  aL,  (1996)  who  employed  in  vitro 
repeated  T  cell  antigenic  stimulation  to  produce  T  cells,  that  expressed  single  transgenic 
antigen  receptors,  that  led  to  increasingly  polarised  and  irreversibly  committed  "I  and 
Tb2  subsets.  The  cytokine  patterns  dominating  in  a  response  have  yet  to  be  fully 
understood,  especiaRy  when  they  have  been  produced  from  mixtures  of  cefls  in  a 
population,  such  as  from  human  PBMC  samples,  rather  than  from  T  cell  clones.  Because 
of  these  difficulties,  some  reports  have  settled  on  defining  responses  as  Thl-like  and 
Tb2-Uke. 
The  fimctions  of  CD4+  T  cells  are  mediated  through  intimate  interaction  with  other  cells 
in  which  the  T  cell  recognises  cell  surface  molecules  on  the  APCs.  The  figand  for  the  T 
cell  receptor  (TCR)  is  MHC  molecule  with  an  antigen  peptide  bound  into  a  specialised 
30 groove.  Interaction  of  B7  on  the  cell  mdace  of  the  APC  with  CD28  on  the  T  ceR 
provides  a  costimulatory  signal  that  has  received  considerable  attention  (Linsley  et  aL, 
199  1).  Activated  CD4+  T  cells  can  stimulate  both  macrophages  and  B  cells.  To  achieve  B 
ceH  activation,  the  T  cell  provides  two  types  of  stimulL  induced  cell  surface  ligands  and 
soluble  cytokines.  The  interaction  of  the  T  cell  associated  ligand  with  B  cells  results  in 
activation  of  the  B  cell  and  endows  it  with  the  capacity  to  proliferate  in  response  to 
soluble  cytokines  also  produced  by  the  T  cells  (B  anchereau  et  aL,  199  1;  Banchereau  and 
Rousset,  1991).  Ilese  signals  are  also  important  in  the  process  of  immimoglobulin  class 
switching,  the  mechanism  through  which  antibodies  of  classes  other  than  IgM  are 
produced.  According  to  current  available  information,  only  Th2  clones  enhance  secretion 
of  IgG1  and  IgE,  either  by  causing  selective  proliferation  or  maturation  of  B  cells  already 
committed  to  IgGI  or  IgE  production  or  increasing  the  frequency  with  which  B  ceRs 
switch  to  the  expression  of  those  isotypes  (Coffi-nan  et  al.,  1988;  King  and  Nutman,  1993; 
King,  Low  and  Nutman,  1993;  Cheever  et  al.,  1994) 
A  few  studies  have  investigated  cytokine  secretion  during  human  schistosomiasis,  the 
majority  of  the  reports  are  on  S.  mansoni  infections  (Viana  et  al.,  1994;  Williams  et  aL, 
1994;  Couissinier  and  Dessein,  1995;  Araujo  et  al.,  1996),  while  very  few  studies  have 
been  reported  on  S.  haematobium  infection  (Grogan  et  aL,  1996;  King  et  al.,  1996).  Tle 
Th  I  and  112  responses  in  relation  to  resistance  to  infection  and  reinfection  have  not  been 
defined  in  humans  to  the  same  extent  as  in  experimental  animal  models.  However,  the 
extensive  studies  in  animal  models  have  provided  useffil  pointers  toward  the  types  of  the 
immune  responses  that  might  be  protective  in  humans.  The  animal  models  differ  quite 
markedly  from  each  other  in  both  the  extent  and  the  nature  of  the  protective  immune 
responses.  None  of  these  animal  models  can  be  considered  to  mimic  the  situation  in 
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bý humans  in  all  respects  (Colley  et  aL,  1986;  Mosmann  and  Coffman,  1989;  Auriault  et  al., 
1990,1996;  Rebeiro  de  Jesus  et  aL,  1993;  Pemberton  et  al.,  1994). 
It  has  become  of  interest  to  know  if  Thl.  and  T12  CD4+  T  cells  could  be  identified  in 
schistosomiasis  patients.  Studies  of  cloned  T  cells  in  vitro  from  schistosome-infected 
humans  did  not  fit  into  the  Thl/Th2  mould  leading  to  proposition  that  there  are  110  cells 
which  only  differentiate  into  M  and  Th2  upon  prolonged  in  vitro  culture  (Couissinier 
and  Dessein,  1995).  Various  groups  have  attempted  to  determine  if  human  T  cells  fit  into 
this  Thl/Th2  dichotomy  using  cytokine  profiles  from  leukocytes  (Roberts  et  aL,  1993; 
Wflliams  et  aL,  1994;  Grogan  et  al.,  1996).  To  date  there  is  little  evidence  to  support  this 
concept,  with  many  groups  reporting  T  ceRs  producing  IL-2,  IL-4,  IL-5,  IL-6  ,  IL-10 
and  IEFN-y.  TIle  lack  of  confirmation  of  the  ThI/'M2  concept  in  human  schistosomiasis 
may  suggest  that  the  observed  differences  in  the  cytokine  production  in  the  mouse  are 
more  likely  to  mark  the  differences  between  murine  models  and  humans  (Romagnaniý 
1991,1992;  Cousinier  and  Dessein,  1995).  More  work  is  essential  in  this  area  on  human 
schistosomiasis  from  different  transmission  areas  in  endemic  zones  and  on  different 
schistosome  species. 
The  T  cefl-derived  cytokines  are  produced  afler  an  intimate  interaction  of  APC  (which 
can  be  B  ceffs)  and  the  antigen-  specific  T  cefl.  For  IL-4  production,  Poo  et  aL,  (1988) 
showed  that  the  induced  cytokine  is  secreted  directionaUy  toward  the  ceH  that  has 
presented  the  antigen.  Ile  cytokines  produced  by  the  T  cefls  are  concentrated  in  the 
small  spaces  between  the  two  interacting  cells.  Cells  in  the  general  enviroment  of  the 
CD4+  T  cells  that  are  not  participating  in  the  interactions  with  the  T  cells  are  likely  to  be 
exposed  to  little  or  no  cytokine.  This  accounts  for  the  high  degree  of  specificity  of 
32 cytokine-mediated  help.  IL-4,  IL-5,  IL-6  and  IL-10  are  particularly  noted  for  their  action 
on  B  cells.  IL-4  acts  as  costimulant  of  B  cell  growth  (Banchereau  et  al.,  1991;  Williams 
et  al.,  1994),  controlling  immunoglobulin  class  switching  of  the  B  cells  expressing  IgM 
to  two  isotypes,  IgG4  and  IgE.  In  humans  it  has  been  shown  that  both  H,  4  and  its  close 
family  members,  e.  g.  IL-13,  can  cause  immunoglobulin  class  switching  to  IgE  in  in  vitro 
systems,  IL-5  plays  an  important  role  in  the  development  of  stimulated  B  cells  into 
antibodym  secreting  cells  by  controlling  the  induction  of  high  rate  secretion  of 
immunoglobulin  (Punnonen  et  al.,  1993)  and  in  induction  and  activation  of  eosinophils. 
Both  IL-6  and  IL-10  have  been  known  to  promote  immunoglobulin  secretion  and  control 
allergic  inflamm  tion,  with  IL-10  shown  to  be  particularly  prominent  in  inducing 
immunoglobulin  secretion  by  human  B  cells  grown  in  long-term  culture  on  immobilised 
anti-CD40  together  with  IL-4  (Rousset  et  aL,  1992).  The  activated  CD4+  T  cells  interact 
with  macrophages  in  a  similar  pattern  but  do  not  require  a  cell  surface  ligand  for  the 
induction  of  microbicidal  activity  in  response  to  IFN-y,  it  appears  that  cytokines  such  as 
IIFN-y  and  TNF-P  act  directly  on  macrophages  to  enhance  their  microbicidal  activity;  11, 
4  and  IL-10  block  the  microbicidal  activity  induced  by  IFN-y  (Liew  et  aL,  1989; 
Pretolani  and  Goldman,  1997). 
Observations  in  several  other  host/pathogen  interactions  have  reported  that  IFN-y- 
dominated  responses  are  protective  against  infections  with  microbes  that  are  resident 
within  cells  (Snapper  and  Paul,  1987),  while  IL.  -4-dominated  responses  lead  to  enhanced 
disease  in  such  cases  (as  reviewed  by  Abbas,  Murphy  and  Sher,  1996).  Although  there 
have  been  fewer  examples  in  which  IL-4  production  by  CD4'  cells  has  been  shown  to  be 
protective,  a  few  such  instances  are  infection  of  mice  with  nematodes  Heligmosomoides 
POIYNYrus,  Trichuris  muris  and  Tspiralis.  Nce  that  have  been  cured  of  an  H.  polyffrus 
33 infection  fail  to  display  immunity  to  re-challenge  with  parasite  if  ILA  is  neutralised 
(Urban  et  al.,  1991),  while  clearance  of  primary  infectiotts  with  Tmuris  is  blocked  by 
neutralising  anti-IL-4  antibodies  (Finkelman  and  Urban,  1992).  -  Grencis  (1991,1996), 
reported  two  mouse  strains  which  differed  in  IL-4  production  by  antigen-  stimulated 
mesenteric  lymph  nodes  cultures  and  timing  of  primary  expulsion  of  Tspirafts.  'Me 
mesenteric  lymph  node  cultured  secreted  increased  amounts  of  Th2  cytokines  but  low 
IFFN-y.  it  was  concluded  that  a  112  cell  response  mediates  expulsion  of  Tspiralis  as  well 
as  the  associated  inflammation  pathology. 
From  the  studies  cited  above  it  can  be  argued  that  IEFN-y-dominated  responses  are  of 
particular  value  in  intraceffular  infections  through  the  IFN-y-mediated  enhancement  of 
cellular  immunity.  By  contrast,  the  products  of  Th2  cells,  IL-4,  IL-5,  IL-6,  IL-  10  and  IL- 
. 
ponse  and  thus  antibody  13  each  potentially  enhance  some  aspect  of  the-B-  cell,  'Xes 
production.  'Merefore,  Th2  responses  would  be  most  appropriate  in  infections  with 
extracellular  helminths  against  which  antibody  would  have  greatest  cfficacy  in  ADCC. 
Another  fimction  of  Th2-type  responses  may  be  to  ameliorate  the  tissue  damaging  effects 
of  immune  responses  mediated  by  Thl-like  cells.  Such  damage  may  occur  in  the  course 
of  the  protective  function  of  Thl-like  cells  responding  to  an  intraceHular  infectious  agent. 
if  the  microorganism  is  already  widespread  at  the  time  the  response  develops  or  if  the 
response  does  not  quickly  rid  the  host  of  the  infectious  agent,  continued  T  cell  activation 
inducing  both  local  inflamm  tion  and  tissue  damage  may  ensue,  leading  to  potential 
compromise  of  normal  function.  A  Th2-like  response,  by  opposing  the  effects  of  IFN-y 
on  macrophages  through  the  actions  of  IL-10  and  H.  4  and  possibly  by  suppressing 
production  of  IFN-y  and  other  cytokines  by  Thl  cells  could  control  such  self-inflicted 
injury  (Pretolani  and  Goldman,  1997). 
34 The  recognition  of  the  type  of  immune  response  as  defined  by  the  pattern,  of  cytokines 
produced,  may  directly  determine  the  character  of  that  response,  either  its  tissue- 
damaging  character  or  capacity  to  protect  or  both.  This  can  also  assist  in  determining  the 
factors  that  control  induction  of  particular  cytokine-producing  profiles.  It  is  known  that 
naive  T  cells  can  develop  into  effector  or  memory  T  cells  that  have  the  capacity  to 
produce  IFN-y,  IL-4  or  both,  often  described  as  Thl-like,  Th2-like  or  110  effector  cells. 
The  question  of  interest  is  whether  the  production  of  IL-4  and  IFN-y  are  mutually 
exclusive,  as  had  been  suggested  from  early  studies  of  long-term  mouse  T  cell  clones 
(Mosmann  et  al.,  1986).  Initial  studies  of  clones  of  human  CD4+  T  cells  failed  to  show 
the  same  degree  of  striking  divergence  of  cytokine  production,  clones  often  produced 
IL-2,  IFN-y  and  IL-4,  although  ratios  of  IFN-y  to  IL-4  often  varied  markedly.  Some 
antigen-  specific  human  T  cell  clones  have  failed  to  show  a  greater  degree  of  IIIM12- 
type  polarisation.  in  their  cytokine-producing  phenotype  than  was  true  of  murine  clones 
that  had  been  examined  initiaUy  (RomagnanL  199  1;  Couissinier  and  Dessein,  1995), 
while  some  examples  of  mouse  clones  have  reported  clones  that  produced  IL-2,  IFN-y 
and  IL-4,  which  have  been  designated  TbO  clones  (Street  et  al.,  1990).  Effector  T  helper 
cells  appear  to  remain  in  a  state  in  which  they  produce  a  large  amount  of  cytokine  upon 
challenge  for  only  a  relatively  short  period.  However  mice  that  have  been  primed  will 
develop  effector  T  helper  cells  promptly  upon  rechallenge,  indicating  that  they  have 
memory  of  the  initial  immunisation.  (Bradley  et  al.,  1993). 
One  of  the  recent  developments  in  our  understanding  of  T  cell  effiector  development  is 
whether  an  individual  precursor  T  helper  cell  can  give  rise  both  to  ceRs  that  produce  IL-4 
as  weU  as  to  those  that  produce  IFN-y.  More  information  is  required  to  determine 
35 whether  or  not  cell  populations  with  distinct  cytokine-producing  phenotypes  represent 
distinct  cell  lineages  that  are  separated  from  one  another  prior  to  their  initial  contact  with 
antigen,  or  are  products  of  a  differentiation  step  that  occurs  at  the  time  oý  or  associated 
with,  the  antigen-specific  activation  of  the  cell.  However  if  an  intermediary  effector  T'hO- 
like  state  is  a  requisite  step  in  the  acquisition  of  more  restricted  patterns  of  cytokine 
production,  it  would  seem  very  likely  that  some  precursor  T  helper  cells  can  develop  into 
cefls  that  produce  both  IFN-y  and  IL-4,  or  into  ceRs  that  produce  either  IFN-y  or  IL-4. 
The  initial  event  that  determines  cytokine-producing  phenotype  may  not  be  the  selective 
outgrowth  of  already  committed  cells  but  rather  the  differentiation  of  precursor  T  helper 
cells  under  the  influence  of  factors  present  at  that  time  of  primary  stimulation.  Some 
striking  correlation  of  antigen  dose  and  development  of  imnume  responses  dominated  by 
ceRular  immunity  or  by  antibody  production  have  been  reported  (Parish  and  Liew,  1972), 
who  demonstrated  that  low  doses  of  antigen  favoured  cellular  immunity;  intermediate 
doses,  antibody  formation  and  high  doses,  cellular  immunity.  Assuming  that  cellular 
immunity  represents  IFN-y-dominated  responses  and  the  antibody  production,  IL-4- 
dominated  responses,  commitment  to  IFN-y,  or  IL-4  production  may  be  determined  in 
part  by  the  concentration  of  antigen  and  the  time  the  antigen  persists  in  the  body.  This  is 
of  major  interest  in  the  current  work  comparing  cellular  responses  and  cytokine 
production  of  individuals  from  an  endemic  region  living  in  two  areas  of  different 
transmission  pattern,  in  terms  of  prevalence  and  intensity,  of  S.  haematobiuni  infection. 
Besides  the  CD4+  T  ceUs,  CD8+  T  cells  are  also  cytokine  producers  at  an  equal  rate  to 
the  CD4+  T  cells.  Some  CD8+  cells  have  been  reported  to  produce  IL,  2,  IFN-y,  IL-4,  IL., 
6  and  TNF-(x,  which  indicates  that  CD8+  ceUs  produce  essentiaRy  the  same  range  of 
cytokines  as  CD4+  ceffs  (de  Vries  et  al.,  1991).  T  cefls  have  exquisite  specificity  in  terms 
36 of  recognition  of  antigen,  but  in  terms  of  effector  fimction,  T  cells  have  been  said  not  to 
be  specific  in  their  response,  liberating  whatever  cytokines  they  are  capable  of  producing 
(Mosmann  and  Sad,  1996),  although  the  stimulating  antigen  concentration  and  the 
individual's  age  and  duration  of  infection  should  be  suspected  to  play  an  important  role 
in  immunological  responses  of  T  cell  cytokine  production  and  immunoglobulin  profiles, 
which  are  essential  in  schistosome  infection,  susceptibility  and  protection. 
1.11  THE  SPECIFIC  OBJECTIVES  COMPRISE  THE  FOLLOWING: 
1.  To  examine  patterns  of  infection  and  reinfection  with  S.  haematobiuni  in 
different  communities. 
2.  To  relate  levels  of  infection  and  reinfection  with  S.  haematohium  to  cellular 
responses  to  the  parasite  antigens  -cereariaL  worm  and  egg  antigens. 
To  measure  cytokine  profiles  of  PBMC  coflected  pre-  and  post-treatment  and 
relate  these  to  levels  of  infection  or  reinfection  and  resistance  to  infection. 
To  develop  T  cell  clones,  characterise  them  and  study  the  cytokines 
produced  by  them  after  antigenic  stimulation. 
5.  To  examine  the  effects  of  repeated  chemotherapy  on  morbidity,  development  of 
pathology  and  resistance  to  infection. 
6.  To  measure  levels  of  specific  antibodies  to  soluble  worm  and  egg  antigens  of 
S.  haematobium  in  a  population  of  children  receiving  repeated  chemotherapy. 
Ile  above  objectives  will  allow  to  answer  the  following  questions 
do  children  from  different  transmission  areas  have  different  infection  and 
re-infection  intensities? 
do  people  resident  in  areas  where  infection  is  high  develop  resistance  to  infection 
37 earlier  due  to  greater  experience  of  parasites? 
is  the  response  to  antigen  stimulation  influenced  by/dependent  upon  age  or 
history  of  exposure  to  infection? 
which  type  of  cytokines  are  more  dominant  during  infection  and  re-infection 
and  which  antigens  stimulate  these  response? 
are  the  responses  to  infection  and  reinfection  of  the  Thl  or  M  type? 
does  repeated  treatment  with  praziquantel  help  in  the  development  of  protective 
immunity  in  young  children? 
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IMMUNO-EPIDEMIOLOGICAL  COMPARISON  OF  TWO 
GROUPS  OF  INDIVIDUALS  WITH  DIFFERENT  PATTERNS  OF 
Schistosoma  haematobium  INFECTION  LIVING  IN  DIFFERENT 
TRANSMISSION  AREAS  IN  THE  BURMA  VALLEY,  ZIMBABWE. 2.1  INTRODUCTION 
The  humoral  and  ceflular  immune  responses  of  patients  with  different  schistosome 
infections  have  been  reported  from  several  studies,  most  of  them  highEghting  the 
requirement  for  antibodies  such  as  IgE  and  effector  cells  such  as  eosinophils  and  mast 
cells  for  protective  immunity  (Hagan  et  aL,  1985a,  b,  1991;  Butterworth  et  aL,  1985, 
1987,1992;  Rihet  et  aL,  1991).  Ile  cellular  studies  have  stressed  the  differences  in 
proliferation  between  individuals  with  acute  and  chronic  forms  of  schistosome  infection, 
due  to  the  long  duration  of  infection  which  gives  rise  to  chronic  infections  during  which 
time  the  host  is  exposed  to  large  quantities  of  antigenic  materials  from  worms  and  eggs 
of  the  parasite  (Colley  et  aL,  1977a,  1986;  Ottesen  et  aL,  1978;  Barsourn  et  al.,  1982; 
Ellner  et  aL,  1985;  Gazzinelli  et  aL,  1985).  The  usual  response  of  the  host  immune 
system  to  the  repeated  or  continuous  antigen  exposure  has  been  reported  as  essentially 
that  of  downregulating  or  modulating  the  immune  response  to  prevent  continued  over- 
reactivity  which  might  be  harmful  to  the  host  (Hagan,  1987;  Butterworth  et  aL,  1992). 
Ile  immunomodulation  of  responses  during  schistosome  infection  has  been  investigated 
usually  by  using  in  vitro  lymphocyte  transformation  assays,  examining  the  relationship 
between  decreased  immune  reactivity  and  clinically  defined  disease  status  with  levels  of 
infection.  The  investigations  by  CoHey  et  aL,  (1977a,  1986),  reported  unresponsiveness 
in  chronic  infections;  while  those  by  Ottesen  et  aL,  (1978)  and  Barsoum  et  aL,  (1982) 
demonstrated  vigorous  responsiveness  in  those  with  acute  forms  of  infection  and  a  return 
to  responsiveness  in  people  treated  for  Sxiansoni  infection.  Some  workers  have  reported 
the  presence  of  immune  factors  which  are  involved  in  immunomodulation  during 
infections;  these  include  studies  by  CoHey  et  al.,  (1977b),  Gazzinelli  et  aL,  (1980), 
40 Ottesen  and  Poindexter,  (1980)  and  Ellner  et  al.,  (1982),  who  reported  some  serum 
factors  inhibiting  lymphocyte  blastogenesis  to  schistosome,  antigens;  while  Hofstetter  el 
aL,  (1982,1983)  reported  blocking  antibodies  and  some  antigen-  specific  histamine 
release  from  basophils  sensitised  with  S.  mansoni-specific  IgE  as  playing  a  role  in 
suppression  of  responses.  Tle  investigations  cited  above  concluded  that  there  are 
multiple  suppressor  mechanisms  involved  in  immunomodulation  which  demand  closer 
examination  by  the  use  of  longitudinal  reinfection  studies  to  determine  the  factors 
involved  in  cellular  immunity,  including  cytokines. 
Some  reports  on  cellular  immunity  have  included  a  few  selected  cytokine  types,  King  et 
aL,  (1996)  showed  that  IL-10  inhibits  cefl-mediated  immunity  by  suppression  of  IFN-y, 
while  Grogan  et  aL,  (1996)  reported  an  increase  in  ILA  and  unaltered  IL-5  production 
after  treatment  in  S.  haeniatobium  infected  patients.  In  contrast,  Roberts  et  aL,  (1993), 
Viana  et  al.,  (1994)  and  Araujo  et  aL,  (1996),  reported  contrasting  roles  of  IFN-y  Aith 
dominance  of  ILA  in  subjects  from  S.  mansoni  endemic  areas.  Ilus,  a  range  of  cytokines 
are  now  documented  to  be  produced  by  the  effector  T  helper  cells  and  observations  that 
immune  regulatory  events  develop  upon  continued  exposure  to  schistosomes  and  their 
products,  suggests  that  they  are  likely  to  play  a  role  during  the  establishment  and 
maintenance  of  the  infected  condition.  A  comparison  of  individuals  vAthin  an  endemic 
region  and  areas  with  different  infection  patterns,  before  treatment  and  followed-up  12 
and  18  months  after  treatment  with  praziquantel,  may  help  elucidate  the  cellular 
modulation  of  proliferation  and  cytokine  patterns  of  these  individuals.  The  knowledge 
thus  gained  should  be  helpful  in  understanding  how  the  immune  response  is  modulated 
during  infection  and  fbHowing  treatment  with  praziquantel. 
41 Since  the  concept  of  CD4+  Thl  and  M  ceRs  was  introduced  over  a  decade  ago 
(Mosmann  et  aL,  1986),  rapid  progress  in  the  knowledge  of  their  physiology  has  been 
achieved  through  some  experimental  models  of  infection  and  vaccination.  Ile 
importance  of  these  T  helper  cells  ifi  the  induction  of  host  responses  to  S.  mansoni 
infection  has  been  reported  (Mosmann  et  al.,  1986;  Mosmann  and  Coffinan,  1989;  Sher 
et  al,  1990,1991;  Pearce  et  al.,  1991;  Cheever  et  al,  1992,1994).  In  these  studies,  a 
number  of  potential  effector  killing  mechanisms  involving  both  cells  and  antibodies 
directed  against  different  stages  of  the  parasite  have  been  suggested.  The  effector  ceH 
functions  are  now  understood  to  be  under  the  control  of  cytokines  secreted  by  either  ni 
or  Th2  cells.  However,  little  work  has  been  conducted  to  understand  cytokine  secretions 
during  human  schistosomiasis,  in  particular  for  S.  haematobium  infection,  where  only  a 
few  studies  using  mixed  lymphocytes  have  been  completed  (King,  Low  and  Nutman, 
1993;  King  et  al.,  1996;  Grogan  et  aL,  1996). 
Evidence  is  now  available  regarding  the  roles  played  by  cytokines  in  different 
schistosome  infection  stages,  including  the  III  and  Tb2  responses  that  have  been  clearly 
defined  in  animal  models,  (mice  and  rats),  from  which  useful  pointers  have  been  obtained 
for  the  detailed  studies  of  human  schistosomiasis  (Del  Prete  et  al.,  1988,1993;  Del 
Prete,  Maggi  and  Romagnaný  1994;  Sher  et  al.,  1990,1991;  Pemberton  et  aL,  1993; 
Cheever  et  al.,  1994;  Openshaw  et  al.,  1995).  The  Thl  and  T12  cytokines  identified  in 
murine  models  of  S.  mansoni  are  as  follows:  the  Thi  cell  products  are  interferon  gamma 
(IFN-y),  interleukin-2  (IL-2),  lymphotoxin,  and  tumour  necrosis  factor-P  (TNF-P),  vvith 
the  Tb2  ceUs  producing  ILA,  IL-5,  IL-6,  IL-10  and  IL--13.  The  major  signature 
42 cytokines  are  IL-4  and  IFN-y  which  mark  each  subset  and  these  have  a  reciprocal  cross- 
inhibitory  effects  (Mosmann  and  Coffinan,  1989).  According  to  the  work  cited  above, 
the  murine  schistosome  models  have  linked  Thl  mediators  to  protection,  whereas  Th2 
responses  induced  following  infection  and  the  onset  of  egg  laying  are  believed  to 
contribute  to  the  development  of  pathology  (Sher  and  Coffinan,  1992).  The  relative 
importance  of  these  functionaRy  distinct  T  ceU  subsets  and  their  contribution  to 
protective  immunity  have  yet  to  be  fiffly  established  for  the  different  schistosomes 
affecting  humans.  However,  from  recent  reports,  protection  has  been  said  to  probably  be 
either  Thl-  or  Th2-dependent  (Abbas,  Murphy  and  Sher;  1996;  Mosmann  and  Sad, 
1997;  Romagnaný  1997). 
The  evidence  from  murine  models  has  been  utifised  mainly  in  the  study  of  human 
S.  mansoni,  unlike  S.  haematohium  where  only  a  few  studies  have  been  reported.  In  their 
studies  on  S.  mansoni,  Roberts  and  colleagues,  (1993),  reported  high  levels  of  IL-5  and 
r-FN-y  in  individuals  who  were  resistant  to  infection.  In  another  study,  Viana  and 
colleagues  (1994)  observed  individuals  whom  they  classified  as  "endemic  normals", 
having  schistosome  exposure  but  being  uninfected,  who  produced  high  levels  of  IFN-,  y  to 
specific  schistosome  antigen  stimulation.  'Me  reports  on  human  cytokine  studies  during 
S.  mansoni  infection  which  are  now  complete  have  failed  to  clarify  which  particular 
cytokine(s)  play  an  essential  role  in  aiding  protection  or  susceptibility,  with  the  reports 
limited  to  mentioning  the  dominance  of  a  particular  cytokine  (Roberts  et  al.,  1993;  Viana 
et  aL,  1994;  Williams  et  aL,  1994;  Couissinier  and  Dessein  1995;  Araujo  et  al.,  1996). 
However,  the  longitudinal  re-infection  study  described  in  this  chapter  Will  attempt  to 
show  how  the  cytokine  profiles  appear  before  treatment  and  change  in  the  period 
43 following  treatment  with  praziquantel.  'ne  cellular  immunity  experiments  were  designed 
to  investigate  whether  cytokine  responses  could  be  related  to  levels  of  re-infection  and 
whether  resistance  or  susceptibility  could  be  classified  as  being  either  Thl-  or  M-like. 
Tle  comparison  of  individual  residents  from  areas  of  different  infection  intensities  and 
prevalences  may  help  shed  some  fight  on  the  possibility  that  modulation  of 
ological  responses  may  alter  Thl-  and  Th2-like  cytokine  balance  and  therefore 
alter  the  outcome  of  schistosome  infections. 
2.2  MATERIALS  AND  METHODS: 
2.2.1  REAGENTS 
incomplete  medium:  RPM11640; 
Washing  medium:  RPM11640,1%  gcntamycin,  5%  either  FCS  or  human  AB  (hAB) 
serum  (both  from  GIBCO-BRL). 
Freezing  medium:  RPMI  1640,25  %  FCS,  20%  DMSO. 
Complete  medium:  RPMI1640  supplemented  with  2.4  mM  sodium  hydrogen  carbonate, 
1%  gentamycin,  2mM  L-glutamine,  10%  either  FCS  or  hAB  serum,  1%  non  essential 
mino  acids,  1%  sodium  pyruvate  and  25mM  0-2-Mercarptocthanol. 
S.  haematobiunz  antigens:  (lyophiliscd-  SEA-soluble  egg  antigen,  SWAP-solublc  worm 
antigen  preparation  and  CAP-solublc  cercarial  antigen  preparation;  obtained  from 
Schistosomc  Biological  Supply  Programme,  Theodore  Bilharz  Research  Institute,  Giza 
Egypt) 
Soluble  alkaline  phosphatase  substrate  (p-Nitrophenyl  phosphate  (SIGMA  FAST),. 
Monoclonal  antibody:  anti-human  IL,  4  clone  82-4;  IL,  4-biotin  clone  12-1  (Mabtech  ab). 
Mabanti-human][FNgamm  Mabl-DIK;  7B6-lbiotinylatcd(Mabtecliab). 
Purified  rat-anti-mouse/human  IL-5;  Biotin  rat  anti-human  IL-5  (Pharmingen). 
Purified  antihuman/viral  H_,  10;  B  iotin  antihuman/viral  IL-  10  (Pharmingen). 
Streptavidin  alkaline  phosphatase  conjugate  (Amersharn  Life  Sciences). 
methyl'H-thymidine  (Amersham,  LJK) 
44 2.2.2  STUDY  AREA  AND  POPULATION. 
Ile  study  population  was  chosen  from  a  farming  community  of  The  Burma  Valley  Area, 
Eastern.  Ilighlands  of  Manicaland  Province  in  Zimbabwe.  'ne  farming  activities  were 
based  on  irrigation  and  on  seasonal  rains.  In  each  area  there  is  a  permanent  river  with  a 
dam  and  several  seasonal  river  tributaries.  Tlie  two  communities  are  about  10  km  apart 
having  low  Smansoni  prevalence  (<I%  according  to  preliminary  surveys:  Ndhlovu  and 
Mduluza,  unpublished  results).  Kaswa  pfirnary  school  was  the  centre  of  the  surrounding 
area  in  which  the  children  and  adults  had  a  low  S.  haematobium  infection  prevalence  and 
intensity;  while  Valhalla  primary  school  and  the  surrounding  area  had  the  residents  with 
high  S.  haematobium  infection  prevalence  and  intensity. 
The  children  attending  each  school  and  the  adults  living  in  the  surrounding  catchment 
areas  of  each  school  were  selected.  The  criteria  used  for  selection  of  the  cohort  were 
provision  of  a  ffill  set  of  three  urine  and  faecal  samples  collected  over  three  consecutive 
days,  a  blood  sample  and  no  record  of  treatment  received  within  the  previous  two  years. 
The  individuals  who  were  diagnosed  as  having  active  malaria  were  excluded  from  the 
ceBular  studies.  Throughout  this  study,  compansons  were  made  between  groups  of 
individuals  who  were  infected  or  uninfected,  taking  into  account  PBMC  cytokine  levels 
and  proliferation  and  the  variables  age,  follow-up  time  point,  sex  and  area. 
A  total  of  205  individuals  were  selected  for  detailed  study  of  their  cellular  immune 
response  and  parasitology  in  relation  to  schistosomiasis  before  treatment  and  12  months 
post  treatment  with  the  antihelminthic  drug,  praziquantel.  A  separate  group  of  40  school 
children  (aged  7  to  16  years),  were  examined  for  parasitological  infection  and  cellular 
45 immune  responses  at  pre-treatment,  12  and  18  months  post  treatment.  Ilie  cellular 
immunitY  studies  of  this  group  included  detailed  determination  of  their  cytokine  profiles 
measured  at  each  foHow-up  time. 
2.2.3  PARAMOLOGY 
Urine  samples  for  parasitological  examination  for  S.  haematobium  infection  were 
collected  from  all  the  individuals  on  three  consecutive  days  and  were  processed  on  the 
day  of  collection.  Samples  were  collected  between  10.00  hours  and  14.00  hours  to 
coincide  with  peak  S  haematobium  egg  excretion  in  urine  (Warren,  1978).  Urine  samples 
were  examined  for  urinary  schistosomiasis  by  filtration  of  10  ml  samples  after  thorough 
mixing  (Mott  et  al.,  1982)  using  13  mm.  polyamide  Nytrel'  filters  and  5-10%  Lugors 
iodine  stain,  to  help  visualise  the  eggs.  T'he  filters  were  examined  for  eggs  of 
S.  haematobium,  and  counts  were  expressed  as  eggs  per  10  nil  of  urine  (eplOml). 
intensity  of  infection  was  classified  as  negative-no  eggs  detected;  very  light-<  10  ep  I  Oml; 
light-10  to  <50  eplOml;  or  heavyw50  or  more  eplOml. 
Stool  samples  were  examined  by  the  Kato-Katz  technique  (Katz  et  aL,  1972;  as  modified 
by  Peters  et  aL,  1980),  although  the  prevalence  of  S.  mansonj  is  known  to  be  very  low  as 
earlier  described  by  Taylor  and  Makura  (1985)  and  according  to  preliminary  surveys. 
Stool  samples  were  collected  and  processed  to  exclude  from  the  study  those  with 
S.  mansoni  infection. 
46 2.2.4  COLLECTION  OF  VENOUS  BLOOD 
About  20  mls  of  blood  sample  were  collected  from  the  cubital  vein  of  each  child  by 
venepuncture  using  21G  cannulae  into  sterile  syringes  pre-loaded  with  5-10  U/ml  heparin 
for  later  separation  and  collection  of  peripheral  blood  mononuclear  cells  (PBMQ.  After 
blood  collection  the  samples  were  transported  in  a  cooler  box  and  were  processed  at  the 
laboratory  within  two  hours  of  collection. 
2.2.5  TREATMENT 
All  children  were  treated  with  praziquantel,  given  as  a  single  dose  of  40  mg/kg  body 
weight,  at  the  end  of  the  first  (pre-treatment)  examination.  All  children  were  finally 
retreated  at  the  end  of  the  2  year  follow-up.  Ile  study  design  was  approved  by  the 
Medical  Research  Council  of  Zimbabwe  and  the  Zimbabwe  Ministry  of  Health  ethical 
committee. 
2.2.6  PERIEPHERAL  BLOOD  MONONUCLEAR.  CELLS  (PBMC)  SEPARATION 
Blood  was  layered  gently  into  sterfle  LeucoSep  tubes,  prespun  with  LymphoprepTm 
(Nycomed)  and  centrifuged  at  450xg  for  20  min.  The  method  for  cell  separation 
employed  density  gradient  centrifugation  of  anti-coagulated  blood  on  a  dense  solution  of 
lymphoprep  (Nycomed),  using  a  modified  method  from  Boyum.  (1968);  Hunt  (1978)  and 
Madsen  et  al.,  (1980).  Ile  white  buffy  layer  containing  the  PBMC  at  the 
plasma/lymphoprep  interface  was  pipetted  into  another  sterile  tube.  The  remaining 
jymphoprep  with  the  red  cells  and  granulocytes  was  discarded.  Aspirated  PBMC  were 
resuspended  in  complete  media  and  washed  by  centriffigation.  at  350xg  for  15  min.  TIIe 
cells  were  washed  again  in  complete  medium  and  collected  by  pelleting  at  300xg  for  10 
47 min.  Ile  supernatant  was  discarded  and  the  cells  resuspended  into  3  ml  of  complete 
media.  The  resuspended  cells  were  aliquoted  and  distributed  equally  into  three  1.8  ml 
sterile  Nunc  tubes,  mixed  with  I  ml  freezing  medium  and  immediately  transferred  for 
freezing  by  gradient  freezing  in  liquid  nitrogen  following  a  given  standard  curve  as 
described  by  Hviid  et  al.,  (1989). 
2.2.7  PBMC  PROLIEFERATION  ASSAYS  USING  DYE  REDUCTION 
METHODS. 
The  cryopreserved  PBMC  were  rapidly  thawed  at  370C  and  transferred  asceptically  into 
10  ml  RPM1  1640  without  serum.  Tlie  cells  were  washed  at  300xg  for  10  minutes  to 
remove  the  DMSO,  resuspended  in  1  ml  complete  medium  (RPMI  1640  and  10%  AB 
serum.  ).  Cell  viability  and  concentration  were  determined  by  counting  a  portion  of  the 
resuspended  cells  in  0.2%  (w/v)  trypan  blue.  A  final  viable  cell  concentration  of 
approximately  Ix  106  cells/ral  was  cultured  in  100  pl  volumes  in  duplicate  or  triplicate  in 
96  well  flat  bottomed  culture  plate.  The  cells  from  each  individual  had,  as  a  negative 
control,  unstimulated  cells,  and  as  positive  control,  cells  stimulated  with  10  pg/ml  PIIA 
(Wyler  and  Oppenheim,  1974),  the  S.  haematobiuni  antigens  (SEA  -  soluble  egg  antigen, 
SWAP  -  soluble  worm  antigen  preparation  and  CAP  -  soluble  cercarial  antigen 
preparation)  were  used  to  stimulate  the  cells  at  10  pg/ml.  This  concentration  of 
antigen/mitogen  was  determined  on  the  basis  of  preliminary  experimentation  as  being  the 
optimal  level  of  antigen/mitogen  for  stimulation  of  PBMC  from  S.  haeniatobiuni-infected 
individuals  (data  not  shown).  The  plates  were  incubated  in  a  5%  C02  humidified 
incubator  at  370C  for  6  days.  On  day  6  the  cell  proliferation  index  was  measured  using 
Non-Radioactive  Cell  Proliferation  Assay  (CeRiter  96'  Promega)  according  to  the 
48 manufacturers  protocol.  After  4  hours  incubation  with  the  dye  solution,  the  solubiliser 
was  added  to  stop  any  further  utilisation  of  the  dye  by  the  cells  and  the  plate  reincubated 
for  an  hour  to  allow  the  formazan  formed  during  the  ceH  proliferation  and  utilisation  of 
the  dye  to  solubilise.  Ile  contents  of  each  weU  were  thoroughly  mixed  using  a 
multichannel  pipette  and  then  absorbance  values  were  determined  using  an  ELISA  plate 
reader  at  570  nm,  with  a  reference  wavelength  at  630  mm  using  the  BIOLINX 
programme  for  data  handling.  For  each  individual  proliferation  assay,  the  results  were 
accepted  when  the  negative  control  gave  a  value  of  50%  or  less  than  the  positive  control, 
with  a  standard  deviation  of  less  than  0.02  between  the  well  readings  of  each  duplicate 
specunen. 
Cell  proliferation  indices  (stimulation  index)  were  each  expressed  as: 
SI  of  mean  o.  d.  =  Mean  counts  ftom  stimulated  cells 
Mean  counts  from  control  (unstimulated)  cells. 
The  response  to  each  stimulant  was  classified  as  low  response-when  stimulation  index 
(SI)  was  less  than  2  and  moderate  or  high  response  when  SI  was  ý2. 
2.2.8  PBMC  PROLIFERATION  ASSAYS  USING  TRITIATED  TIIYM  I  DINE. 
The  cryopreserved  PBMC  were  rapidly  thawed  at  370C  and  transferred  asceptically  into 
10  mI  RPMI  1640  without  serurn,  as  described  in  the  previous  section.  The  cells  were 
washed  by  centrifugation  at  300xg  for  10  minutes  to  remove  the  DMSO  and 
resuspended  in  1  ml  complete  medium  containing  10%  AB  serum  and  50  pg/ml 
gentamycin.  Cell  viability  and  concentration  was  determined  by  cowiting  20  ld  of  the 
resuspended  cells  in  trypan  blue  (0.2%  w/v).  A  fmal  viable  cell  concentration  of 
49 approximately  Ix  106  cells/ml  was  cultured  in  200  gl  volumes  in  duplicate  in  96  well  flat 
bottomed  culture  plates.  'Me  cells  from  each  individual  had  a  negative  control 
(unstimulated  cells)  and  as  positive  control,  cells  stimulated  with  10  gg/ml  PHA.  The 
S.  haematobium  antigens  SEA  and  SWAP  were  used  to  study  specific  stimulation  of  the 
cells  at  10  gg/ral.  Tile  plates  were  incubated  in  a  5%  C02  hunidified  incubator  at  370C 
for  6  days.  Ile  cells  were  pulsed  with  1.0  gCi  tritiated  thymidine  (methyl  'H-thymidine, 
Amersham,  UK)  after  5  days  incubation,  and  further  incubated  for  approximately  18 
hours.  The  cells  were  then  harvested  onto  filters  using  a  semi-automated  cell  harvester 
and  the  filters  rinsed  with  distilled  water  to  remove  unincorporated  tritiated  thymidine. 
The  amount  of  tritiated  thymidine  incorporation  induced  by  antigen  or  mitogen  was 
determined  with  a  Liquid  Scintillation  Analyser  (TRICAB"'I  Model  1600  CA  Packard 
USA).  Data  were  expressed  as  stimulation  index  of  mean  counts  per  minute  (SI) 
calculated  as  follows: 
Sl  of  mean  cpm-7  Mean  counts  from  stimulated  cells 
Mean  counts  from  control  (unstimulated)  cells. 
Response  to  each  stimulant  was  classified  as  low  response-when  SI  was  less  than  2  and 
moderate  or  high  response  when  Sl  was  >2. 
2.2.9  PBMC  STIMUIATION  FOR  CYTOKINE  PRODUCTION. 
The  frozen  PBMC  from  both  the  high  and  low  transmission  areas  were  retrieved  from 
liquid  nitrogen  and  rapidly  thawed  with  constant  agitation  until  only  a  small  ice  crystal 
remained  and  then  transferred  to  incomplete  medium  with  50  gg/ml  gentamycin.  After 
50 washing  twice  by  centrifugation,  the  cells  were  resuspended  in  complete  medium 
containing  10%  human  AB  serum  and  seeded  at  2x  106  cefls/ml  in  24  weff  microplates  in 
the  presence  of  10  pg/ml  SWAP,  SEA  or  PHA,  and  without  stimulant  as  control.  After 
5  days  at  37'C  in  5%  C02  in  humidified  air,  culture  contents  were  collected  and 
centrifuged  at  350xg  for  10  min.  Cell  free  supernatants  were  coflected  under  sterile 
conditions  and  were  stored  at  -700C  before  assaying  for  cytokines. 
2.2.10  CYTOKINE  DETECTION  BY  ELISA. 
Cytokine  detection  of  IL-4,  IL-5,  IL-10  and  IFN-y  was  performed  on  the  supernatants 
harvested  from  the  PBMC  stimulations  after  5  days  of  incubation.  Nunc-imrnlinoplates 
Maýdsorp'  (InterMed)  were  coated  with  anti-human  monoclonal  antibodies  (mAb)  at 
0.5  gglml  for  IFN-y  and  at  I  [tg/ml  for  ILA,  IL-5  and  IL-10  in  carbonate/bi-carbonate 
buffer,  pH  9.6  overnight  at  4'C  on  a  shaker.  The  plates  were  then  washed  twice  with 
PBS  containing  0.05%  Tween  20,  pH  7.2  and  then  blocked  with  complete  RPMI  or  PBS 
+  3%  BSA  +  0.05%  Tween  20  for  I  hour  at  room  temperature.  The  blocking  solution 
was  removed  by  washing  once  and  then  the  PBMC  supernatants  were  added  in  duplicate, 
at  these  dilution:  1/4  for  the  control,  and  115,1/25  and  1/125  for  the  samples;  and 
incubated  overnight  at  40C  on  a  shaker.  Standards  were  added  in  duplicate  for  each 
concentration  within  the  range  15-2000  pg/ml.  Aller  overnight  incubation,  the  plates 
were  washed  3x.  A  second  biotinylated  monoclonal  antibody  at  0.5  pg/mI  for  IFN-y,  I 
ýtg/ml  for  IL-4  and  IL.  -5,  and  2  gg/ml  for  IL-  10  was  added  and  the  plates  were  incubated 
for  4  hours  at  room  temperature  on  a  shaker.  After  washing  3x,  streptavidin-alkaliiie 
phosphatase  conjugate  or  an  alkaline  phosphatase-conjugated  mAb  was  added  at  1/1000 
for  IFN-y  and  IL-4,  and  at  1/2500  for  IL-5  and  IL-10  and  then  incubated  for  2  hours  at 
51 room  temperature.  Enzymatic  activity  was  revealed  by  incubating  the  plates  with  p- 
nitrophenyl  phosphate  for  10-15  minutes.  Absorbance  was  read  at  405  mn  with  630  mn 
as  reference  wavelength  on  a  DIAS  Multiscan  reader  (Dynatech  Laboratories).  Ile 
absorbances  were  interpolated  ftom  a  standard  curve  to  obtain  cytokine  concentrations 
(pg/ml)  taking  into  account  the  dilution  factor  of  the  culture  supernatants.  Ile  standard 
curves  were  calculated  for  each  plate  according  to  the  sigmoid  curve  equation: 
Y=D  +  (A-D)/(l  +  (X/Cp) 
Where  X  is  the  cytokine  concentration  and  Y  is  the  absorbance  at  405  mm 
A,  B,  C  and  D  are  constants. 
Examples  of  the  standard  curves  for  each  cytokine  are  shown  in  Figure  2.1. 
2.2.11  STATISTICAL  ANALYSES 
Ile  data  sets  were  mostly  not  normally  distributed,  in  view  of  which  non  parametric 
tests  were  applied.  Spearman  rank  correlation  was  used  for  the  correlations  of  infection 
intensity  and  proliferation  and  cytokine  production.  Kruskal-Wallis  one-way  ANOVA 
was  used  to  compare  the  cytokine  levels  within  infection  intensity  groups  and  within  age 
groups.  The  Mann-Whitney  (Rank  sum)  test  was  used  to  compare  the  infected  and 
uninfected  categories  at  each  fbHow-up  time  point,  between  the  two  areas  and  the 
response  groups.  The  Rank  sum  test  was  also  used  to  compare  the  infected  or  uninfected 
groups  at  any  two  of  the  fbHow-up  time  points. 
To  reduce  the  risk  of  type  I  errors  arising  from  making  multiple  pairwise  comparisons, 
Bonfeffoni's  method  was  applied  which  uses  the  function  p=cc/m,  where  cc  is  a 
p(probabflity)  constant  from  statistical  comparison  and  m  is  the  number  of  comparisons. 
52 When  comparisons  were  made  of  levels  of  proliferation  or  production  of  a  particular 
cytokine  between  infected  and  uninfected  individuals,  the  revised  significance  level  was; 
p=0.05/3  =  0.017;  because  three  comparisons  (PHA,  SWAP  and  SEA)  were  made  at 
each  time  point.  When  comparisons  were  made  of  a  particular  category  of  respondent  at 
different  time  points  (e.  g.  PHA  stimulated  responses  of  uninfected  individuals  at  12  and 
18  months  post-treatment),  the  revised  significance  level  was  p=0.05/6  =  0.008. 
Each  individual  immune  response  was  classified  as  aT  helper-like  cytokine  response 
according  to  the  ratios  of  the  signature  cytokines  produced  as  being  of  Tho/l  or  TbO/2 
phenotypes.  The  cytokines  studied  were  IFN-y,  IL-4,  IL-5  and  ILAO  and  the  ratios 
derived  as,  IL-4:  IFN-y,  IL-5:  IFN-y  and  IL-  I  O:  IFN-y.  If  the  ratio  obtained,  x,  satisfied  the 
following  expression  then  the  individual  cytokine  environment  response  was  classified 
accordingly: 
X:!  ý  0.1  strong  ThO/1-like  response 
0.1  <  X::  ý  1  ThO/1-like  response 
1  <x<  10  ThO/2-like  response 
X>10  strong  ThO/2-like  response. 
A  similar  classification  has  been  proposed  for  classification  of  human  T  cell  clones  during 
Leishmaniasis  and  schistosomiasis  mansoni  (Couissinier-Paris  et  aL,  personal 
commimication),  although  it  is  used  here  to  classify  the  general  cytokine  responses  of 
PBMC. 
53 2.3  RESULTS: 
2.3.1  STUDY  POPULATION  AND  PARASITOLOGY  OF  THE  COHORT 
FOR  THE  DYE  REDUCTION  PROLIFERATION  ASSAYS. 
Two  hundred  and  five  participants  were  recruited  from  the  two  areas  for  detailed  study 
of  their  PBMC  proliferation  using  the  dye  reduction  method.  95  participants  were  from 
the  Low  Transmission  area  and  110  from  the  High  Transmission  area.  Of  the 
participants,  81.5%  (167)  were  school  children  from  both  areas  and  13.7%  (28)  were 
adults  recruited  from  the  Low  Transmission  area  while  4.9%  (10)  were  adults  recruited 
from  the  High  Transmission  area.  Ile  distribution  of  the  participants  by  age,  sex  and 
transmission  area  is  shown  in  Figure  2.2.  At  the  start  of  the  study,  21.5%  (44)  and 
42.4%  (87)  were  infected  with  S.  haeniatobiuni  from  the  Low  and  I-ligh  Transmission 
areas,  respectively.  By  12  months  post-treatment  only  5.4%  (11)  and  14.1%  (29),  were 
re-infected  with  S.  haematobium  from  the  Low  and  High  Transmission  areas,  respectively 
(Figure  2.3). 
Parasitologically,  the  populations  from  the  two  areas  showed  a  distinct  difference  in 
infection  intensity,  before  treatment  (LT:  n=95,  U=2763.5  and  HT:  n=110,  U=7686.5; 
p=0.0001)  and  12  months  post-treatment  (LT:  n=88,  U=2765.5  and  IIT:  n=83, 
U=4538.5;  p=0.0062).  For  the  prevalence  of  infection  there  was  also  a  significant 
difference  between  the  two  areas  at  both  examinations  (before  treatment,  LT:  n=95, 
U=3512.5  and  HT:  n=110,  U=6937.5;  P=0.0001  and  after  treatment,  LT:  n=88, 
U=2791.0  and  HT:  n=83,  U=4513.0;  p=0.0114).  Ilie  distfibutions  of  infection 
prevalence  and  intensity  with  age  groups  are  shown  in  the  Figures  2.4  and  2.5. 
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In  the  Low  Transmission  area,  the  distribution  of  infection  prevalence  showed  no 
statisticafly  significant  difference  between  the  age  groups  before  treatment  using  Kruskal- 
Wallis  one  way  ANOVA.  However,  at  12  months  post-treatment  the  peak  prevalence 
was  observed  in  the  12-16  age  group  (Figure  2.4).  In  the  High  Transmission  area  the 
infection  prevalence  showed  no  statistically  significant  differences  between  the  age 
groups  (Figure  2.4  at  both  pre-  and  post-treatment  examinations.  However,  the  peak 
prevalence  of  infection  after  treatment  was  reached  in  the  9-11  age  group.  The 
prevalence  of  infection  remained  high  in  the  12-16  year  olds  while  those  17  and  above 
years  old  were  not  reinfected  (Figure  2.4). 
Tle  infection  intensity  in  both  areas  showed  interesting  features.  In  the  Low 
Transmission  area  before  treatment,  the  age  groups  below  17  years  old  showed  no 
difference  from  each  other,  but  they  were  different  from  adults  17  and  over  years  old 
who  had  low  infection  levels.  At  12  months  post  treatment,  peak  infection  intensity  was 
found  in  the  12-16  age  group  while  those  17  and  over  years  old  were  only  lightly  re- 
infected  (Figure  2.5).  In  the  IEgh  Transmission  area  before  treatment,  the  8  years  old  and 
below  age  group  had  lower  infection  intensity  compared  to  those  over  eight  years  old 
(Figure  2.5),  and  there  was  no  difference  between  the  other  three  age  groups.  By  12 
months  post-treatment,  the  8  years  old  and  below  age  group  had  high  re-infection 
intensity  of  20  eplOmL  which  was  different  from  the  other  age  groups.  Iliere  was  no 
detectable  reinfection  taking  place  in  those  above  17  years  of  age  (Figure  2.5). 
55 2.3.2  PBMC  PROLIFERATION  RESULTS  USING  THE  DYE  REDUCTION 
ASSAYS 
Detection  of  proliferation  after  antigenic  and  mitogenic  stimulation  of  PBMC  over  six 
days  using  the  chromogenic  dye-based  MTT  Promega'  kit,  gave  no  statistical 
differences  between  infected  and  uninfected  individuals  from  the  Low  Transmission  area 
before  treatment  (Figure  2.6).  Before  treatment  PBMC  from  uninfected  5-8  years  old 
age  group  showed  high  levels  of  proliferation  to  both  egg  and  cercarial  antigen 
stimulation  as  did  the  PBMC  from  infected  9-11  and  17+  years  old  age  groups.  At  12 
months  post-treatment  PBMC  from  uninfected  9-11  years  old  age  group  showed  high 
levels  of  proliferation  to  both  worm  and  egg  antigens  stimulation  as  did  PBMC  from 
individuals  uninfected  aged  17  and  above  (Figure  2.7),  while  the  PBMC  from  the 
uninfected  5-8  age  group  children  gave  high  levels  of  proliferation  to  cercarial  antigen. 
However,  the  PBMC  from  9-16  years  old  infected  children  post  treatment,  gave  higher 
levels  of  proliferation  to  CAP  than  the  PBMC  from  younger  children,  5-8  and  adults, 
17+  (Figure  2.7b).  None  of  the  above  trends  approached  statistical  significance. 
When  comparing  the  overaU  pattern  of  responses  in  the  Low  Transmission  area  before 
and  after  treatment  there  was  no  statistical  difference  within  each  age  group  for  all 
stimulants.  However,  when  looking  at  the  trends  in  responses,  the  PBMC  from  the  9-11 
age  group  gave  raised  levels  of  proliferation  with  worm,  egg  and  cercarial  antigens  afler 
treatment  compared  with  the  other  age  groups  where  proliferation  indices  were  usually 
lower  after  treatment  and  this  could  have  some  biological  importance  (Figure  2.8). 
56 Before  treatment,  there  was  no  statisticaRy  significant  difference  in  infection  intensity 
between  low  and  moderate/high  responder  categories,  where  responders  are  defined 
according  to  their  proliferative  stimulation  index  when  PBMC  samples  were  stimulated 
with  antigen  or  mitogen.  However,  on  mitogenic  stimulation  low  responders  tended  to 
have  higher  infection  intensities  than  moderate/high  responders  (Figure  2.9a).  Afler 
treatment,  there  was  no  statisticaRy  significant  difference  between  the  egg  output  of  the 
two  response  categories  for  the  mitogen.  However,  PBMC  from  those  excreting  eggs 
gave  low  responses  to  schistosome  antigen  whereas  the  PBMC  from  those  not  excreting 
eggs  had  moderate  or  high  responses  (Figure  2.9b). 
The  PBMC  from  individuals  living  in  the  IFEgh  Transmission  area  gave  no  statistical 
differences  in  responses  to  the  stimulating  agents  when  comparing  infected  and 
uninfected  individuals  within  each  age  group  (Figure  2.10).  However,  some  biological 
differences  were  observed  between  age  groups.  Infected  9-11  year  olds  gave  a  higher 
response  to  worm  antigen  stimulation  relative  to  those  of  other  age  groups  (Figure 
2.10a).  Responses  to  the  egg  antigen  were  high  in  the  PBMC  from  infected  individuals  in 
the  9-11  and  17+  age  groups.  The  PBMC  from  uninfected  children  below  8  years  old 
gave  a  higher  response  to  cercarial  antigen  than  those  from  the  other  age  groups  (Figure 
2.10b).  At  12  months  post-treatment  the  PBMC  from  the  9-11  age  groups  provided 
some  differences  between  those  from  infected  and  uninfected  for  the  egg  and  cercarial 
antigens  (Figure  2.1  lb).  Interestingly,  most  of  the  individuals  in  the  17  and  above  age 
group  were  not  re-infected. 
57 A  comparison  was  made  of  proliferative  response  categories  of  individuals  from  the  High 
Transmission  area  before  and  after  treatment  (Figure  2.12).  Ile  PBMC  from  the 
individuals  who  were  in  the  9-11  and  17+  age  groups  gave  a  higher  response  to  the  egg 
and  cercarial  antigen  stimulation  than  the  other  age  groups  before  and  after  treatment 
(Figure  2.12). 
Before  treatment,  there  was  no  statisticaRy  significant  difference  in  infection  intensity 
between  low  and  moderate/high  responders  categories.  However,  the  trends  on  cercarial 
antigen  stimulation  showed  that  low  responders  had  higher  infection  intensities  than 
moderate/high  responders  (Figure  2.13a).  In  contrast,  at  12  months  post-treatment  the 
individuals  with  moderate  and  heavy  infection  gave  high  levels  of  proliferation  to  all  the 
stimulants  except  cercarial  antigen  (Figure  2.13b). 
in  summary,  the  data  from  the  dye  reduction  assays  were  difficult  to  interpret  due  to  the 
lack  of  sensitivity  of  the  method.  All  the  stimulants  showed  similar  effects  on  the  PBMC 
from  infected  and  uninfected  individuals  before  and  afler  treatment  within  age  groups 
and  in  both  areas.  Isolated  raised  levels  of  proliferation  were  observed  on  stimulation  of 
PBMC  with  egg  and  cercarial  antigens  from  uninfected  individuals  in  the  9-11  age  group 
in  the  High  Transmission  area  before  treatment,  but  none  of  these  was  statistically 
significantly  different  from  their  infected  counterparts. 
Despite  the  lack  of  sensitivity  of  the  method,  an  interesting  comparison  was  apparent 
between  the  infection  intensities  of  infected  individuals  Who  were  low  or  moderate/high 
responders.  'Me  changes  in  these  patterns  resulting  from  chemotherapy  were  very 
58 different  in  the  two  areas,  when  using  both  worm  and  egg  antigens  to  generate 
proliferative  responses  (Figure  2.9  and  2.13).  In  both  areas  before  treatment,  the  worm 
burden  (as  detected  by  egg  output)  was  fairly  evenly  distributed  between  individuals  with 
PBMC  of  different  proliferative  abilities.  After  treatment  however,  most  infections  were 
in  Low  responders  in  the  Low  Transmission  area  but  in  the  moderate/high  responders  in 
the  lEgh  Transmission  area. 
2.3.3  STUDY  POPULATION  AND  PARASITOLOGY  OF  THE  COHORT  FOR 
PBMC  CYTOKINY,  PRODUCTION. 
Forty  children  were  selected  for  the  detailed  study  of  proliferation  and  cytokine 
production  of  PBMC  from  the  two  transmission  areas.  21  were  from  the  High 
Transmission  area  and  19  were  from  the  Low  Transmission  area.  Prior  to  treatment, 
66.7%  (14  )  children  from  the  High  Transmission  area  were  infected  with 
S.  haematobium,  with  a  mean  egg  count  of  85  eggs  per  10  nil  of  urine.  47.4%  (9)  from 
the  Low  Transmission  area  cohort  were  infected  with  mean  infection  intensity  of  36  eggs 
per  10  ml  of  urine  (Figure  2.14).  Drug  treatment  markedly  reduced  prevalence  and 
intensity  of  infection  at  12  months,  with  a  partial  recovery  to  pre-treatment  levels  at  18 
months,  in  both  areas.  In  the  High  Transmission  area  the  prevalence  of  infection 
increased  to  pre-treatment  levels  by  the  18  montlis  post-treatment,  while  infection 
intensity  increased  to  about  a  quarter  of  the  pre-treatment  level  by  the  18  montlis  post 
treatment  (18  eplOml  of  urine).  For  those  from  the  Low  Transmission  area,  the 
prevalence  and  intensity  of  infection  both  increased  slightly  between  12  and  18  montlis 
post  treatment  examination  (Figure  2.14).  The  prevalence  and  intensity  of  infection  in  the 
children  from  the  High  Transmission  area  was  significantly  higher  than  in  those  from  the 
59 Low  Transmission  area  before  treatment  (LT:  n--19,  U=1134.0,  HT:  n=21,  U=2106.0; 
p=0.0059  and  LT:  n--19,  U=1104.0,  HT:  n=21,  U=2136;  p=0.0034,  respectively)  and  at 
18  months  post-treatment  (LT:  n=18,  U=94.0,  HT:  n=20,  U=266.0;  p=0.0124  and 
p=0.0124,  respectively). 
2.3.4  PBMC  PROLIFERATION  USING  TRITIATED  THYMIDINE 
The  PBMC  from  infected  children  from  the  Low  Transmission  area  gave  higher  levels  of 
response  than  those  from  uninfected  children  to  both  the  schistosome  antigens  at  all  three 
times  examined  (Figure  2.15).  However,  response  to  the  mitogen  showed  no  differences 
between  the  infected  and  uninfected  children  at  any  time  point  (Table  2.1).  Comparing 
infected  or  uninfected  children  at  different  time  points  (e.  g.  PHA  stimulated  PBMC  from 
infected  children),  no  significant  differences  were  observed. 
In  the  High  Transmission  area,  proliferative  response  patterns  were  very  different  to 
those  observed  in  the  Low  Transmission  area.  The  PBMC  from  uninfected  children  had 
highly  significantly  increased  levels  of  proliferation  when  compared  to  those  from 
children  who  were  infected  before  treatment,  for  both  worm  and  egg  antigens  (Figure 
2.16  and  Table  2.2).  There  were  no  differences  between  the  responses  of  PBMC  from 
uninfected  and  infected  children  at  both  the  post-treatment  stimulations.  There  was  an 
overall  increase  in  cellular  response  to  all  the  stimulating  agents  amongst  infected 
children  after  treatment  compared  with  those  for  the  equivalent  children  before  treatment 
(Figure  2.16),  although  these  increases  were  not  statistically  significant,  except  response 
to  egg  stimulation  (Table  2.2). 
60 The  differences  in  proliferative  responses  of  children  living  in  the  two  areas  were 
reinforced  by  egg  intensity  in  low  versus  moderate/high  proliferative  responders  in  the 
Low  Transmission  (Figure  2.17)  and  High  Transmission  (Figure  2.18)  areas.  In  the  Low 
Transmission  area,  the  biological  trends  showed  that  the  groups  giving  moderate/high 
responses  to  the  stimulants  were  those  excreting  eggs  at  both  pre-  and  post-treatment 
examination,  while  the  group  with  low  responses  were  not  infected  (Figure  2.17).  This 
result  was  observed  with  all  three  stimulants.  In  contrast,  in  the  1-figh  Transmission  area 
before  treatment,  some  biological  differences  were  observed  where  the  PBMC  which 
gave  moderate/high  responses  to  the  worm  and  egg  stimulants  were  ftom  children  with 
very  light  intensities  of  infection.  After  treatment  this  pattern  was  dramaticaRy  reversed 
with  PBMC  from  more  heavily  infected  children  giving  moderate/high  responses  to  all 
the  stimulants  (Figure  2.18).  It  is  noteworthy  that  the  PBMC  ftom  infected  children 
living  in  the  Low  Transmission  area  gave  considerably  higher  levels  of  proliferation  on 
stimulation  with  both  schistosome  worm  and  egg  antigens  than  the  PBMC  from  infected 
children  living  in  the  High  Transmission  area,  compare  Figure  2.15  and  2.16. 
In  summ  ry,  the  cohort  comprised  of  40  school  children  aged  7-16  years  from  both  Low 
and  High  Transmission  areas.  The  patterns  of  PBMC  responses  as  determined  by 
incorporation  of  tritiated  thymidine  were  very  different  in  the  two  areas.  In  the  Low 
Transmission  area,  the  PBMC  from  infected  children  gave  higher  levels  of  proliferation 
than  the  PBMC  from  uninfected  children  on  stimulation  with  both  schistosome  antigens, 
this  pattern  was  not  changed  Mowing  chemotherapy  and  most  eggs  were  produced  by 
children  with  moderate/high  proliferative  responses.  In  the  High  Transmission  area, 
before  treatment,  PBMC  from  uninfected  children  had  higher  levels  of  proliferation  to  all 
61 stimulants  than  those  of  infected  children  and  most  eggs  were  produced  by  children  with 
low  proliferative  responses.  Tlese  proliferative  responses  were  reversed  after  treatment, 
higher  levels  of  proliferation  were  observed  in  the  infected  than  in  the  uninfected  children 
and  most  eggs  were  produced  by  children  with  higher  proliferative  responses. 
2.3.5  PBMC  CYTOKINE  PRODUCTION  PROF11LES. 
PBMC  samples  were  stimulated  in  ex  vivo  cultures  using  the  schistosome  egg  and  worm 
antigens  and  the  mitogen,  PHA,  and  production  of  four  cytokines  was  measured  in  the 
culture  supernatants:  IFN-y,  IL-4,  IL-5  and  IL-10. 
The  PBMC  from  infected  children  in  the  Low  Transmission  area  showed  trends  of 
producing  higher  levels  of  IFN-y  than  uninfected  children  to  all  stimulants  (Figure  2.19) 
but,  after  application  of  a  Bonferonni  correction  (p<0.017),  none  of  these  differences 
were  statistically  significant  except  for  the  comparison  at  18  months  when  PBMC  were 
stimulated  with  PHA  (Table  2.3). 
The  PBMC  from  the  infected  and  the  uninfected  children  in  the  Low  Transmission  area 
produced  similar  levels  of  IL-4  and  IL-5  at  all  time  points  for  all  the  stimulants  (Figures 
2.20  and  2.2  1;  Tables  2.4  and  2.5),  but  there  was  a  non  statistically  significant  trend 
towards  higher  levels  of  IL-4  production  in  PBMC  from  uninfected  children.  Tle  levels 
of  production  of  IL-  10  were  higher  from  the  PBMC  of  uninfected  children  than  those  of 
infected  children,  using  all  three  stimulants  before  treatment  and  12  months  after 
treatment  (Figure  2.22).  These  differences  approached  statistical  significance  when 
PBMC  were  stimulated  with  PHA  and  egg  antigen  before  treatment  and  for  the  worm 
62 and  egg  antigens  at  12  months  post  treatment  (Table  2.6).  A  comparison  was  made  of 
the  levels  of  IL-10  produced  by  PBMC  from  either  infected  or  uninfected  children 
between  any  two  of  the  time  points.  Only  one  difference,  PHA  stimulation  of  PBMC 
from  infected  children  at  pre-  and  18  months  post-treatment,  approached  statistical 
significance,  with  the  PBMC  from  the  re-infected  children  after  treatment  producing 
higher  levels  of  IL-  10  (Table  2.6). 
The  PBMC  from  the  infected  children  in  the  High  Transmission  area  produced  higher 
levels  of  IFN-y  compared  with  those  from  uninfected  children  at  all  three  time  points 
examined  (Figure  2.23).  The  PHA  stimulations  showed  significant  differences  at  12 
months  post  treatment  (Table  2.7),  but  there  was  no  statistically  significant  difference 
before  treatment  and  at  18  months  post-treatment  (Table  2.7).  The  schistosome  antigen- 
specific  stimulation  of  the  PBMC  from  infected  children  resulted  in  high  production  of 
IFN-y  (Figure  2.23)  for  both  antigens  before  treatment  and  12  months  after  treatment. 
The  comparison  between  infected  or  uninfected  groups  at  any  two  of  the  time  points 
showed  some  differences  which  were  not  statistically  significant,  in  which  higher  levels  of 
IFN--j  were  produced  by  the  PBMC  obtained  before  treatment,  and  at  12  months  post- 
treatment,  when  compared  with  18  months  post-treatment  (Table  2.7). 
Higher  levels  of  IL-4  were  produced  by  the  PBMC  from  infected  children  compared  to 
the  uninfected  children  before  treatment  but  this  pattern  was  reversed  at  12  months  and 
18  months  post-treatment  with  the  uninfected  children  producing  higher  levels  of  ILA 
than  the  re-infected  children  (Figure  2.24).  The  differences  between  levels  of  ILA 
production  in  infected  and  uninfected  children  approached  statistically  significance  (Table 
63 2.8).  In  terms  of  IL-4  production  the  PBMC  from  uninfected  children  when  compared 
between  time  points  showed  differences  between  pre-treatment  and  post-treatment,  with 
the  post  treatment  groups  producing  higher  IL-4  levels  at  both  12  and  18  months  (Figure 
2.24  and  Table  2.8).  No  difference  in  ILA  levels  could  be  observed  when  PBMC 
obtained  from  the  uninfected  children  at  12  months  post-treatment  were  compared  with 
those  from  the  equivalent  children  18  months  post-treatment  (Figure  2.24  and  Table 
2.8). 
The  pattern  of  results  for  IL-5  and  ILAO  were,  in  general  terms,  similar  to  those 
observed  for  ILA.  The  PBMC  from  infected  children  obtained  before  treatment 
produced  higher  levels  of  IL-5  compared  with  the  uninfected  children,  statistically 
significant  for  schistosome,  antigens  but  not  PHA  (Figure  2.25  and  Table  2.9).  A 
comparison  of  IL-5  production  by  PBMC  between  infected  and  uninfected  children  with 
PBMC  obtained  at  other  time  points  indicated  no  statisticafly  significant  differences  in 
responses  to  any  stimulant  at  other  time  point,  but  the  trends  showed  that  the  PBMC 
from  uninfected  children  produced  higher  levels  of  IL-5  cytokine.  The  PBMC  from  the 
uninfected  children  before  treatment  produced  lower  levels  of  IL-5  when  compared  with 
those  from  uninfected  children  at  both  12  and  18  months  post-treatment  (Figure  2.25) 
but  these  differences  were  not  statistically  significant  (Table  2.9). 
The  IL-10  levels  produced  by  PBMC  from  infected  children  were  higher  than  those 
produced  by  non-infected  children  before  treatment  but  not  at  either  12  or  18  months 
post-treatment,  but  there  was  a  trend  towards  lower  production  by  the  PBMC  from 
infected  children  after  treatment,  such  that  there  was  little  difference  in  levels  between 
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significant  differences  in  this  data  were  comparisons  of  IL-10  levels  produced  by  the 
PBMC  from  the  infected  children  before  treatment  and  18  months  post-treatment  which 
showed  higher  levels  were  produced  before  treatment  on  stimulation  with  both  PHA  and 
egg  antigen  (Table  2.10). 
These  cytokine  data  can  be  summarised  as  follows:  Cytokine  levels  produced  by  PBMC 
from  children  in  High  Transmission  area  were  several  fold  higher  than  the  levels 
produced  by  PBMC  from  children  in  Low  Transmission  area  at  all  time  points.  Ile 
PBMC  from  infected  children  from  both  areas  produced  higher  levels  of  IIFN-y  than 
uninfected  children  to  all  stimulants  at  all  time  points.  The  trends  of  IL-4  and  IL-5 
production  by  PBMC  from  children  in  Low  Transmission  area  showed  similar  levels 
between  infected  and  uninfected  children  before  treatment,  but  higher  levels  of  IL-4  were 
produced  by  PBMC  from  uninfected  than  infected  children  after  treatment.  The  trends  of 
IL-10  production  showed  uninfected  children  in  Low  Transmission  area  producing 
higher  levels  than  infected  children  at  all  time  points.  In  contrast,  the  PBMC  from 
infected  children  in  High  Transmission  area  produced  higher  levels  of  IL-4,  ILA  and  IL.  - 
10  than  uninfected  children  to  all  stimulants  before  treatment.  12  and  18  months  after 
treatment,  these  patterns  were  reversed  and  the  cytokine  levels  were  higher  from 
uninfected  children  than  the  infected  children  to  all  stimulants. 
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In  addition  to  investigating  the  changes  in  absolute  levels  of  cytokines,  described  above, 
the  changes  in  ratios  of  'signature'  cytokines  were  also  analysed.  This  analysis  was  based 
on  the  premise  that  Thl.  and  Th2  cytokines  cross-regulate  the  other  T  cell  subset  and 
changes  in  the  relative  abundance  of  Thl  and  Th2  cytokines  may  be  more  sensitive 
indices  of  the  in  vivo  T  cell  enviromnent  and  how  it  is  changed  in  response  to  infection, 
treatment  and  re-infection. 
In  both  areas,  the  PBMC  obtained  from  infected  children  before  treatment  produced 
significantly  higher  levels  of  IFN-y,  IL-4  and  IL,  5  than  PBMC  from  uninfected 
counterparts.  The  mean  ratios  of  the  cytokines  produced  by  the  PBMC  from  the  Low 
Transmission  area,  however,  gave  no  statistical  difference  between  infected  and 
uninfected  groups  for  IL-4:  IFN-y  and  IL-5:  IFN-y  (Tables  2.11  and  2.12).  However, 
there  was  a  clear  trend  toward  a  higher  ratio  among  uninfected  than  infected  children  12 
months  post-treatment  (Figure  2.27  and  2.28).  The  trends  in  the  IL,  10:  IFN-y  ratio  data 
indicated  higher  ratios  among  uninfected  than  infected  children  before  treatment  and  12 
months  post-treatment  for  all  the  stimulants  but  these  also  were  not  statistically 
significant  (Figure  2.29  and  Table  2.13). 
In  the  Iligh  Transmission  area  the  ratio  of  H,  4:  IFN-y  showed  no  difference  between 
infected  and  uninfected  children  for  all  the  stimulants  before  treatment  (Figure  2.30).  12 
months  post-treatment  there  was  higher  ratio  of  IL-4:  IFN-y  in  uninfected  than  infected 
children  and  on  stimulation  with  egg  antigen  these  differences  approached  statistical 
significance  (Table  2.14).  The  IL-5:  IFN-y  and  IL-10:  IFN-y  ratios  showed  no  statistically 
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addition  the  IL-5:  IFN-y  ratio  showed  no  statisticaUy  significant  differences  after 
treatment  (Figures  2.31  and  2.32).  There  were  however,  some  marked  differences  for  IL- 
10:  IFN-y  between  the  groups  at  12  and  18  months  post  treatment  for  all  the  stimulants; 
uninfected  children  produced  statistically  significantly  higher  ratios  of  IL-10:  IIFN-y.  ne 
trends  of  the  IL-4:  IFN-y,  IL-5:  IFN-y  and  IL-10:  IFN-y  ratios  all  indicated  that  the  PBMC 
from  the  uninfected  children  produced  high  ratios  of  IL-4,  IL-5  and  ILAO  to  IFN-y  for 
all  the  stimulants  (Figures  2.30,2.31,2.32  and  Tables  2.14,2.15,2.16). 
In  summary,  the  mean  ratios  of  the  cytokines  H,  -4:  IFN-y,  IL-5:  IFN-y  and  IL.  -IO:  IFN-y 
produced  by  PBMC  from  children  in  the  Low  Transmission  area  gave  no  significant 
differences  between  infected  and  uninfected  groups.  But  the  trends  showed  higher  ratios 
in  uninfected  than  infected  children,  particularly  12  months  after  treatment.  The  mean 
ratios  of  IL-4:  IFN-y  and  IL-5:  IFN-y  between  infected  and  uninfected  children  in  the  High 
Transmission  area  showed  similar  patterns.  Before  treatment,  there  were  no  differences 
but  12  and  18  months  after  treatment  the  ratios  were  higher  in  uninfected  than  infected 
children  to  all  stimulants.  IL,  10:  IFN-y  ratios  were  higher  in  uninfected  than  infected 
children  at  all  time  points. 
2.3.7  PROLIFERATION  AND  CYTOKINE  LEVELS 
Children  from  the  Low  Transmission  area  were  grouped  according  to  their  proliferative 
responses  and  their  cytokine  levels  compared.  No  differences  between  low  and 
moderate/high  proliferative  responders  were  observed  in  their  cytokine  levels  on  PHA 
stimulation  both  before  and  after  treatment  (Figure  2.33).  Equivalent  analyses  comparing 
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stimulation  produced  a  slightly  different  pattern  (Figures  2.34  and  2.35).  Before 
treatment,  the  PBMC  giving  moderate/high  proliferative  responses  to  both  worm  and 
egg  antigens  produced  higher  levels  of  FFN-y  and  IL-5,  whilst  the  PBMC  giving  low 
proliferative  responses  produced  higher  levels  of  IIL-10  (Figure  2.34a  and  2.35a).  After 
treatment,  the  PBMC  giving  low  proliferative  responses  to  worm,  but  not  egg  antigen 
produced  higher  levels  of  IL-5  than  the  PBMC  giving  moderate/high  responses  (Figure 
2.34b).  The  levels  of  IL-10  were  higher  in  the  PBMC  that  had  low  responses  to  the  egg 
antigen  stimulation  after  treatment  (Figure  2.35b),  whilst  the  levels  of  IFN-y,  IL-4  and 
IL-5  were  similar  for  the  response  groups. 
A  comparison  of  proliferative  responses  and  cytokine  production  in  the  Fligh 
Transmission  area  was  also  conducted.  PBMC  samples  giving  low  proliferative 
responses  on  stimulation  with  PHA  produced  higher  levels  of  IFN-y  and  IL-5  than  those 
giving  moderate/high  responses  before  treatment  (Figure  2.36a).  After  treatment,  the 
levels  of  IL-4  were  higher  among  the  PBMC  giving  low  proliferative  responses.  The 
response  to  the  worm  antigen  stimulation  gave  Mgh  production  of  IFN-y,  IL-5  and  IL-  10 
in  the  PBMC  giving  low  proliferative  responses  before  treatment,  but  after  treatment  no 
differences  could  be  found  between  the  two  response  groups  for  each  cytokine  (Figure 
2.37).  The  PBMC  which  had  low  proliferative  responses  to  egg  antigen  stimulation 
produced  higher  levels  of  all  four  cytokines  when  compared  to  the  PBMC  which  had 
moderate/high  responses,  before  treatment  (Figure  2.38a).  After  treatment,  high  levels  of 
IFN-y  were  produced  by  the  PBMC  giving  moderate/high  proliferative  response  to  egg 
68 antigen,  whilst  no  differences  could  be  found  between  the  two  groups  of  responders  for 
the  other  three  cytokines  (Figure  2.38b). 
In  summary,  proliferation  and  cytokine  levels  of  PBMC  from  children  in  Low 
Transmission  area  showed  that  similar  levels  of  cytokines  were  produced  from  PBMC 
showing  low  and  moderate/high  proliferative  responses  to  PHA  stimulation,  before  and 
after  treatment.  Ile  responses  to  both  schistosome  antigens  resulted  in  similar  patterns 
of  cytokine  levels  at  both  time  points  with  the  moderate/high  responders  producing 
higher  levels  of  IL-5  and  IFN-y  than  low  responders  before  treatment  and  lower levels  of 
IL-10  both  before  and  after  treatment.  Low  responding  PBMC  from  children  in  High 
Transmission  area  gave  higher  levels  of  IFN-y,  ILA  and  IL-10  to  all  stimulants  before 
treatment,  while  only  the  egg  antigen  stimulation  of  low  responding  PBMC  gave  high  IL, 
4  levels.  After  treatment,  the  trend  was  for  higher  levels  of  H-A  from  low  responders  to 
PHA  stimulation  and  higher  levels  of  IFN-y  produced  by  moderate  /high  responding 
PBMC  to  egg  antigen. 
2.3.8  T  HELPER  PHENOTYPE  RESPONSES 
An  attempt  was  made  to  classify  the  T  helper  response  phenotypes  of  individuals  in  this 
study  according  to  the  ratios  of  IL,  4:  IFN-y,  IL-5:  IFN-y  and  IL-10:  IFN-y  in  response  to 
stimulation  with  mitogen,  egg  or  worm  antigens.  'Me  data  for  children  from  the  Low 
Transmission  area  are  given  in  Table  2.17.  These  data  suggest  that  uninfected  children 
show  a  greater  tendency  to  a  ThO/2-like  response  than  infected  children  with  this 
difference  most  clearly  seen  in  the  IL-5:  IFN-y  and  IL-10:  IFN-y  ratio  in  response  to 
antigens.  A  sirailar  pattern  was  seen  in  the  equivalent  data  for  children  from  the  High 
69 Transmission  area  (Table  2.18).  Uninfected  children  showed  a  greater  tendency  to  a 
ThO/2-like  responses  than  infected  children  with  the  difference  most  clearly  seen  in  IL, 
4:  IFN-y  and  IL-5:  IIFN-y  ratio  in  response  to  schistosome  antigen  stimulation. 
2.4  DISCUSSION 
The  Low  Transmission  area  was  characterised  by  a  low  prevalence  and  intensity  of 
infection  in  the  resident  population.  There  is  only  restricted  access  to  the  perennial  river 
and  the  dam  and  as  a  result  only  seasonal  water  contact  is  likely.  Most  of  those  infected 
were  the  young  and  the  adult  males  who  access  the  restricted  water  points  in  the 
perennial  river  and  the  dam  As  might  be  expected  for  a  low  transmission  area,  there  was 
little  difference  between  the  age  groups  in  levels  of  infection  before  giving  treatment. 
After  treatment,  however,  the  pattern  of  infection  was  observed  to  reach  the  peak 
prevalence  and  intensity  of  infection  in  the  12-16  years  old  age  group,  and  some  adults 
17  and  above  years  old  were  reinfected,  perhaps  indicating  an  absence  of  protective 
immune  responses  in  those  individuals.  These  data  suggest  a  possible  slow  development 
of  immunity  in  areas  where  transmission  and  exposure  is  low. 
The  High  Transmission  area,  where  uncontrolled  water  contact  took  place  and  several 
open  water  bodies  were  widely  available  for  domestic  and  recreational  use  was 
characterised  by  very  high  infection  intensity  and  prevalence.  However,  at  12  months 
post  treatment  the  peak  of  infection  prevalence  occurred  in  the  9-11  years  old  age  group 
which  is  earlier  than  observed  in  the  Low  Transmission  area.  The  lower  age  group,  8 
years  old  and  below,  had  the  highest  infection  intensity  at  the  examination  after 
70 treatment.  The  adults,  17  years  old  and  above  who  had  been  infected  prior  to  treatment, 
generaRy  remained  uninfected  post-treatment,  suggesting  that  intense  transmission  might 
provide  a  greater  level  of  protective  immunity. 
A  comparison  of  the  reinfection  data  for  the  two  areas  is  consistent  with  an  interpretation 
that  immunity  plays  a  role  in  preventing  the  acquisition  of  infection,  which  has  been 
reported  by  others  to  be  age-related  (Elialife  et  aL,  1986;  WilUns  et  al.,  1987; 
Butterworth  et  aL,  1987,1992;  Haggi  et  al.,  1990;  Hagan  et  al.,  1987,1991;  Rihet  et 
aL,  1991;  Woolhouse  et  al.,  1991;  Dunne  et  al.,  1992;  Ndhlovu  et  aL,  1996).  Tle 
parasitology  data  from  the  two  cohorts,  one  for  which  proliferation  was  determined  by 
the  dye  reduction  method  and  the  other  for  which  proliferation  and  cytokine  production 
was  determined,  showed  similar  patterns  of  infection  prevalence  and  intensity.  Infection 
prevalences  and  intensities  were  very  low  after  treatment  in  both  areas  for  both  cohorts. 
However,  the  individuals  from  the  two  different  areas  showed  different  infection 
prevalences  and  intensities  even  when  re-infection  was  low  at  12  months  post-treatment. 
The  data  on  proliferative  responses  assessed  using  tritiated  Thymidine  uptake  and  on 
cytokine  production  are  limited  by  the  small  size  of  the  cohort  studied.  It  is  encouraging, 
therefore,  that  the  comparison  of  parasitological  data  between  the  smaller  and  larger 
cohorts  suggests  that  the  smaller  cohort  which  was  subjected  to  detailed  analysis  was 
likely  to  have  been  representative  of  the  larger  group.  There  were  several  instances 
where  analysis  of  the  data  for  the  smaller  cohort  indicated  clear  biological  trends  (for 
instance  in  the  similarity  of  patterns  for  Th2  'signature'  cytokines)  but  these  differences 
were  not  statistically  significant,  especially  after  necessary  application  of  a  Bonferonni 
71 correction.  It  seems  reasonable  to  assume  that  the  main  source  of  these  statistical 
limitations  is  the  small  n  values.  While  remaining  aware  of  this  important  statistical 
limitation  the  data  were  generally  interpreted  emphasising  the  biological  trends  observed, 
rather  than  the  statistical  significances  and  the  limitations  this  imposed. 
The  results  from  the  two  methods  used  in  determining  the  proliferative  responses  of 
PBMC  from  children  in  Low  and  11igh  Transmission  areas  showed  the  sensitivity  of  the 
two  methods  to  be  markedly  different  with  the  tritiated  thymidine  being  the  most 
appropriate,  reliable  and  sensitive  assay.  This difference  may  be  due  to  the  fact  that  one 
assay  measures  the  amount  of  tritiated  thymidine  that  is  incorporated  into  the  DNA 
during  blastogenesis  and  proliferation,  whilst  the  other  dye  reduction  assay  measures 
only  viable  cells  and  these  may  not  be  proliferating.  Tberefore,  the  results  discussed  here 
are  restricted  to  the  tritiated  thymidine  incorporation  assays. 
Proliferative  responses  to  the  specific  schistosome  antigens  of  PBMC  samples  from  the 
Low  Transmission  area  before  treatment,  showed  that  only  those  from  infected 
individuals  had  a  marked  response  to  stimulation.  Those  from  uninfected  individuals  did 
not  react  to  the  stimulus,  perhaps  indicating  that  they  had  not  previously  encountered 
schistosome  infection.  After  treatment,  the  proliferative  responses  in  uninfected 
individuals  remained  lower,  perhaps  indicating  a  lack  of  exposure  to  schistosome 
infection  in  uninfected  individuals,  than  those  in  reinfected  children.  Nevertheless,  after 
treatment  uninfected  individuals  showed  several  fold  increases  in  proliferative  responses 
to  stimulation  when  compared  with  pre-treatment  proliferative  responses  for  the 
uninfected  individuals.  At  18  months  after  treatment,  some  infected  individuals 
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though  they  were  infected,  and  this  may  indicate  that  immuno-modulation  had  taken 
place,  as  reported  in  other  studies  (Domingo  and  Warren,  1968;  Barsoum.  et  aL,  1982; 
Hofstetter  et  aL,  1983;  Feldmeier,  Gastl  and  Poggensee,  1985a,  b;  Gazzinelli  et  aL,  1985, 
Bahia-Oliveira  et  aL,  1992;  Auriault  et  aL,  1996). 
The  individuals  in  the  High  Transmission  area  had  high  infection  intensities,  including 
those  re-infected  after  treatment.  On  testing  PBMC  samples  for  proliferative  responses 
to  schisto  some-  specific  stimulation,  uninfected  individuals  before  treatment  showed 
higher  responses  than  infected  individuals,  suggesting  the  possibility  of  an  acquired 
protective  immunity.  'Me  infected  children  revealed  a  frequently  reported  immuno- 
modulation  of  their  responses  resulting  in  cellular  unresponsiveness.  This  seems  to  occur 
when  infections  are  intense  and  as  the  parasite  and  the  host  defences  establish  an 
apparent  equilibrium  enabling  continued  coexistence.  Similar  results  were  reported  in 
S.  mansoni-infected  patients  by  Colley  and  colleagues  (1977a,  1986),  Ottesen  and 
colleagues,  (1978),  Ellner  and  colleagues  (1985),  Gazzinelli  and  colleagues  (1985), 
Roberts  and  colleagues  (1993)  and  Ribeiro  de  Jesus  and  colleagues  (1993).  Grogan  and 
colleagues  (1996)  also  reported  similar  findings  to  this  study  of  low  proliferative 
responses  to  stimulation  with  schistosome  antigens  before  treatment  in  S.  haenzatobium- 
infected  patients. 
Infected  children  from  the  1-figh  Transmission  area  (in  the  age  range  7-  16  years  old), 
often  reported  showing  highest  infection  intensity  and  prevalence,  were  found  to  have 
lower  proliferative  responses  to  worm  and  egg  antigen  stimulation  before  treatment. 
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observed  by  Grogan  and  colleagues  (1996).  A  possible  interpretation  of  these  data  is  that 
antigens  became  available  for  immune  recognition  after  treatment,  and  thus  treatment 
may  have  promoted  the  development  of  a  protective  immune  response.  12  and  18 
months  after  treatment,  there  was  a  general  increase  in  proliferative  responses  in  both 
infected  and  uninfected  groups  of  individuals. 
Cytokine  production  in  response  to  the  stimulating  antigens  and  mitogen  showed 
contrasting  features  between  the  two  sites.  Ile  PBMC  from  infected  children  in  the  Low 
Transmission  area,  showed  raised  levels  of  proliferation  but  produced  only  small 
quantities  of  cytokines  when  compared  with  the  infected  children  in  the  High 
Transmission  area  who,  in  turn  had  very  low  levels  of  proliferation  but  gave  high  levels 
of  cytokine  production.  These  data  may  indicate  that  infected  children  in  the  two  areas 
are  at  different  stages  of  an  immune  response  in  which  there  is  a  marked  proliferative 
responses  during  low  infections,  Whilst  during  heavy  infections  the  deleterious  effect  of 
cellular  proliferation  is  modulated  (switched-off)  early  but  maintains  a  sufficient  cytokine 
flow  in  the  environment.  Such  an  interpretation  is  consistent  with  the  age/prevalence  and 
age/intensity  data  for  the  two  areas. 
The  involvement  of  raised  IFN-y  levels  in  driving  the  cellular  immune  response  was 
demonstrated  in  individuals  who  were  infected.  The  same  individuals  showed  raised 
proliferative  responses  and  taken  together  this  may  be  an  indication  of  a  newly  initiated 
(naive)  immune  response  to  the  infection  which  is  less  prevalent  in  this  Low 
Transmission  area.  Such  patterns  of  response  may  mark  the  existence  of  acute  infection 
74 in  individuals  living  in  the  Low  Transmission  area.  Confirmation  of  the  low  infection 
intensities  and  prevalences  of  infection  was  observed  by  the  cytokines  that  drive  the 
humoral.  responses,  IL-4  and  ILA  levels  which  were  similar  between  infection  groups, 
although  IL,  10  was  raised  in  the  uninfected  children  before  treatment  and  12  months 
after  treatment. 
In  the  ffigh  Transmission  area,  a  similar  cytokine  pattern  to  that  shown  in  the  Low 
Transmission  area  was  shown  by  the  raised  IFN-y  in  those  who  were  infected,  during  aH 
the  examination  times.  In  the  same  individuals,  raised  levels  of  IL-4  and  IL-5  were  also 
observed,  which  is  consistent  with  the  dominance  of  IL-4,  IL-5  and  IL-  10  later  in  chronic 
infections.  The  data  is  indicative  of  the  counter-balancing  of  ILA,  IL-10  and  IFN-y, 
opposing  or  downregulating  each  other's  effects,  especiaBy  before  treatment  was 
administered.  ILA  and  H,  5  were  markedly  raised  in  uninfected  children  after  treatment. 
Similar  results  were  reported  by  Grogan  et  aL,  (1996)  of  restored  and  increased  IL-4 
levels  post  treatment  from  S.  haematobium  patients,  also  from  the  studies  by  Roberts  et 
al.,  (1993)  on  S.  mansoni  patients  who  had  elevated  levels  of  IL,  5  in  those  who  were  said 
to  be  resistant  to  infection.  The  same  effect  was  shown  for  ILAO  after  treatment.  It  is 
reasonable  to  suggest  therefore  that  these  raised  levels  of  IL-4,  IL-5  and  IL-10  indicate 
that  drug  treatment  has  had  an  immimising  effect. 
The  patterns  of  the  production  of  the  cytokines  IFN-y,  IL-4  and  IL-5  in  individuals  from 
the  two  different  areas  in  relation  to  infection  intensity  and  prevalence  are  likely  to  be 
indicative  of  the  way  the  immune  response  is  evoked  and  matures  in  different 
transmission  situations.  In  the  High  Transmission  area  the  children  were  heavily  infected 
75 and  possibly  had  cellular  responses  that  matured  earlier  and  are  being  driven  by  IIFN--f- 
At  the  same  time,  the  cytokines  IL-4  and  IIL-5  were  raised  to  drive  the  humoral  immunity 
which  may  potentially  be  involved  in  the  attrition  of  the  parasite  through  ADCC 
mechanisms.  In  addition  IL-4  and  ILAO  could  serve  to  downregulate  the  harmfid  effects 
of  any  otherwise  uncontrofled  and  rapid  ceHular  mobilisation  which  is  being  driven  by  the 
higher  levels  of  IFN-y  (Del  Prete  et  aL,  1988,1993;  Fiorentino  et  aL,  199  1;  Kamogawa 
et  aL,  1993;  Del  Prete,  Maggi  and  RomagnanL  1994). 
Before  treatment  with  praziquanteL  most  of  the  ratios  of  IL-4:  FFN-y,  IL-5:  IFN-y  and  IL.  - 
10:  IFN-y  were  lower  than  2.5  for  most  groups  of  children  in  both  areas  and  irrespective 
of  stimulant.  This  may  indicate  the  involvement  of  all  the  cytokines  in  trying  to  limit 
infection  and  indicate  their  co-operative  role  which  fimctions  in  part  through  cross- 
regulation.  However,  an  exception  to  this  finding  is  IL-5.  Higher  IL-5:  IFN-y  ratios  were 
common,  perhaps  reflecting  the  role  IL-5  may  play  in  populations  living  in  areas  where 
they  are  exposed  to  a  variety  of  other  helminths  (Lopez  et  al.,  1988;  Mahanty  et  al., 
1997),  in  this  study  area  exposure  was  to  S.  haematohiuni. 
This  observation  supports  the  reports  of  eosinophilia  as  one  of  the  hallmarks  of 
schistosome  infections  (Butterworth  et  al.,  1982;  Hagan  et  al.,  1985a,  b).  Ile  individuals 
in  the  current  study  showed  higher  ratios  of  IL.,  IO:  IFN-y,  perhaps  indicating  the 
involvement  of  this  cytokine  in  modulating  the  effects  of  WN-y,  as  suggested  in  the 
context  of  parasite-specific  anergy  in  human  urinary  schistosomiasis  by  King  and 
coHeagues,  (1996).  At  12  and  18  months  post-treatment,  the  effects  of  the  mechanisms 
that  drive  humoral  responses  could  be  dominating,  which  is  a  possible  interpretation  of 
76 the  high  ratios  of  IL,  4:  IFN-y  and  IL,  5:  IFN-y  which  were  above  2.5  for  the  specific 
schistosome  antigens  stimulation  in  uninfected  children  living  in  the  High  Transmission 
area. 
The  cytokine  phenotypes,  as  determined  using  the  ratios  of  the  'signature'  cytokines 
known  to  mark  each  T  helper  subset,  showed  that  individuals  living  in  different  areas  of 
transmission  in  an  endemic  region,  have  similar  cytokine  profiles  marking  their  immune 
responses.  Tlle  PBMC  produced  a  mixture  of  cytokines  suggesting  both  Thl  and  Th2 
cell  phenotypes  were  involved  during  infection.  All  the  uninfected  and  non  re-infected 
children  produced  a  pattern  of  ThO/2-like  or  a  strong  110/2-like  cytokine  responses.  The 
infected  children  had  mixed  classes  of  cytokines  in  their  peripheral  blood  environment, 
showing  some  individuals  with  a  110/1-like  and  a  few  with  TbO/2-like  responses.  I'lie 
infected  children  showed  the  balance  tipping  towards  the  TbO/I-Iike  response  which 
could  have  contributed  to  the  individuals  with  the  ThO/I-like  cytokine  phenotype  being 
susceptible  to  infection. 
Tle  cytokine  balances  determined  from  PBMC  stimulation  with  the  schistosome  antigens 
and  phytohaematoglutinin,  can  help  in  determining  the  parameters  that  control  Immoral 
and  cellular  immune  responses  during  S.  haenzatobium  infection.  Ile  PBMC  stimulation 
by  schistosome  -specific  antigen  can  produce  cytokines  whose  quantitative  levels  may 
show  the  dominating  T  helper  type  of  response.  Human  T  helper  subsets  being  classified 
as  'MO/I  and  ThO/2,  the  balance  and  imbalance  points  to  either  susceptibility  or 
protection,  with  a  TbO/2-like  cytokine  response  dominating  in  uninfected  individuals. 
However,  any  small  quantitative  change  in  a  particular  parameter  of  the  cytokine  profiles 
77 of  the  immune  response  can  switch  the  host  from  susceptibility  to  protection,  or  vice 
versa,  depending  on  the  balances  of  the  contrasting  'signature'  cytokine  profiles  in  the 
enviromment  which  are  believed  to  be  cross-inhibitory  to  each  other.  Ile  ThO/2-like 
subset  cytokines  are  believed  to  enhance  secretion  of  antibodies  either  by  causing 
selective  proliferation  or  maturation  of  B  cells  already  committed  to  the  isotype 
production  or  increasing  the  frequency  with  which  B  cells  switch  to  the  expression  of 
those  isotypes  that  maybe  involved  in  ADCC,  the  cytokine  phenotype  thus  denoting  a 
protecting  immune  status  (Finkelman  et  al.,  1986;  Coffman  et  al.,  1988;  King,  Low  and 
Nutman,  1993;  Del  Prete,  Maggi  and  RomagnanL  1994). 
The  'MO/1-like  cytokine  phenotype  observed  in  this  study  can  not  be  considered  as 
inducing  susceptibility  to  schistosome  infection  but  may  possibly  indicate  a  driving  role 
of  110/1-like  cytokines  in  the  early  responses  to  infection.  IFN-y  has  been  suggested  to 
be  involved  in  conferring  protection  when  found  in  high  levels  in  resistant  individuals 
infected  with  S.  mansoni  in  a  Kenyan  study  by  Roberts  et  aL,  (1993).  But  in  this  present 
study,  it  was  observed  that  when  a  'MO/1-like  phenotype  dominates,  the  individuals  were 
liable  to  infection.  Perhaps  due  to  lack  of  the  effectors  which  mediate  protection  and 
which  are  marked  by  a  TbO/2-like  phenotype.  IL-4  and  IL-5  which  mark  the  110/2-like 
response  are  known  to  stimulate  B  cells  to  selectively  mature  and  proliferate  for 
production  of  particular  antibody  isotypes,  which  could  ultimately  be  involved  in  ADCC 
reactions  resulting  in  multiceflular  parasite  killing  and  preventing  any  further  invasion. 
Ile  ThO/1-like  cytokine  shown  by  IFN-y,  was  found  to  exist  during  infection  but  the 
cytokine  persisted  at  lower  levels  in  uninfected  individuals  before  and  after  treatment, 
indicative  of  a  dynamic  system  which  possibly  begins  with  raised  levels  of  IFN-y,  a  710/1 
78 cytokine;  and  ThO/2-like  responses  dominating  later  in  the  response  to  infection  (Vella 
and  Pearce,  1992),  with  this  shift  in  response  phenotype  being  enhanced  by  praziquantel 
treatment.  This  study  has  shown  the  existence  of  a  cytokine  "see-saw"  balance  in  humans 
infected  or  uninfected  with  S.  haematobium. 
Although  dominance  of  IFN-y  may  be  associated  with  susceptibility  to  schistosome 
infection,  the  findings  of  this  study  also  suggest  that  it  may  be  involved  in  some  early 
stages  of  the  immune  response  to  schistosome  infection.  IFN-y  is  generally  involved  in 
DTH  reactions  dominating  in  individuals  having  acute  infections.  During  this  period  the 
finmune  response  is  involved  in  antigen  processing  and  mobilisation  of  the  cellular  ving 
in  which  IFN-y  plays  a  key  role.  Also  IFN-y  has  been  reported  to  help  APCs  express 
MIFIC  class  II  required  for  antigen  processing  (Marrack  and  Kappler,  1994;  Sprent, 
1994). 
As  reported  in  several  other  studies  and  reviews  cited  in  Section  2.1  for  both  S.  mansoni 
and  S.  haematobium  infections,  M-like  responses  are  considered  protective  and  the  data 
presented  in  this  study  support  this  conclusion.  The  potential  role  played  by  Thl  and  U2 
cytokines  in  individuals  from  areas  of  low  and  high  transmission  have  been  further 
clarified  by  the  data  presented  in  this  chapter.  Individuals  in  high  transmission  areas  of 
S.  haematobium  are  likely  to  be  sensitised  more  than  individuals  in  Low  Transmission 
areas,  as  shown  by  high  cytokine  production  to  schisto  some-  specific  antigen  stimulation. 
However,  infection  with  S.  haeniatobiuni  in  individuals  in  the  Low  Transmission  area 
may  exist  in  an  acute  phase  such  that  levels  of  proliferation  to  schisto  some-  specific 
antigen  stimulation  remain  raised.  The  reports  of  T  cell  anergy,  shown  by  T  cell 
79 unresponsiveness  to  stimulation,  was  observed  in  heavily  infected  individuals  from  the 
HP-h  Transmission  area.  These  data  may  be  helpful  in  future  vaccine  distribution  to  C7- 
individuals  living  in  different  transmission  areas.  Further  studies  are  required  however  on 
larger  populations  which  should  consider  the  cytokine  profiles  in  adults  as  well  as 
children  with  follow-up  at  closer  time  intervals. 
80 Figure  2.1:  Fxamples  of  standai-d  curves  used  in  the  detennination  ofthe  cytokine 
concenti-ation.  (i)  ll,  -N-v,  (ii)  IL-4,  (iii)  IL-5  and  (iv)  11,10. 
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82 Figure  2.2:  The  distribution  of  the  study  population  before  treatment  examination 
according  to  age,  sex  and  transmission  area. 
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9-  11  12-  16  17  1- Figure  2.3:  Intensity  (mean  ±S.  E)and  prevalence  of  infection  in  the  colion  for  which 
proliferation  of  PBMC  was  determined  by  the  dye  reduction  method  fi-oill  tile  two  study 
areas,  before  and  12  months  after  treatment  with  praziquantel.  Intensity  and  prevalence 
were  determined  by  filtration  of  10  ml  urine  samples  on  each  of  three  consecutive  days. 
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Pre-t  rea  tn  ien  t  12  motiths 
Pre-treatment  12  montlis Figure  2.4:  llý-evalence  of  infection  according  ,  to  age  groups  ill  the  collort  fi-om  tile  two 
study  ai-eas  for  which  prolifet-ation  of  PBMC  was  determined  by  the  dye  reduction 
method,  before  and  12  months  aftei-  ti-eatment  with  pi-aziciliantel.  h-evalence  was 
cleten-nined  by  filti-ation  of  10  ml  urine  samples  on  each  of  thi-ee  consecutive  days. 
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9-  11  12  -  10 
Age  groups  (years) Figure  2.5:  Intensity  of  infection  according  to  age  groups  in  the  cohort  fi-om  the  two 
study  areas  Im  which  1)  ro  life  ration  of  PBMC  was  determined  bv  the  dve  reductioli 
method,  before  and  12  montlis  after  treatment  with  praziquantel.  Intensity  was 
determined  by  filtration  of  10  mi  urine  samples  on  each  of  three  consecutive  days. 
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9-  11  12  -  16  17, Figure  2.6:  Proliferation  (mean  Sl  ±  SD)  of  the  PBMC  fi-oin  individuals  fiving  in  the 
Low  Transmission  ai-ea  as  detected by  the  dye  i-eduction  assay,  showing  the  i-esponse 
accoi-ding  to  infection  status,  stimulant  and  age  groups  befoi-e  tivatment. 
4 
X 
(U 
"C 
0 
5-811  12-  16  17 
Figure  a  Age  groups  (years) 
Legend  for  Figure  a 
PHA  minfected 
PHA  infected 
SWAP  aninfected 
SWAP  infected 
Legend  for  Figure  b 
SEA  uninfected 
SEA  infected 
CAP  uninfected 
CAP  infected 
6 
)4 
0 
0 
5-811  12-  16  17 
Figure  b 
Age  gro  Lips  (yeai-s) 
87 Figure  2.7:  Proliferation  (mean  Sl  ±  SD)  of  the  PBMC  from  individuals  living  in  Low 
Transmission  area  as  detected  by  the  dye  reduction  assay,  shov.,  ing  the  response 
according  to  infection  status,  stimulant  and  age  groups  after  treatment  with  praziquantel. 
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5-9  9-  11  12  -  10  17 
Figure  b  Age  groups  (yeai-s) Figure  2.8:  Proliferation  (inean  Sl  ±  SD)  of  the  PBMC  firom  infected  and  uninfected 
individuals  living  in  Low  Transmission  area  as  detected  by  tile  dye  reduction  assay 
comparing  responses  before  and  after  treatment  with  praziquantel. 
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Age  gl-OLIPS  (YC,  11'S) Figure  2.9:  Infection  intensity  (ep  I  Oml  mine,  mean  ±S.  11.  )  and  prolifet-ation  classes  (low 
and  moderate/high)  ofthe  PBMC  fi-om  individuals  fi-om  the  Low  Transmission  ai-ea,  as 
detected  by  the  dye  reduction  assay,  before  (a)  and  afier  (b)  ti-eatment  with  praziquantel. 
Onoi-e  values  are  shown  in  Appendix  'Fable  6.1  ). 
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IIIIA  SWIM,  SFA  CAP Figure  2.10:  Proliferation  (mean  Sl  ±  SD)  of  the  PBMC  fi-om  individuals  living  in  the 
I  ligh  Transmission  area  as  detected  by  the  dye  i-eduction  assay,  showing  the  response 
according  to  infection  status,  stimulant  and  age  groups  before  treatment. 
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Age  groups  (years) Figure  2.11.  Proliferation  (mean  Sl  ±  SD)  of  the  PBMC  li-om  individuals  living  ill 
the  I  ligh  Transmission  area  as  detected  by  the  dye  reduction  assay,  shoving 
the  response  according  to  infection  status,  stimulant  and  age  groups  afier 
treatment  with  praziquantel. 
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Age  groups  (-years) Figure  2.12:  Proliferation  (mean  Sl  ±SD)  of  the  PBMC  fi-onfl  infected  and  uninfected 
individuals  living  in  High  Transmission  area  as  detected  by  the  dye  reduction  assay 
comparing  responses  before  and  after  treatment  with  praziquantel. 
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SWAP Figure  2.14:  Intensity  and  prevalence  of  infection  in  the  cohort  for  which  proliferation 
and  cytokine  production  of  PBMC  were  deten-nined  frorn  the  two  study  areas,  before,  12 
and  18  months  after  treatment  with  pranquantel.  Intensity  and  prevalence  were 
determined  by  filtration  of  10  ml  urine  samples  on  each  of  three  consecutive  days. 
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95 Figure  2.15:  Proliferation  (mean  SI,  ±  S.  E  of  inean)  of  the  PBMC  fi-om  the  cohon  living 
in  Low  Transmission  area  for  which  proliferation  and  cytokine  production  was  etermined 
accoi-dinO  to  infection  status  with  follow-up  time  following  treatment  with  praziquantel, 
(moi-e  values  are  showii  in  Appendix  Table  6.3). 
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Table  2.1.  Showing  the  significance  levels  between  the  comparison  ol'two  groups  of' 
diffierent  infection  status  or  fiollow-tit)  time.  usina  the  Rank  sum  test- 
Groups  z  value  P  Val  tic  Groups  z  value  P  Value  Groups  z  Value  P  vallic 
a  vs  b  -0.1491  0.8815  a  vs g  -0.7454  0.4561  j  vs  p  -0,8381)  0.4015 
c  vs  d  -2.2361  0.0253  b  vs  li  -1,0170  0.3092  k  vs  q  -2.1213  0.0331) 
0  vs  f  -2.2361  0.0253  c  vs  1  -0.7454  0.4561  L  vs  r  -0,7506  0.4521) 
g  vs  11  -1.3809  Oý  1655  d  vsj  -L2019  0.2294  111  vs  a  -1.7146  0.08ol 
I  vsj  -2.3113  0.0208  e  vs  k  -0.4472  0.6547  n  vs  b  -0.4623  0.6431) 
k  vs  L  -2.4962  0.0126  f  vs  L  -1.3868  0.1655  o  vs  c  ().  0000  1.0000 
III  vs  11  -1.0801  0.2801  g  vs  ill  -0.3536  0.7237  p  vs  d  -0.2774  0.7915 
0  vs  p  -2.1602  0.0308  11  vs  11  -1.4570  0,1451  q  vs  e  -0.2449  0.80oý, 
q  vs  1-  -2.1002  0.0308  1  vs  o  -0.7071  0.4795  1.  vs  f  -0.6472  0.5  17ý 
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Pre-treatment  12  months  IS  illontlis 
1,01low-up  tillie Figure  2.16:  Proliferation  (mean  SI,  ±  S.  E  of  mean)  of  the  13BMC  fi-oill  the  colloll  living 
in  I  ligh  Transmission  area  for  which  proliferation  and  cytokine  production  was 
determined  according  to  infection  status  "ith  fiollow-up  time  following  treatment  with 
praziquantel,  (more  values  are  shown  in  Appendix  Table  6.4). 
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'Fable  2.2:  Showing  the  significance  levels  between  the  comparison  ol'two  groups  of' 
(fillerent  infection  status  or  follow-m)  time.  usina  the  Rank  min  teý,  t 
Groups  z  valtio  P  value  Groups  I 
z  Value  P  Value  Groups  z  value  P  value 
a  vs  b  -2.6112  0.0090  a  vs  g  -0.9139  0.3608  j  vs  p  -2.6112  0.0090 
c  vs  d  -2.7417  0.0061  b  vs  h  -0.2447  0.8065  k  vs  q  -1.5286  0.1264 
o  vs  f  -2.9723  0.0041  c  vs  i  -1.9584  0.0502  L  vs  r  -0.9400  0.3472 
o n  vs  h  -1.7146  0.0864  d  vs.  j  -0.9798  0.3272  111  vs  a  -L3212  0.1864 
I  "'S.  j  0.0000  1.0000  e  vs  k  -2.7417  0.0001  n  vs  b  -1.4097  0.141o 
k  vs  L  -1.7146  0.0864  f  vs  L  -2.2045  0.0275  o  vs  c  -1.0734  0.2831 
III  vs  11  -0.5855  0.5592  g  vs  111  -0.5095  0.0104  p  vs  d  -2.4495  0.0143 
0  vs  p  -0.2928  0.7697  11  vs  Il  -1.3579  0ý  1745  q  vs  e  -2.2295  0,02  ýS' 
q  vs  r  -0.5,955  0.5582  i  vs  o  -0.8492  0.3958  1.  vs  f  -1.714o  0.08o4 
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P  re-  I  rea  tin  en  12  in  o  it  th  s  IS  111011111S 
Follow-tip  time Figure  2.17:  Infection  intensity  (ep  I  Oml  mine,  ±  S.  E.  of  mean)  and  prolifieration  classes 
(low  and  moderate/high)  of  the  PBMC  fi-om  individuals  fi-oni  the  Low  Transmission 
area,  for  which  proliferation  (determined  using  t6tiated  thymidine)  and  cytokine 
production  was  determined,  before  (a)  and  12  months  after  (b)  treatment  With 
praziquantel,  (more  values  are  shomi  in  Appendix  Table  6.5). 
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PHA  SWAP 
Stilliukult Figure  2.18:  Infection  intensity  (ep  I  Oml  utine,  ±  S.  E.  of  mean)  and  proliferation  classes 
(low  and  moderate/high)  of  the  PBMC  fi-om  individuals  fi-om  tbe  High  Transmission 
area,  for  which  proliferation  (detected  using  tfitiated  thymidine)  and  cytokine  production 
was  determined,  before  (a)  and  12  nionths  after  (b)  treatment  with  praziquantel,  (moi-e 
values  are  shomi  in  Appendix  Table  6.6). 
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99 Figure  2.19:  IFN-garmna  levels  (±  S.  E.  of  mean)  according  to  stimulant  and  schistosome 
infection  status  of  the  children  fi-om  the  Low  Transmission  area  with  follow-up  time 
following  treatment  with  praziquantel,  (more  values  are  shown  in  Appendix  Table  6.7). 
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Table  2.3:  Showing  the  significance  levels  between  the  comparison  oftwo  groups  of 
different  infection  status  or  same  infection  stattis  but  at  difTerent  fOllOW-LIJ)  time  (tising 
the  Rank  sum  test). 
Groups  z  value  P  value  GrOLIPS  z  value  P  value  Groups  z  value  P  value 
a  vs  b  -1.9432  0.0520  a  vs  g  -0.3429  0.7317 
-j 
vs  p 
- 
-0.9239  0.3550 
c  vs  d  -1.6003  0.1095  b  vs  li  -0.8660  0.3865  k  vs  q  -2.1213  0.0339 
c  vs  f  -2.1652  0.0304  c  vs  i  -0.4572  0.6475  L  vs  r  -0,4267  0.6696 
g  vs  11  -1.0835  0.2786  d  vsj  -1,4434  0.1489  In  vs  a  -1.3259  0.1849 
I  vsj  -2.3094  0.0209  e  vs  k  -0.2286  0.8  196  n  vs  b  -1.3868  0.1655 
k  vs  L  -2.3115  0.0208  f  vs  L  -1.0113  0.3119  0  vs  c  -1.1890  0.8501 
III  vs  11  -2.6232  0.0087  g  vs  111  -0,7071  0.4795  p  vs  d  -0.4623  0.6431) 
0  vs  p  -0.6172  0.5371  11  vs  11  -1.2081  0.2270  q  vs  o  -2.4568  0.0140 
q  vs  r  -0.7726  0.4398  i  vs  o1  -0.1794 
1  0.8584  1  r  vs  f  -0.6483  0.5  16,9 
100 
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Pre-treatment  12  months  IS  111ontlis 
Follow-tip  time Figure  2.20:  IL-4  levels  (±  S.  E.  of  mean)  according  to  stimulant  and  schistosonle 
infection  stattis  of  the  children  fi-oni  the  Low  Transmission  area  vith  fiollow-up  time 
fiolio"ing  treatment  "ith  praziquantel,  (more  values  are  showi  in  Appendix  Table  6.8). 
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'Fable  2.4:  Showing  the  significance  levels  between  the  comparison  ol'two  groups  of' 
diffierent  infiection  stattis  or  same  infiection  stattis  but  at  diffierent  fiollow-up  time,  using- 
the  Rank  stim  test. 
Groups  z  val  tic  P  Value  Groups  z  value  P  value  Groups  z  val  tic  P  value 
a  vs  b  -1.0435  0,2967  a  vs  g  0.0000  1,0000 
.1 
vs  p  0000  1.0000 
c  vs  d  -0,7498  0.4534  b  vs  li  -1.3410  0  1797  k  vs  q  0000  1.0000 
0  vs  f  -1.3416  0.1797  c  vs  1  -1.7748  0.0751)  L  vs  r  -09799  0.3272 
g  vs  11  -0.7746  0.4386  d  vs.  j  -1.3416  0.1797  111  vs  ýl  -0,4899  0.6242 
I  vs.  j  -1.5492  0.1213  o  vs  k  -0,3973  0.6995  n  vs  b  -1.0607  0.2998 
k  vs  L  -1,1619  0.2453  f  vs  L  -1.3416  0,1797  0  vs  c  -0.4920  0.0228 
III  vs  11  0.0000  1.0000  g  vs  111  0.0000  1.0000  p  vs  d  -1  0607  0.2988 
0  vs  p  -0,5  774  0.5637  11  vs  n  -0.7348  0,4024  q  vs  c  -0.1230  0.0021 
q  vs  r  -1.1547  0ý2482  I  vs  o  -1.951o  0,0641  r  vs  f  1 
-1,0007 
1  0,2888  1 
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Pre-tivatment  12  months  18  months 
Folloýý-up  tinie Figure  2.21:  1  L-5  levels  (±  S.  E.  of  mean)  according  to  stimulant  and  schistosonle 
infection  status  of  the  children  fi-om  the  Low  Transmission  area  with  follow-III)  time 
following  treatment  with  praziquantel.  (more  values  are  shown  in  Appendix  Table  6.9) 
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Table  2.5:  Showing  the  significance  levels  between  the  comparison  of  two  groups  of' 
diffierent  infection  status  or  saine  infection  status  but  at  diffierent  flollow-up  time,  using, 
the  Rank  stim  test. 
Groups  z  value  P  Value  Groups  z  value  P  Value  Groups  z  Value  P  Value 
a  vs  b  -0,2582  0.7963  a  vs g  -0.5164  0.6056  j  vs  p  -0.9891  0.3220 
c  vs  d  -1.5492  0,1213  b  vs  h  -0.7217  0,4705  k  vs  q  0.0000  1.0000 
e  vs  f  -0.7746  0.4386  c  vs  1  -0,7740  0.4380  L  vs  r  -0.0330  0.9737 
g  vs  11  -0.4330  0.6650  d  vs.  j  -1.0104  0.3123  111  vs  a  -0.6396  0.5224 
I  vsj  -1.1547  0.2482  o  vs  k  -0.2582  0.7963  n  vs  b  -1.0142  0.3105 
k  vs  L  -0.4330  0.6650  f  vs  L  -0.4330  0.6650  o  vs  c  -0.2132  0,8312 
III  vs  11  -1.5556  0.1198  g  vs  111  -1.0607  0,2988  p  vs  d  -1.5213  0.1292 
0  vs  p  -0.1414  0.8875  11  vs  11  -0.7913  0.4288  q  vs  e  -0.2132  0,8312 
q  vs  r  -1.4142  0.1573  i  vs  0  -0.3536  0.7237  1r  vs  f  -05924  0.5530  1 
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p  re-t  reat  III  ell  t  12  months  18  months 
Follow-up  time Figure  2.22:  IL-  10  levels  (±  S.  F.  of  mean)  according  to  stimulant  and  sclustosonie 
infection  status  of  the  children  fi-oin  the  Low  Transmission  area  with  follow-Lip  tinie 
following  treatment  with  prazicluaritel,  (more  values  are  showii  in  Appendix  Table  6,10), 
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'Fable  2.6:  Showing  the  significance  levels  between  the  comparison  ol'two  groups  of' 
different  infiection  status  or  same  infection  stattis  but  at  dillerent  follow-up  time,  using 
the  Rank  stim  test. 
Grou  s  z  value  P  val  tie  Groups  z  value  P  value  Groups  z  value  P  VIlLlC 
av 
rsb 
-2.2361  0.0253  .1  vs  g  -1.1619  0.2453  vs  p  -0.6630  0.5074 
c  vs  d  c  vs  d  -1.9496  0.0512  b  vs  11  -0.4623  0.6439  k  vs  q  -1.8516  0.0641 
ý_f  _r  e  vs  f  -  2.2361  0.0253  c  vs  i  -1.2058  0.2279  L  vs  r  -1.6336  0.1023 
vs  11  -1,1785  0.2386  d  vs.  j  -0.4631  0.6433  111  vs  a  -2.4495  0.0143 
i  vs  -2.1262  Oý0335  e  vs  k  -1.9365  0,0529  n  vs  b  -0,2774  0.7915 
k  vs  L  -2.1213  0,0331)  f  vs  L  -0.8321  0.4054  o  vs  c  -19078  0.0491 
III  vs  11  -03086  0,7576  g  vs  111  -1.8516  0.0641  p  vs  d  -0.4031  0,0433 
0  vs  p  -0.8510  0,3948  11  vs  11  -0.6030  0.5074  q  vs  o  -1,2247  0  2207 
q  vs  r  -1.2344  0.2170  i  vs  o  -1.9516  0.0041  r  vs  f1  -2.1204  1  0.0335_j 
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P  re-t  reat  III  c  [It  12  months  IS  111011ths 
Follow-tip  time Figure  2.23:  IFN-gamma  levels  (±  S.  E.  of  mean)  according  to  stimulant  and  schistosome 
infection  status  of  the  children  fi-orn  the  High  Transmission  area  wth  follow-up  time 
fiollowing  treatment  with  praziquantel,  (more  values  are  shovoi  in  Appendix  Table  6.11 
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Table  2.7.  Showing  the  significance  levels  between  the  comparison  of  two  groups  of 
different  infection  status  or  saine  infection  status  but  at  different  fiollow-up  time,  Lising 
the  Rank  sum  test. 
GrOLIPS  z  value  P  value  Groups  z  value  P  value  Groups  z  value  P  valtic 
a  vs  b  -2.0494  0.0404  a  vs  g  -0.2315  0.8170  j  vs  p  -1.6432  0.1003 
c  vs  d  -2.9277  0.0034  b  vs  11  -1.3578  0.1745  k  vs  q  -1.5972  0.1102 
e  vs  f  -2.9277  0.0034  c  vs  1  -0.6944  0.4875  L  vs  r  -1.0954  0.2733 
g  vs  11  -2.6796  0.0074  d  vsj  -0.9400  0.3475  111  vs  a  -1.8510  0.0641 
I  vsj  -2.8420  0.0045  e  vs  k  -1.2730  0.2030  n  vs  b  -2.3735  0.017o 
k  vs  L  -2.9420  0.0045  f  vs  L  -0.7311  0.4647  o  vs  c  -2.7775  0.0055 
III  vs  11  -1.2857  0.1985  g  vs  111  -2.1083  0.0350  p  vs  d  -2.7386  0.0062 
0  vs  p  -2.7143  0.0066  11  vs  11  -1.6432  0.1003  q  vs  e  -2.1988  0.0271) 
q  vs  r  -2.4286  0.0  152  1  vs  o  -1.9805  OM476  r  vs  f  -2.7390 
1  0.0062 
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Pre-treatment  12  moliths  18  months 
Follow-Lip  time Figure  2.24:  IL-4  levels  (±  S.  E.  of  mean)  according  to  stimulant  and  schistosorne 
infection  status  of  the  children  fi-orn  the  High  Transmission  area  with  follow-tip  time 
fallowing  treatment  with  praziquantel  (more  values  are  showii  in  Appendix  Table  6.12). 
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Table  2.8:  Sho"ing  the  significance  levels  between  the  comparison  ol'two  groups  of' 
different  infection  status  or  same  infection  status  but  at  diflerent  l'ollow-up  time,  using, 
the  Rank  stini  test. 
Groups  z  value  P  value  GrOLIPS  z  val  tic  P  value  Groups  z  valtic  P  value 
a  vs  b  -2.5476  0.0108  a  vs  g  -2.7175  0.0066  j  vs  p  -1.1547  0.2492 
c  vs  d  -2.5476  0.0108  b  vs  h  -2.1213  ()  0339  k  vs  q  -1.4697  0,1410 
e  vs  f  -2.7175  0.0066  c  vs  1  -2.7175  0.0066  L  vs  r  0.0000  1.0000 
g  vs  11  -2.1213  0.0339  d  vsj  -2.1213  0.0339  111  vs  ýl  -1.1711  0.2416 
I  vsj  -2.1213  0.0339  e  vs  k  -2.7175  0.0066  n  vs  b  -1.8516  0.0041 
k  vs  L  -2.1213  0.0339  f  vs  L  -2.1213  0.0339  0  vs  c  -0.7319  0.4642 
III  vs  11  -1.9365  0.0528  g  vs  111  -0,7348  0.4624  p  vs  d  -1.8516  0,0041 
0  vs  p  -1.5492  0,1213  ll  vs  11  -1,7321  0.0933  q  vs  0  -0.7319  0.4642 
q  vs  I-  -Iý  1619  0.2453  1  vs  o  -1.2247  0.2207  r  vs  f  -1.8510 
1  0,0641 
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P  re-tre  at  in  ent  12  months  18  niontlis Figure  2.25:  IL-5  levels  (±  S.  F.  of  mean)  according  to  stimulant  and  schistosome 
infection  status  of  the  children  fi-oni  the  High  Transmission  area  with  follow-up  time, 
following  treatment  with  praziquantel,  (more  values  are  shomi  in  Appendix  Table  6.1  3 )). 
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Table  2.9:  Showing  the  significance  levels  between  tile  collipa  1-i  soil  oftwo  grolips  of' 
different  infection  status  or  same  infiection  status  but  at  (1111'erent  fioilow-up  time,  using 
the,  Rank  suni  test. 
Groups  z  value  P  value  Groups  z  value  P  value  Groups  z  val  tic  P  value 
a  vs  b  -2.0059  0,0449  a  vs  g  -1.1333  0.2571  j  vs  p  -0.3651  0.7150 
c  vs  d  -2.6232  0.0087  b  vs  h  -2.1320  0.0330  k  vs  q  -0.7319  0.4642 
0  vs  f  -2.6232  0.0087  c  vs  1  -1.2667  0  2053  L  vs  r  -1.0054  0.2733 
g  vs  11  -1,4606  0.1441  d  vs.  j  -2.3452  0.0190  111  vs  a  -L3472  0  1771) 
i  vsj  -0.5477  0.5839  e  vs  k  -2.2000  0.0278  n  vs  b  -1.4697  0.141o 
k  vs  L  -2.0083  0.0446  f  vs  L  -2.5584  0.0105  o  vs  c  -2.2132  0.0201) 
III  vs  11  -0.2928  0.7697  g  vs  111  -1,4639  0.1432  p  vs  d  -1.4497  0.141o 
0  vs  p  -0.5855  0.5582  11  vs  11  -0.7303  0.4652  q  vs  e  -2.5019  OM124 
q  vs  r  -1.0247  0.3055  1  vs  o  -1.1711  Oý2416  r  vs  f  -1.2247 
1  0.2207 
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P  re-t  re  at  in  en  t  12  months  18  111011ths Figure  2.26:  1  L-10  levels  (±  S.  F.  of  mean)  according  to  stimulant  and  schistosolue 
infiection  status  of  the  children  fi-om  the  High  Transiulssion  area  with  follow-up  tinte. 
following  treatment  "ith  praziquantel,  (more  values  are  slio-mi  in  Appendix  Table  6.14). 
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Table  2.10:  Showing  tile  significance  levels  between  the  collip'll-ison  oftwo  1-m-otips  of' 
different  infection  status  or  same  infection  status  but  at  diffierent  flollow-up  time,  using 
the  Rank  sum  test. 
Groups  z  value  P  value  Groups  z  value  P  value  Groups  z  value  P  value 
a  vs  b  -1.0801  0.2801  a  vs  g  -1.0000  0.3175  J  vs  p  -1.6432  0.1003 
c  vs  d  0.0000  1.0000  b  vs  h  -0.6396  0.5224  k  vsq  -1.0261  0.3049 
e  vs  f  -0.9258  0.3545  c  vs  1  -1.0000  0.3173  L  vs  r  -09129  0.301  3 
vs  11  -0.3651  0.7150  d  vs,  j  -0.1069  0.9148  111  vs  a  -2.6943  0.0071 
vs  j  -1.0954  0.2733  e  vs  k  -1.4000  0.1615  n  vs  b  0.0000  1,  ()()()() 
k  vs  L  -1.1894  0.2343  f  vs  L  0.0000  0  vs  c  -1,781  3  0()741) 
III  vs  11  -1.7566  0,0790  g  vs  111  -1.9030  0,0570  p  vs  d  -09798  0.3272 
0  vs  p  -1.0247  0.3055  11  vs  11  -0.3651  M150  q  vs  o  -2.4071  0,0101 
q  vs  I-  -1  ý0261 
0.3049  1  vs  o  --  I.  0214  7  0.3055  r  vs  f  -1.106() 
1  0.2683 
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Pre-t  re  at  it]  en  t  12  itiontlis  18  111011ths 
Follow-tip  time Figure  2.27:  Compaiison  of  IL-4:  IFN-y  cytokme  ratios  (±  S.  E.  of  mean)  in  infected  and 
uninfected  children  fi-orn  the  Low  Transmission  area  with  follow-up  time,  fiollowing 
treatment  with  praziquantel. 
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SWAP  uninfected 
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Table  2.11:  Showing  the  significance  levels  between  the  comparison  of'two  groups  of' 
different  infection  status  at  each  timepoint,  using  the  Rank  sum  test. 
Groups  z  value  P  value 
a  vs  b  -1.6398  0.1011 
c  vs  d  -L6398  0.1011 
e  vs  f  -0.4472  0.6547 
g  vs  11  -1.2910  0.19o7 
I  vsj  -0.2593  0.7054 
k  vs  L  -0.7746  0.438o 
III  vs  11  -2.1213  0.0331) 
0  vs  p  -2.1213  0.0331) 
q  vs  r  -2.1213  0,0330 
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Pre-treatilient  12  montlis  Is  111011ths 
Follow-tip  time Figure  2.28:  Compadson  of  IL-5:  IFN-y  cytokine  ratios  (±  S.  E.  of  mean)  on  infected  and 
uninfected  children  fi-oin  the  Low  Transmission  area  with  fiollow-up  time,  following 
treatment  "4h  pt-aziquantel. 
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Stimulant  and  infection  stattis 
F-I 
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m  1111A  uninfected 
F-I 
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Fý 
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SFA  uninfected 
Table  2.12:  Sho  wing  the  significance  levels  between  the  comparison  oftwo  groups  of' 
diffierent  infectio  n  status  at  each  time  point,  tising  (lie  Rank  sum  test. 
Groups  z  Value  P  vallic 
a  vs  b  -1.9365  0.0528 
c  vs  d  -1.9365  0.0528 
0  vs  f  -1.5492  0.1213 
g  vs  11  -0.7006  0.4835 
i  VS.  j  -0.8563  0.3018 
k  vs  L  -1.9462  0.0516 
in  vs  n  -1.5667  0.1172 
0  vs  p  -2.0889  0.0367 
q  vs  r  2.0889  0.0367 
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Pre-treatment  I  -)  111011th's  I  's  Illontlis 
Follow-up  time Figure  2.29:  Comparison  of  I  I,  -10:  IFN-y  cytokine  ratios  (±  S.  E.  ofineali)  oil  infected 
and  itninfected  children  fi-oin  the  Low  Transmission  area  Nvith  follow-up  time.  flollowing, 
treatment  with  prazi(juantel. 
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Table  2.13:  Shox"ng  the  significance  levels  between  the  comparison  ol'two  groups  of' 
dififerent  infection  stattis  at  each  time  point.  using,  the  Rank  stim  test. 
Groups  z  Value  P  value 
a  vs  b  -1.1547  0.2492 
c  vs  d  -0.2887  0.7728 
0  vs  f  -0,2987  0.7728 
g  vs  11  -1.3887  0.1649 
i  vs.  )  -0.1543  0.8774 
k  vs  L  -0.3086  0.7576 
III  vs  11  -2.3146  0.0206 
0  vs  p  -1.0801  0.2801 
q  vs  r  1 
-L3987  0.1641) 
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Pre-treatment  12  montlis  18  Illontlis Figure  2.30:  Compaiison  of  IL-4:  IFN-y  cytokine  ratios  (±  S.  E.  of  mean)  oil  infected  and 
uninfected  children  fi-om  the  High  Transmission  area  \Nith  fiollow-up  time,  following 
treatment  with  praziquantel. 
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Table  2.14:  Showing  the  significance  levels  between  the  comparison  oftwo  groups  of 
different  infection  status  at  each  time  point,  using  the  Rank  sum  test. 
Groups  z  value  P  value 
a  vs  b  -1,0660  0.2864 
c  vs  d  -0.2132  0,8312 
0  vs  f  -1.0660  0.2864 
g  vs  It  -0.1890  0.9501 
i  vsj  -1,1339  0.2568 
k  vs  L  -2,4568  0.0140 
In  vs  11  -0.5669  0.5708 
0  vs  p  -2.6458  0.0082 
q  vs  r  -2.6459  0.0082 
ill Figure  2.31:  Compadson  of  IL-5:  IFN-y  cytokine  i-atios  (±  S.  F.  of  mean)  on  infected  and 
itninfected  childi-en  fi-om  the  High  Transmission  ai-ea  with  l'ollow-up  time,  follo"ing 
ti-eatment  with  pi-aziquantel. 
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Table  2.15:  ShovAng  tile  significance  levels  betwcen  the  comparison  ol'two  groups  of' 
different  infection  status  at  each  time  point,  using  the  Rank  SLIM  test. 
Groups  z  Value  P  Value 
a  vs  b  -1.5492  0.1213 
c  vs  d  -L1619  0.2453 
0  vs  f  -0.7746  0.4380 
vs  11  -0.8932  0.3718 
%,  S.  l  -L5429  0.1220 
k  vs  L  -1.5428  0.1221) 
III  vs  11  -1.7052  0.0882 
0  vs  p  -1.8670  0.0619 
q  vs  r  -1.5428  0.1229 
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Pre-treatment  12  nionths  18  111011ths 
Follow-tip  time Figure  2.32:  Comparison  of  I  I,  -10:  IFN-y  cytokine  ratios(±  S.  E.  of  mean)  on  infected 
and  uninfected  children  fi-om  the  High  Ti-ansmission  area  with  fiollow-up  time,  follmAling 
treatment  with  pi-anquantel. 
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'Fable  2.16:  Showing  the  significance  levels  between  the  comparison  ol'two  groups  of' 
different  infection  stattis  at  each  time  point,  using  the  Rank  sum  test. 
Groups  z  value  P  valtic 
,I  vs  b  -1.8516 
0.0041 
c  vs  d  -1.8510  0.0641 
e  vs  f  -1.8516  0.0641 
g  vs  11  -2.6112  0.0090 
I  VS.  j  -2.6112  0.0090 
k  vs  L  -2.6112  0.0090 
III  vs  11  -1.0945  0.0472 
0  vs  p  -2.6112  0.0090 
q  vs  r  -2.6112  0.0090 
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Pre-treatment  Is  111011ths  12  Illontlis 
Follow-up  tillie Figure  2.33:  Cytokine  production  levels  (±  S.  F.  of  mean)  by  low  and  moderate/high 
responding  13BMC  fi-om  the  Low  Transmission  area,  to  PHA  stimulation  befoi-e  (Fig.  a) 
and  after  (Fig.  b)  treatment  with  praziquantel,  (more  values  are  shovoi  in  Appendix  Table 
6.15  and  6.16). 
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114 Figure  2.34:  Cytokine  production  levels  (±  S.  E.  of  mean)  by  low  and  moderate/high 
responding  1313MC  fi-om  the  Low  Transmission  area,  to  SWAP  stimulation  before  (Fig.  a) 
and  alter  (Fig.  b)  treatment  with  praziquantel,  (more  values  are  shom  in  AppendixTable 
6.15  and  6.16). 
280 
240 
?  00 
160 
120 
80 
40 
0 
500 
400 
01) 
300 
00 
WO 
0 
Figure  b. 
D  LoNN,  0  Moderatclugh 
115 
IFN-g  IIA  IL-5  11,10 
Figure  a. 
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Cylokine  typc Figure  2.35:  Cytokine  production  levels  (±  S.  E.  of  rnean)  by  low  and  moderate/high 
responding  PBMC  fi-orn  the  Low  Transmission  at-ea.  to  SEA  stimulation  before  (Fig.  a) 
and  after  (Fig.  b)  treatment  with  praziquantel,  (more  values  are  showu  in  Appendix  'Fable 
6.15  and  6.16). 
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I  FN-g  I  L-4  IL-5  IL-  10 
Cytokine  type 
IL-A  IL-5  IL-  10 Figure  2.36:  Cytokine  production  levels  (±  S.  E.  of  mean)  by  low  and  111oderate/hIgh 
responding  PBMC  ftom  the  High  Transmission  area,  to  PIIA  stimulation  before  (Fig.  a) 
and  after  (Fig.  b)  treatment  with  praziquantel,  (more  values  are  shomi  in  Appendix  Table 
6.19  and  6.20). 
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IFN-g  IL-4  IL-5  IL-10 
Cytokine  type 
IFN-g  I  L-4  IL-5  I  L-  10 
Cvtokine  type Figure  2.37:  Cytokine  production  levels  (±  S.  E.  of  mean)  by  low  and  moderate/high 
i-esponding  PBMC  fi-om  the  High  Ti-ansmission  at-ea,  to  SWAII  stimulation  befoi-e  (Fig.  a) 
and  aftei-  (Fig.  b)  O'eatinent  v"th  praziquantel.  (moi-e  values  ai-e  shomi  in  Appendix  Table 
6.1  Q  and  6.20). 
6000 
5000 
td) 
4000 
3000 
2000 
1000 
0 
4000 
ýj  3000 
Sb 
>  -,  WO 
1000 
0 
Lo\ý  ModerateAilgh 
118 
IFN-g  I  L-4  IL-5  IL-10 
Cvtokine  type 
IFN-g  IL-4  IL-5  I  L-  1() 
Cytokine  type Figure  2.38:  Cytokine  production  levels  (±  S.  E.  of  mean)  by  low  and  moderate/hIgh 
i-esponding  lIBMC  fi-om  the  Fligh  Transmission  area,  to  SFA  stimulation  befoi-e  (Fig.  a) 
and  after  (Fig.  b)  ti-eatment  with  prazicluantel,  (moi-e  values  are  shown  in  Appendix  'Fable 
6.19  and  6.20). 
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Cvtokme  type 
1  FN-  IL-4  1  L-  5  IL-10 
Cvtokiiie  tge Table  2.17:  The  ratios  of  IIL-4:  IFN-y,  IL-5:  IFN-y  and  IL-10:  IFN-y  in  children  from  the 
Low  Transmission  area,  data  from  all  time  points  combined.  The  ratios  of  these 
'signature'  cytokine  are  here  considered  to  reflect  in  the  extent  to  which  individuals  are 
Thl-  or  Th2-like  in  their  responses  to  PHA,  egg  or  worm  antigens. 
Uninfected  individuals: 
Ratio  per 
stimulant 
Strong 
ThO/1-like 
ThO/1-like  ThO/24ike  Strong 
ThO/2-like 
IL,  4:  IFN-y  SEA  0  1  10  1 
IL-4:  IFN-y  SWAP  0  0  12  0 
EL-4:  IFN-y  PHA  0  1  11  0 
IL,  5:  IFN-y  SEA  0  0  20  17 
IL-5:  IFN-y  SWAP  0  0  22  8 
IL-5:  IIFN-y  PHA_  0  0  23  1 
IL-  10:  IFN-y  SEA 
- 
0  0  21  0 
IL-10:  IFN-y  SWAP  0  0  21  0 
IL-10:  IFN-yPHA  0  0  21  0 
infected  individuals: 
Cytokine/IFNg 
stimulant 
Strong 
ThO/1-like 
ThO/1-like  ThO/2-like  Strong 
ThO/2-like 
IL-4:  IFN-y  SEA  0  3  6  0 
IL-4:  IFN-y  SWAP  0  1  8  0 
IL-4:  IFN-y  PHA  2  5  2  0 
IL-5:  IFN-y  SEA  0  0  11  0 
IL,  5:  IFN-y  SWAP  0  0  11  0 
IL,  5:  IFN-y  PHA  0  2  9  0 
IL-10:  IFN-y  SEA  0  3  1  0 
- 
IL,  10:  IFN-y  SWAP  0  3.  4 
.0 
IL-10:  IFN-yPILA 
- 
0  61  4 
10 
120 Table  2.18:  The  ratios  of  IL-4:  IFN-,  y,  IL.  -5:  IFN-y  and  IL-  10:  IFN-y  in  children  from  the 
High  Transmission  area,  data  from  all  time  points  combined.  The  ratios  of  these 
'signature'  cytokine  are  here  considered  to  reflect  in  the  extent  to  which  individuals  are 
Thl-  or  112-like  in  their  responses  to  PHA,  egg  or  worm  antigens. 
Uninfected  individuals: 
Ratio  per 
stimulant 
Strong 
ThO/1-like 
ThO/1-like  ThO/2-like  Strong 
ThO/2-like 
IL-4:  IFN-y  SEA  0  0  8  2 
H,  4:  IFN-y  SWAP  0  0  8  2 
IL-4:  IFN-y  PHA 
_ 
0  1  6  3 
IL-5:  IFN-y  SEA  0  0  10  6 
IL-5:  IFN-y  SWAP  0  0  11  5 
IL-5:  IFN-y  PHA  0  0  12  4 
IL-10:  IFN-Y  SEA  0  0  16  0 
IL,  10:  IFN-y  SWAp  0  0  16  0 
IL,  10:  IFN-YPHA  0  01  16 
ý 
O 
infected  individuals: 
Cytokine  per 
stimulant 
Strong 
ThO/1-like 
ThO/I-like  ThO/2-like  Strong 
ThO/2-like 
H-,  4:  IFN-y  SEA  1  4  7  0 
IL-4:  IFN-y  SWAP  1  4  7  0 
IL-4:  IFN-y  PHA  1  2  9  0 
IL,  5:  IFN-y  SEA  0  1  15  0 
IL-5:  IFN-y  SWAP  0  1  15  0 
IL-5:  IFN-y  PHA  0  1  15  0 
IL-10:  IFN-y  SEA  0  5  11  0 
IL,  10:  IFN-Y  SWAP  0  4  12  0 
IL-  10:  IFN-y  PHA  0  5  11 
121 CHAPTER3 
T  CELL  CLONING  OF  PERILPHERAL  BLOOD  MONONUCLEAR 
CELLS  FROM  FOUR  CHILDREN  FROM  A  HIGH 
TRANSMISSION  AREA  FOR  S.  haematobium  IN  THE  BURMA 
VALLEY. 3.1  EXTRODUCTION 
Evidence  has  been  accumulated  which  has  underlined  the  existence  of  fimctionally 
distinct  T  helper  (Th)  cell  subsets.  These  originate  from  CD4+  T  cell  precursors  and  are 
defined  by  the  cytokines  they  produce  (Mosmann  et  al.,  1988;  Mosmann  et  al.,  1989; 
Mosmann  and  Coffinn,  1986,1989;  Romagnaný  1991,1994;  Sher  and  Coffinan,  1992; 
Abbas,  Murphy  and  Sher,  1996).  These  subsets  have  been  shown  to  have  a  central  role  in 
the  control  and  regulation  of  many  immune  responses  including  those  directed  against 
parasitic  infections  such  as  Leishmania  major  and  Schistosoma  mansoni.  In  murine 
models  of  S.  mansoni  infection,  a  well  defined  T  helper  subset  dichotomy  has  been 
reported  in  which  T  helperl  (Thl)  produce  interferon  gamma  (IEFN-y)  and  tumour 
necrosis  factor-P  (TNF-0),  which  activate  macrophages  as  part  of  a  delayed  type 
hypersensitivity  (DTH)  reaction.  In  mice  this  has  been  reported  to  provide  protection 
against  S.  mansoni  infection  (Sher  et  aL,  1994).  Th2  lymphocytes  are  known  to  produce 
IL-4,  IL-5,  IL-10  and  IIL-13,  which  are  essential  for  the  production  by  B  cells  of  IgE, 
IgGI,  IgA  and  IgM  isotypes,  and  eosinophil  and  mast  ceH  activation.  Th2  type  ceRs  are 
believed  to  be  essential  in  human  protection  from  schistosome  infections  but  have  been 
shown  to  play  a  role  in  pathology  which  accompanies  the  deposition  of  eggs  in  the 
tissues  of  S.  mansoni  infected  mice  (Sher  and  Coffi-nan,  1992). 
The  patterns  of  cytokines  produced  by  mouse  T  cell  clones  seems  adequately  defined  by 
the  Thl  and  Th2  labels  (Mosmann.  and  Coffi-nan,  1989).  Initially  the  same  classification 
was  applied  to  human  T  cell  clones  but  the  results  of  studies  of  T  cell  clones  derived 
from  patients  with  schistosomiasis  showed  that  they  lacked  the  distinct  Thl/Tb2 
polarisation  observed  in  the  murine  models.  Instead  responses  ranged  from  ThO,  Tlil, 
Th2  to  Tb3  (RomagnanL  1991;  Couissinier  and  Dessein,  1995).  Many  groups  have 
122 reported  PBMC  cultures  from  schistosomiasis  infected  individuals  producing  IL-2,  IL-4, 
IL-5,  IL-6  , 
IL-10  and  EFN-y  (Roberts  et  aL,  1993;  Viana  et  aL,  1994;  Williams  et  aL, 
1994;  Araujo  et  al.,  1996;  Grogan  et  aL,  1996).  This  lack  of  confirmation  of  the 
'MI/Th2  concept  in  human  schistosomiasis  suggests  that  the  observed  differences  in  the 
cytokine  production  in  the  mouse  are  more  likely  to  reflect  differences  between  the 
murine  models  and  humans  (Couissinier  and  Dessein,  1995).  Additional  studies  are 
required  on  human  schistosomiasis  from  different  transmission  areas  in  endemic  zones 
and  on  different  schistosome  species. 
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Depending  on  the  distinct  cytokine,  profiles  produced  by  the  T  helper  cells  involved  in 
activation,  expansion  and  differentiation  of  B  ceR  responses,  the  antibody  isotype 
production  and  isotype  regulation  of  B  cell  responses  to  most  antigens  may  be  finely 
regulated.  Coffman  and  colleagues  (1988)  found  that  Th2  supernatants  enhanced  IgE, 
IgGI  and  IgA  production,  while  Th  I  supernatants  inhibited  IL-4  mediated  effects.  IFN-y 
at  relatively  low  concentrations  completely  inhibited  IL-4  enhanced  IgE  production  and 
reduced  IgE  levels  in  mice  (Sher  et  aL,  1992).  IgE  production  was  regulated  by  the 
opposing  effects  of  two  cytokines,  ILA  and  IIFN-y,  which  may  be  considered  to  be  made 
by  two  different  subsets  of  the  T  helper  cell  subsets.  Tle  model  of  Coffinan  and 
colleagues  (1988)  predicts  that  Thl  cells  may  be  acting  as  helper  ceUs  for  the  response  of 
other  isotypes.  Given  appropriate  conditions,  the  majority  of  both  Thl.  and  112  clones 
can  produce  cytokines  which  can  provide  help  to  B  cells  but  the  immunoglobulin 
isotypes  produced  by  these  B  cells  varies  in  accordance  with  the  quality  and  quantity  of 
the  cytokines  produced,  as  discussed  in  Section  1.10.3. 
123 Most  groups  which  have  attempted  to  identify  the  T  helper  cell  subsets  involved  in 
schistosomiasis  susceptibility  and  protection  have  extrapolated  their  findings  from 
cytoldne  profiles  as  seen  in  PBMC  cultures  and  not  from  single  cell  culture  studies.  The 
use  of  PBMC  has  helped  in  identifiOng  and  observing  the  overall  changes  in  response  to 
schistosome  infections  especially  with  S.  mansoni  which  has  received  much  attention,  in 
contrast  to  S.  haeniatobium  infection.  The  observed  changes  in  cytokine  profiles  from 
PBMC  work  has  been  used  as  evidence  to  identify  the  T  helper  cell  subset  as  Thi  or  Th2 
type.  This  includes  work  on  S.  haematobium  by  Grogan  and  colleagues  (1996),  who 
reported  an  increased  production  of  IL-4  by  PBMC  after  treatment  with  praziquanteL 
and  unchanged  production  of  IL-5  in  response  to  adult  worm  antigen  stimulation.  IFN-y 
and  IL-2  production  were  low  before  treatment  and  unchanged  after  treatment.  Other 
studies  on  S.  mansoni  by  Viana  et  al.,  (1994);  Wifliams  et  al.,  (1994)  and  Araujo  et  al., 
(1996)  on  Brazilian  patients,  observed  the  cytokine  response  of  PBMC  when  stimulated 
with  worm  antigen  preparations.  WiRiams  and  colleagues  (1994)  reported  that  patients 
with  acute  and  hepatosplenic  infections  produced  higher  levels  of  IL-4  and  IL,  5  than 
uninfected  persons.  According  to  this  study,  the  responses  of  PBMC  to  mitogen  and  egg 
antigen  stimulations  revealed  a  Th2  pattern  of  cytokine  production,  while  the  response  to 
worm  antigen  was  said  to  result  in  a  ThO  cytokine  pattern.  Araujo  and  colleagues  (1996) 
reported  evidence  of  a  Th2  response  in  patients  with  S.  mansoni  infection.  The  patients 
showed  no  lymphoproliferation  and  IFN-,  y  production  following  stimulation  with  SWAP, 
in  contrast,  IL-5  and  H--10  were  detected  after  stimulation  with  SWAP.  Another  group, 
Roberts  and  cofleagues,  (1993)  working  on  Smansoni  infection  in  Kenya  reported 
elevated  levels  of  HA  and  IFN-y  in  individuals  considered  to  be  resistant  to  S.  mansoni 
infection. 
124 The  studies  cited  above  have  associated  the  dominance  of  the  particular  sets  of  cytokines 
produced  by  PBMC  to  a  particular  T  helper  cell  subset  and  are  therefore  of  limited  value 
in  determining  the  precise  details  of  the  T  helper  cell  dichotomy  of  the  immune  response 
to  schistosome  infection.  In  contrast  to  studies  using  PBMC,  the  use  of  T  cell  clones 
provides  an  opportunity  to  examine  responses  under  well-defined  culture  conditions.  Tle 
present  study  was  designed  to  develop  T  cell  clones  from  the  PBMC  from 
S.  haematobium  infected  and  uninfected  children  living  in  an  area  of  high  transmission  of 
S.  haematobium.  Studies  of  the  cytokine  production  of  such  T  cell  clones  would  shed 
some  fight  on  the  immune  processes  triggered  by  natural  repeated  exposures  to 
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S.  haematobium  infection. 
3.2  MATERIALS  AND  METHODS: 
3.2.1  REAGENTS 
Cell  culture  reagents  were  similar  to  those  listed  in  Section  2.2.1. 
Additional  reagents  were  required  specifically  for  T  cell  cloning: 
Monoclonal  antibodies,  mouse  antihuman  CD8  (Immunotech  ref  no.  0178-1yophilised) 
Monoclonal  antibodies,  mouse  antihuman  CD4  (Immunotecii-lOb4O  ref-1374) 
Lysis  reagent  and  Fixing  reagent  (FixDenat',  Immunotech). 
PMA,  Phorbol-12-Myristate  13-Acetate  P-8139  (SIGMA) 
5-Bromo-2'-deoxyUridine  (BrdU-Boehringer  Mannheim) 
Anti-BrdU  Peroxidase  Dismutase  (antiBrdU  POD) 
FITC  (Immunotech) 
125 3.2.2  STUDY  AREA  AND  POPULATION. 
The  study  population  was  selected  from  a  farming  community  of  The  Burma  Valley 
Area,  Eastern  HigWands  of  Manicaland  Province  in  Zimbabwe.  The  farming  activities 
were  based  on  irrigation  and  on  seasonal  rains.  In  the  area  there  is  a  permanent  flowing 
river  with  a  dam  and  several  seasonal  river  tributaries.  The  community  has  low 
S.  mansoni  prevalence  and  subjects  were  selected  from  Valhalla  primary  school  having  a 
high  S.  haematobium  infection  intensity. 
Four  school  children,  aged  10,11,11  and  12  years  were  selected  for  a  detailed  study  of 
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their  cellular  immime  response  by  cloning  T  cells  derived  from  their  PBMC  prior  to 
treatment  with  praziquantel.  Two  of  the  children  were  infected,  one  moderately  and  the 
other  heavily  with  S.  haematobium  as  determined  by  egg  counts  on  urine  specimens. 
Neither  of  these  children  had  received  treatment  in  the  two  years  before  the  study.  Ile 
other  two  children  were  uninfected.  The  aim  of  this  part  of  the  study  was  to  examine 
whether  the  presence  or  absence  of  S-haematobium  infection  could  be  related  to  cytokine 
responses  which  could  be  classified  as  Thl,  Th2  or another  subset  type. 
3.2.3  PARASITOLOGY 
Urine  and  stool  samples  for  parasitological  examination  for  S.  haeniatobium  and 
S.  mansoni  infections  were  collected,  processed  and  classified  as  described  in  Section 
2.2.3. 
126 3.2.4  COLLECTION  OF  VENOUS  BLOOD  AND  PBMC  PREPARATION 
Approxitnately  20  mls  of  blood  was  collected  ftom  each  child  using  a  21G  cannulae  and 
sterile  heparhiized  syringes.  Blood  was  transported  to  the  laboratory  in  a  cooler  box  and 
PBMC  were  separated  from  the  blood  within  2  hours  of  collection.  Tlie  PBMC  were 
then  gradient  frozen  in  liquid  nitrogen  as  described  in  Section  2.2.6. 
3.2.5  TREATMENT 
All  children  were  treated  with  praziquantel,  at  a  dose  of  40  mg/kg  body  weight.  Children 
were  finaRy  retreated  at  the  end  of  the  two  year  fbHow-up  study  period. 
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3.2.6  PBMC  PROLIFERATION  ASSAYS  USING  TRITIATED  THYMIDINE: 
The  cryopreserved  PBMC  were  washed,  resuspended,  ceR  concentration  determined  and 
the  cells  cultured  using  the  method  described  previously  (Section  2.2.7).  The  stimulants 
used  were  PHA  and  the  S-haematobium  antigens:  SEA  and  SWAP  at  10  gg/ml  (the 
concentration  being  predetermined  from  early  experiments,  data  not  shown). 
Tlle  amount  of  tritiated  thymidine  incorporation  induced  by  antigen  or  mitogen  was 
determined  with  a  Liquid  Scintillation  Analyser  (TRICAB",  Model  1600  CA  Packard 
USA).  Data  were  expressed  as  stimulation  index  of  mean  counts  per  minute  (SI) 
calculated  as  follows: 
SI  of  mean  cpm-7  Mean  counts  from  stimulated  cells 
Mean  counts  from  control  (unstimulated)  cells. 
Response  to  each  stimulant  was  classified  as  low  response-when  Sl  was  less  than  2  and 
moderate  or  high  response  when  Sl  was  >2. 
127 3.2.7  T  CELL  LINES  FOR  T  CELL  CLONE  DERIVATION  AND  T  CELL 
CLONES. 
Short  term  T  cell  lines  (TCL)  were  established  from  the  PBMC  of  subjects  numbers  309, 
311,329  and  350,  aR  from  the  High  Transmission  area.  Tle  frozen  PBMC  were 
retrieved  from  liquid  nitrogen  and  rapidly  thawed  with  constant  agitation,  until  a  small 
ice  crystal  remained,  they  were  then  transferred  to  incomplete  media  with  5%  FCS  and 
50gg/ml  gentamycin.  After  washing  twice,  the  cells  were  resuspended  in  complete  media 
containing  10%  hAB  senim  and  seeded  at  IX  106  ceffshul  in  the  presence  of  20  pg/ml 
SEA,  SWAP  or  PPD.  After  6  days  at  37*C  in  5%  C02  in  humidified  air,  ceRs  were 
washed  and  resuspended  in  complete  media  containing  10%  human  AB  serum 
supplemented  with  10  IU/mI  human  IL-2,  and  cultured  for  5-10  days.  After  the  first 
stimulation  the  TCL  were  directly  cloned  by  the  limiting  dilution  method  (Lefkovits  and 
WaIdmann,  1984).  Cells  were  seeded  at  0.3  or  I  cell/well  in  the  presence  of  irradiated 
(3500  rads)  heterologous  PBMC  as  feeder  ceHs  (5  -7.5  x  105  cells/ml),  PHA-P  at  2 
gglnA  and  hIL,  2  (20  IU/ml).  Ile  clones  were  left  to  proliferate  and  expand  for  2-4 
weeks,  with  repeated  observation.  Plates  with  less  than  30%  of  the  wells  with  growing 
clones  were  selected  for  finther  study  and  the  clones  were  then  expanded  first  in  96  well 
round  bottomed  plates  then  48  well  plates  and  finally  in  24  well  plates  (I  mVweU)  by  re- 
stimulation  every  15  days  with  irradiated  feeder  cells  at  7.5  x  10'  cells/ml,  with  2  pg/ml 
PHA-P  and  20  IITJ/mI  hH-,  -2.  T  cell  clones  (TCC)  were  maintained  in  complete  media 
with  10%  FCS  supplemented  with  20  IU/ml  hIL-2  between  each  stimulation. 
3.2.8  ANTIGEN  SPECIFICITY  TEST  OF  CLONES. 
T  cell  clones  were  tested  for  their  proliferative  response  to  parasite  antigen  10-15  days 
after  the  last  stimulation.  After  two  washes  in  RPMI  supplemented  with  50  pg/ml 
128 gentamycin,  the  cells  were  suspended  in  complete  media  with  10%  FCS  and  seeded  at  2 
X  104  cells  per  well  in  flat  bottomed  microtitre  plates  contafifing  5x  104  (ceUsIml  ) 
irradiated  (3500  rad)  autologous  PBMC.  After  addition  of  parasite  antigen  or  (non- 
specific)  mitogen  (PHA-P),  cultures  were  incubated  for  3  days  at  37'C  in  5%  C02  in  an 
humidified  air.  Cultures  were  pulsed  with  5-bromo-2'-deoxyuridine  (BrdU;  Boehringer 
Mannheim)  during  the  last  16-18  hours.  After  aspirating  the  labelling  media,  Cells  were 
0  briefly  finther  cultured  in  complete  media  for  2  hours  at  370C  in  5,  "0  C02  humidified 
incubator.  The  cells  were  then  washed  and  the  plates  dried  before  fixing  the  cells  with 
FixDenatTm  solution  and  incubating  for  30  minutes  at  room  temperature.  Ile  FixDenat 
was  removed  by  washing  3x,  the  anti-BrdU  labelled  with  Peroxidase  dismutase  (POD) 
added  and  incubated  for  3  hours  at  room  temperature.  The  plates  were  then  washed  3x 
before  adding  substrate  and  the  absorbance  measured  using  an  ELISA  reader  set  at  405 
nm  with  630  nm  as  the  reference  wavelength. 
3.2.9  STIMULATION  OF  T  CELL  CLONES  FOR  CYTOKINE  PRODUCTION 
T  cell  clones  were  stimulated  for  assay  of  lymphokine  secretion  10-15  days  after  the 
stimulation  with  feeder  cells  and  PHA-P.  The  feeder  cells  have  a  limited  life-span  and 
having  been  irradiated  were  considered  to  be  no  longer  active,  and  the  T  cell  clones 
produced  no  lymphokine  spontaneously.  Tle  T  cell  clones  were  washed  twice  and 
seeded  at  10'  cells/100ýtl  in  flat  bottomed  microtitre  plates  in  complete  media  vvith  10% 
FCS.  '17he  cells  were  then  incubated  for  24  hours  at  37T,  in  media  alone  or  in  the 
presence  of  mitogenic  stimuli:  anti-CD3  Ab  (20  ng/nd)  plus  PMA  (10  ng/ml)  and  PHA-P 
(2  gg/ml)  plus  PMA  (10  ng/ml).  Cell  free  supernatants  were  collected  24  hours  later 
under  sterile  conditions  and  were  stored  at  -70'C  before  assaying  for  cytokines.  All  the 
supernatants  derived  from  T  cell  clones  were  tested  for  IL-4,  IL-5  and  INF-y. 
129 3.2.10  CYTOKINE  TITRATION  BY  ELISA. 
Cytokine  detection  was  performed  on  the  supernatants  harvested  after  24  hours 
mitogenic  stimulation.  The  Nunc-Immunoplates  Maxisorp  TM  (InterMed)  were  coated 
with  anti-human  monoclonal  antibodies  (mAb)  at  0.5  pg/mI  for  IEFN-y  and  at  I  gg/ml  for 
IL-4  and  IL-5  in  carbonate/bicarbonate  buffer  at  pH  9.6  at  4'C  on  a  shaker.  After  the 
overnight  incubation,  the  plates  were  washed  twice  with  PBS  containing  0.05%  Tween. 
20  at  pH  7.2  and  then  blocked  with  complete  RPMI  for  an  hour  at  room  temperature. 
The  RPMI  was  aspirated  and  the  plates  washed  once  with  PBS  containing  0.05%  Tween 
20.  Standards  for  each  cytokine  were  added  in  duplicate  for  each  concentration  within 
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the  range  15-2000  pg/ml.  'Men  various  dilutions  of  clonal  supernatants  were  added  in 
duplicate  and  diluted  in  complete  RPMI  at  1/4  for  the  control,  115,1/25  and  1/125  for 
the  samples  and  incubated  over  night  at  4'C  on  a  shaker.  After  three  washes  with 
PBS+0.05%  Tween.  20,  the  plates  were  incubated  for  4  hours  at  room  temperature  with 
a  second  anti-human  biotinylated  monoclonal  antibody  specific  for  each  cytokine,  at  0.5 
gglml  for  IFN-y,  I  gg/ml  for  11A  and  IL-5.  After  washing  3x  with  PBS+0.05%  Tween 
20,  streptavidin-  alkaline  phosphatase  conjugate  or  an  alkaline  phosphatase-conjugated 
mAb  at  a  dilution  of  1/1000  for  IFN-y  and  IL-4,  and  at  a  dilution  of  1/2500  for  ILA  then 
incubated  for  2  hours  at  room  temperature.  Enzymatic  activity  was  determined  by 
incubating  the  plates  with  p-nitrophenyl  phosphate  (SIGMA  FAST).  Absorbance  was 
read  at  405  nm  with  630  nm  as  the  reference  wavelength  on  a  DIAS  Multiscan  reader 
(Dynatech  Laboratories).  The  standard  curves  were  calculated  for  each  plate  according 
to  the  sigmoid  curve  equation: 
Y=  D+(A-D)/(I+(X/C)") 
Where  X  is  the  cytokine  concentration  and  Y  is  the  absorbance  at  405  nm 
A,  B,  C  and  D  are  constantS. 
130 Examples  of  the  standard  curves  for  each  cytokine  are  shown  in  Figure  2.1 
3.2.11:  CD4+  AND  CD8+  SURFACE  PHENOTYPING 
Approximately  10'  cells/well  of  each  T  cell  clone  were  placed  into  each  of  three  weHs  for 
assessment  of  CD4  and  CD8  numbers,  with  the  third  well  serving  as  the  control.  The  T 
cell  clones  were  then  centrifuged  and  the  culture  medium  supernatant  aspirated.  Tle  cells 
were  washed  with  200  [LI  PBS  buffer  by  centrifugation  at  400xg  for  5  minutes.  The 
supernatant  was  discarded  and  the  cells  resuspended  in  a  solution  containing  mouse  anti- 
human  IgG  primary  monoclonal  antibodies  (diluted  in  PBS  vvith  0.1%  BSA)  specific  for 
CD4  and  CD8  surface  markers.  The  T  cell  clones  were  then  incubated  at  room 
temperature  for  45-60  minutes,  after  which  the  ceRs  were  washed  twice  in  150  gl  of  PBS 
by  centrifugation  at  400xg  for  5  minutes.  Then  50  gl  of  FITC-conjugated  anti-mouse 
IgG  diluted  50x  in  PBS  with  0.1%  BSA  was  added  and  incubated  at  room  temperature 
for  45-60  minutes.  Ile  ceffs  were  washed  twice  and  then  re-suspended  in  PBS  +  0.1% 
BSA  +  EDTA.  Cells  were  mounted  in  PBS  +  50%  glycerol  (1:  1  cell 
suspension:  PBS/glycerol)  and  observed  by  fluorescence  microscopy. 
3.2.12  STATISTICAL  ANALYSIS 
The  levels  of  IFN-y,  IL-4  and  IL-5  were  expressed  as  pg/ml.  Ile  data  sets  were  mostly 
not  normally  distributed  hence  non-paraMetric  tests  were  used  for  the  analyses. 
Wilcoxon  matched  pairs  sign  ranks  test  was  used  for  comparison  between  two  cytokine 
phenotypes  of  each  clone.  Kruskal-Walfis  one-way  ANOVA  was  used  to  compare  the 
cytokine  levels  of  all  the  clones.  The  Mann-Whitney  Rank  sum  test  was  used  to  compare 
the  responses  of  the  antigen  specific  and  non-specific  clones. 
131 To  reduce  the  risk  of  type  I  errors  arising  from  making  multiple  pairwise  comparisons, 
Bonferroni's  method  was  applied  which  uses  the  fimction  p=cchn,  where  cc  is  ap 
constant  for  statistical  comparison  and  m  is  the  number  of  comparisons.  When 
comparisons  were  made  of  levels  of  cytokines  produced  by  T  cell  clones  from  an 
individual,  the  revised  significance  level  was;  p=0.05/3  =  0.017;  because  three 
comparisons  (PPD,  SWAP  and  SEA)  were  made  at  each  time  point. 
Each  clone  was  categorised  as  aT  helper  class  using  a  ratio  obtained  from  the  measured 
classes  of  cytokine  IFN-y,  IL-4  and  IL-5.  Ile  ratio  was  obtained  using  the  following 
expression: 
H,  -4:  HN-y  or  It,  -5:  IFN-y 
Based  on  the  ratio,  the  phenotype  of  each  clone  was  reported  as  Tlil,  110/1,  ThO/2  or 
Th2  as  shown  below: 
x<0.1  then  the  clone  is  Thl 
0.1  <  X:  5  1  then  the  clone  is  ThO/1 
1<X:  5  10  then  the  clone  is  ThO/2 
x  >10  then  the  clone  is  Th2 
A  similar  classification  has  been  proposed  for  classification  of  human  T  cell  clones  during 
Leish.  maniasis  and  schistosomiasis  mansoni  although  it  remains  to  be  tested  in  further 
studies  (Couissinier-Paris  et  aL,  personal  communication). 
132 3.3  RESULTS 
3.3.1  PARASUOLOGY 
Of  the  four  children  selected  from  the  11igh  Transmission  area,  two  were  infected  with 
S.  haematobium  and  the  other  two  were  not  infected  as  indicated  by  the  urine 
examinations.  Parasitology  results  for  the  four  children  at  various  times  during  the  study 
are  shown  in  Table  3.1.  One  of  the  children,  309,  was  heavily  infected  with  mean 
infection  intensity  of  53  eggs  per  10  ml  of  urine.  Ile  other  child,  350,  was  moderately 
infected  with  an  egg  output  of  20  eggs  per  10  ml  of  urine.  'Me  heavily  infected  child 
became  heavily  reinfected  by  one  year  post  treatment  (115  ep  I  Oml)  and  was  re-treated, 
while  the  other  initially  moderately  infected  child,  350,  remained  uninfected  during  the 
two  year  follow-up.  The  two  children  initially  uninfected  were  found  to  be  infected  when 
examined  at  six  months  post-treatment  (child  329)  or  one  year  post  treatment  (child 
311).  The  intensities  of  infection  in  these  children  were  heavy  and  light,  respectively 
(Table  3.1). 
3.3.2  PROLIFERATION 
The  PBMC  from  each  of  the  children  were  examined  for  proliferative  responses  to 
mitogen  and  worm  and  egg  antigens.  Tle  proliferative  responses  of  PBMC  from  children 
329  (uninfected),  309  (infected)  and  350  (infected)  were  not  statistically  significantly 
different  from  one  another  but  there  was  a  clear  biological  trend  of  the  PBMC  from  child 
329  (uninfected)  having  higher  levels  of  proliferation  to  schistosome  antigen.  The 
proliferative  responses  of  PBMC  from  child  311  (uninfected)  were  higher  than  the 
responses  of  the  PBMC  from  the  other  three  children  (Figure  3.1). 
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PHENOTYPE. 
After  expanding  the  T  cell  clones,  each  clone  was  tested  for  antigen  specificity  using  the 
antigen  used  in  their  derivation.  The  PBMC  from  the  heavily  infected  child  had  few  T 
cell  clones  testing  positive  to  the  worm  and  egg  antigens.  The  other  children  had  high 
numbers  of  T  cell  clones  testing  positive  to  the  worm  and  egg  antigens  used  to  derive 
them.  Total  number  of  T  cell  clones  derived  from  each  child  according  to  the  deriving 
antigen  and  the  number  of  clones  which  were  antigen  specific  are  shown  in  Table  3.2.  All 
the  tested  T  cell  clones  were  CD4+  (positive). 
3.3.4  CYTOVJNE  PROFILES 
The  cytokine  profiles  produced  by  T  cell  clones  derived  from  the  schistosome  antigen 
stimulation  of  PBMC  from  each  individual  differed  markedly  from  each  other.  The 
results  are  surmnarised  in  Figures  3.2-3.7  and  additional  results  are  given  in  Appendix 
6.23,6.24  and  6.25;  corresponding  statistical  results  are  shown  in  Tables  3.3-3.6. 
Child  309  (heavily  infected) 
T  cell  clones  derived  from  worm  antigen  stimulation  of  PBMC  from  the  heavily  infected 
child,  309,  produced  higher  levels  of  IL-4  than  IFN-y  (Figure  3.2  and  Table  3.3).  The  T 
cell  clones  derived  from  egg  antigen  stimulation  of  PBMC  from  child  309,  produced 
similar  levels  of  IL-4  and  IFN-y  (Figure  3.2  and  Table  3.3).  Comparison  of  the  other 
cytokines  produced  by  the  T  cell  clones  derived  from  worm  and  egg  antigens  stimulation 
of  PBMC  from  child  309  showed  that  IL-5  levels  were  higher  than  the  levels  of  IFN-y 
and  11A  (Figure  3.2  and  Table  3.3).  'Me  PPD  derived  T  cell  clones  produced  higher 
levels  of  IFN-y  and  IL-5  than  IL-4  (Figure  3.2  and  Table  3.3).  The  levels  of  ILA 
134 production  were  higher  than  the  other  measured  cytokines  produced  by  the  T  cell  clones 
derived  from  worm  and  egg  antigens  stimulation  of  PBMC  from  child  309,  except  PPD 
derived  T  cell  clones  which  produced  similar  levels  of  IL-5  and  IFN-y  (Figure  3.2  and 
Table  3.3). 
When  considering  the  biological  trends  of  the  antigen  specific  T  cell  clones,  the  worm 
antigen  specific  T  cell  clones  which  were  derived  from  worm  antigen  stimulation  of 
PBMC  from  child  309,  produced  higher  levels  of  IL-4  and  H-.  -5  than  IFN-,  y  (Figure  3.3 
and  Table  3.4).  Ile  T  cell  clones  that  were  egg  antigen  specific,  and  derived  from  the 
egg  antigen  stimulation  of  PBMC  from  child  309,  produced  similar  levels  of  IL-4  and 
IFN-y,  but  higher  levels  of  IL-5  (Figure  3.3  and  Table  3.4). 
Child  350  (moderately  infected) 
T  cell  clones  derived  from  worm  antigen  stimulation  of  PBMC  from  the  moderately 
infected  child,  350,  produced  higher  levels  of  IFN-y  and  IL-5  than  IL-4  (Figure  3.2  and 
Table  3.3).  These  T  cell  clones  also  produced  higher  levels  of  IL,  5  than  IFN-y  (Table 
3.3).  Ile  T  cell  clones  from  child  350  derived  from  egg  antigen  stimulation  of  PBMC, 
produced  similar  levels  of  IL-4  and  IFN-y,  but  low  levels  of  IL-5  (Table  3.3).  The  PPD 
derived  T  cell  clones  produced  similar  levels  of  IL-4  and  IFN-y,  but  the  levels  of  these 
cytokines  were  higher  than  the  levels  of  IL-5  (Figures  3.2  and  Table  3.3). 
When  considering  only  the  antigen  specific  T  cell  clones,  the  T  cell  clones  that  were 
worm  antigen  specific,  and  derived  from  worm  antigen  stimulation  of  PBMC  from  cbild 
350,  produced  similar  levels  of  ILA  and  IFN-y,  but  higher  levels  of  ILA  than  ILA 
135 (Figure  3.3  and  Table  3.4).  Only  one  T  cell  clone  from  child  350  responded  specifically 
to  egg  antigen  stimulation. 
Child  329  (uninfected) 
The  T  cell  clones  derived  from  worm  antigen  stimulation  of  PBMC  from  uninfected 
child,  329,  produced  higher  levels  of  IFN-y  than  ILA  and  IL-5  (Figure  3.4  and  Table 
3.5).  These  T  cell  clones  also  produced  higher  levels  of  IL,  5  than  IL-4  (Table  3.5).  The 
T  cell  clones  derived  from  egg  antigen  stimulation  of  PBMC  from  child  329,  produced 
similar  levels  of  IL-4  and  IFN-y.  However,  the  T  cell  clones  produced  lower levels  of  IIL, 
4  and  IFN-y  than  the  levels  of  IL-5  (Table  3.5).  Tbe  PPD  derived  T  cell  clones  produced 
similar  levels  of  IL-4,  IL-5  and  IFN-y  (Figure  3.4  and  Table  3.5). 
When  considering  only  the  antigen  specific  T  cell  clones,  the  T  ceH  clones  derived  from 
worm  antigen  stimulation  of  PBMC  from  child  329,  that  were  specific  to  worm  antigen 
stimulation  produced  higher  levels  of  IFN-y  and  IL-5  than  levels  of  IL-4  (Table  3.6).  The 
T  cell  clones  derived  from  egg  antigen  stimulation  of  PBMC  from  child  329,  that  were 
specific  to  egg.  antigen,  produced  a  similar  pattern  to  the  clones  that  were  specific  to 
worm  antigen  stimulation  (Figure  3.5  and  Table  3.6). 
Child  311  (uninfected) 
The  worm  antigen  derived  T  cell  clones  from  PBMC  from  the  uninfected  child,  311ý 
produced  similar  levels  of  IL-4  and  IFN-y,  and  higher  levels  of  IL,  5  than  IL-4  and  IFN-y 
(Figure  3.4  and  Table  3.5).  TBe  T  cell  clones  derived  from  egg  antigen  stimulation 
produced  similar  levels  of  IL-4  and  IFN-y,  but  these  cytokine  levels  were  lower  than  IL- 
5  levels  (Table  3.5).  'Me  PPD  derived  T  cell  clones  produced  higher  levels  of  IL-4  than 
136 IFN-y  (Figure  3.4),  while  the  levels  of  HA  were  higher  than  ILA  and  IFN-y  levels 
(Table  3.5).  The  levels  of  IL,  5  production  were  higher  than  all  the  other  cytokines 
produced  by  the  T  cell  clones  from  the  PBMC  from  child  3  11  (Figure  3.4  and  Table  3.5). 
When  considering  only  the  antigen  specific  T  cell  clones,  the  T  cell  clones  derived  from 
worm  antigen  stimulation  of  PBMC  from  child  311,  that  were  specific  to  worm  antigen 
stimulation  produced  higher  levels  of  IL-4  than  IFN-y  (Figure  3.5).  The  T  cell  clones  that 
were  derived  from  egg  antigen  stimulation  of  PBMC  from  child  311  and  were  egg 
antigen  specific,  produced  higher  levels  of  RA  and  IL-5  than  IFN-y  (Table  3.6),  while 
IL-5  levels  were  higher  than  IL-4  levels  (Figure  3.5  and  Table  3.6). 
3.3.5  CYTOKM  RATIOS 
in  addition  to  investigating  the  changes  in  absolute  levels  of  cytokines,  described  above, 
the  changes  in  ratios  of  'signature'  cytokines  were  also  analysed.  This  analysis  is  based 
on  the  premise  that  III  and  Th2  cytokines  cross-regulate  the  other  T  cell  subset  and 
changes  in  the  relative  abundance  of  Thl  and  Th2  cytokines  may  be  more  sensitive 
indices  of  the  in  vivo  T  helper  cell  environment  with  the  'signature'  cytokine  acting  as  an 
indicator  of  the  T  helper  cell  subset  dominating  during  an  immune  response  to 
schistosome  infection. 
The  T  cell  clones  from  the  heavily  infected  child,  309,  gave  a  high  IL-5:  IFN-y  ratio  for 
the  clones  derived  from  worm  and  egg  antigen  stimulation  (Figure  3.6a).  Ilie  moderately 
infected  child,  350,  had  T  cell  clones  derived  from  worm  antigen  stimulation  of  PBMC 
giving  a  high  IL-5:  IFN-y  ratio,  while  the  egg  antigen  derived  T  cell  clones  showed  a  Mgh 
137 H--4:  IFN-y  ratio.  The  PPD  derived  T  cell  clones  from  children  309  and  350  both  showed 
a  low  ratio  for  both  comparison  of  IL-4:  IFN-y  and  IL-5:  IFN-y  (Figure  3.6a). 
When  considering  only  the  T  cell  clones  that  were  antigen  specific,  the  T  cell  clones  from 
infected  children  showed  an  IL,  5:  IFN-y  ratio  to  be  higher  than  IL-4:  IFN-y  for  the  T  cell 
clones  derived  from  egg  and  worm  antigen  stimulation  of  PBMC.  The  T  cell  clones 
derived  from  worm  antigen  stimulation  of  PBMC  from  infected  children,  309  and  350, 
showed  an  IL-5:  IFN-y  ratio  of  approximately  10,  indicating  the  levels  of  IL-5  being  10 
times  the  levels  of  IFN-y  (Figure  3.6b),  indicating  the  cytokine  balance  of  the  response 
tipping  towards  a  Th2  type. 
The  mean  cytokine  ratios  from  T  cell  clones  from  the  uninfected  children,  329  and  3119 
showed  marked  differences  in  the  patterns  of  the  cytokine  ratios  between  them.  Child 
329  showed  a  high  IL-5:  IFN-y  ratio  from  the  egg  antigen  derived  clones  only,  with  the 
other  ratios  being  low  (Figure  3.7a).  Child  311  showed  higher  IL-5:  IFN-y  ratios  than  IL- 
4:  IFN-y  for  all  the  stimulants  (Figure  3.7a).  The  IL-4:  IFN-y  ratio  showed  IL-4  to  be 
between  approximately  eight  and  13  times  higher  than  IFN-y  levels  from  worm  and  PPD 
stimulants,  respectively. 
When  considering  only  the  T  cell  clones  that  were  antigen  specific,  the  T  cell  clones  from 
uninfected  children  showed  the  IL-5:  IFN-y  ratio  to  be  higher  than  the  IL,  -4:  IFN-y  for  the 
T  cell  clones  derived  from  egg  and  worm  antigen  stimulation  of  PBMC.  I'lie  T  cell 
clones  derived  from  worm  and  egg  antigen  stimulation  of  PBMC  from  the  uninfected 
child,  329,  showed  that  the  IL-5:  IFN-y  ratio  was  sEghtly  raised,  While  IL-4:  IFN-y  ratio 
was  very  low  (Figure  3.7b),  indicating  a  mixed  cytokine  environment  of  the  response  in 
138 this  child,  with  neither  T  helper  subset  dominating.  The  child  3  11,  showed  the  IL,  4:  IFN- 
y  and  IL-5:  ]EFN-y  ratios  being  high,  showing  the  levels  of  IILA  and  IL-5  to  be 
approximately  10  times  the  levels  of  IFN-y  (Figure  3.7b),  showing  the  cytokine 
environment  tipping  towards  a  strong  110/2  type. 
3.3.6  T  HELPER  SUBSETS 
The  T  helper  subset  classification  is described  in  Section  3.2.13,  and  is  repeated  here  for 
convenience.  Each  clone  was  categorised  as  one  of  four  possible  T  helper  subsets  using  a 
ratio  obtained  from  the  foRowing  expression: 
H-.,  -4:  UFN-y  or  It,  -5:  IFN-y 
Based  on  the  ratio,  the  phenotype  of  each  clone  was  reported  as  Thl,  TIM,  ThO/2  or 
Th2  type  as  shown  below: 
X:!  ý  0.1  then  the  clone  is  Thl 
0.1  <  X:!  ý  1  then  the  clone  is ThO/I 
X.  -5  10  then  the  clone  is  ThO/2 
x  >10  then  the  clone  is  Th2 
Tle  classifications  of  all  derived  T  cell  clones  according  to  their  stimulant  source  and 
according  to  the  II,  4:  IFN-y  ratios  are  shown  in  Table  3.7a  and  according  to  the  IL- 
5:  ]IFN-y  ratios  are  shown  in  Table  3.7b.  The  percentage  distribution  of  the  T  cell  clones 
according  to  subject  and  stimulant  for  all  the  T  cell  clones  is  shown  in  Figure  3.8  and  for 
worm  and  egg  antigen  specific  T  cell  clones  Shown  in  Figure  3.9.  Ile  T  cell  clones 
derived  from  the  PBMC  from  children  living  in  high  transmission  area  of  S  haematobium 
proved  to  be  predominantly  classified  as  TbO/2. 
139 Child  309  (heavily  infected) 
T  cell  clones  derived  from  either  worm  or  egg  antigen  stimulation  of  PBMC  from  the 
heavily  infected  child,  309,  using  IL-4:  IFN-y  ratio,  proved  to  be  predominantly  classified 
as  TbO/2  subset  and  a  small  number  of  T  cell  clones  being  classified  as  TIO/l,  '11il,  and 
Th2  type.  Using  the  IL,  5:  IFN-y  ratio,  some  of  the  T  cell  clones  were  classified  as  Th2 
type.  However,  the  PPD  derived  T  cell  clones  produced  cytokines  that  led  to  their  being 
classified  as  TIO/2  type  with  a  small  number  of  T  cell  clones  as  TIO/I  and  M  type 
(Table  3.7  and  Figure  3.8). 
When  considering  only  the  T  cell  clones  that  were  antigen  specific,  the  cytokines 
produced  led  to  the  T  cell  clones  being  classified  as  ThO/2  type,  with  a  small  percentage 
of  T  cell  clones  being  classified  as  ThO/I  and  Th2  types  (Figure  3.9). 
Child  350  (moderately  infected) 
T  cell  clones  derived  from  either  worm  or  egg  antigen  stimulation  of  PBMC  from  the 
moderately  infected  child,  350,  using  H--4:  IFN-y  ratio,  proved  to  be  predominantly 
classified  as  ThO/2  type  (Table  3.7a).  A  small  number  of  the  T  cell  clones  were  classified 
as  ThO/1  and  Th2  type.  When  using  the  IL-5:  IFN-y  ratio,  a  similar  distribution  of  the  T 
cell  clones  as  for  IL.  -4:  IFN-y  was  observed  (Table  3.7b  and  Figure  3.8).  'nie  PPD 
derived  T  cell  clones  produced  cytokines  that  led  to  their  being  classified  as 
predominantly  110/2  with  a  small  number  of  T  cell  clones  as  TIiO/I  and  Tli  I  type  (Table 
3.7b  and  Figures  3.8). 
140 When  considering  only  the  T  cell  clones  that  were  antigen  specific,  the  cytokines 
produced  led  to  the  T  cell  clones  being  classified  as  'MO/2  type,  with  a  small  percentage 
of  T  cell  clones  being  classified  as  n0/1  and  Th2  types  (Figure  3.9). 
Child  329  (uninfected) 
T  cell  clones  derived  from  either  worm  or  egg  antigen  stimulation  of  PBMC  from  the 
uninfected  child,  329,  using  II,  4:  IFN-y  ratio,  proved  to  be  predominantly  classified  as 
TbO/2  type  (Table  3.7a).  A  small  number  of  T  cell  clones  were  classified  as  TIO/l  and 
Th2  type.  Using  the  11,5:  IFN-y  ratio,  most  of  the  T  cell  clones  were  classified  as  ThO/2 
with  a  small  number  of  T  cell  clones  being  classified  as  ThO/I  and  Thi  types  (Table  3.7b 
and  Figure  3.8).  The  PPD  derived  T  cell  clones  produced  cytokines  that  led  to  their 
being  classified  as  predominantly  TIO/2  with  a  small  number  of  T  cell  clones  as  110/1, 
Thl.  and  Th2  type  (Table  3.7b  and  Figure  3.8b). 
When  considering  only  the  T  cell  clones  that  were  antigen  specific,  the  cytokines 
produced  led  to  the  T  cell  clones  being  classified  as  predominantly  110/2  type,  with  a 
small  percentage  of  T  cell  clones  being  classified  as  TbO/I  and  'I'li  I  types  (Figure  3.9). 
Child  311  (uninfected) 
T  cell  clones  derived  from  worm  and  egg  antigen  stimulation  of  PBMC  from  uninfected 
child,  3  11,  using  IL-4:  ]EFN-y  ratio,  proved  to  be  predominantly  classified  as  'niO/2  type. 
A  smaH  number  of  T  cell  clones  were  classified  as  TIO/I  and  T12  type  (Table  3.7a). 
Using  the  IL-5:  EFN-y  ratio,  similar  distribution  of  the  T  cell  clones  as  for  IL-4:  IFN-y  was 
observed  with  the  T  cell  clones  predominantly  being  classified  as  Th2  type  (Table  3.7b 
141 and  Figure  3.8).  The  PPD  derived  T  cell  clones  showed  similar  classification  patterns  as 
for  the  schistosome  antigen  derived  T  cell  clones  (Table  3.7  and  Figure  3.8). 
When  considering  only  the  T  cell  clones  that  were  antigen  specific,  the  cytokines 
produced  led  to  the  T  cell  clones  being  classified  as  TbO/2  type,  with  an  increased 
percentage  of  T  cell  clones  being  classified  as  M  types  (Figure  3.9). 
3.4  DISCUSSION 
At  the  start  of  the  study  the  children  showed  different  levels  of  S.  haematobium  infection, 
which  might  be  interpreted  as  supporting  the  idea  reviewed  by  Hagan,  (1987)  that 
individuals  living  in  endemic  areas  have  different  immune  responses,  making  them  either 
resistant  or  susceptible  to  infection.  Parasitology  follow-up  results  for  two  years  after 
isolation  of  T  cells  and  treatment  with  praziquantel,  supported  the  view  that  immune 
responses  may  be  playing  a  role  in  making  some  individuals  resistant  and  others 
susceptible  to  schistosome  infection.  The  heavily  infected  individual,  309,  became  heavily 
reinfected  by  one  year  after  treatment,  and  one  of  the  individuals  who  was  uninfected, 
3  11  , 
became  lightly  infected  after  one  year.  The  individual  who  was  moderately  infected, 
350,  before  treatment  surprisingly  remained  uninfected  throughout  the  two  years  follow- 
up.  Tle  other  uninfected  individual,  329,  became  heavily  infected  early,  about  six  months 
after  treatment.  Such  results  are  of  major  interest  and  studies  involving  detailed  analysis 
of  individual's  T  lymphocyte  responses  may  offer  one  possible  explanation  for  the  above 
results.  ne  immunological  responses  can  be  elucidated  further  by  studying  the  cytokines 
produced  by  peripheral  blood  mononuclear  cells  or  by  cloned  T  lymphocytes  that  may 
142 contribute  to  determining  whether  an  individual  is  either  susceptible  or  resistant  to 
further  S.  haematobium  infection. 
T  lymphocytes  play  a  significant  and  important  role  in  immune  responses  to  infection 
with  schistosomes  through  the  different  members  of  the  cytokine  classes  they  produce. 
During  heavy  schistosomiasis  infection,  it  is  usuaffy  observed  that  the  PBMC  do  not  give 
raised  levels  of  proliferation  after  stimulation  with  schistosome-specific  antigens.  This 
characteristic  has  been  reported  in  adults  chronically  infected  with  S.  mansoni  (Ottesen  et 
aL,  1977,19781,1979;  CoHey  et  aL,  1977a,  b,  1986;  Roberts  et  aL,  1993).  Ile 
individuals  in  the  present  study  were  children  of  an  average  age  of  II  years  old  living  in  a 
highly  endemic  area  for  S.  haematobium.  Tlie  heavily  infected  child  gave  very  low  levels 
of  proliferation  to  schistosome-specific  antigens,  while  the  moderately  infected  gave 
slightly  raised  levels  of  proliferation.  In  a  related  study  by  Grogan  et  al.,  (1996)  and  King 
et  aL,  (1996)  on  S  haematobium  infected  patients,  unresponsiveness  was  seen  prior  to 
treatment,  but  after  treatment  was  reported  to  be  increased  several  fold  high.  Such 
unresponsiveness  is  thought  to  be  the  way  the  immune  response  is  regulated  during 
heavy  infection  when  the  parasite  establishes  a  favourable  environment  which  is 
beneficial  to  itself  The  heavily  infected  child  may  be  considered  as  having  had  infection 
for  a  long  duration.  As  heavy  infections  normally  take  some  time  to  accumulate  in  an 
individual,  the  heavily  infected  child  in  this  study  probably  acquired  their  first  infections 
at  an  early  age  and  might  now  be  considered  to  have  a  chronic  infection.  In  contrast,  for 
the  non-infected  individuals,  levels  of  proliferation  to  the  schistosome  antigen  stimulation 
were  observed  to  be  high. 
143 During  an  acute  schistosomiasis  infection  the  immune  response  is  characterised  by  raised 
levels  of  proliferation  by  PBMC  on  stimulation  with  schistosome  antigen,  but  during 
heavy  or  chronic  infection  some  immune  evasion  mechanism  that  includes 
immunomodulation  by  the  worms  renders  the  host  unresponsive  to  any  further 
stimulation.  Studies  by  Colley  et  aL,  (1977b);  Ottesen  and  Pointdexter,  (1980)  and 
Gazzinefli  et  aL,  (1985)  reported  the  presence  of  some  suppressive  factors  in  serum  of 
subjects  who  had  a  long  duration  of  infection,  which  suggested  that  immunomodulation 
is  a  characteristic  of  those  individuals  who  are  heavily  or  chronically  infected,  whereas 
individuals  in  acute  stages  of  infection  have  strong  cellular  responses  to  specific 
schistosome  antigens.  However,  in  another  study  by  CoHey  et  aL,  (1986)  an  association 
was  reported  between  levels  of  response  to  antigens  and  levels  of  reinfection.  People 
who  were  reinfected  had  lower  responses  to  schistosome  antigens  than  people  who 
remained  uninfected.  Similar  proliferation  results  were  obtained  in  this  study  from 
children  311  and  329,  who  were  uninfected,  but  child  329  gave  lower  levels  of 
proliferation  to  schistosome  antigen  stimulation  than  child  311  and  became  infected 
earlier. 
Ile  levels  of  proliferation  to  schisto  some-  specific  antigen  may  be  related  to  the  number 
of  T  cell  clones  derived  from  the  stimulation  that  would  react  specifically  to  the  antigen 
after  expanding  the  clones.  The  heavily  infected  child  who  displayed  low  levels  of 
proliferation  had  a  small  number  of  T  cell  clones  testing  positive  to  the  antigen  used  to 
derive  them.  However,  considerable  number  of  T  cell  clones  (specific  and  non-specific) 
were  derived  from  each  child's  PBMC  after  stimulation  with  schisto  some-  specific 
antigen  and  PPD.  Further  investigations  are  required  to  understand  the  generation  of  T 
cell  lines  and  T  cell  clones  growing  well  that  become  non-specific  to  the  antigen  used  in 
144 their  derivation  after  expansion.  However,  the  T  cell  clones  were  derived  from  the  T  cell 
lines  generated  from  PPD  and  schistosome  worm  and  egg  antigen  stimulation  of  PBMC 
from  the  individuals,  analyses  of  the  cytokine  profiles  and  the  dominating  T  helper  cell 
subsets  were  carried  out  on  both  the  few  antigen-  specific  T  cell  clones  and  all  the  T  cell 
clones  as  per  stimulant  source. 
The  T  cell  clones  from  infected  children,  309  and  350,  and  one  of  the  uninfected 
children,  329  (who  became  heavily  infected  early),  produced  either  high  levels  of  IFN-y 
and  IL-5  but  low  levels  of  HA  or  similar  levels  of  IFN-y  and  ILA.  This  may  indicate 
that  during  schistosomiasis  infection  and  susceptibility  (as  in  child  329)  either  IFN-y  is 
found  dominating  or  the  two  contrasting  cytokines  (IFN-y  and  ILA)  are  produced  at 
similar  levels,  though  the  sample  size  limits  confidence  in  this  interpretation.  'Me  egg 
antigen  derived  T  cell  clones  produced  similar  levels  of  IFN-y  and  IL-4,  while  the  worm 
antigen  derived  T  cell  clones  produced  predominantly  higher  levels  of  IFN-y  than  IL-4. 
This  may  indicate  differences  in  antigenicity  of  the  schistosome  antigens  according  to  life 
cycle  stages.  T  cell  clones  derived  by  stimulation  with  egg  antigens  had  the  abi1ity  to 
stimulate  production  of  IFN-y  and  IL-4  at  similar  levels  in  individuals  who  were 
moderately  infected  and  those  susceptible  to  infection.  The  cytokine  levels  from  the  other 
uninfected  child,  3  11  ,  showed  high  levels  of  IL-4  and  IL-5,  but  low  levels  of  IFN-y.  'Mis 
could  be  interpreted  as  indicating  that  high  levels  of  11A  production  may  be  associated 
with  absence  of  infection  or  resistance  to  infection.  In  contrast,  high  levels  of  IFN-y 
production  may  be  an  indicator  of  ongoing  infection  or  susceptibility  to  infection,  as  seen 
in  the  infected  children  309  and  350.  However,  chfld  329  was  initially  uninfected,  but  by 
the  end  of  six  months  post  treatment  became  heavily  infected.  The  presence  of  IFN-y 
may  not  denote  susceptibility  but  instead  a  raised  level  of  IFN-y  may  indicate  a 
145 developmental  stage  in  acquisition  of  protective  immunity  with  the  IFN-y  mobilising  the 
cells,  that  may  be  involved  in  later  protective  responses.  Tle  presence  of  IFN-y  may  mark 
an  immune  state  which  is  not  sufficient  to  give  complete  protection.  The  dominance  of 
IFN-y  may  also  mark  the  presence  of  T  helper  subsets  that  develop  through  a  110  phase 
then  into  Thl,  during  early  infection  and  become  further  polarised  as  the  infection 
progresses. 
The  role  played  by  cytokines  in  the  control  of  S.  haematobium  infection  was  extrapolated 
from  comparing  cytokines  and  infection  status  at  the  time  of  collecting  the  PBMC  and 
the  parasitological  status  that  was  determined  from  examining  urine  samples  collected 
during  the  follow-up  time  points.  Raised  levels  of  IILA  and  IL,  5  (Th2  type  cytokines) 
were  clearly  related  to  a  lack  of  infection  as  shown  by  the  parasitological  status  of 
uninfected  child,  3  11.  'Me  T  cell  clones  from  this  child  were  classified  as  predominantly 
ThO/2  and  M,  which  indicates  that  a  cytokine  balance  that  is  dominated  by  ILA  and  IL- 
5  over  IFN-y  is  protective.  IL-4  has  been  reported  to  be  involved  in  switching  B  cells  to 
secrete  specific  antibody  isotypes  (notably  IgE,  IgGI  and  IgA)  and  also  IL,  4  is  involved 
in  activation,  proliferation,  differentiation  and  enhanced  production  by  B  cells  of 
antibodies  which  may  be  involved  in  ADCC  reactions  during  schistosome  infection  (as 
reviewed  by  Romagnaiiiý  1991,1994;  Abbas,  Murphy  and  Slier,  1996;  Mosmann  and 
Sad,  1997). 
The  moderately  infected  child,  350,  and  the  uninfected  child,  329,  produced  higher  levels 
of  IFN-y  than  the  heavily  infected  chfld  309.  High  IFN-y  levels  may  be  a  feature  of 
moderately  infected  individuals  or  individuals  who,  though  uninfected  may  be  at  least 
partially  susceptible  to  infection.  During  heavy  or  chronic  infection  (as  in  child  309) 
146 much  of  the  T  cell  responsiveness  may  be  downregulated,  effectively  "switched  ofF'  and 
this  is  reflected  in  low  levels  of  IFN-y.  While  this  may  minimise  the  pathological 
consequences  of  infection  and  therefore  be  of  benefit  to  the  host  once  infection  has 
reached  this  stage,  prior  to  this  stage  some  element  of  T  cell  responsiveness  is  desirable 
and  the  raised  IFN-y  levels  of  the  infected  child,  350,  and  uninfected  child,  329,  may  be 
indicative  of  continuing  T  cell  reactivity  in  these  children.  The  presence  of  significant 
levels  of  IL-4  and  IL-5  in  these  children  may  indicate  that  this  is  a  crucial  stage  in  the 
development  of  their  responses  to  infection  when  IL-4  or  IL,  5  are  beginning  to  dominate 
the  response  with  humoral  responses  becoming  significant.  It  may  be  possible  to 
speculate  that  at  this  stage  the  immune  responses  may  continue  to  develop  giving  rise  to 
protection  or  may  instead  result  in  susceptibility  to  infection.  This  of  course  will,  in  part, 
be  dependent  upon  the  cytokine  profile  which  dominates. 
Antigen  dosage  studies  suggest  that  it  is  the  initial  response  event  that  detennines 
cytokine-producing  phenotype  and  this  may  be  under  the  influence  of  factors  present  at 
the  time  of  primary  stimulation.  Some  striking  correlation  of  antigen  dose  and 
development  of  immune  responses  dominated  by  cellular  immunity  or  by  antibody 
production  have  been  reported  (Parish  and  Liew,  1972).  In  these  experiments  low  doses 
of  antigen  favoured  ceflular  immunity;  intermediate  doses,  antibody  formation  and  high 
doses  both  cellular  immunity  and  antibody  formation.  Assuming  that  cellular  immunity 
represents  IFN-y-dominated  responses  and  the  antibody  production,  IL-4-dominated 
responses,  commitment  to  IFN-y  or  IL-4  production  may  be  determined  in  part  by  the 
concentration  of  antigen  and  the  time  the  antigen  persists  in  the  body.  The  data  tnight  be 
used  to  support  the  idea  that  the  moderately  infected  individual  (350)  and  the  individual 
showing  the  cytokine  phenotype  tipping  towards  susceptibility  (329)  show  elevated  IFN- 
147 y  and  presence  of  low  levels  of  ILA  could  be  considered  to  downregulate  IFN-y  and  it's 
likely  damaging  effects.  At  the  same  time  IEFN-y  may  be  inducing  macrophages  to  express 
MHC  class  R  for  antigen  presentation  during  fight  infection  helping  curb  the  invading 
parasite  and  limiting  the  antigen  load  by  driving  the  immu.  ne  response  toward  killing  of 
the  invading  parasite.  When  such  an  immune  response  takes  place,  the  events  lead  to 
expression  of  both  T  helper-Eke  responses  that  resultantly  downregulate  each  other.  The 
cytokine  phenotypes  lead  to  the  T  cell  clones  being  classified  as  TbO/2  vvith  some  clones 
being  classified  as  ThO/1  and  Thl  for  the  moderately  infected  and  the  susceptible  child 
with  some  T  cell  clones  as  M,  TbO/I  andMI. 
Tbl/Th2  polarisation.  is  thought  to  increase  with  the  chronicity  of  the  immune  responses 
which  in  turn  depends  on  intensity  of  exposure  to  infection  and  the  consequences  of  the 
exposure.  Some  reports  have  described  that  mixed  cytokine  patterns  exist  early  in 
lymphocyte  activation  with  a  clearer  Tlil  and  Th2  subset  definition  in  chronic  disease 
states  (Chikunguwo  et  aL,  1991,1992;  Seder  et  aL,  1993;  Abbas,  Murphy  and  Slier, 
1996).  Although  the  children  in  this  study  were  relatively  young  and  had  a  limited 
number  of  years  of  exposure  to  infection  (children  of  one  year  old  are  exposed  to 
infection  in  these  communities)  chronicity  could  not  be  ruled  out  but,  based  on  the  mixed 
cytokine  patterns  recorded,  any  chronicity  of  infection  had  not  yet  been  translated  into 
distinct  polarisation  of  T  cell  subset  responses  based  on  the  murine  classification.  Instead 
ThO/I  and  ThO/2  subsets  were  isolated  and  the  possibility  remains  that  these  could  have 
fluther  differentiated  into  Thl  and  Tl12  if  exposure  and  infection  had  continued. 
148 The  children  were  residents  in  a  S.  haematobium  endemic  area  and  showed  high  levels  of 
IL-5.  IL-5  is  the  principal  eo  sinophil-  activating  cytokine  and  eosinophils  have  been 
reported  to  be  elevated  in  individuals  with  parasitic  infections  (Hagan  et  al.,  1985a,  b; 
Butterworth  et  al.,  1992).  However  both  IL-5  and  IL-4  are  normally  expressed  together 
although  at  different  levels.  The  co-expression  of  the  two  cytokines  by  the  same  T  cell 
subsets  may  indicate  their  involvement  in  a  common  effector  mechanisn-L  Several  other 
cytokines  produced  by  Th2  cells  play  an  anti-inflammatory  role.  For  example,  IL-4  and 
IL-  10  antagonise  the  macrophage-activating  action  of  IFN-y  (Fiorentino  et  aL,  199  1;  Del 
Prete  et  al.,  1993).  IL-10  also  suppresses  macrophage  responses  resulting  in  an  anti- 
proliferative  response  of  cells  (King  et  al.,  1996).  Tbus,  'M2  type  cytokine  responses 
may  act  as  inhibitors  of  acute  and  chronic  inflamm  tion  and  as  a  result  act  as  regulators 
of  cellular  immune  responses  and  not  necessarily  as  effectors  in  the  same  manner  as  M 
cells.  Thl  may  appear  early  in  an  immune  response,  generating  a  'MI  cell-mediated 
protective  inuntme  response,  while  112  type  comes  late  to  control  the  damaging  effects 
potentially  caused  by  Thl-mediated  response  and  is  believed  to  accumulate  as  the 
response  progresses  (Pearce  et  al.,  199  1,  Sher  et  aL,  199  1). 
Both  subsets  are  believed  to  originate  from  the  same  T  cell.  precursor  whose 
differentiation  is  influenced  by  the  manner  and  enviromment  in  which  the  precursor  is 
stimulated  (Swain  et  aL,  1990;  Janeway  and  Bottomley,  1994).  The  production  of  the 
tsignature'  cytokines  may  indicate  the  developmental  processes  to  originate  from  the 
same  precursor  cell.  During  schistosome  infection,  events  may  take  place  in  stages  with 
the  initial  stage  being  the  development  of  Thl  type  of  response  which  has  been  revealed 
at  a  clonal  level  by  the  dominance  of  IFN-y.  The  progression  of  the  disease  seems  to  lead 
149 into  Th2  type  response  shown  by  raised  levels  of  IL-4,  this  status  having  the  ability  to 
suppress  the  earlier  events  dominated  by  IFN-y  of  the  Thl  response. 
in  this  study  the  major  'signature'  cytokines  marking  Thl  or  Th2  subsets  type  were 
found  to  be  co-expressed  by  the  same  T  cell  clones.  In  a  study  by  Couissinier  and 
Dessein,  (1995)  the  'signature'  cytokines  marking  each  subset  were  found  to  be  co- 
expressed  and  this  resulted  in  difficulties  in  classifying  the  subsets  in  terms  of  the  M 
and  M  subsets  reported  from  murine  models.  This  may  mark  T  cell  clones  lacking 
distinct  cytokine  profiles  for  71111/Th2  polarisation  in  human  schistosomiasis  unlike  the 
distinct  polarised  cytokine  profiles  marking  the  T  helper  cell  subsets  in  mice. 
In  addition  to  their  role  in  effector  immune  responses  cytokines  are  also  responsible  for 
activating  the  development  of  T  cells  into  particular  subset  "finee'.  Normally,  cytokines 
produced  by  aT  ceR  subset  serve  to  activate  and  increase  production  of  cell  lineages 
which  will  result  in  increased  frequencies  of  the  same  T  cell  subset  and  in  turn  production 
of  the  same  cytokines  (Coffinan  et  al.,  1991;  Vella  and  Pearce,  1992;  Bradley  et  al., 
1993;  Coffinan  and  von  der  Weid,  1997).  When  a  cytokine  reaches  a  threshold  level  then 
that  T  cell.  subset  is  initiated  and  the  cytokine  production  increases  progressively.  With 
repeated  stimulation  taking  place  in  individuals  in  areas  of  high  transmission,  the  high 
exposure  and  continuous  stimulation  may  drive  the  response  in  the  direction  of  the  first 
selected  response  or  along  the  dominating  cytokine  response.  Other  factors  important  in 
determining  the  balance  between  Thl  and  Tb2  subsets  in  immune  responses  are  the  dose 
or  concentration  of  the  antigen  and  this  may  influence  the  types  of  responses 
encountered  when  infýctions  become  chronic.  A  low  antigen  concentration  and  low 
infection  load  tends,  it  seems,  to  induce  Thl  response  whereas  a  high  dose  induces  'n12 
150 development.  At  low  antigen  concentration  the  APCs  crucial  to  the  response  have  been 
reported  to  be  dendritic  ceRs  and  macrophages  which  produce  the  cytokines  that  drive 
the  development  of  the  Thl  response.  At  high  antigen  concentration  the  APC  may  not 
produce  the  Thl  favouring  cytokines,  thus  IL-4  is  produced  and  further  drives  the 
response  towards  the  Th2  type  (Seder  et  aL,  1991,1992;  Paul  and  Seder,  1994;  Sprent, 
1994).  Also  at  high  antigen  concentration  there  is  repeated  T  cell  stimulation  that 
increases  IL-4  production  and  Th2  development  and  sometimes  induces  a  state  of 
immunological  unresponsiveness  or  tolerance  which  switches  off  Thl  development 
(Swain  et  aL,  1990,1991;  Pearce  et  aL,  1991).  However  in  this  state,  as  shown  by 
heavily  infected  child  309,  both  subset  cytokine  markers  may  be  elevated  and  the  levels 
of  proliferation  are  low. 
The  data  presented  in  this  part  of  the  thesis  have  related  the  cytokine  -profiles  and 
phenotypes  of  T  cell  clones  from  PBMC  of  children  living  in  a  High  Transmission  area  of 
an  endemic  region.  The  cytokine  profiles  of  the  T  cell  clones  from  PBMC  obtained 
before  treatment  were  also  related  to  parasitological  data  from  a  two  year  follow-up 
period.  The  T  cell  clones  were  classified  into  T  helper  subsets  and  the  frequency  of  each 
subset  from  the  total  number  of  T  cell  clones  was  determined.  The  overall  immune 
response  of  the  individuals  in  terms  of  the  T  helper  subsets  appeared  to  be  related  to 
putative  susceptibility  or  resistance.  Ile  T  cell  clones  from  the  heavily  infected  child 
showed  low  levels  of  antigen  specificity,  while  the  uninfected  children  had  more  T  cell 
clones  responding  specifically  to  the  antigen  used  to  derive  the  T  cell  clone. 
151 A  ratio  of  'signature'  cytokines,  used  to  identify  T  ceU  subsets  in  mice, was  used  to 
classify  the  human  T  cell  clones  produced  in  this  study.  'ne  co-expression  of  'signature' 
cytokines  by  a  single  human  T  cell  clone  demanded  that  the  standard  Thl/T`h2 
classification  from  murine  studies  be  modified.  As  a  consequence  a  revised  classification, 
based  on  the  ratio  of  cytokines  expressed  was  derived,  allowing  T  cell  clones  to  be 
assigned  to  Thl,  ThO/l,  ThO/2  and  Th2  categories.  In  this  respect  the  T  cell  clones 
derived  from  PBMC  of  S.  haematobium  infected  or  exposed  humans  appear  to  be  similar 
to  those  identified  in  earlier  studies  of  S.  mansoni  infected  humans  from  Brazil 
(Couissinier  and  Dessein,  1995).  In  that  study  the  ThO/2  subset  was  identified  as  a 
marker  of  resistance  while  the  ThO/I  subset  was  associated  with  susceptibility  or  the 
absence  of  protection.  In  the  present  study  as  judged  by  the  changes  in  infection  status 
with  time,  the  T  cell  responses  appeared  to  be  less  stable  and  more  dynamic,  suggesting 
that  small  quantitative  changes  in  the  balance  of  the  cytokines  response  could  result  in 
either  susceptibility  or  resistant  to  S.  haematobium  infection. 
152 Table  3.1:  Results  of  S.  haenialohiuni  parasitological  examination  (eggs  per  10  ]111  of 
urine)  over  a  two  year  follow-up  period  of  the  children  whose  PBMC  were 
cloned.  'Hie  egg  counts  were  determined  by  filtration  of  10  1111  ofurine  collected 
on  three  consecutive  days.  (ND-not  done) 
Subject  Aqc,  ý,  Q4  Nov'()4  Feb'()5  Ma,  ý05  Jul)N5  I  yea  r  1.5  vea  rs  2  vears 
(a,  (,  )  e  pre-treat  post  I  post2  post3  post4  post5  post6  post7 
Infected 
I 
_)OQ 
(I1  53  0  0  0  0  ND  115  70 
1 
_350(12) 
20  0  ND  0  0  0  0 
Uninfected 
3 
_3 
2c)  (  10)  0  0  0  55  82  27  ND 
31  1  (11)  0  0  0  0  0  7  7  4 
Figure  3.1:  11ie  levels  of  pi-olifei-ation  to  PHA  and  schistosome  antigen  stinitilation  of' 
PBMC  fi-om  children  befoi-e  denving  T  cell  fines  foi-  T  cell  cloning.  Pi-olifienition 
levels  wei-e  determined  by  ti-itiated  thymidine  incoipoi-ation. 
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309  Infected  350  Infected  321)  UnInfected  31  1  LJimifected Table  3.2:  'Me  total  number  of  T  cell  clones  obtained  per  subject,  per  stimulant  and  the 
number  of  T  cell  clones  that  were  antigen  specific  per  stimulant. 
ND=  not  done 
Infection  status  Stimulus  used  for  Total  number  of  Number  of  antigen 
Subject  clone  derivation  clones  derived 
] 
specific  clones  (%) 
Heaý&  Infected 
Worm  19  3  (15.8) 
Child  309  Egg  14  2  (14.3) 
PPD  15  ND 
Infected 
Worm  68  18  (26.5) 
Child  350  Egg  12  1  (8.3) 
PPD  9  ND 
Uninfected 
Worm  43  11  (25.6) 
Child  329  Egg  21  2  (9.5) 
PPD  13  ND 
Uninfected 
Worm  17  4  (23.5) 
Child  3  11  Egg  36  7  (19.4) 
PPD  8  ND 
154 Figure  3.2:  S.  haematobhnn  infected  subýjects:  -  '309  and  '350.  Mean  cytokine  levels  (mean 
±SE)  pi-oduced  by  all  clones  accoi-ding  to  subject  and  stimulation  vith  worm  and 
egg  antigen  and  P131).  Ilie  IlUmbei-  of  clones  tested  is  shown  in  bi-ackets. 
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Table  3.3:  Sig"ificance  levels  for  all  the  derived  clones  pei-  sublect  an(l  ant'jel,  11s"19 
Wilcoxon  matched  pair  sign  rank  test  Im  cytokine  comparison. 
Subject  309  int'ected  350  inlec(ed 
Comparison  worin  Egg  13131)  Worm  Fgg  11131) 
-  IL-4  vs  IFN-y 
n  19  14  15  69  12 
1)  0.0218  0.4326  0.0007  0.0003  0.3882  0.5147 
z  -2.294  -0.7847  -3.4078  0  ',  40  -0.8629  -0.6516 
11A  vs  IL-5 
11  19  14  15  49  12  9 
1)  0.0001  0.00  1  0.0007  0.0000  0.0047  0.0077 
z  -3.823  -3.2958  -33.4078  -4.533  10  -2.92-11  -2.0656 
If-'N-,  /  vs  IL-5 
n  19  14  15  49  12 
1)  0.0003  0.0043  0.1398  0.0150  0.0229  0.0077 
z  -).  5816  -2.  (  0-3)  -1.4707  -2.4321  -2.2749  -2.27,1() 
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(111.1111bel-  Of  ClOlleS  teSted) Figure  3.3:  S.  haematobium  infected  subjects:  -  309  and  350.  Mean  cytokine  levels  (mean 
±SE)  produced  by  antigen  specific  clones  accoi-ding  to  stibJect  and  stimulation 
mth  worm  and  egg  antigen.  The  numbei-  ot'clones  tested  is  shown  in  bi-ackets. 
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Table  3.4  :  Significance  levels  for  all  antigen  specific  clones  per  subject  and  the  antigen 
used  to  defive  the  clones  using  Wilcoxon  matched  pair  sign  rank  test  lbr  cytok"Ic 
comparison. 
Subject  309  (heavily  infected)  350  (moderately  infiected) 
Comparison  Worm  Fgg  worill  Fgg 
11A  vs  IFN-,  / 
n  2  3  Is  I 
1)  0.6547  1.000  0.0707 
z  -0.447  0.000  -1.807 
IIA  vs  IL-5 
2  17  1 
0.1797  0.109  0.0004  - 
z  -  1.342  -  1.60  -  3).  ',  27  - 
IFN-7  vs  11,5 
2  17  1 
0.1797  0.285  0.2659  - 
z  -1.342  -1.07  -1.112 
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Table  3.5  :  Significance  levels  fol-  111  tile  dei-ived  clones  per  stibJect  and  antigen  ti..  "'ing 
Wilcoxon  matched  pair  slyn  rank  test  fior  cytokine  compal-IS011. 
Subject  329  311 
Comparison  worill  I'm  11111)  W01,111  lVi:  'll'7,  ý------ 
IIA  v's 
1)  43  21  13  16 
1)  0.0001  0.7413  0.8068  0.0557  0.7894 
z  -3.9495  -0.3302  -0.24-46  -  1.9  1 
_3  )2  -0.2671 
IIA  vs  ll.  -*ý 
11  39  is  13  17  30 
1)  0.0057  0.0074  0.8068  0.0003  0.0000 
z  -2.7631  -2.0783  -0.2446  -3.021-1  -5.121o 
IFN-y  vs  IL-5 
11  39  18  133  16 
1)  0.0491  0.0018  0.4216  0.0005  0.000  1 
z  -1.9077  -  -'). 
1  139  -0.8037  -3.4045  -I 
9 
0.7794 
-0.2801 
8 
0.0117 
-2.5205 
8 
0.0251 
-2.2-10.4 
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pi-oduced  by  antigen  specific  clones  accoi-ding  to  subject  and  stimulation  With 
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Table  3.6  -.  Significance  levels  Im  ail  antigen  specific  clones  per  subject  and  the  intigen 
used  to  derive  the  clones  using,  Wilcoxon  matched  pair  sign  rank  test  I'm 
cytokine  comparison. 
Subject  329  uninfiected  311  uninfiecte  d 
Comparison  Worm  Fgg  .  Worm  -',  gg 
IIA  \s  ll-N--,! 
4  7 
1)  0.0044  0.1797  0.0678  0.0180 
z  -2.845  -1.3416  -  1.9257  -2.3664 
IIA  vs  11.  -5 
n  I1  4  7 
1)  0.0033  0.6547  0.0679  0.0425 
z  -2.  Q34  -0.4472  -1.9257  -2.028-1 
IFN-y  vs  IL-5 
n  4  7 
1)  0.0754  0.6547  0.0679  0.0180 
z1  -1.778  -0.447  -1.8257  -2.3004 
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(mean  ±SE),  IL-4-.  IFN-,,  /  and  IL-5:  IFN-y  fi-om  all  the  clones  accOl-ding  tO  subject 
and  stimulation  with  ýNorm  and  egg  antigen  and  11131).  The  numbei-  ot'clones 
tested  is  shomi  in  bi-ackets. 
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160 Figure  3.8:  T  helper  cell  dichotomy  showing  the  pei-centage  of  clones  in  each  subset 
accoi-ding  to  the  antigen  used  to  stimulate  the  13BMC  fi-om  each  child  Im  T  cell  clone 
de6vation:  Figure  a.  showing  the  numbei-  ofT  cell  clones  fi-om  the  IIA:  1  l,  N-,,  /  t-atio  and 
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Figure  b.  Subject/antigen Figure  3.9:  T  helper  cell  dichotomy  sho"ing  the  percentage  of  clones  in  each  subset 
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5:  IFN-y  ratio.  The  numbei-  of  clones  tested  is  shovoi  in  brackets. 
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309  1  tifected  350  infected  321)  uninfected  3  11  uninfected 
(5)  (13) 
Fioure  a. 
Subject/antigrell 
(Number  of  clones) 
30()  infected  350  infected  321)  uninfected  311  uninfected 
IQ)  (13) 
Subject/antii  (yen 
(Number  of  clones) Table  3.7a  :  The  distiibution  of  all  the  derived  T  cell  clones  (number)  into  I'  lielper 
subsets  according  to  lL-4:  lFN-y  ratio  and  as  desciibed  in  Section  3.2.  jI  'nie  T  cell 
clones  are  classified  according  to  sulýject  and  the  stimulant  used  to  derive  the  clones. 
Subject/stinitilant  T11  I  -nio/  I  'HiO/2  'H12 
Infected  children 
309worill  4  13  2 
309 
gg 
1  2 
3091111D  7  7 
350xNorin  15  48  5 
_  350es4g  1  8  3 
350PPD  9 
Unnifected  children 
329worm  9  30  2 
329eg,  2  19  2 
329PPD  3  10 
3  11  worin  1  12  4 
31  1  egg  4  27  5 
31  IPPD  1  5 
Table  3.7b  :  The  distribution  of  all  the  dedved  T  cell  clones  (number)  into  T  helper 
subsets  according  to  ll,  -5:  lFN-,,  /  ratio  and  as  described  ill  Section  33.2.1,33.  The  T  cell 
clones  are  classified  according  ,  to  subject  and  the  stimulant  used  to  derive  the  clones. 
Subject  Th  I  TlIO/  I_  ThO/2  'I'l  2 
Infected  children 
309wonn  9 
309e,  ag  1  5  9 
3309PPD  1  14 
350worm  1  32 
350eg  2  9 
)5013PD 3  1  4  4 
Uninfected  children 
3329worni  1  5  32 
329e,  gg  I  I  1  6 
329PPD  1  4  6  2 
)II  worill  1  21 
311  ege,  16  24 
311  PPD  5  3 
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REPEATED  PRAZIQUANTEL  TREATMENT  OF 
SCHISTOSOMIASIS  IN  CHILDREN  UNDER  SIX  YEARS  OLD 
LIVING  IN  NLADZIWA;  AN  ENDEMIC  AREA  FOR  Schistosoma 
haematoblum  INFECTION. 4.1  MRODUCTION 
Information  on  schistosomiasis  infection  from  a  number  of  different  geographical  settings 
indicates  that  infection  intensities  and  the  development  of  immunological  resistance  to 
infection  are  related,  in  some  way,  to  age  (Barsourn  et  aL,  1982;  Butterworth  et  al., 
1984ýp  1985,1991,1992;  Hagan  et  aL,  1987,1991;  WilMns  et  al.,  1987;  Dessein  et  aL, 
1992  and  Roberts  et  al.,  1993).  Infection  levels  are  normally  highest  in  children  and 
following  chemotherapeutic  cure,  children  are  more  rapidly  reinfected  and  at  higher  rates 
than  older  children  and  adults  (Wilkins  et  aL,  1987;  Butterworth  et  aL,  1992).  These 
higher  rates  of  reinfection  are  in  part  related  to  higher  levels  of  water  contact  by  children, 
a  feature  characteristic  of  the  majority  of  endemic  settings  (Barbour,  1985).  While  the 
severe  clinical  forms  of  schistosomiasis  infection  may  take  many  years  to  develop,  there 
is  general  agreement  that  targetting  treatment  to  children  can  make  a  considerable  impact 
on  the  development  of  pathology  (Kloetzel,  1967;  Sturrock,  1987).  Ile  use  of 
chemotherapy  to  control  schistosomiasis  is  usually  based  on  annual  rounds  of  screening 
and  treatment.  In  many  endemic  settings  this  has  been  successful  but  in  areas  of  intense 
transmission  more  frequent  interventions  could  ensure  a  greater  impact  on  infection 
levels. 
in  the  past,  schistosomiasis  intervention  programmes  aimed  at  controlling 
schistosomiasis  with  chemotherapy  were  hampered  by  the  treatment  regimes  which,  with 
the  drugs  available  at  that  time,  necessitated  several  doses  at  intervals  for  a  single 
treatment.  One  of  the  drugs  used  extensively  for  treating  S.  haematobiuni,  for  example, 
was  metrifonate  that  is  given  in  three  doses  at  weekly  intervals.  In  the  recent  past  the 
probibitive  cost  of  praziquantel  restricted  its  use,  but  now  that  the  drug  is  being 
produced  on  a  vAder  scale,  and  by  a  variety  of  manufacturers  the  cost  has  been  reduced 
164 to  a  level  at  which  more  frequent  use  can  be  contemplated.  Frequent  repeated  parasite 
elimination  with  praziquantel  may  possibly  reduce  the  pathology  which  normally 
acccompanies  the  repeated  cycles  of  infection  and  reinfection  in  normal  endemic  foci.  It 
could  also  conceivably  influence  the  development  of  protective  itntnime  responses  to 
infection. 
Chemotherapy-induced  changes  in  responses  to  infection  have  been  reported  on  a 
number  of  occasions  (Barsoum  et  aL,  1982;  EHner  et  al.,  1982;  Sturrock  et  aL,  1983; 
Gazzinelli  et  aL,  1985;  Colley  et  aL,  1986;  Dunne  et  aL,  1992;  Butterworth  et  aL,  1991; 
Demeure  et  aL,  1993;  Roberts  et  aL,  1993;  Grogan  et  aL,  1995,1996),  often  as  an 
increased  lymphoproliferative  ability  of  PBMC  collected  after  treatment.  Tle  impact  of 
frequent  repeated  treatments  on  immimological  responses  to  sschistosome  infection 
have,  however,  never  been  reported.  Whether  repeated  treatments  block  the 
development  of  protective  immune  responses  to  infection  or  accelerate  the  development 
of  protective  immune  responses  has  yet  to  be  established.  Studies  of  the  effects  of 
chemotherapy  on  other  (intestinal)  helminths  indicate  that  the  drug  treatment  can 
facilitate  the  development  of  resistance  to  reinfection  (as  reviewed  by  Wilson,  1993). 
Even  if  chemotherapy  slows  the  development  of  immunological  responses,  this  may  be 
counterbalanced  by  the  benefits  to  be  gained  from  the  reduction  in  levels  of  pathology 
arising  from  infection. 
A  similar  dilemma.  has  been  addressed  in  studies  designed  to  reduce  the  impact  of  malaria 
infection  on  pregnant  women  and  on  children  (Picard  et  aL,  1993;  Greenwood  et  al, 
1994;  Menendez  et  aL,  1994  and  as  reviewed  by  Garner  and  Brabin,  1994;  Cot  et  al., 
1995).  A  positive  effect  of  chemoprophylaxis  on  mean  birth  weight  in  primigravidae  and 
165 in  grand  multigravidae  has  been  demonstrated  in  The  Gambia,  but  the  extent  to  which  it 
can  be  generalised  to  other  parts  of  the  world  is  unclear.  Evidence  has  been  presented 
that  chloroquine,  proguanil  and  mefloquine  prophylaNis  was  essential  in  reducing 
antenatal  illness  and  malaria  in  children.  In  addition  Cot  et  aL,  (1995)  in  a  study  of 
randomised  chloroquine  chemoprophylaNis  trials  during  pregnancy  reported  a  reduction 
in  malaria  parasites  in  the  placenta,  even  in  conditions  of  chloroquine  resistant  malaria. 
A  child  born  in  an  area  where  schistosomiasis  is  endemic  can  be  expected  to  harbour 
worms  for  most  of  his  or  her  life  owing  to  repeated  exposure  to  infection,  although  some 
protective  immunity  is  likely  to  develop,  depending  on  exposure  to  the  infectious  agent 
(Woolhouse  et  aL,  1991).  Schistosomes  are  known  to  survive  in  the  host  for  long 
periods,  about  3-8  years  with  some  reports  stating  survival  of  up  to  30  years  (Warren, 
1972,1978;  Vermund,  Bradley  and  Ruiz-Tiben,  1983;  Harris,  Russel  and  Charters, 
1984),  despite  the  development  of  concomitant  immunity.  A  key  characteristic  of 
schistosomiasis  promoting  this  logevity  is  the  development  of  several  mechanisms  by 
which  the  parasites  evade  or  modulate  the  host's  immunological  attack.  Since  parasites 
and  hosts  may  co-eýdst  for  lengthy  periods,  this  might  indicate  that  some  degree  of 
immunological  tolerance  or  anergy  become  induced  (Ottesen,  1979;  Hofstetter,  Fasano 
and  Ottesen,  1983;  Maizels  et  aL,  1993).  It  is  because  of  the  longevity  of  infection  that 
the  disease  causes  serious  chronic  morbidity  rather  than  acute  mortality,  with  severity 
related  to  worm  burdens  to  which  is  related  egg-laying  (Warren,  1972;  Weinstock,  1992; 
Weist,  1996;  Gryseels  and  de  Vlas,  1996).  In  addition  to  the  longevity  of  individual 
infections,  there  is  also  persistence  of  infection  due  to  repeated  re-infection  throughout 
the  host  life  (Bradley  and  McCullough,  1973;  Arap  Siongok  et  aL,  1976). 
166 It  has  been  reported  that  most  stages  of  schistosome  infection  may  be  identified  by 
circulating  antibodies.  Some  of  these  antibodies  are  known  to  be  protective  while  others 
are  believed  to  block  the  activities  of  the  protective  isotypes.  The  antibody  isotypes  of 
IgE  and  IgG4  have  been  reported  to  be  produced  in  high  levels  during  infections  (Hagan 
et  al.,  199  1;  Rihet  et  al.,  199  1)  and  are  affected  differently  by  chemotherapy  (Grogan  et 
al.,  1995),  but  protection  may  be  modulated  by  the  IgG4  to  IgE  ratio  which  tends  to  be 
high  in  heavily  infected  individuals.  Antibodies  of  the  IgM  and  IgG2  isotypes,  directed 
against  carbohydrate  determinants,  also  block  responses  to  ADCC  responses  in 
schistosomiasis  (Khalife  et  al.,  1986,1989;  Butterworth  et  al.,  1988).  Ile  presence  of 
blocking  antibodies  is  coffelated  with  susceptibility  to  're-infection  following 
chemotherapy  of  human  population,  whereas,  expression  of  IgGI  and  IgG3  antibodies  to 
some  epitopes  correlated  with  resistance  (Butterworth  et  al.,  1992).  Understanding 
immune  mechanisms,  both  protective  and  blocking,  may  assist  in  the  development  of 
other  methods  of  control  such  as  vaccination. 
Effective  vaccines  are  a  long  way  from  being  developed,  even  when  good  candidates 
have  been  identified,  they  may  take  many  years  to  pass  through  pre-clinical  trials 
(Bergquist,  1994).  In  the  absence  of  a  vaccine,  the  most  effective  current  method  to 
combat  the  scourge  of  schistosomiasis  is  through  targeted  chemoprophyla)ds  of  children 
(Hagan  et  aL,  1994).  Even  after  mass  chemotherapy,  as  reported  from  several 
programmes,  the  children  become  reinfected  with  heavy  intensities  such  that  there  is  a 
need  for  improved  early  diagnosis  and  treatment  of  young  children  in  endemic  areas  who 
seem  to  lack  developed  immune  systems  against  the  disease  (Stuffock  et  aL,  1983; 
Mahmoud  et  aL,  1983;  Wilkins  et  al.,  1984a,  b).  A  possible  method  to  combat  this 
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problem  would  be  to  keep  the  children  under  staggered  treatment  until  they  are  of  an  age 
where  they  are  capable  of  developing  their  own  protective  immunity. 
This  current  study  was  designed  such  that  transmission  of  infection  would  have 
continued.  Older,  and  usually  more  heavily  infected,  children  who  normally  have  high 
levels  of  water  contact  were  not  part  of  the  study  and  they  can  reasonably  be  assumed  to 
be  responsible  for  most  of  the  environmental  contamination  which  results  in  transmission 
of  infection.  As  a  result,  the  children  in  this  study  would  have  continued  to  have 
exposure  to  infection  and  therefore  be  exposed  to  repeated  parasite  challenges.  The 
timing  of  the  chemotherapy  was  designed  to  remove  any  adult  worms  which  may  have 
developed  after  the  preceding  treatment  therefore  minimising  the  number  of  eggs  which 
may  have  been  produced  and  thus  reducing  exposure  of  the  children  to  egg  antigens.  lie 
hypothesis  on  which  this  study  was  based  was  that  the  continued  exposure  to  the  worm 
antigens  released  by  the  praziquantel  treatment,  would  result  in  the  development  of 
protective  immunological  responses,  but  the  prevention  of  deposition  of  large  numbers  of 
eggs  would  ablate  development  of  immunopathology.  To  monitor  anti-schisto  some 
responses,  the  children  were  examined  for  development  of  potentially  protective, 
schisto  some-  specific  antibody  isotypes. 
4.2  MATERIALS  AND  METHODS 
4.2.1  STUDY  AREA  SELECTION  AND  STUDY  POPULATION 
Ile  study  was  carried  out  in  the  Madziwa  area  in  the  high  veldt  in  north  eastern 
Zimbabwe.  The  Madziwa  area  is  a  rural  setting  based  on  seasonal  small-scale  commercial 
and  subsistence  farming.  'Me  living  conditions  of  the  people  in  the  area  are  reasonably 
comfortable  but  sanitation  facilities  and  water  supplies  for  domestic  use  are  not  well 
168 developed.  The  area  was  chosen  because  there  was  no  evidence  of  infection  with  other 
hehninths,  a  low  S.  mansoni  prevalence  and  a  high  S.  haematobium  prevalence  (Table 
4.1).  The  villagers  have  unlimi  ed  use  of  river  water.  The  area  has  several  river  tributaries 
which  are  seasonal  and  a  major  perennial  river  running  through  the  settlements. 
Madziwa  lies  about  100  km  north-east  of  the  capital  city  Harare  and  has  been  studied  by 
the  Blair  Laboratory  for  a  number  of  years  (Chandiwana,  1987a,  b;  Chandiwana,  Makaza 
and  Taputaira,  1987;  Chandiwana  and  Christensen,  1988).  Information  from  previous 
research  formed  the  basis  of  the  initial  plan  for  the  study.  There  was  good  background 
information  on  this  region,  and  only  a  limited  amount  of  intervention  had  been  carried 
out  in  the  form  of  chemotherapy  to  all  infected  school  children  in  199  1,  four  years  prior 
to  the  start  of  this  study.  This  current  study  was  focused  on  pre-school  children  attending 
pre-school  centres  within  2  to  6  years  old  age  range,  who  would  not  have  participated  in 
the  previous  intervention.  However,  with  the  help  of  the  local  Environmental  Health 
Technician,  some  younger  children,  below  pre-school  age,  were  brought  to  the  centres 
by  their  mothers  and  participated  in  the  study.  This  was  facilitated  through  community 
meetings  between  the  research  group  and  the  parents  of  the  children  when  consent  was 
obtained.  Due  to  previous  work  in  the  area,  the  community  and  especially  the  mothers, 
were  already  aware  of  the  schistosomiasis  problern.  This  resulted  in  a  high  level  of 
participation. 
4.2.2  PARASITOLOGY 
Urine  samples  for  parasitological  examination  for  S.  haematobium  infections  were 
collected  from  all  the  children  on  three  consecutive  days  and  were  processed  on  the  day 
of  collection.  Samples  were  collected  between  10.00  hours  and  14.00  hours  to  coincide 
169 with  peak  egg  excretion  in  urine  (Warren,  1978).  Urine  samples  were  examined  for 
urinary  schistosomiasis  by  filtration  of  10  ml  samples  after  thorough  mixing  (Mott  et  aL, 
1980,1982)  using  polyamide  13  mm  Nytrel'  filters  and  5-10%  Lugors  iodine  stain,  to 
help  visualise  the  eggs.  The  filters  were  examined  for  eggs  of  S.  haematobjum,  and 
expressed  as  eggs  per  10  ml  of  urine  (eplOml).  Intensity  of  infection  was  classified  as 
negative  -no  eggs  detected;  light  -  <10  epl0m];  moderate  -  10  to  <50  ep  I  Oml;  or  heavy 
-  ý:  50  eplOml. 
A  stool  sample  was  examined  by  the  Kato-Katz  technique  (Katz  et  al,  1972  as  modified 
by  Peters  et  al,  1980).  'Me  prevalence  of  S.  mansoni  was  known  to  be  low,  and  those 
found  to  be  infected  with  S  mansoni  were  excluded  from  the  study. 
4.2.3  COLLECTION  OF  VENOUS  BLOOD  FOR  SERA 
Prior  to  the  first  treatment,  up  to  2  ml  of  blood  was  collected  by  venepuncture  using 
vacuum  bleeding  into  vacutubesý'.  Blood  was  allowed  to  clot  at  room  temperature,  then 
stored  overnight  below  80C,  the  clot  removed  and  the  sera  obtained  by  centrifugation  at 
300xg  for  ten  minutes.  The  sera  were  stored  at  -200C  in  cryotubes  until  required  for 
assays. 
4.2.4  REPEATED  TREATMENT  WITH  PRAZIQUANTEL 
Aft6r  collection  of  demographic  data,  three  parasitology  samples  were  collected  over 
three  consecutive  days,  after  blood  collection,  the  children  were  treated  with  40  mg/kg 
body  weight  regardless  of  their  infection  status.  Every  eight  weeks,  after  further 
collections  of  parasitology  data  and  blood  samples  were  made  and  the  children  were 
retreated  on  each  occassion.  During  treatment,  the  nurse  and  research  team  observed 
170 each  child  take  the  drug  which  was  normally  given  with  an  orange  juice  drink  and  some 
bread.  This  was  repeated  during  the  follow-up  period  of  14  months  for  this  aspect  of  the 
study.  The  study  design  was  approved  by  the  Medical  Research  Council  of  Zimbabwe 
and  the  Zimbabwe  Ministry  of  Health  ethical  committee. 
4.2.5  ]HRJMORAL  ASSAYS  BY  ELISAs 
Ile  optimum  conditions  for  the  assays  used  for  antibody  detection  were  initially  set  up 
using  sera  from  another  study  area  which  had  study  populations  ranging  from  5-  64 
years  old  (Mutapi  et  al,  1997).  For  this  current  study,  some  confirmation  and 
modification  of  the  concentrations  were  carried  out  by  titration  of  several  dilutions  of  the 
sera  from  the  study  population.  Some  modifications  were  made  of  antigen 
concentrations,  serum  dilutions  and  incubation  times.  These  are  shown  in  the  Appendix 
6.41  and  6.42.  The  cohort  for  humoral  assays  was  selected  on  the  basis  of  those 
providing  parasitological  samples,  who  were  free  of  S.  mansoni  infection  and  who  were 
examined  at  each  fbHow-up  point. 
4.2.5.1  ANTIGEN  PREPARATION 
Schistosoma  haenzatobium  egg  and  worm  antigens  were  obtained  from  Schistosome 
Biological  Supply  Programme,  Tlieodore  Billiarz  Research  Institute,  Giza  (Egypt),  vAth 
the  egg  antigens  in  soluble  form  Ile  worm  antigen  was  obtained  as  intact  freeze  dried 
adult  worms  which  were  then  homogenised  by  grinding  in  PBS  buffer  pH  7.4, 
centrifuged  three  times  at  400xg  for  25  minutes  and  the  total  protein  concentration 
determined  using  Bicinchoninic  Acid  (BCA,  Pierce)  as  outlined  in  the  method  supplied 
by  the  manufacturer  (Smith,  1985).  The  SEA  concentration  was  determined  by  the  same 
method. 
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The  whole  worm  homogenate  was  diluted  in  carbonate  bicarbonate  buffer  (pH  9.6)  to  a 
concentration  of  5  pg/ml  and  distributed  as  100  pl  of  the  antigen-buffer  mixture  per  well 
in  Immulon  4  plates  (Dynatec  Ltd)  then  left  to  react  overnight  at  4'C.  ne  plates  were 
then  blocked  with  200  gl  per  well  of  5%  skimmed  milk  for  an  hour  at  room  temperature 
on  a  shaker.  The  plates  were  then  washed  three  times  with  PBS,  pH  7.4.  Dilution  of  sera 
was  carried  out  in  PBS  buffer  at  pH  7.4  and  100  gl  aliquots  placed  in  duplicate  wells. 
The  sera  dilutions  were  1:  10  for  IgE,  IgGl,  IgG2  and  IgG3;  1:  100  for  total  IgA,  total 
IgG  and  IgG4;  while  for  IgM  it  was  1:  200.  The  plates  were  then  incubated  for  two  hours 
at  room  temperature  on  a  shaker  while  for  IgE  assays  the  incubation  was  continued 
overnight  at  4'C.  Then  the  plates  were  washed  three  times  and  100  pl  of  monoclonal 
conjugate  specific  for  each  antibody  isotype  was  added  in  PBS.  For  A  the  isotypes,  the 
monoclonal  conjugates  were  horse  radish  peroxidase  (HRP)  conjugated  and  the  final 
dilution  was  1:  2000.  Ile  monoclonal  antibodies  were  obtained  from  Sigma,  total  IgG, 
total  IgA  and  IgM;  from  DAKO,  IgE  and  from  Serotec  all  the  IgG  subclasses.  The  plates 
were  incubated  for  one  hour  at  room  temperature  except  for  IgE  where  incubation  was 
extended  overnight  at  40C.  After  washing  four  times,  100  pl  of  OPD  substrate  was  added 
per  well  and  allowed  to  react  in  the  dark  for'total  IgA,  total  IgG,  IgM,  IgG3  and  IgG4 
for  20  minutes,  IgE  for  30  minutes  and  IgGI  and  IgG2  for  3  hours  (Appendix  6.41).  On 
each  plate,  standard  pools  were  assayed  together  with  the  test  samples.  The  standards 
were  a  pool  of  sera  obtained  from  individuals  from  an  area  with  high  egg  counts  and  a 
negative  standard  using  sera  from  Norwegians.  Duplicate  wells  were  left  with  no  sera  as 
the  blanks.  The  reaction  was  stopped  Nvith  25  ýd  of  10%  H2SO4  and  the  absorbance  read 
at  492  nin 
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The  ELISA  detection  of  anti-egg  antibodies  was  carried  out  using  a  protocol  similar  to 
that  used  in  the  V;  WH  ELISA.  The  Immulon  plates  were  coated  with  100  pl  of  antigen 
at  10  gghnl  diluted  in  carbonate-bicarbonate  buffer  (pH  9.6)  per  well  and  left  to  react 
overnight  at  4'C.  Sera  and  conjugate  dilutions  and  incubation  times  were  similar  to  the 
assays  for  anti-worm  antibodies  (Appendix  6.26).  Washing  times  and  stages  were  also 
similar. 
4.2.6  STATISTICAL  METHODS 
At  pre-treatment  parasitological  examination,  heavy  infections  were  detected  in  some 
children  while  at  the  follow-up  time  points  only  very  low  levels  of  infection  were 
recorded.  Since  the  parasitology  and  antibody  assay  results  were  mostly  not  normally 
distributed,  non  parametric  tests  were  applied  and  the  Spearman  rank  correlation  used. 
Kruskal-Wallis  one-way  ANOVA  was  used  to  compare  the  antibody  isotype  profiles 
obtained  at  each  treatment  point.  The  Mann-Whitney  Rank  sum  test  was  used  to 
compare  the  infected  and  uninfected  categories  before  treatment.  The  Rank  sum  test  was 
also  used  to  compare  the  antibody  isotypes  levels  between  the  two  schistosome  antigens, 
WWH  and  SEA  at  any  of  the  fbHow-up  points. 
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4.3.1  STUDY  POPULATION  AND  PARASITOLOGY 
Results  from  preliminary  parasitological  surveys  of  the  children  attending  schools  near 
the  pre-school  centres  indicated  that  the  area  had  high  S.  haematobium  infection  with 
some  S.  mansoni  infection  (Table  4.1).  After  examination  of  the  preliminary  sampling,  the 
centres  at  the  following  schools  were  selected:  Chimbira,  Chihuri  and  Mupfure.  For 
Mupfure  primary  school,  two  other  centres  in  the  school's  catchment  area  were  included, 
as  the  prevalence  of  infection  in  them  was  over  90%.  At  the  start  of  the  study,  a  total  of 
595  children  between  2-6  years  old  were  recruited.  Blood  samples  could  be  obtained 
from  only  32.8%  (195),  and  at  the  14  month  follow-up  about  42.1%  (82)  could  be 
sampled  of  which  28.2%  (55)  provided  blood  samples. 
NON  HUMORAL  ASSAY  PARTICIPANTS 
A  total  of  595  children  below  6  years  old  were  included  in  the  study  from  the  different 
pre-school  centres  identified  by  a  primary  school  centre.  The  prevalence  of  infection  was 
about  60%  before  treatment  (at  the  start  of  the  study).  After  the  first  treatment  follow- 
up,  the  prevalence  of  infection  was  reduced  to  below  9%  which  later  dropped  to  below 
1%  by  12  months  follow-up  (Figure  4.1).  After  the  initial  parasitological  examination  of 
the  595  examined  children,  the  mean  intensity  of  infection  was  about  I  10  eggs  per  10  ml 
of  urine.  However,  during  the  follow-up  examination,  the  intensity  of  infection  was  low 
(Figure  4.2). 
HUMORAL  ASSAYS  COHORT 
The  prevalence  of  infection  patterns  with  follow-up  time  is  shown  in  Figure  4.3.  At  the 
beginning  of  the  study,  before  treatment,  the  prevalence  of  infection  was  about  51.8% 
174 which  was  different  from  the  follow-up  prevalences  after  treatment,  which  were  below 
20%  with  the  last  examination  showing  no  infected  children. 
The  intensity  of  infection  of  the  cohort  was  moderate  before  treatment  giving  a  mean  egg 
count  of  18  eplOmI  urine.  After  treatment  the  intensity  of  infection  was  less  than  4 
eplOml  of  urine  at  2  months  and  9  eplOml  of  urine  by  4  months.  Tliereafter  infection 
intensity  was  below  2  ep  10ml  of  urine  examined  (Figure  4.3b).  'Me  children  who  were 
infected  and  belonging  to  the  cohort  for  the  humoral  assays  had  moderate  to  heavy 
infection  intensity  (Figure  4.4).  Before  treatment  of  the  infected  children,  the  intensity  of 
infection  among  them  was  35  eplOmI  of  urine,  the  results  of  the  infection  intensity 
(among  the  infected  only)  are  shown  in  Figure  4.4. 
4.3.2  TREATMENT 
Madziwa  is  an  area  endemic  for  schistosomiasis  which  is  a  major  health  problem  since 
the  area  suffers  from  a  lack  of  developed  water  for  domestic  use.  Even  after  provision  of 
treatment  to  the  children  some  infection  still  occurred  and  the  few  reinfected  children 
showed  moderate  to  heavy  infection  intensities.  Treatment  with  praziquantel  was  shoval 
to  be  effective,  however,  at  population  level  few  individuals  became  reinfected  at 
moderate  intensity,  in  the  eight  week  periods  between  re-treatments  and  re-examinations. 
4.3.3  HUMORAL  IMMUNITY  -  ANTIBODY  PROFILES. 
4.3.3.1  ANTI-EGG  ANTIGEN  ANTIBODY  ISOTYPE  LEVELS. 
The  cohort  that  provided  sera  and  were  treated  at  consecutive  follow-ups  had  their  sera 
assayed  for  these  isotypes:  IgA,  IgE,  IgGI,  IgG2,  IgG3,  IgG4  and  IgM.  At  each  foflow- 
up  a  comparison  was  made  between  the  antibody  responses  of  infected  and  the 
175 uninfected  children,  even  though  the  samples  sizes  varied,  with  only  a  few  children 
becoming  reinfected  after  treatment.  On  comparison  of  antibody  responses  of  infected 
and  uninfected  children  at  any  time  point,  no  differences  were  observed  for  any  isotype 
(Figure  4.5  -  4.11).  Also,  no  differences  were  observed  when  comparing  either  infected 
children  at  different  time  points  or  uninfected  children  at  different  time  points  (Figure  4.5 
-4.11). 
4.3.3.2  ANTI-WORM  ANTIGEN  ANTIUBODY  ISOTYPE  LEVELS. 
Only  four  isotypes  (IgA,  IgE,  IgG4  and  IgM)  were  assayed  against  the  worm  due  to 
availability  of  the  antigen  and  sera.  No  differences  in  antibody  isotype  levels  were 
observed  between  the  antibody  responses  of  infected  children  at  different  thue  points  or 
the  uninfected  children  at  different  time  points  (Figure  4.12  -  4.15).  Also,  no  differences 
were  observed  when  comparing  either  infected  children  at  different  time  points  or 
uninfected  children  at  different  time  points  (Figure  4.12  -  4.15). 
4.3.3.3  ANTIBODY  RESPONSE  PROFILES  WITH  TIME  AND  CORRELATION 
Prior  to  praziquantel  treatment  the  antibody  responses  of  both  infected  and  uninfected 
children  to  VONH  and  SEA  antigens  showed  similar  patterns  (Figure  4.16a  and  4.16b). 
The  antibody  profiles  for  each  isotype  against  egg  and  wonn.  for  all  the  children 
examined  with  follow-up  time  showed  similar  patterns  at  each  time  point  for  the  antigens 
used  (Figure  4.18).  Ile  patterns  showed  higher  levels  of  anti-egg  IgE  than  anti-worm 
IgE  at  A  the  time  points  (Figure  4.18b).  Of  interest  were  the  high  correlations,  using 
Spearman's  rank  correlation,  of  anti-egg  IgE  and  anti-egg  IgG4  to  infection  intensity 
measured  as  egg  output  at  the  start  of  the  programme  (Table  4.2,  when  all  the  children 
were  considered  p=0.013  and  p=001  for  IgE  and  IgG4,  respectively).  Ile  infected 
176 children  showed  a  high  correlation  of  anti-egg  IgG4  to  egg  output  and  anti-worm  IgM  to 
egg  output  (p<0.0001  and  p=0.035,  respectively,  Table  4.2). 
Correlations  were  observed  between  infection  intensity  (egg  output)  and  anti-egg  IgA 
and  IgG4  (p=0.050  and  p=0.027,  respectively)  at  four  months  after  the  treatment 
programme  began.  At  10  months,  egg  output  and  anti-egg  IgE  (p=0.032)  were  positively 
correlated  yet  infection  intensity  was  low  (Table  4.2),  while  at  remaining  examination 
points  no  correlations  were  found. 
In  general  the  patterns  of  the  antibody  isotypes  profiles  to  WVM  and  SEA  antigens  were 
similar  throughout  the  repeated  treatment  programme.  Of  interest  was  the  difference 
between  the  anti-worm  IgE  and  anti-egg  IgE  responses.  Higher  levels  of  anti-egg  IgE 
antibodies  were  detected  than  anti-worm  IgE  antibodies  throughout  the  study  (Figures 
4.16a,  b,  c;  4.17a-f).  Anti-egg  IgG3  and  anti-egg  IgG2  antibodies  were  detected  at  lower 
levels  than  any  of  the  other  isotypes  at  all  of  the  examination  points  (Figures  4.16a-c;  and 
4.17a-f).  , 
4.4  DISCUSSION 
Ile  results  from  the  preliminary  examinations  indicated  that  the  area  has  a  major 
problem  with  schistosomiasis.  Children  living  in  this  area  were  heavily  exposed  to 
infection.  After  selection  of  the  study  cohort,  defined  as  those  below  school-attendance 
age,  the  results  indicated  that  even  among  the  young  children  the  prevalence  of  infection 
was  high  and  this  was  coupled  with  heavy  infection  intensities.  For  background 
information  after  obtafifing  these  results,  mothers  who  brought  their  children  to  the 
177 centres  were  asked  as  to  how  their  children  became  infected.  One  of  their  common 
answers  was  that  these  children  accompanied  their  mothers  to  the  rivers  during  their 
daily  activities  of  tending  vegetable  gardens  and  some  domestic  chores  like  washing 
dishes  and  clothes  and  also  bathing.  They  reported  that  during  these  activities  the 
children  had  the  opportunity  to  have  contact  with  the  water,  thereby  becoming  exposed 
and  ultimately  infected. 
Madziwa  area  was  identified  as  one  of  the  areas  in  Zimbabwe  with  high  S.  haematobiuni 
infection  with  some  areas  within  the  region  having  some  S.  mansoni  infection  (Taylor  and 
Makura,  1985;  Chandiwana,  Makaza  and  Taputaira,  1987;  Preliminary  results,  Table 
4.1).  The  results  obtained  at  the  start  of  the  study  indicated  that  the  children  are  at  very 
high  risk  of  the  schistosome  infections  and  the  likely  accompanying  morbidity  and 
pathology.  Praziquantel  is  not  available  at  the  local  clinics  and  treatment  is  instead  with 
metrifonate,  mothers  rarely  take  the  children  back  for  the  second  and  third  doses.  From 
the  current  study  it  became  apparent  that  even  after  controlling  schistosomiasis  with 
retreatment  in  areas  of  intense  transmission  some  cbildren  will  became  reinfected,  most 
of  those  reinfected  was  at  moderate  to  heavy  intensity.  The  results  confirmed  similar 
findings  in  a  S.  haematobiuni  study,  in  The  Gambia  by  Wilkins  and  colleagues  (1987) 
where  children  having  frequent  contact  with  water  containing  infected  snails  became 
reinfected  at  higher  infection  intensities  than  the  adults. 
When  examining  Immoral  responses,  no  major  variations  in  the  antibody  isotypes  were 
noted,  possibly  due  to  the  age  of  the  children.  17he  development  of  demonstrable 
protective  immunity  has  been  reported  to  take  place  in  older  children  above  10  years  old 
(Butterwoth  et  al.,  1984,1985,1987,1992;  Wflkins  et  d,  1987;  Hagan  et  al.,  1987, 
178 1991,1994;  Roberts  et  aL,  1993,  Webster,  et  al.,  1997a,  b).  The  correlations  of  IgE  and 
IgG4  antibodies  with  infection  probably  indicates  that  they  are  a  marker  of  infection 
intensity  rather  than  an  indicator  of  resistance  to  infection.  Of  the  two  isotypes,  IgE  was 
detected  at  higher  levels  compared  with  the  IgG4  in  response  to  egg  antigen.  But  no 
major  change  in  the  antibody  isotype  profiles  with  time  was  seen,  since  the  children  in 
this  study  were  below  six  years  old.  This  may  point  to  a  possibility  that  development  of 
protective  immunity  is  not  only  duration  of  exposure  and  infection  intensity  dependent 
but  age  may  also  be  necessary  on  which  will  depend  the  experience  of  schistosome 
parasite  infection.  Tlis  later  point  may  support  the  report  that  residents  in  a  new 
S.  mansoni  epidemic  focus  in  Senegal  (Gryseels  et  aL,  1994a,  1994b,  1995)  lacked  clear 
developed  protective  immunity  after  treatment  irrespective  of  age  suggesting  that 
experience  of  infection  acquired  over  a  long  period  plays  a  major  role  in  the  development 
of  protective  immunity. 
The  isotype  profiles  showed  small  biological  trend  changes  with  the  treatments.  In  other 
studies,  greater  changes  (statistically  significant)  have  been  reported.  Mutapi  et  aL, 
(1997  and  submitted)  reported  that  antibody  isotype  class  switching  of  IgA  to  IgGl  take 
place  in  younger  individuals  after  treatment.  This  change,  which  may  be  associated  with 
resistance  or  susceptibility,  has  been  documented  as  being  protective  when  worrn 
induced  and  pathological  when  egg  induced.  But  age  may  be  involved  in  development  of 
such  protection  development  since  this  was  not  demonstrable  in  the  young  children  in 
this  study.  The  close  repeated  treatment  may  not  have  assisted  in  any  change  of  the 
antibody  isotypes,  perhaps  challenge  (repeated  exposure)  is  more  important  in 
determining  antibody  responses.  This  can  be  achieved  possibly  by  a  wider  treatment 
179 intervals,  although  giving  no  opportunity  for  the  worms  to  establish  a  stage  of  massive 
egg  deposition. 
Chemotherapy  with  praziquantel  can  be  beneficial  in  the  young  children  living  in 
schistosomiasis  endemic  areas  as  found  in  this  study  showing  reduction  in  prevalence  and 
intensity  of  infection  which  become  low  throughout  the  follow-up.  Even  though  the  two 
monthly  repeated  treatment  was  very  effective,  with  indications  of  a  drastic  reduction  in 
prevalence  and  intensity  of  infection  soon  after  the  begining  of  the  programme,  it  is 
possible  that  similar  effects  might  be  achieved  when  the  treatment  intervals  are  increased 
and  this  would  warrant  fiuther  investigation.  The  study  has  clearly  demonstrated  that, 
repeated  treatment  can  be  used  to  remove  infections  and  minimise  production  of  eggs. 
The  egg  are  the  main  cause  of  pathology.  But  it  is  not  clear  whether  removal  of 
pathology  also  caused  failure  of  development  of  protective  immunity.  17he  results  can  be 
interpreted  as  lack  of  development  of  humoral  indices  of  protective  immunity  of  IgE, 
IgGl,  IgA  may  suggest  a  decline  in  immunity  with  repeated  treatment  due  to 
unavailability  of  antigen  in  the  immune  system.  Clear  intepretation  is  difficult  due  to 
unavailability  of  a  parallel  group  of  children  not  receiving  praziquantel.  Follow-up  of  an 
untreated  group  of  children  was  against  the  ethics  of  the  Zimbabwe  Medical  Research 
Council  and  Ministry  of  Healthy  ethical  committees.  However,  there  is  a  possibility  of  a 
follow-up  of  the  treated  children  for  a  period  of  time  after  treatment  is  stopped  to 
observe  any  imunological  development  pattern  which  is  beyond  the  limits  of  this  study. 
180 Table  4.1:  Results  of  a  preliminary  parasitology  survey  from  six  schools  in  the  Madziwa 
area  marking  each  central  point  in  the  catchment  area  for  the  study.  Ile  prevalence  of 
S.  haematobium  determined  by  urine  filtration  of  three  samples  collected  on  three 
consecutive  days.  S.  mansoni  infection  prevalence  determined  by  Kato-Katz  method  of 
three  stool  samples  collected  on  three  consecutive  days. 
School 
centre 
No.  of  children 
examined 
S.  haematobiuni 
Prevalence%  (n) 
No.  of  children 
examined 
S.  mansoni 
Prevalence%  (n) 
Madziwa  97  42.71  (41)  86  4.65  (4) 
Chihuri  95  71.58  (68)  100  18.0  (18) 
Mupfure  90  90.0  (81)  74  28.38  (21) 
Nyarnaruro,  97  66.0  (64)  96  14.58  (14) 
Chimbira  99  61.62  (61)  97  12.37  (12) 
Kaziro  99  58.59  (58)  97  7.22  (7) 
Total  577  64.64  (373)  550  13.82  (76) 
Table  4.2:  ne  correlation  between  different  antibody  isotype  profiles  (measured  in  O.  D 
at  492  mn)  to  egg  output  (infection)  at  each  examination  and  treatment  point. 
before  treatment  2  months  after  4  months  after 
Antibody  No.  Spearman  P-  No.  Spearman  P-value  -  No.  Spearman  P- 
isotype  coefficient  value  coefficient  coefficient  value 
Anti-egg 
Ig,  A  83  -0.0931  0.402  35  0.0910  0.603  66  -0.2421  0.05 
IgF_  83  0.2705  0.013  35  -0.3990  0.018  49  0.3070  0.032 
IgGI  31  0.1120  0.549  13  0.1572  0.608  21  0.0000  1.000 
IgG2  56  0.1587  0.243  23  -0.3574  0.094  43  0.0786  0.616 
IgG3  23  -0.0067  0.976  7  0.1786  0.702  16  -0.3349  0.205 
IgG4  83  0.3571  0.001  35  0.1322  0.449  62  0.2810  0.027 
Igm  83  0.1163  0.295  35  -0.2690  0.118  66  0.2157  0.902 
Anti- 
worm 
IgA  83  0.0762  0.494  35  0.0838  0.632  66  -0.0546  0.664 
Ig)E  83  0.3695  0.001  35  -0.0698  0.690  55  0.3453  0.010 
IgG4  83  0.0589  0.597  35  0.2238  0.196  66  0.0468  0.709 
Igm  83  -0.0494  0.657  1  35  -0.0430  0.806  65  -0.0886  0.483 
181 Table  4.3:  Number  of  children  examined  for  S.  haematobium  infection  and  number  of 
children  in  the  Immoral  assays  cohort  after  parasitology  examination  and  provision  of 
blood  samples.  ne  numbers  shown  represents  the  total  number  of  children  assayed  for 
the  antibody  isotype  at  each  follow-up  time  point  and  in  each  infection  status  group. 
Follow-up  time 
(Months) 
Total 
number 
examined 
Number 
infected 
Total 
number  in 
cohort 
Number 
infected 
Start  (Pre-treatment)  595  357(60.0)  83  43  (51.8) 
2  465  32  (6.7)  35  5  (14.3) 
4  567  34  (6.0)  66  12  (18.2 
6  209  5  (2.4)  55  3  (5.5) 
8  220  5  (2.3)  47  2  (4.3) 
10  230  5  (2.2)  49  3  (6.1) 
14  246  3  (1.2)  25  none 
182 Figure  4.1  :  Prevalence  of  infection  of  the  children  examined  including  the  children  In  the 
study  coliort  for  Immoral  assays  with  the  follow-up  time.  'I'lie  prevalence  determined  by 
examining  eggs  in  three  10  ml  urine  samples  collected  over  three  consecutive  days.  (The 
number  of  children  examined  at  each  time  point  is  shovoi  on  the  bar). 
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Figure  4.2:  Intensity  of  infection  (mean  ep  I  Oml,  ±S.  F.  )  ofthe  children  examined 
includinp  the  children  in  the  study  cohon  for  Immoral  assays  With  the  l'ollo"-up  time. 
-Hie  intensitv  of  infection  determined  by  examining  eggs  in  three  10  nil  urine  samples 
collected  over  three  consecutive  days.  (The  number  ot'children  examined  at  each  time 
point  is  shov"i  in  Table  4.3  and  the  graph  above). 
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GENERAL  DISCUSSION  AND  CONCLUSION 5.  o  GENERAL  DISCUSSION 
5.1  THE  IMMUNO-EPIDEMIOLOGYOFS.  haematobium  INFECTIONS. 
Human  immune  responses  to  schistosome  infections  have  been  extensively  investigated 
with  the  main  objective  of  understanding  the  mechanisms  involved  in  determining 
susceptibility  and  resistance  to  infection  or  reinfection.  Several  researchers  have  reported 
on  the  potentially  protective  and  'blocking'  roles  of  IgE,  IgG4,  IgA,  IgG2  and  IgM 
antibodies  in  determining  resistance  or  susceptibility  to  reinfection  after  drug  treatment 
(Butterworth  et  aL,  1985,1987,1991,1992,  Hagan  et  aL,  1987,1991;  Rihet  et  aL, 
199  1;  Dunne  et  aL,  1992;  Derneure  et  aL,  1993  and  Ndhlovu  et  al.,  1996).  Others  have 
studied  the  role  of  macrophages,  eosinophils  and  other  effector  cells  during  ADCC, 
(Capron  et  aL,  1977;  Capron  and  Capron,  1986;  Hagan  et  al.,  1985a,  b,  1987;  Dunne  et 
aL,  1987)  but  not  much  is  known  about  the  cellular  immune  responses  of  the  vulnerable 
age  groups  in  endemic  regions,  and  how  much  these  might  reflect  different  transmission 
patterns  and  differences  in  infection  prevalence  and  intensity,  especially  for 
S.  haeniatobiuni  infection. 
Over  the  last  decade,  evidence  has  accumulated  that  following  chemotherapeutic  cure  of 
S.  mansoni  and  S.  haematobium  infections,  older  individuals  display  resistance  to  infection 
in  comparison  to  younger  children  (Butterworth  et  aL,  1985,1988;  Wilkins  et  al.,  1987; 
Hagan  et  al.,  1987,1991).  T'he  extent  to  which  reinfection  occurs  is  dependent  in  part 
upon  age  (Wilkins  et  aL,  1987;  Butterworth  et  al.,  1988,1991ý  1992;  Haggi  et  aL,  1990; 
Dunne,  Hagan  and  Abath,  1995)  and  in  conditions  of  continued  transmission  of  infection, 
young  children  usually,  and  sometimes  rapidly,  become  reinfected  (Hagan  et  al.,  1987, 
1991;  Butterworth,  1991,1992;  Roberts  et  aL,  1993).  In  contrast,  adults,  if  they  become 
reinfected  at  all,  normally  become  reinfected  only  at  very  low  infection  intensities. 
198 The  cffect  of  age  on  the  development  of  resistance  has  been  observed  in  several  studies 
of  S.  mansoni  infection  (Stuffock  et  al.,  1983;  Dunne  et  al.,  1992;  Dessein  et  al.,  1992) 
and  of  S.  haematobium  (Ndhlovu  et  aL,  1996).  It  has  been  a  repeated  finding  in  studies  of 
human  schistosomiasis,  that  resistance  to  infection  develops  slowly,  often  taking  many 
years.  Ilis  has  been  supported  by  the  findings  of  the  study  described  here,  in  which 
evidence  of  acquired  immunity  could  not  be  detected  in  young  children  below  six  years 
old  living  in  Madziwa  an  endemic  area  for  S.  haematobium.  Two  important  factors  in 
resistance  to  infection  have  been  reported  to  be  age  and  duration  (history)  of  exposure  to 
infections  (Butterworth  et  aL,  1985,  Wilkins  et  aL,  1987,  Woolhouse  et  aL,  1991).  Tle 
delay  in  the  expression  of  resistance  may  be  due  to  the  slow  maturation  of  certain 
protective  immune  mechanisms  or  to  factors  that  inhibit  the  expression  of  immunity.  Tle 
development  of  resistance  has  been  said  to  take  years  in  children  but  also  in  adults  who 
move  into  endemic  areas  from  non-endemic  areas  suggesting  that  the  development  of 
protection  is  dependent  on  repeated  exposure  to  the  parasite. 
in  an  endemic  area  for  schistosomiasis,  the  current  understanding  is  of  infection  and 
reinfection  in  young  children  with  gradual  development  of  resistance.  Since  this 
resistance  is  apparently  dependent  on  the  history  of  exposure  to  infection,  (Vickle' 
infections  or  'the  ghost  of  worms  past'),  then  it  is  possible  to  speculate  that  in  areas 
where  transmission  is  at  a  high  leveL  children  would  be  exposed  to  higher  quantities  of 
infection  and  at  a  higher  rate  and  therefore  that  they  might  develop  resistance  to  infection 
more  rapidly  than  in  areas  where  children  had  low  levels  of  exposure  to  infection 
(Woolhouse  et  aL,  1991;  Hagan  et  al.,  1994).  Woolhouse  et  aL,  (1991)  reported  this 
early  development  of  acquired  immunity  as  a  'peak  shift'  in  S.  haematobiunz  infections, 
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Peak  shifts  have  now  been  reported  for  other  helminth  parasites.  The  early  peak  in 
intensity  of  infection  found  in  this  study,  in  individuals  from  the  ffigh  Transmission  area 
post-treatment,  may  represent  a  'peak-shift'  effect  and  could  be  due  to  the  earlier 
development  of  at  least  an  acquired  partial  resistance.  Resistance  to  re-infection  was  also 
displayed  by  the  adults  from  the  High  Transmission  area  after  treatment.  Butterworth  et 
aL,  (1985)  and  Wilkins  et  aL,  (1987),  in  studies  in  Kenya  and  The  Gambia  respectively, 
attributed  the  lack  of  reinfection  in  treated  adults  previously  infected  to  depend  on 
previous  experience  of  infection  which  had  induced  an  acquired  immunity.  Other  workers 
consider  that  some  age  dependent  physiological  changes  including  hormonal  changes 
cannot  be  excluded  as  important  factors  in  the  development  of  resistance  to  infection 
(Fulford  et  aL,  1992).  Whether  physiological  or  immunological,  the  development  of 
resistance  is  age-dependent  and  a  long  period  of  exposure  to  repeated  challenges  is 
necessary  for  its  fWl  development  (Wilkins  et  aL,  1987;  Butterworth  and  Hagan  1987; 
Woolhouse  et  aL,  199  1;  Hagan  et  al.,  199  1;  Dessein  et  aL,  1992;  Dunne  et  aL,  1992  and 
Ndhlovu  et  al.,  1996). 
5.1.1  CELLUIAR]IMMUNIWOFS.  haematobium  INFECTION. 
Although  much  work  has  been  done  on  the  role  of  antibodies  in  resistance  to  infection 
with  schistosomiasis,  less  work  has  been  done  on  the  role  of  cellular  factors  in  resistance. 
Levels  of  proliferation  of  PBMC  in  response  to  specific  and  non  specific  stimulants  have 
been  exploited  as  a  measure  of  cellular  immunity  in  individuals  with  schistosomiasis.  It 
has  been  a  repeated  finding  that  only  low  levels  of  proliferation  of  PBMC  could  be 
detected  from  heavily  or  chronically  infected  patients  following  schistosome  antigen 
stimulation  (Domingo  and  Warren,  1968;  Ottesen  et  aL,  1977;  Colley  et  aL,  1977a,  b, 
200 1986).  However,  similar  studies  by  Gazzinelli  et  aL,  (1985),  Roberts  et  aL,  (1993), 
Ribeiro  de  Jesus  et  aL,  (1993)  on  Smansoni  infected  individuals  and  Grogan  et  al., 
(1996)  on  S.  haematobium  infected  individuals  reported  that  low  levels  of  proliferation  to 
schistosome,  antigens  take  place  before  treatment.  The  same  PBMC  responded  well  to 
unrelated  non-schistosome  stfinulants  before  treatment.  The  PBMC  were  observed  to 
show  elevated  levels  of  proliferation  after  treatment.  This  unresponsiveness  of  PBMC, 
before  treatment,  to  schistosome-specific  antigen  stimulation  appears  to  be  related  to  an 
immunomodulation  that  takes  place  during  schistosome  infection.  The  immunoregulation 
was  said  to  involve  several  other  poorly  defined  agents  in  sera,  reportedly  causing  anergy 
in  T  cell  responses  during  heavy  and  chronic  infections  (Colley  et  al.,  1977b,  1983; 
Fieldmeier,  Gastl  and  Poggensee,  1985a,  b;  Ellner  et  al.,  1985). 
Immimoregulation  was  also  thought  to  be  involved  in  the  responses  shown  by  PBMC 
from  individuals  living  in  the  High  Transmission  area  studied  here.  Before  treatment, 
PBMC  from  individuals  with  a  heavy  infection  intensity  showed  lower  levels  of 
proliferation  than  PBMC  from  uninfected  individuals  from  the  same  area.  However,  afler 
treatment  proliferation  levels  were  reversed,  and  were  observed  to  be  higher  among  the 
re-infected  than  the  uninfected  individuals.  One  explanation  for  this  is  that  praziquantel 
treatment  had  an  effect  on  the  immune  response.  The  antigens  released  by  dead  and 
damaged  schistosome  worms  as  a  result  of  the  treatment  boosted  cellular  responsiveness. 
As  a  consequence,  reinfection  is  marked  by  a  higher  level  of  cellular  reactivity  indicated 
by  increased  levels  of  proliferation  to  schistosome-specific  antigen  stimulation. 
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Transmission  area,  do  not  experience  massive  schistosome  invasion  by  the  parasite. 
PBMC  from  the  infected  individuals  from  the  Low  Transmission  area  showed  higher 
levels  of  proliferation  to  schistosome  antigen  stimulation  than  PBMC  from  uninfected 
individuals.  Ile  same  pattern  was  observed  at  the  follow-up  points  afler  treatment. 
5.2:  CYTOKINE  PROFILES  AND  T  HELPER  CELL  SUBSETS  IN  HUMAN 
S.  haematobium  INFECTION. 
T  lymphocytes  are  now  well  understood  as  the  central  regulatory  cells  of  the  immune 
system,  with  their  fimction  being  mediated  by  cytokines  whose  production  is  induced  as  a 
result  of  antigen  stimulated  cellular  activation.  Ile  T  lymphocytes  involved  in  this  cross 
regulation  have  been  designated  as  T  helper  type  I  (TIA)  and  112  subsets,  and  it  is 
recognized  that  the  pattern  of  cytokines  produced  may  directly  determine  whether 
responses  are  protective  in  character  or  may  induce  susceptibility.  T'lle  role  played  by  the 
T  cell  subsets  and  cytokines  in  directing  immune  responses  in  schistosomiasis  is  still 
unclear.  Animal  studies  have  not  helped  clarify  the  situation  since  results  of  protection 
studies  using  mice  seem  to  conflict  with  those  obtained  from  the  human  studies  (see 
below).  Observing  cellular  and  cytokine  responses  to  S.  haeniatobiuni  in  humans  from 
areas  of  different  endemicity  have  added  to  our  understanding  of  how  individuals 
respond  to  infection  and  in  this  study  have  helped  in  the  identification  of  the  roles  played 
by  particular  cytokines  in  determining  susceptibility  or  resistance  to  further 
S.  haematobium  infection.  Although  members  of  each  of  the  cytokine  classes  play 
important  regulatory  roles  in  the  immune  responses,  attention  has  been  focused  in  this 
and  in  other  studies  on  IIFN-y  as  a  cytokine  which  is  a  dominant  feature  of  the  T111 
response  and  Il,  -4,11,  -5  and  IL-10  which  are  dominant  features  oftheT12  response.  The 
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has  been  examined  in  this  study,  principally  in  the  context  of  regulation  of  immune 
responsiveness  by  T  cells.  The  Thl-like  responses  have  been  found  to  dominate  early 
during  infection  while  Th2-like  responses  begin  to  be  elevated  during  infection  and 
dominate  responses  post-treatment  in  uninfected  individuals. 
Cytokines  normally  finiction  in  concert  with  one  another  and  may  be  involved  in 
generating  a  network  or  cascade  of  other  cytokines  that  interact  with  other  cell 
regulators  such  as  hormones  and  nueropeptides  that  are  in  turn  capable  of  stimulating  the 
generation  of  many  others  (as  reviewed  by  Romagnaniý  1991,1997;  Abbas,  Murphy  and 
Sher,  1996).  In  all  infected  individuals  examined  before  treatment,  IFN-y,  ILA,  ILA  and 
IL-10  were  found  at  high  levels.  This  presumably  reflects  the  'normal'  situation  in  which 
the  outcome  of  particular  responses  is  determined  by  the  interaction  of  a  variety  of 
cytokines  which  may  have  cross-regulatory  activities,  a  condition  which  may  be  essential 
to  ensure  fine  modulation  of  the  immune  responses  as  the  host  immune  response  deals 
with  newly  establishing  infection. 
Studies  on  murine  schistosomiasis  have  shown  that  III  responses  indicated  by  IFN-y 
production  are  associated  with  protection  whereas  112  responses  appear  to  cause 
immunopathology  (Sher  and  Coffman,  1992).  In  contrast,  studies  on  reinfection  after 
chemotherapy  in  humans  have  shown  that  resistance  is  associated  with  eosinopliilia  and 
with  production  of  specific  IgE  (Hagan  et  al.,  1985a,  b,  1991;  Rillet  et  al.,  1991). 
Production  of  eosinophil  is  dependent  on  IL-5  while  the  production  of  IgE  is dependent 
on  IL-4  both  T12  type  responses  (Lopez  et  al.,  1988;  Slier  et  al.,  1990;  Malianty  et  al., 
1997).  However,  it  may  be  considered  that  both  Thl  and  T12  may  be  involved  in 
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and  IFN-y  production  in  response  to  S.  mansoni  antigens  in  resistant  individuals. 
Another  approach  to  such  work  is  to  examine  T  cell  lines  or  clones  derived  from  the 
PBMC  of  infected  or  exposed  individuals.  This  has  the  advantage  that  the  celIs 
producing  the  cytokines  can  be  reasonably  accurately  defined  but  the  disadvantage  that 
cytokines  derived  from  other  cell.  types  are  no  longer  represented  in  the  system. 
Nevertheless  despite  the  efforts  involved  in  generating  thern,  T  cell  lines  and  clones  are 
proving  to  be  a  valuable  source  of  information  on  human  responses  in  general  and  to 
infections  in  particular.  Tbi  clones  or  cell  lines  through  their  production  of  IFN-y  and 
TNF-P  have  been  reported  to  induce  enhanced  activity  in  macrophages  (enhanced 
cellular  immunity),  while  the  Th2  clones  or  cell  lines  make  products  which  are  well 
adapted  to  promoting  B  cells  to  antibody  producing  cells  (Del  Prete,  Maggi  and 
RomagnanL  1994).  The  products  of  T12  ceRs  ILA,  ILA,  IL-6,  ILAO  and  IL-13  may 
each  potentially  enhance  some  aspects  of  the  B  ceR  response  and  thus  of  antibody 
production  (Coffman  et  aL,  1988).  A  712-like  response,  by  opposing  the  effects  of  IFN- 
on  macrophages  through  the  action  of  ILAO  and  IL-4,  and  possibly  suppressing 
production  of  IFN-y  and  other  cytokines  of  T111.  cells,  could  exert  influence  on  the 
control  of  antibody  production.  Th2  induction  may  depend  on  the  route  of  immunisation 
or  infection  or  on  the  nature  and  concentration  of  the  antigen  (Bradley  et  aL,  1993). 
IFN-y  secreted  by  T  ceRs  causes  induction  of  MIIC  class  11  on  macropliages.  More 
APCs  expressing  MEC  class  II  results  in  more  antigen  presentation  to  T  cells  and  more 
IFN-y  availability  in  the  environment  (Marrack  and  Kappler,  1994;  Sprent,  1994).  11is 
may  explain  the  high  levels  of  IFN-y  found  in  the  infected  individuals  in  the  cuff  cnt  study 
as  IFN-y  is  suspected  to  be  one  of  the  first  cytokines  to  be  produced  in  abundance  during 
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infection. 
In  the  study  reported  here,  the  dominance  of  112-like  cytokines  after  treatment  aflows 
the  speculation  that  the  Th2-like  cytokine  environment  favoured  immune  reactivities, 
possibly  including  ADCC  mechanisms,  which  could  have  contributed  to  resistance  to 
reinfection.  This  interpretation  would  be  entirely  consistent  with  the  evidence  from  other 
studies  which  indicates  that  M-associated  responses  appear  to  be  associated  with 
resistance  to  reinfection  (Hagan  et  aL,  1985  a,  b,  199  1;  Rihet  et  aL,  1991,1992,  Dunne  et 
.4 
al.,  1992,  Dessein  et  al.,  1992). 
The  IhI-  and  Th2-like  cytokine  patterns  have  been  implicated  in  several  other  disease  states 
including  hehninths  infections,  NNhere  the  M  subset  has  been  linked  to  pathogenesis.  But 
from  the  critical  analysis  of  these  studies  it  appears  the  T  helper  cell-dependent  effector  and 
regulatory  mechanisms  as  well  as  the  critical  role  played  by  the  cytokines  in  controlling 
immune  responses  during  schistosomiasis  need  further  elucidation. 
in  contrast  to  intracellular  microbes,  extracellular  pathogens  including  helminths,  trigger  TIC- 
dominated  responses  (Urban  et  al.,  1994).  In  some  studies  these  TIQ  responses  which 
dominate  after  infection  have  been  related  to  immunological  unresponsiveness.  This  may  be 
suspected  to  be  the  situation  in  the  individuals  from  the  Iligh  Transmission  area  before 
treatment  and  in  those  with  heavy  infections.  The  T12-like  responses  are  involved  in  driving 
eosinophil  production  and  activation  and  in  antibody  production  by  B  cells.  Ilie  dotninance  of 
the  M  response  results  in  downregulating  the  effects  of  IFN-y  that  is  involved  in  DTIL  As  a 
results  of  long-term  dominance  of  this  response  it  is  suspected  that  T  cell  anergy  develops  and 
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of  proliferative  responses  to  stimulation  with  schistosome-specific  antigens  and  this  could 
have  been  due  to  the  shmiltaneously  elevated  levels  of  IL-4,  IL-5,  IL-10  and  IFN-y  before 
treatment. 
Cytoldne  studies  carried  out  over  the  last  decade  have  demonstrated  that  T  ceRs  produce 
cytokines  that  serve  as  autocrine  growth  factors  for  their  own  lineage  (Coffinan  et  al.,  199  1). 
This  may  be  the  reason  that  the  uninfected.  people  in  the  study  cohort  maintained  an  elevated 
Th2  type  cytoldne  environment  at  the  12  and  18  months  post-treatment  examination  points. 
Prior  to  treatment,  it  seems  that  the  T  cell  responses  maintained  a  balanced  state  of  both  Thl- 
and  112-  like  cytokine  environment  which  was  observed  in  both  infected  and  uninfected 
children  having  low  IL-4:  IFN-y,  IL-5:  fFN-y  and  IL-10:  IFN-y  ratios.  After  treatment  it 
appears  that  the  state  of  T  cell  anergy  is  removed  resulting  in  increased  proliferation  to 
specific  antigen  stimulation,  and  consequently  setting  up  of  a  Th2-like  cytoldne  enviromment 
(Coffinan  and  von  der  Weid,  1997). 
After  early  cloning  in  vitro  the  CD4+  T  cell  pool  does  not  always  fit  easily  into  the 
ThlfM  classification  leading  to  the  proposition  that  there  are  TbO  T  cells  which  only 
differentiate  into  III  and  Tb2  upon  prolonged  in  vitro  culture  (Romagnani,  1991; 
Couissinier  and  Dessein,  1995).  This  interpretation  challenges  the  importance  of  the  Tlil 
and  'M2  dichotomy  and  has  raised  the  possibility  that  it  inight  be  an  artifact  of  in  vitro 
differentiation.  Another  view  is  that,  depending  on  the  signals  received,  the  duration  of 
the  stimulation  and  maturity  of  the  immune  effector  responses,  T  cells  can  produce 
different  pattern  of  cytokines.  Various  groups  have  attempted  to  determine  if  human  T 
cells  fit  into  the  ThIM2  dichotomy.  To  date  there  is  little  hard  and  fast  evidence  to 
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IL-5  and  INF-y.  The  lack  of  confirmation  of  the  Tbl/Th2  concept  in  human 
schistosomiasis  may  suggest  that  the  observed  differences  in  the  cytokine  production  in 
the  mouse  are  more  likely  to  be  a  characteristic  unique  to  the  murine  models.  What  is 
clear  and  demonstrated  once  again  in  this  study  is  that  in  human  schistosomiasis,  no 
distinct  polarised  cytokine  types  for  Thl/Th2  subsets  e)dst,  due  to  production  by  single  T 
cell  clones  of  both  'signature'  cytokines  which  are  normally  used  to  identify  each  T  cell 
subset. 
5.3  CONCLUSIONS 
5.3.1  ESDIVIDUALS  FROM  AREAS  OF  DIFFERENT  TRANSMISSION 
PATTERNS  HAVE  DIFFERENT  INFECTION  AND  RE-INFECTION 
PATTERNS. 
This  study  has  shown  that  individuals  living  in  Schistosoma  haematohium  endemic  areas 
show  different  patterns  of  infection  prevalence  and  intensity  depending  on  the 
transmission  pattern  in  the  area.  This  study  added  to  the  findings  reported  by  other 
workers  that  infection  prevalence  and  intensity  peaks  in  young  children.  No  differences 
were  detected  in  infection  levels  for  all  age  groups  below  16  years  old,  who  were  found 
to  be  heavily  infected.  However,  the  infection  prevalence  and  intensity  was  found  to  be 
low  in  the  adult  age  groups  for  both  study  cohorts  living  in  Low  and  High  Transmission 
areas.  After  treatment  the  patterns  were  seen  to  differ  between  the  transmission  areas. 
The  individuals  from  Iligh  Transmission  area  showed  a  sharp  rise  in  infection  prevalence 
and  intensity  relative  to  age,  with  the  infection  prevalence  peaking  earlier  than  in  the  age 
group  in  the  Low  Transmission  area.  Considering  infection  intensity,  it  was  found  that 
the  lower  age  groups  were  re-infected  earlier  and  at  higher  intensities  than  the  older  age 
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Low  Transmission  area  the  peak  reinfection  prevalence  occurred  in  an  older  age  group 
than  in  Fligh  Transmission  area  and  in  this  case  the  age  group  was  found  to  be  most 
heavily  infected  prior  to  treatment  and  was  most  heavily  re-infected. 
5.3.2  INDIVIDUALS  RESIDENT  IN  AN  AREA  WHERE  INFECTION 
PREVALENCES  AND  MENSMES  ARE  HIGH,  DEVELOP 
RESISTANCE  TO  INFECTION  EARLIER  DUE  TO  GREATER 
'EXPERIENCE'  OF  PARASUES. 
In  this  study,  cellular  immime  response  levels  appear  to  reflect  the  different  infection 
patterns  and  exposure  histories  of  the  people  in  the  11igh  and  Low  Transmission  areas. 
Ile  individuals  from  the  Low  Transmission  area  are  exposed  to  low  levels  of  infection 
and,  as  a  result,  only  experience  a  low  antigen  load.  Consequently  their  infection  status 
does  not  progress  beyond  an  'acute'  phase  and  this  is  reflected  in  their  continuing 
susceptibility  to  infection  and  immunological  reactivity  to  stimulation  with  schistosome 
antigens  in  vitro.  nose  living  in  this  area  who  are  not  infected  are  probably  not  infected 
due  to  the  relatively  restricted  opportunities  for  exposure.  Therefore  they  have  only 
limited,  and  possibly  no,  experience  of  the  parasite.  Reflecting  this  'naive'  status,  PBMC 
obtained  from  them  fail  to  respond  to  schistosome  antigen. 
The  failure  of  cells  derived  from  individuals  living  in  High  Transmission  area  to  respond 
to  schistosome  antigen  stimulation  probably  reflects  a  state  of  T  cell  anergy.  This  is  a 
characteristic  feature  of  schistosomiasis  mansoni  and  is  weR  documented  in  the  Rterature. 
Occurring  as  a  result  of  intense  infection  this  relatively  simple  host  adjustment  to  the 
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essential  for  the  long-term  maintenance  of  the  adult  parasite  and  of  its  life-cycle. 
The  individuals  from  the  11igh  Transmission  area  who  were  not  infected  showed  a  high 
response  to  schistosome,  antigen  stimulation.  This  may  be  indicative  of  some  degree  of 
resistance  to  infection  which  is  constantly  re-stimulated  through  repeated  exposures. 
Immunological  reactivity  is  maintained  while  invading  parasites  are  eliminated.  In 
contrast  to  these  infected  individuals  from  High  Transmission  area,  infected  individual 
from  the  Low  Transmission  area  gave  even  higher  levels  of  responses  presumably 
reflecting  the  absence  of  development  of  any  immunomodulation,  whereas  the  uninfected 
individuals  in  Low  Transmission  area  who  gave  very  low  levels  of  response  to 
stimulation. 
Treatment  with  praziquantel  caused  some  form  of  immune  boosting  which  was  shown  in 
this  study  to  result  in  increased  reactivity  to  stimulation  with  all  schistosome  antigens 
relative  to  pre-treatment  reactivity  levels.  Although  the  overall  response  to  stimulation 
increased,  the  infected  individuals  from  the  Low  Transmission  area  remained  high 
responders  while  the  non-infected  still  showed  low  responses  to  schistosome  antigen 
stimulation.  Ile  individuals  in  the  High  Transmission  area  showed  a  reverse  of  their 
responses  possibly  indicating  the  development  of  protective  immunity  post-treatment 
perhaps  resulting  from  the  enhanced  exposure  to  parasite  antigens  induced  by  treatment. 
This  may  also  have  been  reflected  in  reinfection  after  treatment  vvith  the  adults  remaining 
uninfected.  In  contrast,  adults  from  the  Low  Transmission  area  were  re-infected  afler 
treatment.  This  would  be  consistent  with  the  view  that  as  yet  they  had  failed  to  develop 
an  effective  protective  immune  response  and  that  the  low  levels  of  infection  (antigenic 
209 load)  they  had  were  insufficient  to  induce  an  enhanced  reactivity  following  treatment. 
Taken  together  these  findings  suggest  that  repeated  exposure  to  the  parasite  is  essential 
for  the  development  of  protective  immune  responses.  Although  the  increased  reactivity 
after  treatment  of  individuals  from  the  ffigh  Transmission  area  may  in  part  be  explained 
by  the  lifting  of  the  observed  immunoregulation.  it  was  noted  that  following  treatment 
A-  -,  this  status  was  not  readily  regained  as  re-infected  individuals  in  the  11igh  Transmission 
area  showed  high  responses  to  specific  schistosome  antigens  even  at  18  months  post- 
treatment  compared  with  the  pre-treatment  infected  groups. 
5.3.3:  THE  CYTOKINE  PROFTLES  VARY  ACCORDING  To  WFECTION 
PATTERNS  OF  EACH  AREA  AND  THE  ANTIGENS  STIMULATING 
THEIR  PRODUCTION. 
individuals  living  in  different  areas  of  schistosome,  transmission  show  different  patterns 
of  cytokine  production  after  schisto  some-  specific  antigen  stimulation.  The  individuals 
from  the  High  Transmission  area  where  infection  was  high  produce,  overall,  high  levels 
of  A  the  cytokines  as  measured  in  this  study  (IL-4,  M-5,  IL-  10  and  IFN-y),  compared  to 
the  individuals  from  Low  Transmission  area  of  schistosomiasis.  Even  though  the  PBMC 
from  individuals  living  in  the  Iligh  Transmission  area  were  found  to  give  low  levels  of 
proliferation  to  stimulation,  they  were  capable'  of  producing  higher  levels  of  cytokines 
when  compared  with  the  responding  PBMC  obtained  from  individuals  living  in  the  Low 
Transmission  area.  Within  each  transmission  area,  the  levels  of  each  cytokine  have  been 
found  to  differ  according  to  infection  status.  Before  treatment,  the  infected  individuals 
from  both  areas  produced  high  levels  of  IFN-y  (a  111-type  cytokine)  which  may  be 
involved  in  early  stages  of  the  development  of  immune  responses  aimed  at  curbing 
infection.  However,  it  was  clearly  shown  when  examining  the  PBMC  from  the  Mgh 
210 Transmission  area,  that  the  Th2  cytokines  (IL-4,  IL,  5  and  IL-10)  were  also  produced  at 
high  levels  during  infection  and  before  treatment.  This  raises  the  possibility  of  having  an 
immune  response  geared  both  to  mobilise  ceH-mediated  immunity  and  drive  humoral 
responses,  by  involvement  of  both  IM  and  M  cytokines.  As  Thl  and  Th2  cytokines 
are  normally  considered  to  be  cross-regulatory,  finiher  work  is  needed  to  confirm  if  this 
combined  cytokine  production  is  reflected  in  both  ceHular  and  antibody  responses  to 
schistosome  infection.  This  study  has  revealed  that  following  treatment  the  individuals 
who  remain  uninfected  in  the  fligh  Transmission  area  had  a  dominating  Th2-like 
response  with  high  levels  of  ILA,  IL-5  and  IL-10  relative  to  IFN-y.  However,  individuals 
who  become  re-infected  had  high  levels  of  IFN-y  compared  with  those  who  were 
uninfected  but  the  ratios  of  the  Thl/Th2  cytokines  showed  that  the  cytokines  for  these 
classes  (IL-4:  IFN-y,  IL,  5:  IFN-y)  were  found  at  a  similar  level  both  before  and  after 
treatment. 
5.3.4  THE  EXISTENCE  OF  T110/1-  AND  T110/2-LIKE  CYTOKINE 
SUBSETS  EVIIDENCED  FROM  T  CELL  CLONING. 
The  work  in  this  study  on  T  cell  cloning  for  the  characterisation  of  T  cell  responses 
involved  in  schistosomiasis  immune  responses  produced  clearly  unpolarised  cytokine 
profiles  of  the  T  helper  cell  subsets.  This  is in  contrast  vvith  the  findings  in  other  studies 
cited  above,  many  of  them  from  studies  of  murine  models  of  S.  niansoni  infections. 
However,  the  findings  on  the  T  cell  cloning  miffored  the  results  reported  in  human 
S.  mansoni  infection  reported  by  Couissinier  and  Dessein,  (1995).  In  their  experiments 
Couissinier  and  Dessein  found  that  both  'signature'  cytokines  were  co-expressed,  with 
the  T  cell  clones  having  a  dominating  Th2-like  cytokine  profiles  being  ffom  resistant 
individuals.  In  this  current  study  the  PBMC  were  obtained  from  individuals  from  the 
211 Hi2h  Transmission  area  prior  to  treatment.  Age  and  duration  of  infection,  (history  of  IL7-- 
exposure  to  infection)  may  play  a  role  in  influencing  the  development  of  unpolarised  T 
helper  cells  with  the  combined  'signature'  cytokine  profiles  which  have  been  recorded.  In 
terms  of  IL-4:  IFN-y  and  ILý5:  117N-y  the  'signature'  cytokines  for  defining  each  T  helper 
cell  subset,  most  of  the  clones  derived  from  all  the  children  showed  co-expression  of  the 
cytokines,  resulting  in  the  subsets  being  classified  as  'MO/I  and  TIO/2,  depending  on  the 
ratio.  Although  the  extremes  of  each  subset  class,  i.  e.  Thl  and  Th2  were  recorded,  these 
were  relatively  rare.  Although  the  sample  size  is  limited,  from  this  work  it  is  concluded  that 
the  balance  of  the  cytokines  relative  to  each  subset  marks  the  immune  state  of  an  individual. 
Ilose  able  to  resist  parasite  invasion  and  establishment  mounted  protective  immune 
responses  reflected  in  elevated  levels  of  IL-4,  IL-5  and  HAO,  cytoldnes  marldng  ThO/2-like 
responses.  In  contrast,  the  dominance  of  IFN-y  marks  a  state  of  susceptibility  to  infection  of  a 
given  individual.  However,  the  balance  between  these  'Ih  I-  and  M-like  responses  appears  to 
be  finely  tuned  and  depending  on  the  timing,  quantity  and  duration  of  exposure  to  infection, 
the  cytokine  balance  may  shill,  possibly  resulting  in  a  change  in  the  immune  response  from 
putative  protective  to  susceptibility  or  vice  versa  (Figure  5.1).  Additional  work  is  required  to 
confirm  this  hypothesis. 
212 Figure  5.1:  T  helper  subsets  accoi-ding  to  cytokine  phenotA)es  in  human  schistosomiasis 
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5.3.5  PRAZIQUANTEI,  IS  USEFULASA  IN 
PREVENTING  FURTHER  HEAVA'INFECTION  IN  VOUNG 
CIIII.  DREN,  ALTHOUGH  PROTECTIVE  IMMUNFINSFEMS  NOTTO 
DEVELOP. 
The  study  has  shown  that  praziquantel  can  be  useful  as  a  cheinoprophylaxis  without  any 
adverse  elfects  on  young  children.  Reinfiection  at  lo\,,,  intensity  was  observed  taking  place 
in  the  study  children  during  the  early  stages  ofthe  repeated  treatment  prograinine.  The 
period  during  which  reinfection  took  place  has  been  reported  to  be  the  high  transmission 
season  in  Zimbabwe,  during  which  the  liot  weather  is  conducive  to  snail  population 
propagation  and  the  weather  also  contributing  to  high  water  contact  activities,  even  in 
small  children  accompanying  their  mothers  to  the  rivers  (Chandiwana,  Makaza  and 
213  Bb Taputaira,  -  1987).  Similar  to  studies  undertaken  in  Kenya  by  Butterworth  and  coHeagues 
on  S.  mansoni  (1988),  in  The  Gambia  by  Wilkins  and  colleagues  on  S.  haematobium 
(1987),  in  Brazil  by  Dessein  and  colleagues  on  S.  mansoni  (1992);  the  findings  of  this 
study  proves  that  reinfection  takes  place  in  young  children  who  are  likely  to  lack  the 
capacity  to  combat  further  infection.  However  with  repeated  praziquantel  treatments  it 
was  observed  that  levels  of  reinfection  were  markedly  reduced  in  the  study  children.  Tlie 
antibody  isotype  profiles  gave  a  similar  picture  to  those  often  reported  from  children  in 
reinfection  studies. 
The  results  obtained  from  this  study  provide  a  possible  effective  way  to  reduce  infection 
levels  and  hence  associated  morbidity  and  pathology  of  S.  haeniatobiuni.  Treatment  on  a 
repeated  basis,  of  all  children  living  in  endemic  areas  at  staggered  intervals  remains  as  the 
most  attractive  alternative  for  alleviating  suffering  in  children  whose  immune  responses 
are  not  yet  fully  developed.  However  due  to  the  cost  of  such  programmes,  a  targeted 
approach  may  be  helpfuL  in  which  only  infected  children  are  treated.  Of  course  this  has 
an  inherent  cost  in  the  need  for  relatively  skilled  manpower  for  diagnosis  before 
treatment  but  with  schistosomiasis,  simpler  diagnostic  methods  (dipsticks)  are  being 
investigated.  Mass  treatment  of  children  without  diagnosis  is  also  possible  but  costly  in 
terms  of  drug  use.  Ile  need  for  skilled  manpower  for  drug  administration  can  be  met 
ideally  by  using  existing  health  systems  in  the  endemic  areas.  Although  children  in 
endemic  areas  start  to  acquire  schistosome  infections  from  the  age  of  2  to  4  years,  they 
do  not  become  readily  immune  to  infection.  In  this  study  reinfection  continued  to  take 
place  and  there  was  a  lack  of  development  of  protective  antibody  isotypes. 
214 5.4  RECOMMENDATIONS 
Human  immuno-epiderniological.  studies  are  always  desirable  for  an  improved  understanding 
of  the  disease  conditions  in  the  actual  host  and  ultimately  for  the  final  understanding  and 
application  ofvaccine  candidates  when  they  become  available.  However,  such  studies  have  to 
contend  with  several  hurdles  as  far  as  the  use  oý  and  working  with,  the  human  host  is 
concerned,  including  the  participation  and  vAlingness  to  provide  the  required  biological 
samples,  especially  blood.  The  use  of  communities  in  many  endemic  areas  may  require  some 
application  ofvisible  immediate  benefits  during  implementation  and  progress  of  the  study,  e.  g. 
provision  of  treatment  for  the  disease  under  study.  In  an  ideal  situation,  studies  of  this  t)pe 
would  be  fully  integrated  into  the  existing  health  care  system  of  the  areas  where  they  are 
carfied  out. 
The  findings  on  Shaenwtobium  reported  in  this  thesis  seem  to  be  in  line  vAth  other  work 
reported  from  other  endemic  areas  on  S.  mansoni  and  S.  haenwtobium.  The  use  of  relatively 
unpurified  antigenic  extracts  of  different  life  cycle  stages  can  be  justified  on  the  basis  that  the 
organism  is  so  complex,  that  immunity  and  immune  responsiveness  is  unlikely  to  be 
determined  by  responses  to  a  single  antigen.  Instead  the  net  level  of  immunity  may  depend  on 
a  combination  of  different  responses  to  different  antigens.  However  it  is  still  valid  to  select  to 
study  responses  to  individual  purified  or  recombinant  antigens  --Aich  can  provide  usefid 
information  in  the  development  ofvaccines  and  in  eliciting  pwticular  immune  responses. 
The  findings  presented  in  this  work  indicate  fliat  M-like  immune  effects  may  be  important  in 
mediating  human  protective  immunity  to  schistosome,  infection.  This  does  not  exclude  die 
possibility  that  the  mechanisms  of  resistance  reported  from  studies  of  the  mouse  model  of 
immunity  to  schistosomes,  with  a  reported  M-like  bias  involving  a  predorninance  of  IFN-y 
215 are  not  also  important  in  human  schistosomiasis.  IFN-y  was  produced  early  and  in  abundance 
during  infection  indicating  a  useful  role  during  this  infection  stage. 
T  helper  cell  subset  determination  is  still  complex  and  requires  more  work  Considering  the 
number  of  patients'  samples  that  can  be  handled  at  any  one  time  in  the  determination  of  the 
subsets  using  single  cell  assays,  the  methodology  needs  to  be  modified  and  simplified  to  make 
it  more  practical  for  routine  field  use.  Although  over-modification  can  sometimes  result  in  a 
weakening  of  the  specificity  of  the  methods,  the  use  of  two  or  more  methods  for  a 
determination  may  help  strengthen  the  significance  of  the  findings,  e.  g.  T  cell  cloning  by  cell 
cultures  and  the  use  of  mRNA  detection  of  cytokines  genes  by  reverse  transcriptase- 
polymerase  chain  reaction  (RT-PCR)  at  the  same  time.  The  use  of  RT-PCR  and/or  intra- 
cellular  cytoldne  staining  may  help  the  study  of  the  T  helper  subsets  in  a  -vNider  age  range  of  a 
population  living  in  endemic  areas.  This  may  be  important  as  cytoldne  polarisation  may  be 
present  in  a  particular  age  group  or  group  with  a  particular  history  of  exposure  to  infection. 
Another  method  currently  available  is  the  use  of  ELISPOT,  the  method  is  usefid  in 
determining  the  specific  number  of  cells  in  a  clone  involved  in  the  cytoldne  production. 
This  study,  has  looked  at  an  age  group  within  the  range  where  peak  infection  prevalence  and 
intensity  is  found  and  coincidentaUy  this  may  be  the  age  group  where  cytokine  polarisation  is 
lacldng  due  to  the  effects  of  infection  intensity.  Therefore,  a  cautious  interpretation  of  the  data 
demands  that  a  distinct  cytoldne  polarisation  of  'MlfM  subsets  should  not  as  yet  be 
excluded,  possibly  being  found  in  adults  living  in  the  High  Transmission  area,  vAio  had  more 
expefience  of  infections. 
216 Ihe  use  of  praziquantel.  as  a  chemoprophylaxis  should  now  be  regarded  as  the  only  useful 
alternative  to  protect  young  children  living  in  schistosome  endemic  areas  from  infection  and 
subsequent  pathology.  Since  the  cost  of  the  drug  has  now  been  reduced  and  significant  drug 
resistance  has  not  been  reported,  the  duration  of  retreatment  can  be  extended  six  to  12  month 
intervals.  Several  studies  have  reported  reinfection  prevalence  reaching  half  the  pre-treatment 
levels  from  six  months  post-treatment.  nus  a  six  monthly  treatment  schedule  may  make  the 
programmes  supportable  in  terms  of  the  cost  of  drug  purchase.  This  approach  would  benefit 
greatly  the  young  children  in  these  endemic  areas  by  protecting  them  from  further  re-infection 
and  the  heavy  infection  levels  that  result  in  morbidity  and  pathology,  since  it  is  well 
documented  that  the  severity  of  clinical  disease  is  dependent  on  intensity  of  infection  rather 
than  sirTly  presence  or  absence  of  infection. 
The  findings  summarised  in  this  concluding  chapter,  like  those  presented  elsewhere  in  this 
thesis,  give  some  additional  information  for  the  development  of  a  vaccine  for  use  against 
schistosome  infections  in  human.  Immunity  can  be  demonstrated  in  naturally  infected 
individuals  after  subsequent  chemotherapy,  and  the  indications  are  that  it  is  the  nature  of  the 
response  that  is  important,  and  not  just  the  exact  identity  of  a  particular  antigen  vdiich 
provides  protective  immunity.  The  most  important  and  crucial  issue  appears  to  be  the 
achievement  of  the  right  balance  of  protective  as  opposed  to  inappropriate  responses. 
Considerable  work  is  required  on  ways  to  elicit  the  correct  responses  in  humans  already 
primed  to  infection,  which  seem  to  be  different  where  infections  exist  naturally  and  the  period 
post-treatment.  This  leaves  a  huge  gap  that  requires  filling  especially  for  the  possibly 
developed  vaccines,  the  stages  at  which  they  may  have  to  be  administered,  with  or  before 
treatment,  and  the  age  groups  that  may  require  the  vaccines. 
217 6.0  APPENDIX APPENDIX: 
Table  6.1:  Low  Transmission  area  -  Infection  intensity  (ep  I  Oml)  according  to 
response  categories  at  pre-  and  post-treatment  determined  using  dye  reduction 
method. 
Antigen/  PHA  WORM  EGG  CAP 
mitogen 
low  mod/high  low  mod/high  low  mod/high  low  mod/high 
Pre 
treatment 
n  47  41  60  28  45  43  60  28 
mean  14.0  3.8  11.0  6.1  10.0  9.0  10.4  6.6 
±  SD  40.0  11.0  34.0  21.0  35.0  25.0  33.0  21.0 
median  1.0  0  0  0.5  0  1.0  0  0.5 
range  0-210  0-58.0  0-210  0-110  0-210  0-114  0-210  0-110 
Post- 
treatment 
n  26  22  43  5  40  8  44  4 
mean  1.0  1.0  1.0  0  0.7  0  0.6  0 
±  SD  1.7  2.1  2.0  0  2.1  0  2.0  0 
median  0  0  0  0  0  0  0  0 
range  0-7 
. 
0-10  0-10  0  0-10  0  0-10  0 
__j 
Table  6.2:  Rgh  Transmission  area  -  Infection  intensity  (ep  I  Oml)  according  to 
response  categories  at  pre-  and  post-treatment,  determined  using  dye  reduction 
method. 
Antigen/  PHA  WORM  EGG  CAP 
mitogen 
low  mod/high  low  mod/high  low  mod/high  low  mod/high 
Pre-  _ 
treatment 
n  63  46  92  17  68  41  91  is 
mean  52.0  41.0  47.0  45.0  54.0  35.0  54.0  12.0 
±  SID  113.0  86.0  101.0  109.6  112.0  94.6  110.0  26.0 
median  0  5.0  6.0  2.0  9.0  2.0  8.0  2.0 
range  0-567  0-448  0-567  0-448  0-567  0-448  0-567  0-93 
u  1035.5  602.5 
p-value  0.078 
Post- 
treatment 
n  29  32  57  4  55  6  58  3 
mean  2.0  22.0  10.0  40.0  8.0  49.0  13.0  0 
±  SD  5.3  50.0  33.6  79.0  29.4  76.2  38.5  0 
median  0  0  0  0  0  0  0  0 
range  0-26  0-192  0-192  0-  158  0-192  0-158  0-192  0 
U  356.0  572.0  110.5  117.3  142.0  188.0 
p-value  0.121  0.93  0.586 
218 Table  6.3:  Low  Transmission  Area,  Stimulation  Index,  determined  by  using 
tritiated  thymidine. 
Antigen/  Pre-  12  months  post-  18  months  post- 
mitogen  treatment  treatment  treatment 
Uninfected  Infected  Uninfected  Infected  Uninfected  Infected 
PHA  n  3  5  9  3  9  4 
mean  81.2  73.8  44.8  125.3  115.5  160.1 
±  SD  69.1  56.8  55.8  102.3  123.0  78.2 
median  96.9  62.2  36.6  124.0  93.9  194.3 
range  5.7  ý  14161  21-163.2  3.5-  181.1  23-227.6  8.2-380  44-208.1 
WORM  n  3  5  9  3  9  4 
mean  10.3  135.1  29.4  137.8  18.1  108.8 
±  SD  5.1  96.5  26.6  49.0  16.1  74.0 
median  11.1  83.5  25.8  136.0  11.7  108.8 
ranze  4.7-14.9  68-298  2.0-90.1  89-  187  1.4-43  19.6-196 
EGG  n  3  5  9  3  9  4 
mean  12.2  224.2  45.1  229.1  30.2  120.6 
±  SD  10.6  214.3  50.6  0.9  31.7  65.9 
median  12.3  125.0  35.0  229.6  8.7  145.3 
range 
. 
1.5-22.6  46-581  2.0-170  229-230  2.7-87  24-167.5 
Table  6.4  High  Transmission  Area  Stimulation  Index,  determined  using  tritiated 
thymidine. 
Antigen/  Pre-  12  months  post-  18  months  post-treatment 
mitogen  treatment  treatment 
Uninfected  Infected  Uninfected  Infected  Uninfected  Infected 
PHA  n  4  11  5  4  5  8 
mean  77.5  23.4  59.0  34.6  35.4  91.1 
±  SD  35.8  21.6  24.5  23.6  29.5  96.4 
median  67  18.7  57.4  40.7  37.0  41.0 
range  49-  125  2.6-76  25-94  2.8-54  3.0-73  3.5-235 
WORM  n  4  11  5  4  5  9 
mean  28.3  6.3  24.9  21.6  4.8  17.0 
±  SD  6.0  8.4  4.7  20.7  1.8  22.2 
median  31.0  2.8  24.9  21.5  4.9  5.7 
range  20-32  1.1-30  18.2-32  3.3-40  2.1-7  1.7-66 
EGG  n  4  11  5  4  5  8 
mean  48.0  7.3  19.8  38.7  18.1  31.5 
±  SD  13.1  8.4  12.8  14.8  21.2  41.3 
median  45.7  3.6  15  37.5  6.2  17.9 
range  35-66  1.1-23 
, 
10-41  22.5-57  ,  4.6-55  2.3-129 
219 Table  6.5  Low  transmission  area  Infection  intensity  (ep  I  Oml)  according  to 
response  categories  at  pre-  and  post-treatment,  determined  using  tritiated 
thymidine. 
Antigen/  PHA  WORM  EGG 
mitogen 
low  mod/high  low  mod/high  low  mod/higb 
Pre- 
treatment 
n  3  5  3  5  3  6 
mean  0  6.2  0  6.0  0  5.0 
±  SD  0  8.9  0  8.7  0  5.0 
median  0  1.0  0  1.0  0  1.0 
range  0  0-21  0  1-21  0  1-21 
u  1.0  7.0  0.00  15.0  1.0  11.0 
p-value  0.3830  0.0369  0.1336 
Post- 
treatment 
n  6  19  10  15  8  17 
mean  0  1  0.2  2.0  0  2.0 
±  SD  0  2.0  0.6  2.2  0  2.1 
median  0  0  0  0  0  0 
range  0  0-7  0-2  0-7  0  0-7 
U  13.5  40.5  21.5  88.5  17.5  80.5 
p-value  0.1914  0.0201  0.0207 
Table  6.6:  High  Transmission  area  -  Infection  intensity  (ep  I  Oml)  according  to 
response  categories  at  pre-  and  post-treatment  determined  using  tritiated 
thymindine. 
Antigen/  PHA  WORM  EGG 
mitogen 
low  mod/high  low  mod/high  low  mod/hig 
h 
Pre- 
treatment 
n  6  9  11  4  11  4 
mean  34.0  28.0  39.0  6.0  39.0  6.0 
±  SD  40.0  61.9  59.3  11.5  59.3  11.5 
median  16.0  0  6.0  0  6.0  0 
range  1-103  0-185  0-185  0-23  0-  185  0-23 
U  41.5  12.5  35.5  8.5  35.5  8.5 
p-value  0.0990  0.0896  0.0896 
Post- 
treatment 
n  5  17  13  9  11  11 
mean  2.4  11.2  6.2  13.4  4.0  15.0 
±  SD  3.2  26.3  13.0  33.7  7.5  31.7 
median  2.0  1.0  1.0  2.0  0  2.0 
range  0-8  0-103  0-43  0-  103  0-25  0-103 
u  109.0  70.0  80.0  67.0  93.0  78.0 
p-value  0.375  0.750  0.731 
220 Table  6.7:  Values  of  IFN-y  determined  from  the  individuals  from  the  Low 
Transmission  Area. 
Antigen/  Pre-  12  months  post-  IS  months  post- 
mitogen  treatment  treatment  treatment 
Uninfected  Infected  Uninfected  Infected  Uninfected  Infected 
PHA  n  3  7  12  3  9  4 
mean  289.1  945.5  865.1  980.2  471.7  2146.9 
±  SD  229.0  742.7  1879.0  666.9  242.2  2169.3 
median  186.7  728.5  251.0  1318.7  436.0  1203.5 
range  129-552  280-2444  159-6800.0  212-1410  171-935.0  803-5377 
WORM  n  3  7  12  3  9  4 
mean  86.3  155.6  62.0  149.7  91.5  132.2 
±  SD  35.1  65.0  43.5  37.0  68.2  77.4 
median  103.0  140.0  42.5  140.0  71.0  159.4 
ranize  46-110  100-284  10-161  119-190  27-214  20-190.0 
EGG  n  3  7  12  3  9  4 
mean  69.3  176.2  55.2  179.0  64.4  85.0 
±  SD  42.0  86.0  51.1  79  57.1  47.1 
median  70.0  138.0  26.5  140  51.0  106.3 
range  27-111  110-359.3  12-181.0 
, 
126-270  9-186  14.5-113 
Table  6.8:  Values  of  IL-4  determined  from  the  individuals  from  the  Low 
Transmission  Area. 
Antigen/  Pre-  12  months  post-  18  months  post- 
mitogen  treatment  treatment  treatment 
Uninfected  Infected  Uninfected  Infected  Uninfected  Infected 
PHA  n  3  5  5  2  4  4 
mean  64.9  83.0  173.7  91.0  130.2  112.0 
±  SD  7.8  44.0  98.0  48.0  74.3  80.7 
median  68.0  78.0  169.0  91.0  144.9  108.1 
range  56-70.7  19.2-128  55-310  57-  125  27-204  42-189.7 
WORM  n  3  5  5  2  4  4 
mean  54.0  45.0  99.4  15.0  91.8  68.7 
±  SD  9.5  19.0  52.6  7.0  44.9  52.7 
median  54.0  40.0  105.0  15.0  105.0  57.5 
ranize  43-62.0  20-69  16-161  10-20  29-  128.0  23.7-  136 
EGG  n  3  5  5  2  4  4 
mean  25.0  47.0  131.2  34.0  91.8  41.6 
±  SD  8.1  28.0  90.7  21.0  54.6  35.5 
median  27.0  36.0  125.5  34.0  117.5  30.0 
range  16-32.0  14-80  15-262  19-48  10-122  14-92.0 
221 Table  6.9:  Values  of  IL-  5  determined  from  the  individuals  from  the  Low 
Transmission  Area. 
Antigen/  Pre-  12  months  post-  IS  months  post- 
mitogen  treatment  treatment  treatment 
Uninfected  Infected  Uninfected  Infected  Uninfected  Infected 
PHA  n  3  6  12  3  10  4 
mean  1470.6  1042.0  755.8  821.2  526.6  1547.0 
±  SD  1276.0  1017.0  623.6  947.5  265.7  1029.7 
median  1568.3  709.6  565.8  890.0  546.5  1703.0 
range  149-2694  204-2923  210-2481  108-  1896  115-896.7  272-2511 
WORM  n  3  6  12  3  10  4 
mean  115.7  243.5  191.6  388.4  277.5  283.0 
±  SD  32.7  122.0  145.3  291.0  258.6  250.1 
median  134.2  279.0  145.0  370.0  168.0  192.0 
range  78-  135  40-371.8  60-569  106-689  103-884  109-640.3 
EGG  n  3  6  12  3  10  4 
mean  151.1  323.0  252.7  283  200.5  265.4 
±  SD  36.0  211.0  329.3  230.0  126.1  176.0 
median  169.0  339.0  170.4  270.0  172.0  208.0 
range  . 
110-174.2  90-600  70-1275.2  60-519  107-509.0  121.5-522 
Table  6.10:  Values  of  H-,  -10  determined  from  the  individuals  from  the  Low 
Transmission  Area. 
Antigen/  Pre-  12  months  post-  18  months  post- 
mitogen  treatment  treatment  treatment 
Uninfected  Infected  Uninfected  Infected  Uninfected  Infected 
PHA  n  3  5  9  2  9  4 
mean  124.2  47.0  127.2  74.5  115.4  129.3 
±  SD  19.4  25.0  56.0  6.4  39.8  39.4 
median  118.0  41.0  127.0  74.5  113.0  118.0 
range  109-146.0  16-84  40-209  70-79  51-182.0  99-  183.0 
WORM  n  3  5  9  2  9  4 
mean  68.0  17.6  80.4  9.0  59.6  50.0 
±  SD  32.7  17.0  63.1  1.4  27.8  32.0 
median  80.0  10.0  101.0  9.0  60.0  49.0 
range  31-93  9-48  13-200  8.0-10.0  23-90  18-84.0 
EGG  n  3  5  9  2  9  4 
mean  154.0  18.0  121.8  7.5  76.7  42.5 
±  SD  44.7  9.4  71.3  0.7  42.8  27.9 
median  149.0  18.0  116.0  7.5  60.0  41.0 
range  1  112-201  1  9-32  23-245.0  1  7.0-8.0  40-170  1  17-70 
222 Table  6.11:  Values  of  IFN-y  determined  from  the  individuals  from  the  I-ligh 
Transmission  Area. 
Antigen/  Pre-  12  months  post-  18  months  post- 
mitogen  treatment  treatment  treatment 
Uninfected.  Infected  Uninfected  Infected  Uninfected  Infected 
PHA  n  5  8  5  7  6  7 
mean  1565.6  4019.0  1111.0  4419  534.1  1935.7 
±  SD  673.0  2124.0  554.0  1779.0  379.5  1581.0 
median  1613.0  4068.0  889.0  4864,0  335.5  2300.7 
range  917-2563  500-7169  630-2033  1907-7240  227-1127  265-4163 
WORM  n  5  8  5  7  6  7 
mean  641.2  3779.9  452.0  3190.0  165.7  1119.4 
±  SD  137.0  1749.0  356.0  2173.0  127.6  828.3 
median  611.0  3836.0  279.0  2010.0  124.0  1070.0 
range  470-819  1276-6992  118-942  1229-7000  40-407  200-2157 
EGG  n  5  8  5  7  6  7 
mean  403.0  3662.0  354.0  2877.0  173.1  1418.4 
±  SD  69.0  2312.0  267.0  2386.0  61.7  1133.9 
median  421.0  3201.0  319.0  1640.0  160.4  1102.0 
range  290-470  1347-8648  98-770  1240-7780 
, 
112-249  125-2860 
Table  6.12:  Values  of  IL-4  determined  from  the  individuals  from  the  High 
Transmission  Area. 
Antigen/  Pre-  12  months  post-  18  months  post- 
mitogen  treatment  treatment  treatment 
Uninfected  Infected  Uninfected  Infected  Uninfected  Infected 
PHA  n  4  8  3  4  2  5 
mean  460.0  1871.0  1499.0  418.0  7711.0  1521.2 
±  SD  362.0  1688.0  560.0  324.0  2179.0  2034.3 
median  361.0  1109.0  1254.0  365.0  7711.0  848.0 
range  141-979  936-5936  1104-2140  89-853  6170-9252  31-5070 
WORM  n  4  8  3  4  2  5 
mean  269.0  1414.0  1536.0  258.0  2803.0  1116.0 
±  SD  216.0  1054.0  558.0  120.0  1862.9  1291.2 
median  229.0  992.0  1380.0  261.0  2803.0  772.0 
ranze  79-541  490-3527  1073-2155  110-399  1486-4120  12-3294.0 
EGG  n  4  8  3  4  2  5 
mean  359.0  1226.0  2156.0  188.0  2326.3  1452.7 
±  SD  292.0  829.0  892.0  107.0  1108.4  1990.2 
median  317.0  931.0  1895.0  178.0  2326.0  760.0 
range  , 
63-738  820-3267 
,  1423-3150  ,  69-328  1543-3110  ,  10-4923.5 
223 Table  6.13:  Values  of  IL,  5  determined  from  the  individuals  from  the  ffigh 
Transmission  Area. 
Antigen/  Pre-  12  months  post-  18  months  post- 
mitogen  treatment  treatment  treatment 
Uninfected  Infected  Uninfected  Infected  Uninfected  Infected 
PHA  n.  4  9  6  5  5  8 
mean  1378.0  5262.0  4539.0  6641.0  3516.1  3391.5 
±SD  411.0  4031.0  2496.0  2783.0  2340.0  3454.0 
median  1424.0  4827.0  4235.0  6658.0  3265.1  2344.8 
range  908-  1758  1316-13370  1654-8700  2115-9134  598-7797.0  208-9645.0 
WORM  n  4  9  6  5  5  8 
mean  987.0  5194.0  3612.0  2874.0  2614.4  1979.2 
±  SD  283.0  2684.0  3255.0  2505.0  2264.1  2393.5 
median  926.0  4613.0  2111.0  1205.0  2104.0  869.3 
range  732-1366  1134-10060  1152-9820  780-5840  120-6066  129-6241 
EGG  n  4  9  6  5  5  8 
mean  1096.0  4494.0  3757.0  1540.0  2416.6  1470.9 
±SD  291.0  2787.0  2075.0  861.0  1816.6  1531.8 
median  1093.0  4329.0  3319.0  1158.0  2460.0  853.6 
range  800-1399  1299-10160  1626-6882  670-2572  370-5217  270-4539 
Table  6.14:  Values  of  IL-  10  determined  from  the  individuals  from  the  High 
Transmission  Area. 
Antigen/  Pre-  12  months  post-  18  months  post- 
mitogen  treatment  treatment  treatment 
Uninfected  Infected  Uninfected  Infected  Uninfected  Infected 
PHA  n  4  9  6  5  5  8 
mean  1030.0  2387.0  1495.0  1503.0  1607.8  544.3 
±SD  110.0  1740.0  1027.0  1183.0  1040.0  537.6 
median  996.0  1724.0  919.0  1106.0  990.0  290.0 
range  941-1189  841-5583  755-3109  330-3409  801-3012  74-  1515 
WORM  n  4  9  6  5  5  8 
mean  861.0  1558.0  1099.0  698.0  744.2  484.8 
±  SD  119.0  1348.0  511.0  476.0  294.9  535.7 
median  906.0  870.0  875.0  661.0  690.0  189.0 
range  689-944  ,  211-3933  740-2110  201-  1340  416-1210  30-  1395.0 
EGG  n  4  9  6  5  5  8 
mean  727.6  2466.0  879.0  564.0  618.6  483.3 
±  SD  211.0  2218.0  361.0  208.0  245.6  583.1 
median  828.0  1110.0  745.0  678.0  740.0  219.5 
range 
. 
411-844  420-6098  560-1498 
. 
310-741  244-840.0 
, 
56-1705.0 
224 Table  6.15:  Value  of  cytokine  levels  according  to  response  categories  determined 
from  the  individuals  from  the  Low  Transmission  area  before  treatment. 
Antigen/  WORM  EGG 
mitogen 
low  mod/high  low  mod/high  low  mod/high 
IFN-y  n  1  7  3  5  2  6 
mean  552.0  780.0  86.3  169.8  91.0  169.0 
±  SD  -  801.0  35.0  72.0  28.0  109.0 
median  552.0  687.0  103.0  170.0  90.0  151.0 
range  -  129-2444.0  46-110.0  105-284.0  70-111.0  27-359.0 
IL-4  n  1  6  3  4  2  5 
mean  71.0  69.9  53.0  46.5  24.0  46.0 
±  SD  -  35.0  9.5  21.0  11.0  28.0 
median  71.0  69.0  54.0  48.0  24.0  36.0 
range  -  19-128.0  43-62.0  20-69.0  16-32.0  14-80.0 
IL-5  n  1  7  3  5  2  6 
mean  156.8  1098.0  116.0  228.0  140.0  252.0 
±  SD  -  1193.0  32.7  129.0  41.0  166.0 
median  156.8  640.0  134.0  240.0  139.0  206.0 
range  -  149-2923.0  78-  135.0  40-372.0  110-  90-470.0 
1  169.0 
IL-10  n  1  6  3  4  2  5 
mean  108.7  76.3  68.0  20.0  131.0  57.0 
±  SD  -  49.0  32.7  19.0  26.0  81,0 
median  108.7  71.0  80.0  11.0  130.0  21.0 
range  -  16-146.0  31-93.0  9-48.0  112-  10-201.0 
1  1  1  11  149.0 
Table  6.16:  Value  of  cytokine  levels  according  to  response  categories  determined 
from  the  individuals  from  the  Low  Transmission  area  after  treatment. 
Antigen/  PHA  WORM  EGG 
mitogen 
low  mod/high  low  mod/high  low  mod/high 
IFN-y  n  6  19  10  15  9  17 
mean  393.3  876.0  101.0  87.0  60.0  82.0 
±  SD  213.0  1168.0  60.0  70.0  38.0  72.0 
median  380.0  436.0  87.0  41.0  53.0  78.0 
range  163-613.0  170-5377.0  27-190.0  10-214.0  9-110.0  14-270.0 
IL-4  n  4  10  5  9  4  10 
mean  111.0  127.0  84.0  71.0  102.0  69.0 
±  SD  87.0  61.0  62.0  49.0  118.0  45.0 
median  98.0  137.0  85.0  90.0  68.0  70.0 
range  27-220.0  42-204.0  16-161.0  Io-  136.0  10-262.0  14-126.0 
IL-5  n  5  19  10  14  8  16 
mean  1051.0  793.0  315.0  203.0  201.0  215.0 
±  SD  830.0  686.0  285.0  164.0  144.0  130.0 
median  808.0  530.0  165.0  118.0  133.0  190.0 
range  310-2481.0  107-2511.0  79-884.0  60-689.0  100-509.0  60-522.0 
IL-10  n  4  16  10  10  8  12 
mean  136.0  112.0  68.0  46.0  109.0  47.0 
±  SD  35.0  41.0  33.0  35.0  65.0  32.0 
median  128.0  113.0  93.0  35.0  107.0  50.0 
range  102-186.0  51-183.0  17-110.0  8-116.0  42-221.0  , 
7-110.0 
225 Table  6.17:  Value  of  cytokine  ratios  according  to  response  categories  determined 
from  the  individuals  from  the  Low  Transmission  area  before  treatment. 
Antigen/  PHA  WORM  EGG 
mitogen 
low  mod/high  low  mod/high  low  mod/high 
IL-4:  IFN-y 
n  1  6  3  4  2  5 
mean  0.13  0.23  0.68  0.32  0.24  0.44 
SD  -  0.16  0.23  0.22  0.04  0.37 
median  0.13  0.23  0.60  0.22  0.26  0.48 
range  -  0.07-0.43  0.40-0.93  0.10-0.66  0.20-0.29  0.07-1.00 
IL-5:  IFN-y 
n  1  7  3  5  2  6 
mean  2.84  3.37  1.65  1.36  1.55  2.40 
±  SD  -  5.10  1.14  0.76  0.03  2.31 
median  2.84  1.16  1.31  1.31  1.55  1.81 
range  -  0.08-14.43  0.7-2.92  0.30-2.29  1.54-1.57  0.45-6.45 
IL-  10:  IFNy 
n  1  6  3  4  2  5 
mean  0.20  0.32  1.00  0.10  1.57  1.57 
±  SD  -  0.41  0.70  0.05  0.79  3.28 
median  0.20  0.09  0.90  0.10  1.57  0.11 
range  -  0.02-0.91  0.20-1.74  0.05-0.17  1.01-2.13  0.07-7.44 
Table  6.18:  Value  of  cytokine  ratios  according  to  response  categories  determined 
from  the  individuals  from  the  Low  Transmission  area  afler  treatment. 
Antigen/  PHA  WORM  EGG 
mitogen 
low  mod/high  low  mod/high  low  mod/high 
IL-4:  IFN-y 
n  4  10  5  9  4  10 
mean  0.43  0.21  1.11  1.88  3.42  1.90 
±  SD  0.61  0.17  1.21  2.50  5.25  2.50 
median  0.17  0.20  0.45  0.56  1.20  0.75 
Tange  0.04-1.34  0.07-0.48  0.16-2.84  0.07-6.80  0.10-11.15  0.07-6.97 
IL-5:  IFN-y 
n  5  19  10  14  8  16 
mean  2.78  1.33  4.61  4.65  4.95  5.02 
±  SD  2.01  0.77  5.60  6.35  4.03  4.17 
median  1.35  1.28  2.50  3.22  3.02  4.28 
Tange  1.29-5.27  0.007-2.95  0.55-19.64  0.54-25.7  0.90-12.20  0.20-14.50 
IL-10:  IFNy 
n  4  16  10  10  8  12 
mean  0.44  0.21  0.81  1.42  2.49  1.40 
±  SD  0.47  0.15  0.45  1.98  1.85  1.54 
median  0.23  0.16  0.67  0.27  1.69  0.74 
range  0.16-1.14 
. 
0.02-0.57 
, 
0.19-1.67  0.04-5.80  0.70-5.64  0.02-4.34 
226 Table  6.19:  Value  of  cytokine  levels  according  to  response  categories  determined 
from  the  individuals  from  the  Ifigh  Transmission  area  before  treatment. 
Antigen/  PHA  WORM  EGG 
mitogen 
low  mod/high  low  mod/high  low  mod/high 
IFN-y  n  4  8  8  4  8  4 
mean  4036.0  2859.0  3449.0  1321.0  3325.0  1067.0 
±  SD  241LO  1926.0  2106.0  1202.0  2576.0  1396.0 
median  4979.0  2491.0  3836.0  776.0  2679.0  408.0 
range  500-5684.0  917-7169.0  470-6992.0  611-3120.0  470-8648  290-3160 
IL-4  n  4  7  8  3  7  4 
mean  1446.0  1518.0  1144.0  964.0  1269.0  486.0 
±  SD  524.0  1988.0  1088.0  1124.0  885.0  414.0 
median  1474.0  1030.0  802.0  541.0  934.0  475.0 
range  936-1900.0  141-5936.0  79-3527.0  112-2239.0  820-3267  63-929.0 
IL-5  n  4  8  9  3  8  4 
mean  6539.0  3129.0  4940.0  1623.0  4792.0  1302.0 
±  SD  1983.0  4197.0  2996.0  1289.0  2821.0  598.0 
median  6334.0  1618.0  4613.0  1037.0  4412.0  1150,0 
range  4827.  -.  8659  907-13370  815-  10060  732-3101  1299-10160  800-2110 
IL-10  n  4  8  9  3  8  4 
mean  2557.0  1805.0  1565.0  897.0  2690.0  685.0 
±  SD  1722.0  1595.0  1343.0  75.0  2259.0  197.0 
median  2573.0  1102.0  876.0  937.0  2368.0  743.0 
range 
. 
1008-4073  841-5583.0  211-3933  810-944.0  420-6098  4511-844 
Table  6.20:  Value  of  cytokine  levels  according  to  response  categories  determined 
from  the  individuals  from  the  Rgh  Transmission  area  after  treatment. 
Antigen/  PHA  WORM  EGG 
mitogen 
low  mod/  ih  low  modAiigh  low  mod/high 
IFN-y  n  4  15  12  12  12  12 
mean  1034.0  2007.0  922.0  1555.0  482.0  2004.0 
±  SD  1142.0  1611.0  1198.0  1638.0  728.0  2259.0 
median  590.0  1902.0  315.0  1070.0  212.0  1241.0 
range  . 
265-2690.0  227-5416.0  109-4020.0  118-4860.0  98-2240.0  112-7780 
IL-4  n  3  9  6  5  4  7 
mean  5242.0  1624.0  1251.0  1078.0  1556.0  1098.0 
±  SD  5670.0  2313.0  1506.0  1308.0  1147.0  1758.0 
median  5242.0  444.0  751.0  772.0  1371.0  328.0 
range  1232-9252  31-6170  110-4120  12-3294  370-3110  10-4924 
IL-5  n  5  14  12  7  9  10 
mean  3881.0  3810.0  2059.0  2580.0  2070.0  1817.0 
±  SD  1992.0  3320.0  1963.0  2251.0  1492.0  1534.0 
median  3375.0  3267.0  1632.0  1894.0  1626.0  1152.0 
range  2115-7136.0  208-9645.0  120-6066.0  214-6241.0  280-5217  270-4539 
IL-10  n  4  15  13  6  9  10 
mean  1414.0  874.0  615.0  848.0  509.0  652.0 
±  SD  1207.0  612.0  412.0  452.0  335.0  449.0 
median  1253.0  868.0  661.0  933.0  499.0  645.0 
range  138  -  3012.0  ,  74-2430.0  ,  30-1340.0  40-  1395.0 
, 
56-916.0  70-1705.0 
227 Table  6.21:  Value  of  cytokine  ratios  according  to  response  categories  determined 
from  the  individuals  from  the  High  Transmission  area  before  treatment. 
Antigen/  PHA  WORM  EGG 
mitogen 
low  mod/high  low 
_mod/high 
low  mod/high 
IL-4:  IFN-y 
n  3  6  6  3  5  4 
mean  0.87  0.55  0.27  0.55  0.55  0.70 
±  SD  1.07  0.56  0.14  0.31  0.59  0.71 
median  0.35  0.43  0.23  0.72  0.28  0.42 
ranRe  0.10-2.1  0.07-1.63  0.10-0.50  0.10-0.74  0.10-1.55  0.20-1.75 
IL-5:  IFN-y 
n  3  7  7  3  6  4 
mean  3.98  0.59  1.33  1.23  1.11  2.30 
±  SD  4.90  0.20  0.54  0.40  0.61  1.29 
median  1.43  0.56  1.19  1.00  1.02  2.50 
range  0.80-9.65  0.20-0.91  0.50-1.94  0.90-1.70  0.20-2.04  0.60-3.54 
IL-10:  IFNy 
n  3  7  7  3  6  4 
mean  1.05  0.48  0.55  1.03  0.44  1.43 
±  SD  1.07  0.21  0.61  0.67  0.26  0.86 
median  0.71  0.47  0.22  1.29  0.42  1.68 
range  0.10-2.25  0.10-0.78  0.10-1.86  0.20-1.53  0.10-0.77  0.20-2.14 
Table  6.22:  Value  of  cytokine  ratios  according  to  response  categories  determined 
from  the  individuals  from  the  Mgh  transmission  area  after  treatment. 
Antigen/  PHA  WORM  EGG 
mitogen 
low  mod/high  low  mod/high  low  mod/high 
IL-4:  IFN-,  y 
n  2  9  6  5  4  7 
mean  18.51  4.14  6.93  3.75  7.89  2.44 
±  SD  19.60  7.5  12.4  7.14  5.17  4.76 
median  18.51  0.37  2.16  0.72  9.07  0.09 
range  4.6-32.4  0.01-18.57  0.07-31.94  0.006-16.47  0.60-12.80  0.003-12.89 
IL-5:  IFN-y 
n  4  14  11  7  8  10 
mean  10.08  6.19  9.31  8.0  13.0  4.42 
±  SD  11.6  10.6  13.66  11.6  9.73  6.14 
median  6.34  2.12  7.31  3.0  13.23  0.81 
range  0.70-26.9  0.05-35.33 
. 
05-47.02  0.10-31.21  0.10-23.96  0.09-17.17 
IL-10:  IFNy 
n  3  15  12  6  8  10 
mean  5.78  1.3  2.87  2.77  3.72  1.78 
±  SD  4.72  1.93  2.97  3.45  3.27  2.35 
median  5.7  0.47  2.07  1.0  2.73  0.57 
range  1.1-10.54 
, 
0.02-6.39 
, 
0.06-9.38  0.02-7.42  0.05-8.28  0.02-6.61 
228 Table  6.23:  Cytokine  levels  of  all  the  antigen  derived  clones  according  to  the 
antigen  and  subject. 
Subject/antigen  IFN-y  HA  IL-5  IL-4:  IFN-y  IL-5:  IFN-y 
309worm  n  19  19  19  19  19 
mean  229.4  670.7  3394.0  4.3  45.9 
±  SD  (373.7)  2176  5925  12.6  122.5 
median  61.0  18.0  495.6  0.4  12.2 
range  0.4-1404  1.7-9483  69-  17920  0.03-55  0.7-527 
309egg  n  14  14  14  14  14 
mean  640.6  789.4  4650.3  3.1  36.1 
±  SD  897.3  1824.0  6077.8  9.4  64.5 
median  183.3  160.3  2415.0  0.4  12.5 
range  13-2984  0.2-6669  8.6-  18180  0.004-36  0.05  - 
2AA 
309PPD  n  15  15  15  15  15 
mean  2098.9  608.9  3153.2  0.1  3.5 
±  SD  3540.0  1998.5  5872.0  0.2  2.7 
median  286.9  24.7  447.0  0.1  3.6 
range  57-11600  0.5-7777  277-17630  0.001-0.7  0.07-8.4 
350worm  n  68  68  49  67  48 
mean  1391.1  662.3  2590.1  2.5  11.9 
±  SD  1430.7  978.0  3154.2  6.8  23.8 
median  812.3  438.5  1289.0  0.4  1.3 
range  24-5406  13-7118  9-12630  0.02-40.8  0.004  -  112.5 
350egg  n  12  12  12  12  12 
mean  1137.3  1537.0  230.0  17.9  3.6 
±  SD  1562.3  1336.7  158.1  45.6  11.0 
median  433.8  1387.0  190.0  1.5  0.3 
range  13-5244  54-4363  39-501  0.02-161  0.03  -  112.5 
350PPD  n  9  9  9  9  9 
mean  2061.9  1673.3  184.0  1.0  0.2 
±  SD  1146.6  975.9  120.9  0.7  0.2 
median  1996.0  1791.0  155.0  0.9  0.1 
range  , 
409-3735 
, 
359-3647 
. 
6-455  0.2-2.7  0.003-0.6 
229 Table  6.24:  Cytokine  levels  of  all  the  antigen  derived  clones  according  to  the 
antigen  and  subject. 
Subject/antigen  IFN-y  ]IL-4  IL-5  IL-4:  IFN-y  IL-5:  IFN-y 
329worm  n  43  43  39  43  39 
mean  3664.9  1193.0  2423.4  1.2  1.6 
±  SD  4952.4  1829.5  3920.4  3.0  2.4 
median  2702.5  754.0  996.0  0.3  0.6 
range  98-30560  10-9434  51-  15680  0.002-16.6  0.007-7.8 
329egg  n  21  21  18  21  18 
mean  515.3  750.2  3348.3  3.5  18.1 
±  SD  346.2  843.7  4566.2  6.3  40.0 
median  542.0  326.0  2108.0  0.7  4.9 
range  34-1017  31-2627  2-19040  0.1-27.1  0.003-173 
329PPD  n  13  13  20  13  13 
mean  1917.9  1772.5  4667.9  1.2  3.0 
±  SD  2190.7  2543.5  15670.0  1.3  5.7 
median  1255.0  694.0  159.0  1.0  0.4 
range  331-8572  30-9139  20-70440  0.02-4.2  0.003-18.5 
311worm  n  16  17  22  16  16 
mean  89.7  1244.2  31970.0  8.4  1347.4 
±  SD  193.4  2503.5  98820  19.2  3503.9 
median  25.7  36.4  788.9  2.2  60.4 
range  0.2-774  0.3-8561  26-42290  0.02-78  0.4-11850 
31legg  n  36  37  41  36  36 
mean  667.9  536.4  6183.5  3.6  82.3 
±  SD  1922.0  1125.0  12350.0  4.8  241.9 
median  68.9  65.0  644.8  1.2  19.7 
ranze  1.3-  11130  12-4868.9  13.4-43990  0.4-  19.3  0.2-1454.7 
31  IPPD  n  8  8  8  8  8 
mean  281.1  2666.3  13010.0  13.1  60.5 
±  SD  337.5  4552.3  18180.0  24.6  93.3 
median  220.0  28.0  1052.5  0.4  6,8 
range  . 
27-1065  9.4-10490  100-40300  0.009-68  0.7-260 
230 Table  6.25:  Cytokine  levels  (mean,  ±  SD  and  median)  of  all  the  antigen  specific 
clones  according  to  the  antigen  used  initially  to  derive  thern. 
Subject/antigen  IFN-y  IL-4  IL-5  IL-4:  IFN-y  IL-5:  IFN-7 
309worm  n  2  2  2  2  2 
mean  721.8  4747  9140.3  2.5  8.6 
±  SD  768.0  264.3  10110.0  3.7  4.3 
median  109.4  38.9  451.6  0.4  9.0 
range  40-1404  11.5-94824  360-17920  0.3-6.8  9-12.8 
309egg  n  3  3  3  3  3 
mean  714.7  946.8  7077  0.2  3.0 
±  SD  695.5  146.8  2215.7  0.3  4.1 
median  1035.2  109.8  1636.1  15.0  4327.3 
range  73-  1527  6-2620.8  69-17960  0.004-37  0.05-244 
350worm  n  18  is  18  18  18 
mean  1043.6  821.6  2450.9  1.7  5.9 
±  SD  939.1  1603.5  3384.7  2.9  8.2 
median  672.5  509.0  1025.0  o.  6  1.2 
range  145-2960  37-7118  351-  12630  0.1-10.7  0.3-22 
350egg  n  1  1  1  1  1 
mean  219.5  205.0  39.0  0.9  0.2 
±  SD 
median  219.5  205.0  39.0  0.9  0.2 
range 
329worm  n  11  11  11  11  11 
mean  6343.2  374.9  2257.0  0.4  1.3 
±  SD  8400.0  338.5  3739.0  0.9  2.3 
median  3509.0  276.0  1163.0  0.1  0.5 
range  98-30560  10-994  218-  13330  0.002-3.1  0.007-7.8 
329egg  n  2  2  2  2  2 
mean  877.8  218.5  2729.0  0.3  2.7 
±  SD  197.0  152.0  3856.6  0.2  3.8 
median  977.8  218.5  2729.0  0.3  2.7 
range  739-  1017  111-326  2-5456  0.1-0.4  0.003-5.4 
311worm  n  4  4  4  4  4 
mean  88.0  1981.0  61950.0  28.6  5142.3 
±  SD  123.5  2542.5  10480.0  33.4  5975.3 
median  40.7  1178.9  13090.0  15.1  4327.3 
range  0.2-270.1  2.2-5563.9  2725-218900  6.4-77.9  68.5-  11850 
31legg  n  7  7  7  7  7 
mean  170.2  1104.4  15770.0  9.3  28S.  9 
±  SD  249.3  1255.4  16830.0  6.3  521.0 
median  62.7  809.3  6972.8  7.7  111.2 
range  10-707  36-3415  53-38580  3.1-  19.3  3.2-  1455 
231 Table  6.26:  Concentration  of  reagents  used  for  the  determination  of  specific 
immunoglobulin  against  S.  haematobium  soluble  egg  antigen  (SEA) 
Antibody  SEA 
concentration 
Serum  dilution  Conjugate 
dilution 
Substrate 
incubation 
Total  IgA  10  ug/mI  1:  100  1:  2000  20  minutes 
IgE  10  ug/ml  1:  10  1:  2000  30  minutes 
19M  10  ug/ml  1:  200  1:  2000  20  minutes 
IgGI  IOU  1:  10  1:  2000  3  hours 
IgG2  10  ug/mI  1:  10  1:  2000  3  hours 
IgG3  10  ug/rd  1:  10  1:  2000  20  minutes 
IgG4  10  ug/ml  1  :  100  1:  2000  20  minutes 
Table  6.27:  Concentration  of  reagents  used  for  the  determination  of  specific 
immunoglobulin  against  S.  haematobium  whole  worm  antigen  (WVM) 
Antibody  W" 
concentration 
Serum  dilution  Conjugate 
dilution 
Substrate 
incubation 
Total  IgA  5  ug/mI  I:  100  1:  2000  20  minutes 
IgE  5  UA/ml  1:  10  1:  2000  30  minutes 
Igm  5  ug/mI  1:  200  1:  2000  20  minutes 
IgGI  5  ug/ml  1:  10  1:  2000  3  hours 
IgG2  5  ug/ml  1:  10  1:  2000  3  hours 
IgG3  5  ug/mI  1:  10  1:  2000  20  minutes 
IgG4  5  ug/Ml  1:  100  1:  2000  20  minutes 
232 REAGENTS  PREPARATION  FOR  ELISAs 
1.  Carbonate/Bicarbonate  coating  buffer  pH  9.6: 
Solution  A:  (Carbonate): 
K2C03  3.45  g  dissolve  in  I  litre 
or 
Na2CO3  1.5  5g  dissolve  in  5  00  ml 
Solution  B:  (Bicarbonate): 
KHC03  2.5  g  dissolve  in  1  litre 
or 
NaHC03  1.05  g  dissolve  in  500  ml 
Adjust  to  coffect  pH  by  adding  solution  A  to  solution  B 
2.  Phosphate  Buffered  Saline  (PBS)  xIO:  pH  7.4 
NaCL  80g 
KH2P04  2g 
Na2]HP04,2H20  29  g 
KCL  2g 
H20  I  LITRE 
For  cytokine  ELISAs  PBS  Ix  +  Tween  20  (0.5  ml/1) 
3.  Phosphate/citrate  buffer  pH  5.0 
Na2BP04  7.19  g 
Citric  acid  5.19  g 
H20  I  litre 
4.  Substrate  stock: 
Ortho-phenyl  diamine  (OPD)  100  mg 
Methanol  10  ml 
This  is  kept  at  4'C 
5.  IIRP  substrate: 
Phosphate/citrate  buffer  100  mi 
Stock  OPD  1.0  MI. 
H202  10  ut 
The  H202  should  be  added  last  immediately  before  use 
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